The intersection between science and policy: the case of the development of Belgian drug policy between 1996-2003 by Tieberghien, Julie
  
 
 
The intersection between science and policy: 
The case of the development of Belgian drug policy between 1996 and 2003 
 
By 
Julie Tieberghien 
 
 
Thesis submitted to obtain the academic degree Doctor (Ph.D) in Criminology 
 
 
 
Supervisor:       Prof. dr. Tom Decorte 
Doctoral Guidance Committee:    Prof. dr. Brice De Ruyver 
        Prof. dr. Carl Devos 
        Prof. dr. Guido Van Hal 
 
 
Department Criminology, Penal Law and Social Law 
Ghent University, Belgium 
 
Academic year 2014-2015 
 
 
 
i 
ACKNOWLEDGEMENTS 
 
This thesis is the end of both a tough and enjoyable journey that started in 2007. As a young 
researcher developing a local drug monitoring system in the city of Antwerp, I did not know that 
the ‘science-policy nexus’ would become my main interest and object of my PhD-study. However, 
in the two years that followed, I became more and more interested in this particular research 
topic and, in 2009, my PhD journey eventually took a start. I know I could not have achieved this 
work alone. 
 
First of all, I would like to thank the interviewees that have participated in this study. I 
appreciate your constructive collaboration and openness even though I know that some things 
were difficult to remember and busy agendas were definitely at stake. For reasons of 
confidentiality I am unable to identify these experts by name but I am, nevertheless, grateful for 
their participation. 
 
I also gratefully acknowledge the funding received from the Ghent University as part of their 
doctoral research program. As an academic assistant and PhD-candidate, I am grateful to the 
Ghent University for allowing such a study to be undertaken. 
 
Special gratitude goes to my supervisor, Prof. Dr. Tom Decorte, for initially providing me with 
the opportunity to work on the research project in the city of Antwerp. You patiently provided 
the encouragement and advice necessary for me to complete my dissertation and have always 
given me great freedom to pursue independent work. Tom, thank you for your trust and support 
as well as for your understanding in my search for a balance between research ambitions and 
personal pursuits.  
 
My appreciation also goes out to the members of the guidance committee, Prof. Dr. Brice De 
Ruyver, Prof. Dr. Carl Devos and Prof. Dr. Guido Van Hal, for critically reading parts of my 
dissertation and contributing constructive reflections and useful suggestions.  
 
I would also like to thank Lucy for proofreading my manuscript. Her criticism and suggestions 
definitely provided a 'finishing touch'. 
 
This PhD study would also not have been possible without the support of former and present 
colleagues who crossed my path at the university and especially at the Institute for Social Drug 
research (ISD). I am particularly grateful to Liz, Charlotte, Marieke, Julie, Eline, Mafalda and Lotte 
ii 
for encouraging me and for providing a very enjoyable working atmosphere. My gratitude goes 
out to my ‘office neighbour’ Olga as well for showing interest and providing moral support. I also 
want to thank the members of the departments’ secretariat who have been helpful throughout.  
 
I am indebted to my friends who have personally supported me over the last few years. I 
particularly want to thank Charlotte, Steven, Celine and Ann. It was sometimes difficult to 
explain what I was ‘doing’ but you all kept me optimistic about my work when I needed your 
support the most.  
 
I would also like to say a heartfelt thank you to my mother, father and sister for always believing 
in me and encouraging me endlessly when I did not seem to have the courage. Your genuine 
interest in the things I was studying as well as the encouragement I received from my family-in-
law have been very important to me.  
 
A very special thank you to my husband Bruno who has always been by my side throughout this 
journey, experiencing every single minute of it. Your questions and critical notes about my 
research always kept the helpful outsider’s viewpoint in front of me when I got lost in ‘my world’ 
once again. Thanks for being so supportive of my work and for keeping a sense of humour when 
I had lost mine. Last but not least, life doesn’t stand still, nor waits until you are finished with 
your PhD. Lovely Mette, your enthusiasm and broad smiles definitely brought me a lot of 
inspiration, happiness and joy in the final stages of my PhD. 
 
 
Julie Tieberghien, 
Waregem, 25 April 2015 
 
iii 
ABSTRACT 
 
[English] 
Since the late 20th century, evidence-based policy has become the benchmark by which policies 
are judged. However, the assumption that policy should reflect accurate factual knowledge 
rather than political biases has no basis in reality. In heavily politicised domains, rational, 
instrumental frameworks are devalued in favour of those focusing on political/symbolic ways of 
knowledge utilisation, power relationships and interactions between various players in the 
policy-making process. Against such a background, criminologists also became concerned with 
their own commitments to the policy-making process: the idea of public criminology has 
gathered momentum in a number of fields. 
 
This dissertation wishes to contribute to the (theoretical) debate on knowledge utilisation and 
public criminology and aims to provide a critical analysis of the evidence-based thinking by 
detailing the modalities of knowledge utilisation (theoretically guided by Weiss’ three-folded 
typology) in both policy processes (Parliament and Government), the role of the media and 
interest groups in the science-policy nexus and the ways scientists manage the relationship 
between their academic activities and policy-making (public criminology). Using a case study of 
the development of Belgian drug policy between 1996 and 2003, a qualitative methodological 
approach has been selected: a (critical) discourse analysis of specially selected newspaper 
articles and policy documents and interviews with 55 key informants. 
 
The ideal of evidence-based policy clearly faces significant challenges: the relationship between 
science and policy is neither rational nor exclusive. Through scientists performing public roles as 
observer-turned player or policy advisor, scientific knowledge informs policy (conceptual use) 
rather than constituting a rational foundation for policy-makers. Examples of political/symbolic 
use can also be found: policy-makers readily distorted scientific arguments which were 
detrimental to the chosen policy direction. Scientific knowledge has been just one element in the 
policy-making process characterised by competing interests, electoral ambitions and 
international frameworks. Even scientific knowledge has its limitations: several instances of the 
misuse of science by scientists are observed. While interest groups are not as engaged in the 
science-policy nexus, media coverage appears to be a valuable instrument by means of which 
policy-makers may receive (and use) scientific knowledge. 
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[Dutch] 
Sinds het einde van de 20ste eeuw wordt beleid steevast getoetst aan de kernidee van het 
evidence-based denken. De assumptie dat wetenschappelijk onderzoek een invloed dient uit te 
oefenen op het uitstippelen van het beleid door beleidsmakers is aannemelijk, maar de relatie 
tussen onderzoek en beleid is in werkelijkheid niet zo rechtlijnig. In politiek en maatschappelijk 
geladen beleidsdomeinen wordt aangenomen dat politiek/symbolisch kennisgebruik, 
machtsrelaties en interacties tussen (beleids)actoren een belangrijke rol spelen. In dit verband 
ontwikkelde zich onlangs, onder de noemer ‘publieke criminologie’, een debat over de publieke 
rol van criminologen alsook over hoe de kloof tussen de ‘academische’ criminologie en het 
publieke en politieke discours kan worden overbrugd. 
 
Dit doctoraatsonderzoek wenst bij te dragen tot de (theoretische) debatten inzake 
kennisgebruik en publieke criminologie en beoogt een kritische analyse van het evidence-based 
denken aan de hand van een studie van de vormen van kennisgebruik (geïnspireerd door de 
theoretische modellen van Weiss) in beleidsprocessen (Parlement en Regering), de rol van de 
media en belangengroepen in deze relatie en de manier waarop wetenschappers hun publieke 
rol waarnemen en beoordelen (publieke criminologie). De casestudy inzake de ontwikkeling van 
het Belgische drugsbeleid tussen 1996 en 2003 hanteert een kwalitatief methodologisch opzet: 
een (kritische) discoursanalyse van beleidsdocumenten en krantenartikels en diepte-interviews 
met 55 relevante sleutelfiguren.  
 
Strijdig met de kernidee van het evidence-based denken, toont dit onderzoek aan dat de relatie 
tussen wetenschap en beleid rationeel noch exclusief is. Publieke rollen als observer-turned-
player of policy advisor hebben een belangrijke functie om het politieke bedrijf te informeren 
(conceptueel kennisgebruik). Ideaaltypisch en rationeel kennisgebruik is eerder beperkt in 
tegenstelling tot politiek-symbolisch gebruik: beleidsmakers selecteerden wetenschappelijke 
kennis om hun ('korte-termijn’) belangen te behartigen. Wetenschappelijke kennis vormt, naast 
o.a. conflicterende belangen, electorale ambities en het internationale kader, slechts één van de 
bronnen op grond waarvan beleidsmakers handelen. Ook wetenschappelijke kennis zelf kent 
beperkingen: enkele voorbeelden hebben het misbruik van wetenschappelijke kennis door 
wetenschappers aangetoond. Belangengroepen hebben eerder een beperkte invloed op de 
interactie tussen wetenschap en beleid terwijl de media een waardevol kanaal zijn waarlangs 
wetenschappelijke kennis ingang vindt bij beleidsmakers. 
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INTRODUCTION 
 
Background of the study 
Researchers often wonder what becomes of the results of their research. So did I. The idea for 
this dissertation came from drug research that I have been working on in recent years. I was 
involved in monitoring drug use trends at the local level for the city of Antwerp, which aimed to 
provide information for an evidence-based policy concerning prevention, harm reduction and 
treatment as well as to stimulate the (ongoing) dialogue between policy-makers and a broad 
range of stakeholders (Tieberghien and Decorte, 2009). Over the course of my involvement in 
this research, I presented findings to a broad range of stakeholders including police officers, 
treatment practitioners and local policy-makers, and I felt optimistic about inspiring some small 
policy changes. However, through informal conversations with some stakeholders and drug us-
ers, I had an increasing number of reservations about the potential impact of my research find-
ings on the local (drug) policy context. Generally, I started to wonder if and how scientific 
knowledge can play a role in the drug policy-making process or, in other words, how the science-
policy nexus in the drug policy field actually works. This dissertation is devoted to this particular 
issue.  
 
Since the late 20th century, evidence-based policy has become the benchmark by which policies 
are made and judged. It has been promoted as the ideal model of policy as it is distinct from poli-
cy where intuitive appeal, tradition and politics determine policy (O’Dwyer, 2004; Hughes, 
2007). In theory, demand for evidence-based policy (EBP) should be a matter of common 
sense: scientists produce evidence, which then takes priority over competing factors in the poli-
cy-making process. The EBP account assumes a linear, rational connection between science and 
policy, where policy-making is seen as an authoritative choice with scientists speaking truth to 
power (Wildavsky, 1979). Randomised Control Trial’s (RCT’s) and systematic reviews are con-
sidered as the most high-quality evidence in the evidence hierarchy as they indicate the effec-
tiveness of policy and programmes (what matters is what works). Some other forms of scientific 
knowledge as well as knowledge derived from practitioners’ experiences are perceived to be 
unsystematic and lacking rigour. The increasing focus on EBP has been advocated for by numer-
ous scientists, who have argued that policy should be based on high-quality scientific knowledge. 
International networks such as the Campbell Collaboration have been developed with this in 
mind (Berridge, 2002; Devroe, Deschamps and Hannes, 2008).  
 
Increasingly, however, critics have countered the notion of evidence-based policy-making. They 
have argued that the evidence-based movement obscures the dynamic nature of scientific 
Introduction 
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knowledge and, accordingly, reduces the debate on the science-policy nexus to rather zero-sum 
accounts: a policy is evidence-based or evidence-free (Hammersley, 2005; Monaghan, 2011; 
Bergin, 2013). Scholars have also argued that scientific knowledge as such is far more contested 
(e.g. yielding contradictory or sometimes unreliable findings) than is assumed by the positivist 
view generated by the evidence hierarchy (Lancaster, 2014). At the same time, scholars have 
emphasised that the evidence-based movement ignores the fact that policy-making is far more 
messy and interactive than is acknowledged and involves more actors than just those in the do-
mains of evidence and policy (Rich, 1997; Smith, 2013). Thus, some fundamental questions re-
main unanswered. How exactly does scientific knowledge contribute to the policy-making pro-
cess? How do policy-makers see the role of scientific knowledge? Which other types of infor-
mation compete with scientific knowledge in the policy-making process? What is the particular 
influence of other actors such as the media and interest groups? 
 
Unpicking and investigating these particular issues has concerned a number of scholars before 
and since the debate about evidence-based policy-making emerged. A considerable body of work 
(called knowledge utilisation literature) has accumulated within the political science domain, 
much of it in the 1970s and early 1980s. Theoretical frameworks of knowledge utilisation ex-
plored the questions of when, why and under what circumstances scientific knowledge influ-
ences the policy-making process. While the early paradigm of the two communities thesis offered 
a rather pessimistic view on the connection between two fundamentally different worlds sepa-
rated by a huge gap (Caplan, 1979), Carol Weiss, a prominent author in this field, identified sev-
eral modalities of use (instrumental, conceptual, political/symbolic) in her work regarding 
knowledge utilisation and policy-making (Weiss, 1979). Instead of instrumental utilisation, rep-
resenting an approach where scientific knowledge has a direct bearing on policy, scientific 
knowledge was more often found to be used conceptually (i.e. delayed and diffused use of infor-
mation in policy-making) and politically/symbolically (i.e. policy-makers using scientific 
knowledge in a selective way to delay actions, for example waiting for research results or con-
vincing sceptics about the value of a measure). Assuming that scientific knowledge can influence 
policy under particular circumstances and through different modalities, these knowledge utilisa-
tion models illustrated the complexity of the relationship between science and policy and were 
not supportive of the current evidence-based movement. The idea of rational, direct utilisation of 
scientific knowledge is assumed to be somewhat naïve and too idealistic. In addition to Weiss’ 
typology, the literature on knowledge utilisation contains many convincing accounts of why re-
search does not have a strong direct influence on policy, including those based on differences in 
goals, priorities, languages, time scales and career paths (Caplan, 1979; Landry, Amara and La-
mari, 2001; Burssens, 2007; Smith, 2010). Scientific knowledge appeared to be just one type of 
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information competing with other types of information as well as with political considerations 
(Weiss, 2001; Garland, 2001; Kingdon, 2002; Reimers and McGinn, 1997; Lindquist, 2001; Rich, 
2001; Muscat, 2008; Strydom, et al., 2010). As a result, several scholars have turned their back 
on the principle of evidence-based policy, in favour of a more nuanced account such as evidence-
informed or even evidence-aware policy (Young, et al., 2002; Dobrow, Goel and Upshur, 2004). 
 
Heavily politicised or mediatised policy areas were not typically part of the studies of evidence-
based policy-making. For a long time, attention on the science-policy nexus focused on the health 
sector (due to its emergence as evidence-based medicine) but more recently the focus has moved 
to other policy areas including criminal (juvenile) justice (Farrington, 2006; Farrington, et al., 
2006; Freiberg and Carson, 2010; McNeill, et al., 2012) or migration (Brans, et al., 2004; Bak 
Jørgensen, 2011). As the notion of evidence-based policy has become part of the common policy 
lexicon in the drug policy field, similar questions were being asked by scholars in the context of 
drug policy (Bourgeois 2000; Stevens and Rhodes, 2011; Stevens and Ritter 2013). The interest 
in studying the interaction between science and policy in the field of drugs emerged particularly 
in Australia, the UK and Canada (Erickson, 1998; Duke, 2001; Hall, 2004; Lenton, 2004; Lenton, 
2007; Hughes, 2007; Hall, 2008; Bickford and Kothari, 2008; Monaghan, 2009; Ritter, 2009; 
Hughes and Stevens, 2010; Macleod and Hickman, 2010). Except for two studies focusing on 
how drug policy-makers access scientific knowledge (Bickford and Kothari, 2008; Ritter, 2009), 
others analysed knowledge utilisation in one or more cases, like the development of a policy or a 
new policy measure (e.g. new legislation, the implementation of safe injecting rooms or treat-
ment of heroin dependence, and so on). Building on Weiss’ three-folded typology (Weiss, 1979), 
data was mainly gathered through interviewing key policy-makers and through analysing docu-
ments (policy debates, media reports, etc.). 
 
These international studies critically challenged the notion of evidence-based drug policy and 
showed that political/symbolic use of scientific knowledge (i.e. scientific knowledge is con-
sidered ammunition for political sides; it can be used to silence the arguments of the opposition 
or to support ideas which policy-makers have already adopted) appears highly prevalent in this 
policy area, characterised as it is by intense media scrutiny of policy-making and conflicts be-
tween competing interests. Accordingly, rational frameworks of policy-making (evidence-based 
policy-making) were devalued in favour of assumptions on the power relationships and interac-
tions/networks between various players in the policy-making process (evolutionary model – 
processual model; Stevens, 2007a; Monaghan, 2011). Scientific knowledge was understood to 
play a role in the interactive process of policy-making and not just in the outcome of policy for-
mulation (Johnson, et al., 2004; MacGregor, 2010). In a similar vein, in the drug policy field, dis-
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cussion arose over the definition of scientific knowledge. How policy-makers perceive scientific 
knowledge may itself be politically loaded (Monaghan, 2011; Stevens, 2011). Additionally, given 
the strong emotions and opinions surrounding the use of illicit drugs and the high media profile 
that drug use attracts, the media and interest groups (e.g. drug user organisations) were con-
sidered to be strong facilitators of the science-policy nexus. However, thus far, their particular 
roles in the science-policy nexus have rarely been studied. 
 
This dissertation follows these critical stances on evidence-based drug policy, arguing that the 
discourse ought to move beyond the linear, rational connection between science and policy and 
beyond the notion of science and policy as two distinct domains. The existing case studies are an 
interesting starting point for further (comparative) analysis (Nutley, Walter and Davies, 2007). 
Nevertheless, most knowledge utilisation literature in the drug policy field clearly originates 
from countries with a two-party system, and is thus not representative of the science-policy in-
teraction in a multi-party system as exists in Belgium (Babor, et al., 2010; Tonry, 2010). Thus, 
the question remains whether the development of Belgian drug policy is, just like in other inter-
national studies, actually informed by scientific knowledge and other factors such as political 
interests, institutional rules, personal experiences, newspapers, and so on. 
 
Criminological relevance of the study 
Criminology is a multidisciplinary field of study which often intersects with the field of political 
science. It has always found itself in close proximity to the state and its political needs: for in-
stance, criminologists have challenged official discourses and the exercise of power, or have 
been interested in the influence of media depictions of crimes and crime rates on policy-making 
(Walters, 2003; Garland, 2011; Bauwens, et al., 2013). Historically, however, the tradition within 
criminological research has been to concentrate on offenders, deviant populations and the pow-
erless, those who have been excluded or forced to the margins of the society (Becker, 1967; Fou-
cault, 1976). Except for critical social research, the focus has hardly been on those in positions of 
power in relation to the processes of policy-making and the science-policy nexus (Van 
Swaaningen, 2001; Duke, 2002; Young, 2011). Criminologists are usually not familiar with poli-
cy-making processes, and the world into which scientific knowledge must be integrated if we 
would like to influence policy-makers (Petersilia, 2008; Stevens, 2011). According to Rock 
(2010), “All too often, criminologists have not interrogated with any curiosity or diligence what 
takes place in the private sphere as policies are formed. They have not peered into the black box of 
the political process but have become observers after the event when policies are neatly packaged, 
discursively tidied up, agreed and coherent.” (p.758). It is imperative that criminologists at least 
be interested in what is done with scientific knowledge in the policy-making process (Chan, 
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2000; Wacquant, 2011). In other words, the science-policy nexus needs to be approached in a 
critical and reflexive manner, from within or exposed to profound observation by criminologists. 
 
Nowadays, there is growing criminological interest in understanding how and why policy takes 
the direction that it does (Jones and Newburn, 2007), especially in relation to the political and 
social relations of knowledge production (i.e. some type of knowledge may systematically be 
neutralised or marginalised by social controls/powers: deviant knowledge) (Walters, 2003; Al-
len, 2007). With the rise of the evidence-based policy framework, criminologists have become 
increasingly concerned with the nature of their own commitment to the policy-making process 
(Van Swaaningen, 2009). For instance, the idea of public criminology, an articulation of the idea 
that criminology’s purpose is to contribute to a ‘better’ politics of crime and its regulation, has 
gathered momentum in a number of fields (Wacquant, 2011; Loader and Sparks, 2011). In par-
ticular, public criminology is a distinct approach that criminologists may or may not choose to 
adopt (Loader and Sparks, 2011). The notion that research should be carried out to influence the 
public or policy-making remains controversial. Some scientists feel quite strongly that research 
should not be limited or directed by the demands of policy-makers while others argue that 
providing research for the benefit of policy-makers is legitimate (Carden, 2004). Understanding 
how much and what type of impact a public role might have on the policy-making process re-
quires reflection on the way in which that process actually unfolds in a particular case.  
 
Research objectives and research questions 
This dissertation joins the debate about how the knowledge utilisation process works in a heavi-
ly politicised and mediatised policy domain. Examples of the modalities through which scientific 
knowledge contributes to the drug policy-making process and illustrations of the ways in which 
scientists can be engaged with policy-makers may be of interest for the theoretical debate on 
knowledge utilisation and public criminology but also for those who aim to grasp a reasoned un-
derstanding of the evidence-based thinking in the field of drugs.  
 
I aim to contribute to the development of theory in these areas by combining theoretical contri-
butions with empirical data from an in-depth case study of the development of Belgian drug pol-
icy between 1996-2003. Although, in the last decade, empirical interest in the science-policy 
nexus has grown in several (criminological) policy domains, including Belgium (Devroe, 2002; 
Brans, et al., 2004; Vande Walle, 2010; Smet, 2013), very little is known about whether and how 
the main political institutions (i.e. Parliament and Government) in a parliamentary democracy 
such as Belgium use scientific knowledge in the drug policy-making process, and which other 
factors are at play. 
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The aims of this study are to describe and to understand whether and how scientific knowledge 
(and other competing (f)actors) contributed to the development of Belgian drug policy between 
1996-2003. Taking into account the theoretical considerations and the characteristics of the 
drug policy field in particular, I want to explore if political/symbolic utilisation (and other types 
of knowledge utilisation like instrumental and conceptual utilisation) is particularly prevalent in 
the process of drug policy-making (Parliament and Government). What counts as scientific 
knowledge or, in other words, how scientific knowledge was perceived by policy-makers will 
also be one of the empirical topics to be addressed. Furthermore, since it was suggested in the 
literature that other factors (such as political considerations) also play a role, I want to examine 
which other types of information have competed with scientific knowledge in this case. Given 
the important roles of the media and interest groups in drug policy debates, I also aim to look at 
how interest groups as well as the (mis)representation of scientific knowledge in the media may, 
or may not, have an influence on the contribution of scientific knowledge to the drug policy-
making process.  
 
Accordingly, the study addresses three research questions: 
 
1/ How has Belgian drug policy been developed between 1996 and 2003? 
2/ How did scientific knowledge contribute to the development of Belgian drug policy between 
1996 and 2003? 
2.a./ Through which modalities did scientific knowledge contribute to the drug policy-
making process? 
2.b./ What has counted as scientific knowledge in this particular drug policy-making 
process? 
2.c./ Is there a difference in the role played by scientific knowledge within the main  
political institutions (i.e. Parliament and Government)? 
2.d./ Which other types of information competed with scientific knowledge in this par-
ticular drug policy-making process? 
3/ What is the particular influence of the media and interest groups on the contribution of scien-
tific knowledge to the development of Belgian drug policy between 1996 and 2003? 
 
Framework and methods 
I first provide a brief understanding of the conceptual framework of this study (see also Part I, 
Chapter Three) which is based on relevant concepts put forward by previous studies. The object 
of the study is the knowledge utilisation process. I draw on the three-folded typology of Weiss 
(1979), a commonly cited theoretical framework, who identified in her work on knowledge utili-
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sation and policy-making three models of knowledge utilisation (instrumental, conceptual, politi-
cal/symbolic). Instead of a direct, linear impact of scientific knowledge on drug policy (‘utilisa-
tion as outcome’), scientific knowledge may seep into the policy-making process in unexpected 
and more subtle, indirect ways (‘utilisation as process’). The notions of contribution or utilisation 
(instead of impact) are adopted to encompass not only the direct, instrumental use but also its 
more indirect/conceptual uses. In addition to Weiss’ political/symbolic model, and of particular 
interest in a heavily politicised policy domain, I examine if and how power mechanisms play a 
role in the knowledge utilisation process (evolutionary model; Stevens, 2007a) and how scientific 
knowledge itself is conceptualised in the policy-making process (e.g. how do policy-makers see 
the role of scientific knowledge? What counts as scientific knowledge?) (processual model; Mon-
aghan, 2011). Furthermore, understanding the modalities through which scientific knowledge 
contributed to the development of Belgian drug policy between 1996 and 2003 also incorpo-
rates exchange or linkage issues between science and policy. Building on the knowledge ex-
change literature (Kingdon, 2002; Rich, 2001; Muscat, 2008; Strydom, et al., 2010), I also seek to 
understand and describe the barriers and facilitating mechanisms of knowledge utilisation re-
lated to scientific knowledge; barriers/facilitators related to the policy-making process; and 
shortcomings/facilitators in the links between those two. 
 
The complexity of the knowledge utilisation process is assumed to be related to the characteris-
tics of scientific knowledge (e.g. unsuitability to policy-makers’ needs, academic format of com-
munication, contradictory findings) and the levels of engagement of scientists as well (Rich, 2001; 
Haines, Kuruvilla and Borchert, 2004). Scientific knowledge is just one part of what might be con-
sidered ‘evidence’ (Nutley, Walter and Davies, 2007). In my study, I apply the notion of scientific 
knowledge to refer to scientific research executed by academics who work in university or col-
lege departments as well as to scientific discourse of an academic. Reflecting on public criminol-
ogy, scientists may take different positions in the policy-making process (e.g. they may refrain 
from involvement or they may play a more active role) (Loader and Sparks, 2011). How scien-
tists perceive and handle these engagements themselves may have an influence on the ways 
their findings or knowledge are utilised (Lampinen, 1992).  
 
In examining the different modalities through which scientific knowledge has contributed to the 
policy-making process, this study adopts the framework of policy-making as a structured interac-
tion (including Parliament and Government). Policy-makers include members of the Federal 
Government as well as Members of Parliament (Senate and Chamber of Representatives) and 
their representatives. In contrast with the members of the Federal Government who are respon-
sible for law-making, budgetary allocations and so on, Members of Parliament (MPs) sometimes 
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just show that they are engaged by or concerned about an issue by submitting parliamentary 
questions or interpellations, but they do not have the competence to initiate concrete policy 
measures (Reisigl, 2008). Including both the Parliament and the Government may demonstrate 
how utilisation of scientific knowledge interacts with the institutional and individual character-
istics of policy-making (e.g. budgets, values and opinions of political parties, the type of political 
system, tacit knowledge of individual policy-makers) in a more in-depth way (Geeroms, 1978; 
Weiss, 2001; Black, 2001; Burssens, 2008). The few studies that reflect on whether and how 
knowledge utilisation may differ between the Government and the Parliament have provided 
contradictory results (Johnson, et al., 2004; MacGregor, 2012). 
 
As the field of drugs is considered to be characterised by intense media attention, the media is 
assumed to be a strong facilitator of knowledge utilisation in drug policy debates (Duke, 2001; 
Hughes, 2009; Monaghan, 2009). The media can be seen as a rather ambiguous concept which 
includes several forms of communication: newspapers, television, radio, internet, etc. (McCombs 
and Reynolds, 2009). In this study, I use the concept of ‘media’ to refer specifically to the print 
media, newspapers/magazines in particular. Newspapers and magazines offer practical ad-
vantages: e.g. they are easier to collect than audio-visual data, and they have a more permanent 
character than web material (Mautner, 2008).  
 
Interest (or advocacy) groups give voice to a particular segment of the general public (Marteache, 
2013; Matthew-Simmons, Sunderland and Ritter, 2013). This concept refers to a variety of 
groups of people with shared beliefs and goals in a particular policy area: civil society associa-
tions, NGOs or third sector organisations, alliances, coalitions and networks of existing organisa-
tions, professional associations of lawyers or law enforcement officers, and user groups (Tops, 
2001; Hall, 2004; Lancaster, Ritter and Stafford, 2013; EMCDDA, 2013). In this study, interest 
groups include the associations advocating for drug users’ rights as well as groups representing 
parents or ex-drug users who advocate against drug use. This type of interest groups may be of 
particular interest to the study of the science-policy nexus in the drug policy field, especially 
because (ex-)drug users are the direct objects of drug policy (Lenton, 2004; Bergin, 2013). 
 
To answer the research questions, it is necessary to adopt a comprehensive methodology. This 
study adopts a qualitative methodological approach. In particular, the research questions will be 
investigated through a close examination of the use of scientific knowledge in policy documents 
(i.e. Parliament and Government) on the one hand, and in media documents (i.e. newspapers and 
magazines) on the other hand. I will particularly focus on: the textual elements that characterise 
(differences between) discourses (e.g. the terminology and definition(s) of drug use or drug pol-
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icy options used); how players are represented in the text and from which perspective or view-
point; how scientific knowledge has been represented; and the various types of knowledge utili-
sation. This information will be augmented by interviews with key informants to increase our 
understanding of documentary material and to fill gaps or clarify/explore grey areas. Elite-level 
interviews may help to better understand the complex reality of knowledge utilisation as expe-
rienced by the actors involved and their appreciations of what counts as scientific knowledge in 
the drug policy-making process (Daniels and Lewin, 2008). In addition to existing studies of the 
science-policy nexus in the drug field which mainly involve policy-makers (MacGregor, 2013), I 
will include the perspectives of scientists, journalists and members of interest groups as well. 
 
Structure of the report 
This dissertation is organised into an Introduction and three Parts. Part I provides a theoretical 
and methodological framework for the study. The notion of science-policy nexus is further devel-
oped in Chapter One. The chapter describes the historical origins and evolution of the thinking 
on the relationship between science and policy. Attention is given to the evidence-based move-
ment and the discussion that sparked across social science disciplines (sociology, criminology, 
anthropology, …) about the need to engage with the public domain (Burawoy, 2005; Loader and 
Sparks, 2011). Furthermore, the chapter critically examines theoretical models of knowledge 
utilisation as well as the models of policy-making to demonstrate the different ways scientific 
knowledge can be used in the policy-making process. The linkages between these theoretical 
models and their shortcomings are identified and debated. In addition, this chapter outlines the 
barriers and facilitators of the relationship between science and policy. The review of theoretical 
and methodological approaches is useful translating these issues into the drug policy area in 
Chapter Two. Chapter Three describes the conceptual framework, the research design and the 
methods (including a Critical Discourse Analysis of Norman Fairclough and elite interviews) 
through which the data for this study are collected. Finally, a full description is presented of the 
limitations and the challenges the researcher was faced with during data-collection and data-
analysis. 
 
Guided by the literature and the conceptual framework addressed in Part I, the second part is 
centred on the empirical results of the Critical Discourse Analysis and elite interviews. The find-
ings from the interviews are used to further explore and test the findings from the discourse 
analysis and to develop a more comprehensive understanding of how the nexus is viewed by the 
key players. Chapters One to Five are concerned with the developments of Belgian drug policy 
between 1996 and 2003. I will chronologically address the history of Belgian drug policy and 
legislative framework before 1996 (Chapter One), the Parliamentary Working Group on drugs 
Introduction 
10 
(1996-1997) (Chapter Two), the intermezzo between 1997 and 2000 (Chapter Three), the 
Federal Drug Policy Note (2001) (Chapter Four), and the reform of Belgian drug law (2002-
2003) (Chapter Five).  
 
The aim of the Final Conclusions is twofold. First, I provide a synthesis to pull together the var-
ious topics and examples that have been discussed. Second, the empirical results are framed 
within the wider theoretical and methodological perspectives which have been discussed in the 
first part of this dissertation. In the Final Conclusions, I attempt to provide a critical analysis of 
the evidence-based thinking by detailing the modalities of scientific knowledge (Weiss’ three-
folded typology) in both policy processes (Parliament and Government), the role of the media 
and interest groups in the science-policy nexus and the ways in which scientists perceived and 
managed the relationship between their academic activities and policy-making (public criminol-
ogy). 
 
Improvident reliance on the principle ‘evidence-based policy-making’ is a big hurdle to be faced 
in increasing the rationality of the policy-making process. Covering the challenges and opportu-
nities of the interaction between science and policy, I demonstrate instrumental, conceptual and 
political/symbolic use of scientific knowledge in the development of Belgian drug policy be-
tween 1996-2003, and the influence of the researcher’s public role, including positions of power 
or lack thereof, on the policy-making process involving not only scientific knowledge but also 
interests, electoral ambitions, and so on. While interest groups are not as vigorous, the media 
prove to be a valuable linking mechanism between science and policy, influencing the public’s 
and policy-makers’ understanding as well as the content of the debate. 
 
  
 
 
 
 
 
 
 
 
 
 
 
PART I Literature review and methodology 
 
 
 
Chapter 1  Science – policy nexus: from knowledge utilisation 
models to evidence-based policies 
 
To gain a better understanding of the science-policy nexus in the drug policy arena, it is crucial 
to first consider certain issues central to this topic. After examining the historical origins and 
evolution of the thinking on the relationship between science and policy (§1), this chapter will 
address the theoretical models of the science-policy nexus (§2) as well as empirical studies de-
tailing the (problematic) features of the interaction between science and policy (§3). The partic-
ular roles of the media and interest groups in the science-policy nexus are identified in §4. 
 
1. Increasing attention for the science-policy nexus 
Attention on the relationship between science and policy is not new. Historically, there has been 
a growing interest in the political and social relations of knowledge production (Walters, 2003; 
Allen, 2007). More recently, in association with an evidence-based movement, a discussion 
sparked across social science disciplines (sociology, criminology, anthropology, …) about the 
need to engage with the public domain (Burawoy, 2005; Loader and Sparks, 2011). In this sec-
tion, I address the origins of the interest in the science-policy nexus as well as more recent de-
bates about evidence-based policy and the public role of scientists. 
 
1.1. Historical origins of the interest in the science-policy nexus 
An early view of the science-policy nexus included the idea that scientific rationality could serve 
as a key to problem-solving (Hoppe, 1999). For some time, the idea of an independent, truth-
seeking scientist who conducts his or her work in virtual isolation from societal and political 
influences was instrumental in the protection of scientists from political interventions (Hoppe, 
1999; Jasanoff, 2006). As a result, scientists attempted to establish scientific objectivity in the 
measurement and quantification of social phenomena (e.g. criminal behaviour) and sought to 
identify explanations for individual or social causes that determined this behaviour. However, 
enthusiasm was followed by increasing disillusionment about science’s capacity to address 
complex social issues. In particular, the notion of scientific knowledge as the driving force of 
policy-makers and social progress was challenged as early as mid-20th century when both World 
Wars and an economic crisis strongly impacted upon public belief in scientific rationality (Wal-
ters, 2003; Hammersley, 2013). As the 1960s progressed, it was gradually acknowledged that 
scientific knowledge was fallible as a result of its frequently inconclusive and ambiguous conclu-
sions. In other words, there was a relative consensus that scientists do not possess absolute 
truth about social phenomena: in fact, their assumptions can have a strong effect on the results 
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they find (Head, 2010). Furthermore, it was more strongly argued that policy was being deter-
mined by powerful groups rather than by scientific rationality (Walters, 2003). This shift initiat-
ed a change in critical thinking about the role of the state, society and the public at large (Carra-
bine, et al., 2004) as well as the role that scientific knowledge may play in the policy-making 
process. For instance, Weiss (1991) characterised the increasing interest in the science – policy 
connection as follows: ‘If they (social scientists) no longer claim to find ‘truth’ about ‘reality’, what 
is their role in the policy process?’ (p.309). Within this context, the tradition of knowledge utilisa-
tion studies began (see also below, §3). During the 1970s-1980s, the link between science and 
policy was contextualised in models of knowledge utilisation (see §2). 
 
1.2. Revived attention: evidence-based policy (EBP) 
Interest in the use of scientific knowledge for policy-making purposes revived in the late 1990s. 
From then onwards, the popular label evidence-based policy has strongly influenced the dis-
course on the relationship between science and policy. Evidence-based policy is frequently pro-
moted as the ideal in policy. Davies (2004) defined evidence-based policy as ‘an approach that 
helps people make well-informed decisions about policies, programmes and projects by putting the 
best available evidence from research at the heart of policy development and implementation’ (p. 
3). Marston and Watts (2003) suggested that the concept of evidence-based policy is ‘a powerful 
metaphor in shaping what forms of knowledge are considered closest to the ‘truth’ in decision-
making processes’ (p.145). This distinguishes it from policy governed by intuitive appeal, tradi-
tion or politics (O’Dwyer, 2004).  
 
The evidence-based policy concept is actually derived from the 1970s evidence-based medicine 
framework, whose philosophical origins go back to the mid-19th century (Reimer, Sawka and 
James, 2005). Evidence-based medicine (EBM) includes the thoughtful integration of the best 
available evidence coupled with best practices of medical expertise. This original framework 
gained prominence as the what works approach (Sackett, et al., 1996; Marston and Watts, 2003; 
Behague, et al., 2009). Gradually, this approach has also been advocated for and adopted in other 
fields of professional activity, such as nursing, social work, probation, human resource manage-
ment, education and substance abuse treatment (evidence based practice) (Miller, et al., 2006; 
Santisteban, Vega and Suarez-Morales, 2006; Jack, et al., 2011). Since the late 1990s, the focus 
changed from evidence-based practice to evidence’s influence in non-clinical arenas, such as pub-
lic policy. A prominent example is the UK New Labour Government's commitment to evidence-
based policy-making as a key part of its strategy of ‘Modernization through managerialization’ in 
1997 (Monaghan, 2011). Generally, the growing interest in the area of evidence-based policy led 
to several additions to the (criminological) literature (Sherman, 2003), including in Belgium 
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(Devroe, 2002; Brans, et al., 2004; Devroe, 2010; Vande Walle, 2010; Smet, 2013) (see also be-
low, §3.3.).  
 
The goal of basing a policy on scientific knowledge is to eliminate decisions based on bias or 
arbitrary grounds (Montuschi, 2009). But despite its popular appeal, this approach faces some 
fundamental challenges, in the criminological domain in particular (Burssens, 2007). First, a 
common critique has been that the EBP account assumes a linear, rational connection between 
science and policy while in fact it is far more complex, and involves actors outside the domain of 
evidence and policy. In particular, the EBP paradigm ignores the realities of policy-making (such 
as e.g. parliamentary terms and timetables, and policy-making procedures) and the scientific 
community. Policy-makers have to take into account several considerations (such as affordabil-
ity, salience, or public response) and are not always able to act rationally, a foundational concept 
in EBP (Head, 2010). The decisions they have to make are often more complex and affected by 
institutional, cultural or political factors (Hammersley, 2013). At the same time, researchers do 
not always communicate their findings clearly or prefer to remain distant from public debates 
(cfr. Public criminology, see §1.3.) (Head, 2010). Taking these criticisms into account, some au-
thors have advocated replacing the evidence-based ideal with softer approaches such as evi-
dence-informed, evidence-aware, evidence-influenced or evidence-inspired to underline a more 
reasonable view of the science-policy nexus (Sanderson, 2009; Hammersley, 2013). This reas-
sessment of EBP concludes that evidence can inform policy rather than constitute a foundation 
for policy-makers (Head, 2010). However, some advocates of this more pragmatic position cau-
tion of the risk of undermining efforts for stronger use of scientific knowledge in the policy-
making process (Sanderson, 2009).  
 
Second, what constitutes best evidence is based on the assumption that some types of research 
provide more and better scientific knowledge than others (evidence hierarchy) (Nelen, 2008; 
Nelen, 2010a; Hammersley, 2013). Emerging as it has from evidence-based medicine, the con-
cept evidence based policy assumes that policy-makers are generally best served by studies that 
use experimental and quasi-experimental research designs with good measures (Randomised 
Control Trials – RCT). A softer variant is the claim that a better understanding may emerge from 
systematic reviews. Some hierarchies place this type above RCT’s, since these often combine data 
from multiple RCT’s (Pawson, 2006; Head, 2010). Systematic reviews, which have become very 
popular in the criminological domain nowadays (Farrington, 2006; Devroe, Deschamps and 
Hannes, 2008; Freiberg and Carson, 2010; McNeill, et al., 2012) can be particularly well used 
because they are a high-level overview of the best available evidence about the effectiveness of 
policy and programs (‘what matters is what works’). Organisations such as the Campbell Collab-
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oration (C2) have been developed with this in mind. Created in 2002, it is an international re-
search network that helps policy-makers and practitioners to make well-informed decisions by 
preparing, maintaining and disseminating systematic reviews on education, crime and justice, 
and social welfare1 (Devroe, Deschamps and Hannes, 2008). With this emphasis on evaluation, 
innovative strategies to mandate the use of this type of evidence has been adopted recently: for 
example, some applicants for federal program funds in the United States are required to show 
that their program has been scientifically evaluated and proved successful (Weiss, et al., 2008).  
 
While experimental trials and systematic reviews have been and continue to be perceived as 
providing reliable sources of evidence, some forms of scientific research as well as knowledge 
derived from practitioners’ experiences are automatically portrayed as unsystematic and lacking 
rigor. Although controlled studies and systematic reviews might be useful in evaluating a given 
intervention or policy and such research is increasingly popular in the criminological research 
field, too many policy questions cannot be answered with this approach (Burssens, 2008; Clear, 
2010). For instance, like other criminological topics, drug use is a complex phenomenon that 
cannot be studied and fully understood by only using (quasi-) experimental designs or systemat-
ic reviews (Kraus and Korf, 2005). These methods disregard the context or sociological meaning 
of a finding (Stevens, 2011)2. For instance, qualitative research and expert opinions are required 
to analyse how different drug policies create, recreate and reinforce social inequality and power 
structures (Snertingdal and Basberg Neuman, 2010).  
 
Furthermore, the notion of evidence-based policy-making, with the centrality of its evidence hi-
erarchy, can be perceived as a kind of reaffirmation of the positivist view (Marston and Watts, 
2003; Naughton, 2005; Hammersley, 2013). Lancaster (2014) questioned the fixed and stable 
premise of evidence-based policy endeavour, suggesting that the concepts of evidence and thus 
evidence-based policy are always social constructs. From the postmodernist or social construc-
tivist point of view in social research, social reality can never be objectively known. It is argued 
that the concept of evidence is more contested than it appears: it often fails to cumulate system-
atically resulting in fragmented data or yields contradictory or otherwise untrustworthy find-
ings (Naughton, 2005; Weiss, et al., 2008; Monaghan, 2008b). Formulating conclusions or setting 
operational goals in research will always remain a somewhat uncertain task (Fountain and Korf, 
2007; Burssens, 2008). Thus, a strong research base with rigorous findings is simply not viable 
in many areas (Head, 2010). 
                                                          
1  The Belgian department is called the Belgian Campbell Group.
 
2  Stevens (2011) uses the image of datasorauses to point at researchers with “a very small theoretical brain and a 
huge methodological body” and a lack of “considering their application to the real lives of the people from whom they 
have been extracted” (p.30). 
 
Chapter 1  Science – policy nexus: from knowledge utilisation models to evidence-based policies 
17 
1.3. Public criminology: recent translation of EBP-thinking 
Within the framework of the debate around the role of science in policy-making, social scientists 
became more and more concerned with the nature of their own commitment to the policy-
making process (Van Swaaningen, 2009). Braithwaite (2005) termed this translation of the EBP-
thinking public social science. However, it was sociology as a discipline that played a pioneering 
role in this debate. In particular, Michael Burawoy (2005) championed initiatives to give sociol-
ogy a public voice. A public sociology has to translate scientific knowledge to other arenas (e.g. 
public, policy-makers, professionals) in order to establish a dialectical relationship. On the one 
hand, it allows a scientist to contribute to public and political discussions, while, on the other 
hand, scientists can learn from the experiences of their public in order to broaden their insights 
and ideas about social phenomena. However, it is assumed that public sociology is but one of 
four different types of sociology that also include: professional sociology (i.e. focus is on academic 
peers and producing/discussing academic knowledge and theoretical paradigms; instrumental 
knowledge), policy sociology (i.e. focus is on serving clients in solving a problem, mostly involv-
ing a contract), and critical sociology (i.e. focus is on examining the fundamental assumptions of 
the professional approach; reflexive knowledge). Professional and critical sociology focus on an 
academic audience while policy and public sociology have an extra-academic audience. Never-
theless, the distinctions made are less straightforward than they have been portrayed: scientists 
can belong to more than one type and they may change their approach during their career (Nie-
meijer, 2009; Loader and Sparks, 2010). Indeed, Burawoy’s typology has incited much criticism. 
For instance, critics feared that the discipline of sociology was being diminished by the contami-
nations of the public/policy side. At the same time, it has been argued that all engaged in sociol-
ogy ought to be critical, as this is a core element of professionalism (Ericson, 2005). This think-
ing was incorporated into the criminological debate under the banner public criminology (Chan-
cer and McLaughlin, 2007; Engbergsen, 2008; Garland, 20113). 
 
Before I address the current public criminology debate, it is important to note that this discus-
sion is not entirely new but rather actually reinvigorated several older debates. As criminologi-
cal knowledge is located in three major social settings: (1) the world of social science, (2) the 
world of policy-making and (3) the world of mass media and the public, circuits for its use and 
exchange may be extensive (Garland and Sparks, 2000). Discussing and even acting on the prob-
lem of crime belongs to a diverse network of actors and agencies, some inside the state, but 
many outside of it. For instance, crime and crime policy are often subject to intense, sustained 
attention by the popular media and politicians (Dixon, 1995; Loader and Sparks, 2011). 
                                                          
3  Garland (2011) described a similar three-fold typology: policy-oriented criminologist, academic sociologist of 
crime and a critical criminologist. 
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First of all, criminological research does not take place in a political vacuum; it has always found 
itself in close proximity to the state and its political needs (Walters, 2003; Garland, 2011; Bau-
wens, et al., 2013). The relationship between knowledge and power has explicitly been studied 
in the work of Michel Foucault.4 In the later work of Michel Foucault (genealogy), the govern-
ment is understood to be not simply a political institution but rather a form of activity aiming to 
shape, guide or affect the conduct of some person or persons (Gordon, 1991). The criteria of 
what constitutes knowledge, what is to be excluded and who is designated as qualified to know, 
involves acts of power. For instance, the selective management of scientific knowledge in the 
government is a vital component in the manufacture of legitimate authority (Naughton, 2005; 
Foucault, 1972). Researchers form part of the regime of power/knowledge/truth for each socie-
ty, because they constitute the space that produces, reproduces, legitimates and disseminates 
knowledge/discourse approved as true. Influenced by this work, some authors like Garland 
(2001)5, Walters (2003) and Moore (2008) supported the concept of deviant knowledge to make 
a distinction between knowledge upheld as sophisticated, relevant and useful, and knowledge 
upheld as marginalised, neutralised and disregarded by policy-makers. Thus, deviant knowledge 
refers to knowledge that is critical of the state crime-control apparatus or challenges the existing 
social and political order (Walters, 2003). As a result, these types of knowledge may be system-
atically neutralised or marginalised by social controls/powers (e.g. state controlled research 
institutions or funds). In other words, it is suggested that policy-makers may use techniques of 
neutralisation to rationalise their position choosing to neglect or dismiss findings which do not 
support their political agenda (see also the political/tactical model, §2.4.1.). These techniques 
can be contextualised within political frameworks (macro-level) and within day-to-day prob-
lems that researchers endure (micro-level). They include: the politics of winning grants and con-
tracts; restricted and proceduralised access to information; negotiating and bargaining for inde-
pendence; the use of contracts to legalise control and restrict academic freedom; censorship of 
written work; failure to publicly release research findings, etc. (Walters, 2003).  
 
                                                          
4  The work of Michel Foucault developed from the early text on madness (‘Madness and Civilization’) over the stud-
ies ‘Order of Things’ and ‘Discipline and Punishment’ to the final study of sexuality (‘History of Sexuality’). The first 
period has been described as a period of archaeological investigations, while the later studies have been seen as 
genealogical analyses. This evolution considered a transformation from a descriptive/historical perspective on 
discourses towards a greater critical consideration of the interface between discursive and non-discursive prac-
tices and the power-knowledge nexus (e.g. why and how discourses occur). 
5  With the publication of ‘The Culture of Control’, Garland (2001) pointed to some important currents of change in 
crime policy over the last 30 years: the decline of the rehabilitative ideal; the re-emergence of punitive sanctions 
and intensive control mechanisms; an increase in the emotional tone of crime policy as the fear of crime became a 
prominent cultural theme; the return of the victim; a focus on the protection of the public; the reinvention of the 
prison, etc. A focus on repression and punishment may therefore be considered as a resistance to the curtailment 
of their decision-making power by the power of the scientists, lobbyists or advisors. Populist language and a sim-
plification or distortion of problems may influence the fear of crime and may raise expectations that the govern-
ment is able to secure the citizens (Garland, 2001; Nelen, 2010b). 
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Likewise, in ‘Whose Side Are We On?’, Becker (1967) pointed to the notion of hierarchy of credi-
bility to refer to the accepted view that any tale told by those at the top intrinsically deserves to 
be regarded as the most credible account. In other words, it refers to the fact that some people, 
especially those in socially responsible positions, have more power to define what is true than 
others (Goode and Ben-Yehuda, 1994). Thus, credibility and the right to be heard are differen-
tially distributed through the ranks of the system. As a result, research taking into account the 
viewpoints of powerful groups (‘superordinates’) will be considered more true than research 
focusing towards the interests of subordinates (Becker, 1967). ‘When a researcher tells the story 
from the perspective of the underdog and challenges the conventional, established, official view of a 
problem, and perhaps reveals the shortcomings, limitations of responsible officials in the policy, 
courts, etc. that story is inherently subversive in effect as it challenges the dominant power struc-
ture’ (Carrabine, et al., 2004, p.22). Therefore, Becker (1967) called for researchers to 
acknowledge their personal or political commitments and to be on their guard against any bias 
in their research. He concluded that ‘Whatever side a researcher is on, he must use techniques 
impartially enough that a belief to which he is especially sympathetic could be proven untrue.’ 
(p.246). In fact, his central question ‘Whose Side Are We On?’ now resonates in the recent debate 
about the public engagement of scientists (Bloor and Wood, 2006).  
 
Secondly, the debate about public engagement is associated with a heating up of the public and 
media discourse in relation to crime in recent years. Media are accused of failing to provide the 
public with objective and complete accounts of criminality and of distorting policy-makers’ un-
derstanding of the direction of public opinion (Green, 2008). Barak’s call for a newsmaking 
criminology aimed to encourage criminologists to share their knowledge with the general pub-
lic through the media, to increase the public’s exposure to overlooked crime topics, alternative 
perspectives on existing problems and informing and altering the discourses of crime, justice 
and punishment in order to influence the shape of policy (Barak, 2007; McLaughlin and Muncie, 
2013). Within this framework, Groombridge (2007) argued that ‘If criminologists don’t do crimi-
nology in public – which means the media now – then the media will do it for them.’ (p. 473). Like-
wise, Henry and Milovanovic (1996) argued that criminologists must use media to ensure max-
imum impact of scientific knowledge on policy development. Criminologists can do this by ‘ac-
tively challenging silences, identifying omissions and resurrecting the eliminated through partici-
pating in the making news stories about crime’ (p.216). According to Barak (2007) criminologists 
may take four roles: as an expert, as a crime reporter or journalist, as a subject or as a critic to-
wards media representations. The concept of public criminology goes beyond the traditional 
concerns with the role of media, but this point may raise questions about the public role of scien-
tists as well as the role of the media in the science-policy nexus.  
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While these issues show how interest in the public roles of criminology gradually developed, the 
concept of public criminology first emerged around 2007. Multiple calls have been launched 
arguing that, as criminology flourished in the academy, its influences on policy development as 
well as on public knowledge about realities of crime and justice seemed to be decreasing (Gar-
land and Sparks, 2000; Currie, 2007; Chancer and McLaughlin, 2007; Tonry, 2010; Loader and 
Sparks, 2011). In other words, ‘in times as ours when ‘crime talk’ flourishes, its voice seems – 
somehow, somewhere – to get lost’ (Daems, 2008; p.241). Loader and Sparks (2011) defined this 
situation as a successful failure. Some have argued that this marginalised role, in times when the 
need for criminological insight and understanding has become more and more urgent, is the 
result of both the diverse (pluralist) nature of the perspectives that criminologists have to offer 
and the lack of methodological rigour. In particular, a wide range of perspectives are represent-
ed in the field, as criminologists do not necessarily share a common language or theoretical per-
spective (Garland, 2011). This makes criminology rather vulnerable in a world of political scep-
ticism (Dixon, 1995; Rock, 2010). Furthermore, Chancer and McLauglin (2007) argued that crim-
inological issues are often linked with electoral themes and therefore mediated and contested by 
a range of actors. Findings that are contradictory or out of touch with the needs of policy-makers 
may lead to confusion or so-called endarkenment (instead of enlightenment; see also below) 
(Weiss, 1986). From the perspective of the scientific community, Currie (2007) pointed to the 
increasing pressure to publish in peer-reviewed journals at the expense of efforts to disseminate 
findings towards a non-academic public.  
 
Taking these issues into account, numerous debates have taken place exploring, defining, and 
addressing the varying roles criminologists may choose or have chosen to play in public work 
(Daems, 2008; Uggen and Inderbitzin, 2010; Tonry, 2010; Monaghan, 2014). In particular, sev-
eral objectives and responsibilities of public criminology were advocated as a response to the 
challenges mentioned above (Rock, 2014). Most reflections on public criminology focus primari-
ly on the discipline’s contribution to the policy-making process (as an exception, Fichtelberg and 
Kupchik (2011) have studied the discipline’s contribution to the public opinion at-large). Crimi-
nologists strongly differ in their opinions on public engagement, which range from a total ab-
sence from the public domain, the recognition of a dual role (being a participant in public and 
political debates as well as an independent producer of scientific knowledge), to positions as 
public intellectuals (Deflem, 2005; Chancer and McLaughlin, 2007; De Haan, 2008; Bauwens, et 
al., 2013). In other words, some supporters of public criminology say that criminologists, with an 
independent, academic agenda (i.e. not influenced by political statements, election programs, 
etc.), must become better at communicating findings to external audiences in order to overcome 
false representations in public and policy (Currie, 2007; Carrabine, et al., 2009) while others 
Chapter 1  Science – policy nexus: from knowledge utilisation models to evidence-based policies 
21 
advocate a strategic call for action which involves, for example, building up networks with poli-
cy-makers or journalists.  
 
The latter school of thought is strongly criticised by those who believe that public criminology 
can be considered as an implicit call for a stronger embedded criminology, in which social scien-
tists tend to conform to the realities of power and generally accept the definitions of politicians 
as to what constitutes the most serious social problems (instead of a focus on independent sci-
entific progress). For instance, Allen (2007), De Haan, (2008) and Van Swaaningen (2009) 
warned that criminologists have already been increasingly bound to the state as a result of re-
structuring of research funding over the last decades. They argued that, from the early 1980s 
onwards, most social research has been conducted under contract to government departments 
and moulded to the needs or priorities of the funders to focus on facts (instead of on theoretical 
insights) and questions about what works (instead of how it works). Likewise, Walgrave (2008) 
stated that: ‘Criminologists must be aware that governments use criminology as a menu. They 
choose what best satisfies their political hunger. They select out, or manipulate through selective 
financing, what they can use to support political options chosen beforehand. Very often, it is not 
criminology that is orienting policy, but policy that is orienting and canalizing criminology.’ (p.3). 
The most outspoken critic of public sociology (and thus public criminology) is Prof. Dr. Mathieu 
Deflem. He criticised the idea heavily by means of comparing it with a Marxist sociology oriented 
towards politics instead of science. The danger, as he stated, is sociology turning into political 
activism (Deflem, 2005). Despite these different opinions, there is consensus that if criminology 
is to play a role in shaping the public debate, a better understanding of the policy-making pro-
cess is an important first step. This study aims to be a modest contribution towards this under-
standing.  
 
This debate has further been animated by the publication of a book entitled ‘Public Criminolo-
gy?’ (Loader and Sparks, 2011) and its reviews (Wacquant, 2011; Daems, 2011; Hammersley, 
2013). Loader and Sparks (2011) avoided the debate between advocates or opponents by means 
of reflecting on the sociology of criminological engagement. They offered a subjective typology of 
modes of engagement comprising three cool types (the scientific expert, the policy advisor and 
the observer-turned-player) and two hot types (the social movement theorist/activist and the 
prophet) (Wacquant, 2011). Daems (2011) classified this as a distinction between airco-
criminologists and pyro-criminologists.  
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Table 1: Typology of modes of criminological engagement 
Types Description 
Scientific expert The scientific expert focuses on the production and dissemination of sci-
entific knowledge and does not go beyond infrequent participation in 
formal advisory structures. The scientific expert uses knowledge and 
methodological skills to answer questions of policy-makers in a nuanced 
and well-considered way.  
Policy advisor The policy advisor does a great part of their research on (short-term) 
contracts for the government, and perceives it as a responsibility to bring 
scientific knowledge to policy-makers through formal advisory structures 
or even informal contacts (behind the public scenes) 
Observer-turned player The observer-turned player takes up the opportunity to participate direct-
ly to the development of policy (e.g. as a representative of a Minister). 
This type is colloquially described as an expert who is getting his or her 
hands ‘dirty’. 
Social movement theorist The social movement theorist colloquially supports a critical/alternative 
discourse placing knowledge and skills at the service of those who are 
marginalised. This type does not go beyond infrequent participation in 
formal advisory structures. 
Lonely prophet The lonely prophet focuses on theoretical engagement and the big picture 
while philosophising about social changes and movements. This type also 
does not go beyond infrequent participation in formal advisory structures. 
 
Source: Loader and Sparks, 2011 
 
Loader and Sparks (2010) further argued that each of these types of engagement allows simul-
taneous memberships of both groups: policy-makers and scientists. At the same time, it is 
acknowledged that one researcher may adopt different roles through his/her career. Their 
thinking about criminological engagement ended with the introduction of the concept of demo-
cratic underlabouring. This refers to an acknowledgement that in a democracy, criminological 
knowledge should compete with other discourses (as a participant in the policy-making process) 
but does not have the automatic right to guide policy. A more modest view with respect to the 
rules of politics and competition is supported. Public criminology, then, provides an articulation 
of the idea that criminology’s purpose is to contribute to a better politics of crime and its regula-
tion (Loader and Sparks, 2011; Tonry, 2010). 
 
Notwithstanding the reference to criminology in their title, Loader and Sparks (2011) provided a 
useful account of the general engagements between (social) science and the policy-making pro-
cess, especially in relation to this study. However, as a general comment on their work, even 
though Loader and Sparks acknowledged that scientific knowledge may be just one of many el-
ements in the policy-making process, they focus on individual actors while ignoring the more 
fundamental institutional issues of the policy-making process (e.g. how policy is made) and sci-
entific community (e.g. managerial make-up of the university, the overt and covert intrusion of 
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the concerns of politicians) (Wacquant, 2011). Furthermore, they lacked any reflection on how 
academics perceive and manage the relationship between their academic activities and policy-
making. Academics also often seem to rely on extra-scientific means of persuasion which can 
jeopardise their credibility (Daems, 2008). According to Uggen and Inderbitzin (2010), it is im-
portant to be aware of airport criminologists. These scientists, public criminologists in particular, 
fly around as consultants and experts while losing sight of their scientific knowledge base (e.g. 
by means of misrepresenting their expertise). As such, providing accurate information may 
prove to be a challenge (Lackey, 2007). 
 
2. Models of the science-policy nexus 
Except for some recent (analytical) reflections within the framework of public criminology, there 
are few criminological precedents for an empirical study of the science-policy nexus (see also 
below, §3.3.). Given this scarcity, there has been a tendency and indeed necessity to borrow con-
ceptual frameworks, particularly from political science and knowledge utilisation literature 
(Berridge, 2004; Brewster, 2014). This also applies to the case study. Accordingly, I first address 
some classifications in the diffuse concepts of knowledge and evidence (§2.1. and §2.2.). Second, I 
explore the ways the science-policy nexus has been conceptualised and assessed in early para-
digms (§2.3.). These conceptualisations influenced some of the issues related to the types of 
knowledge utilisation which I will discuss in the following section (§2.4.). Subsequently, I exam-
ine existing models of the science-policy nexus, focusing on the policy-making process itself 
(§2.5.). Exploring policy-making is necessary to better understand how scientific knowledge is 
used and to identify the determinants of utilisation of social science research knowledge (Bek-
kers, et al., 2004).  
 
2.1. Conceptual classifications in knowledge and evidence 
In the relevant literature, the terms knowledge, science, research, data, evidence and information 
are often used interchangeably (Rich, 1997; Nutley, Walter and Davies, 2007). Definitions are 
therefore difficult and complex. A significant part of the evidence-based policy debate revolves 
around the way evidence is defined. In much of the literature, the term evidence is often reduced 
to scientific knowledge which informs or develops policy in a wide range of areas (health, educa-
tion, criminal justice, etc.). In particular, scientific knowledge obtained through randomised con-
trolled trials or systematic review is argued to be the gold standard approach. Reflecting on the 
concept of evidence, evidence-based policy is often seen as synonym for science-based policy. By 
contrast, some authors argued that scientific knowledge means just one form of evidence in the 
EBP account (Garretsen, Brouwersa and Van de Goora, 2010). Therefore, they stressed the role 
of other actors who inform the policy process. For instance, Head (2008) distinguished three 
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lenses of evidence on the assumption that the design, implementation and evaluation of policies 
involve three actors: policy-makers, scientists and professional practitioners. As a result, he 
mentioned political knowledge, scientific knowledge and practical implementation knowledge. 
Political knowledge concerns the know-how, analysis and judgment of political actors while sci-
entific knowledge is the product of systematic analysis of current and past conditions and trends. 
Practical implementation knowledge refers to the practical wisdom of professionals in their 
communities of practice. According to Head, these three lenses may help to understand the evi-
dence base of the policy debate (Head, 2008). 
 
Additionally, there is considerable confusion between the concepts of data, information, research 
and knowledge. Lindquist (2001) distinguished data, information (or analysis) and knowledge 
(or science). Data is seen as raw material, information is considered as refined data which con-
tains an added value to the user, and knowledge is information which has been validated. Bowen 
and Zwi (2005) distinguished research on the one hand and knowledge/information on the oth-
er hand. Here, research refers to empirical evidence, analytic studies, qualitative studies, case 
reports, etc. Knowledge/information stands for results of consultation processes with networks, 
published documents or reports (including policy evaluations and statistical analyses). Weiss 
also made a distinction between scientific knowledge and research. Scientific knowledge is de-
fined as consensually accepted information by the scientific community, involving research evi-
dence (Weiss, 1991; Brans, et al., 2004). Research is interpreted in the context of utilisation. She 
distinguished three types of research (ideas and criticism, data and findings, and arguments and 
briefs for policy action). Research as ideas is perceived to be more general. In this case, research 
is likely to be influential at the early stages of policy discussion. Research as data is described as 
taking a technocratic view of research, and is likely to be influential in situations of consensus. 
Research as argumentation takes an advocacy position and is used when a decision has already 
been made. Reimers and McGinn (1997) did not use the concept scientific knowledge but instead 
distinguished four research approaches, as they implied different questions, answers or purpos-
es (Neilson, 2001). They distinguished academic research, planning research, instrumentation 
research and action research. Academic research tests hypotheses drawn from the conceptual 
framework and planning research uses statistical analysis to generate patterns of relationships 
among variables. Repeated trial and error methods in preparing a new curriculum is related to 
instrumentation research. Finally, the focus of action research is on outcomes rather than on 
knowledge of how to achieve them. 
 
By contrast, Webber examined to the political dimension of knowledge with concepts like politi-
cal knowledge and policy knowledge (Webber, 1991). Political knowledge consists of information 
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about public opinion, party competition, coalition strategy and ethical, ideological or political 
considerations of policy alternatives. Policy knowledge refers to technical, focused, systematic 
analysis of policy inputs and outputs of government and their effects on society. In other words, 
policy-makers need a broad range of knowledge that link together information and explanations 
from various domains (or subfields). Here, research competes with other types of information 
like policy-maker (personal) knowledge, journalistic knowledge and clinical knowledge (or prac-
titioners’ experience). Within this framework, several types of research are distinguished: policy 
research (i.e. studies that attempt to explain a specific policy), policy oriented research (i.e. stud-
ies not undertaken to study a problem but which have applications for explaining how a policy 
works) and disciplinary research (studies that contribute to academic knowledge in understand-
ing the background within which a policy operates).  
 
Despite these different theoretical classifications of knowledge and evidence, there is consensus 
that scientific knowledge is just one of many the types of information influencing the policy-
making process (Davis and Howden-Chapman, 1996; Trostle, Bronfman and Langer, 1999; Hall, 
2004; Brambila, et al., 2007; Lenton, 2007; Hughes, 2007; Daniels and Lewin, 2008; Hall, 2008; 
Monaghan, 2009; Macleod and Hickman, 2010; Hughes and Stevens, 2010). Even though the 
interpretation of scientific knowledge sometimes differs, it is generally perceived as something 
produced by the scientific community which may include (several types of) research as well as 
knowledge provided by scientists, for example in consultations. In this study I do not distinguish 
between types of scientific knowledge (e.g. data, information, knowledge) but I use the broad 
concept of scientific knowledge to refer to research on the one hand and knowledge of scientists 
on the other. Using a strict typology (e.g. between data, information, research and knowledge) 
may run the risk of oversimplification and is not easy to maintain in any empirical research of 
knowledge utilisation processes. It is unlikely that such complex typologies can be shared with 
any degree of stability during the study (Nutley, Walter and Davies, 2007). The intention to dis-
cuss scientific knowledge in general is also motivated by the fact that attaching these labels al-
ready involves a subjective act (e.g. when does data turns into information or knowledge?).  
 
2.2. The concept of utilisation: process or outcome? 
The claim that policy-makers should use the findings of scientific research is legitimate. But what 
is meant by use? Knowledge utilisation has been variously conceptualised following the diffuse 
interpretation of knowledge elaborated before: information utilisation, use of knowledge, re-
search utilisation, knowledge utilisation or knowledge use. However, in general, I can make a 
primary distinction between utilisation as an outcome and utilisation as a process or, in other 
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words, between respectively impact and utilisation (Mulder, et al., 1991; Oh, 1997; Rich, 1997; 
Brans, et al., 2004; Dobrow, Goel and Upshur, 2004).  
 
In many examples, researchers try to determine the direct effects and to establish causal links 
without trying to understand how scientific knowledge may have a particular influence (Carden, 
2004). Utilisation as an outcome can be considered as a narrow and deterministic view on 
knowledge utilisation. The principle is that knowledge automatically produces an effect on a 
policy or decision. The underlying assumption is that if an idea/finding is good enough, it will be 
used (Nutley, Walter and Davies, 2003). Utilisation is considered as the specific (direct or ration-
al) outcome of research on policy (Webber, 1991; Lampinen, 1992), and is therefore also called 
impact (cfr. EBP notion). 
 
Utilisation can also be interpreted in a broad sense, whereby scientific knowledge may play a 
role in the process of policy-making rather than just in the outcome of policy formulation. From 
this perspective, researchers look out for any unexpected and more subtle, indirect ways in 
which scientific knowledge may seep into the policy-making process (utilisation as process). In 
other words, the main point of the process approach is that scientific knowledge has been re-
ceived and read, and that information is judged to be relevant or valuable. It does not imply that 
action has been undertaken but rather that scientific knowledge in some way has contributed to 
a new or advanced thinking about a problem. For instance, Krastev (2000) and Neilson (2001) 
described utilisation as the power to change the prevailing paradigm. Such a broad definition 
refers to a more realistic approach of utilisation as a consideration with an indirect, more subtle 
impact (Rich,1997). 
 
This primitive distinction between utilisation as outcome or process can be linked with models 
of knowledge utilisation, respectively with the so-called instrumental (i.e. direct use of infor-
mation in policy-making) and the conceptual use (i.e. delayed and diffused use of information in 
policy-making) of information (see also below, §2.4.1.). This study adopts the framework of utili-
sation as a process, as I am interested in the different modalities through which scientific 
knowledge may seep into the policy-making process (including Parliament as well as Govern-
ment), not just in decision-making. 
 
2.3. The two communities thesis 
The earliest paradigm concerning the science–policy connection, developed by Caplan (1979), 
describes scientists and policy-makers as part of two communities with different world views, 
values, language, etc. separated by a huge gap. The two communities thesis has had a powerful 
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influence on the ways in which the relationship between science and policy has been and con-
tinues to be understood. The central principle of the thesis is that policy-makers rarely make use 
of scientific knowledge. Explanations for the failure of the connection between science and poli-
cy are dedicated to the gap between researchers and policy-makers.  
 
Even though the two communities thesis has inspired the development of knowledge utilisation 
models (Weiss, 1979; Nutley, Walter and Davies, 2003; Landry, Amara and Lamari, 2001; Hoppe, 
2005; see below, §2.4.1.) as well as knowledge exchange models (sometimes referred to as 
knowledge translation/brokering models)6 which aim to identify remedies for bridging the gap 
(Nutley, 2003; Brans, et al., 2004; Mitton, et al., 2007; Curran, et al., 2011; see also below, §2.6.), 
the two communities thesis has some important shortcomings. While it provided the basis for 
much thinking about the science-policy nexus, it utilises a rather simplistic model which ignores 
other actors (e.g. media, interest groups). It is indeed important to acknowledge that a different 
set of actors is involved in the policy-making process especially when studying how knowledge 
is (not) used in the policy-making process (Sabatier, 1998; Sutton, 1999; Kingdon, 2002) (see 
below, §2.5.). In a response to this critique of the two communities thesis, Lindquist (2001) in-
troduced the concept third community. In an attempt to embrace more actors with an interest in 
policy, the third community includes intermediary institutions standing aside the knowledge 
producers (academic worlds) and knowledge consumers (decision community) such as think 
tanks, political consultants or advisers, commissions, councils, media or journalists. 
                                                          
6  Knowledge exchange literature is the general overarching concept, or according to Ottoson and Hawe (2009), a 
metaphorical umbrella. Both knowledge translation and knowledge brokering focus on particular elements of the 
exchange literature. In particular, knowledge translation refers to the translation of technical findings into more 
readily consumable language, while knowledge brokering focuses on the active mediators in the relationship be-
tween policy-makers and scientists (Goldfeld, 2010). Each of these concepts has to be distinguished from 
knowledge transfer/diffusion literature. Knowledge transfer literature applies a different focus: it is all about how 
and why certain ideas or policies spread internationally (Dolowitz and Marsh, 2000). This falls outside the scope 
of this study. 
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Figure 1: Third community model of Lindquist 
 
 
Source: Lindquist, 2001 
 
However, treating two or three communities as separate entities, still minimises the heterogene-
ity within scientists and policy-makers. Ginsburg and Gorostiaga (2001) claimed that a focus on 
communities can be seen as an ideal-type as it does not take into account simultaneous mem-
berships of these groups (Monaghan, 2011). Researchers can potentially perform a variety of 
influencing roles within the policy process such as performing as experts or advisors (see also 
public criminology; Loader and Sparks, 2011). For example, both professors in criminology Pe-
tersilia (2008) and Stevens (2007b and 2011) worked in a government department for a par-
ticular length of time.  
 
2.4. Knowledge utilisation typologies 
As stated above, there has been increasing interest over the last decades in what has become 
known as the science-policy nexus. In the mid 1970’s social scientists started to study the use or 
non-use of research in policy decisions (Webber, 1991; Weiss, 1995). Unlike the two communi-
ties thesis, several authors refused to accept the simple dichotomy between use and non-use, 
aiming to uncover alternative modes of knowledge utilisation (Landry, Amara and Lamari, 2001; 
Hoppe, 2005; Ottoson and Hawe, 2009). Various theoretical models described throughout the 
literature review go a considerable way in explaining why and how knowledge can be utilised.  
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2.4.1. Meanings of knowledge utilisation 
Weiss, by far the most prominent author in this field, identified seven meanings (or models of 
knowledge utilisation): the knowledge-driven and the problem-solving model, the political and 
tactical model, the interactive, the enlightenment and the intellectual model (Weiss, 1979; Nutley, 
2003). She believed that the utilisation of social sciences in policy development is a highly com-
plex phenomenon that can be perceived in a large number of different ways. 
 
Table 2: Overview of meanings of use 
 
Meanings of use outcome/process Scientific knowledge is 
only guiding factor 
Knowledge-driven outcome yes 
Problem-solving outcome yes 
Political outcome no 
Tactical outcome no 
Enlightenment process yes 
Interactive process no 
Intellectual process no 
 
Source: adopted from Monaghan (2011) 
 
The first two models, the knowledge-driven model and the problem-solving model apply a linear, 
instrumental approach. This approach represents the typical understanding of the science-policy 
nexus, which is based on the expectation that policy-makers will make direct use of scientific 
knowledge to make policies more effective. In this linear account scientific knowledge is consid-
ered to be the only guiding factor for policy-making, leaving aside the fact that utilisation also 
may involve issues of (political) power and media imperatives. It is clear that this idealised ap-
proach represents the central principles of the evidence-based or what works notion. The 
knowledge-driven model places scientific knowledge at the forefront, as an instrument to illumi-
nate opportunities that are relevant for policy. For instance, in physical science, new scientific 
application may (immediately) contribute to policy. Examples of this model in the social sciences 
are rather scarce. More common (but still rare) is the problem-solving model. Where policy is 
already in place, scientific knowledge may help to select a promising policy response/solution or 
policy-makers may commission additional research to fill the knowledge gap.  
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The political and the tactical approach, characterised by the selective use of scientific knowledge 
to satisfy the short-term interests of policy-makers, also incorporates two models. Its underpin-
ning is still linear and tends to focus on the policy-makers and not on other groups who also may 
be able to influence policy. In particular, in the political model scientific knowledge is considered 
as ammunition or persuasion. According to this principle, policy-makers will cherry pick scientific 
knowledge that supports their own position (Hope and Walters, 2008), while scientific 
knowledge that contradicts policy interests will be ignored (Klein Haarhuis, Hagen and Scheep-
maker, 2009). For instance, scientific knowledge can be used to silence the arguments of the 
opposition or to support ideas that colleagues have adopted earlier (Lampinen, 1992). In the 
tactical model, however, policy-makers may use scientific knowledge merely as a tactic for de-
laying action or decision-making (Weiss, 1979; Nutley, 2003). For instance, policy-makers are 
able to postpone policy actions/decisions by stating that they are awaiting the results of ongoing 
research (Duke, 2003). Each of the examples where scientific knowledge is used in a politi-
cal/tactical way are regularly termed as policy-based evidence making (in contrast with the EBP 
notion).  
 
The enlightenment model implies that scientific knowledge may permeate policy-making indi-
rectly (e.g. through media or interest groups) and gradually. The idea of scientific knowledge 
cumulatively influencing the climate in which policies are made is also sometimes called a lime-
stone approach (Stevens, 2007a). In other words, the impact of research is like the action of wa-
ter on limestone: it is not predictable where it will come out. The slow trickle of ideas that find 
their way into policy-making is also sometimes called knowledge creep (Willinsky, 2000). Thus, 
in general, this model offers a dynamic perspective of the science-policy nexus and it emphasises 
how research can be conceived as part of the process of policy-making (utilisation as process). 
 
Scientific knowledge can also influence the policy-making process as part of an interactive 
search for knowledge. Policy-makers may search for information from social scientists as well as 
from administrators, practitioners, planners, journalists, interest groups, etc. Thus, the interac-
tive model assumes that scientific knowledge is not the only factor influencing the policy-making 
process and believes that the relationship between policy and science is iterative, dynamic and 
long-term.  
 
In the intellectual model, scientific knowledge is considered as a part of the intellectual pursuits 
of the society. Scientific knowledge is characterised as another dependent variable running side 
by side with policy, philosophy, journalism, history, law and criticism (Weiss, 1986). Science and 
policy influence each other and are both being influenced by the broader social context. For in-
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stance, policy interests, stimulated by a wider social concern, may result in offering funding for 
research. Results may then shape ways of thinking by policy-makers and society in general (Nut-
ley, Walter and Davies, 2007).  
 
Weiss’ knowledge utilisation typology has been applied widely as the central theoretical frame-
work in many studies on the science-policy nexus. Even though these typologies may be very 
helpful in structuring data analysis and interpretation, some caveats need to be borne in mind. 
First of all, these models assume a voluntarist attitude of policy-makers and scientists: both have 
the intention to maximise the use of scientific knowledge. Of course, in reality such an approach 
rather ignores the institutional context of policy-making (e.g. party hierarchies) (Flitcroft, et al., 
2011) as well as the levels of engagement of scientists (Haynes, et al., 2011b).  
 
Secondly, utilisation cannot be readily classified in types: e.g. a single study may be used in dif-
ferent ways. These models have to be interpreted as parallel processes rather than contrasting 
classifications. Therefore, some authors started to view knowledge utilisation as a continuum 
rather than in terms of static types. Placing the types of utilisation along a spectrum, Greenberg 
and Mandell (1991) suggested a continuum across two dimensions: (1) a concrete/conceptual 
dimension (i.e. ranging from the use of findings to make decisions to the intangible and concep-
tual influence) and (2) a substantive/elaborative/strategic dimension (i.e. defining the extent to 
which research influences an action or serves to legitimate a decision). Nutley, Walter and Da-
vies (2007) also supported the idea of a two-way continuum ranging from conceptual to instru-
mental uses of research. However, even though they recognise the dynamic nature of knowledge 
utilisation, they overlook the importance of strategic or political ways of utilisation. Finally, the 
political/tactical model leaves unanswered the question of what constitutes proper use. Some 
authors support the view that symbolic use reflects the bad use of knowledge while instrumental 
and conceptual use includes good ways of utilisation (Souchon and Dianmantopoulos, 1994). 
However, in general, the knowledge utilisation models only have been focused on addressing the 
selective ways of use and far less attention has been paid to misuse of scientific knowledge (Nut-
ley, Walter and Davies, 2007).  
 
Accordingly, some authors took on the task of refining Weiss’ work on meanings of knowledge 
utilisation (Landry, Amara and Lamari, 2001; Nutley, 2003; Hoppe, 2005; Hoppe 2009). In many 
cases, these elaborations remained limited to the implementation of another terminology. For 
instance, Nutley (2003) identified four main types of knowledge utilisation. Next to the instru-
mental and conceptual use (comparable to Weiss’ classification), they distinguish (1) mobilisa-
tion of support whereby research is an instrument of persuasion and (2) wider influence, which 
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refers to the impact of research for policy paradigms or belief communities. Nevertheless, it is 
clear that the first addition is strongly linked with the political model, while the second shows 
similarities with the conceptual or enlightenment model. However, some efforts have proved to 
be very fruitful in modelling the science-policy nexus.  
 
Cross et al. (2000) further developed the political and tactical model with the introduction of the 
status model, which refers to the use of a well-stocked portfolio of commissioned research as a 
status symbol for policy agencies. Stevens (2007b and 2011) and Monaghan (2011) respectively 
developed the evolutionary model and the processual model, arguing that Weiss’ models contain 
no information about how researchers get their research noticed by policy-makers and which 
selection mechanisms are used by policy-makers. According to Stevens (2011), this typology 
‘does not include issues of power in the filtering process through which research passes into policy 
and so does not predict systematic bias in the use of evidence’. As both models are of particular 
relevance to the drug policy field, they are further discussed in chapter 2.  
 
2.4.2. Chain of utilisation 
A different set of typology interprets knowledge utilisation as an ongoing process incorporating 
a series of stages/steps, rather than describing the avenues through which modalities 
knowledge may be used. As an example, Dobrow, Goel and Upshur (2004) identified three stages 
of knowledge utilisation: (1) introduction of evidence (i.e. availability and accessibility of evi-
dence), (2) interpretation of evidence (i.e. synthesis, evaluation and assessment of evidence) and 
(3) application of evidence (i.e. interpretation of evidence to support or justify decision). How-
ever, the most well-known stage model is that of Knott and Wildavsky (1980). The original scale 
consisted of 7 stages whereby the first four stages (reception, cognition, reference and effort) 
are related to individual activity. The other three levels were policy process accomplishments 
(adoption, implementation and impact) (Knott and Wildavsky, 1980).  
 
Landry, Amara and Lamari (2001) further elaborated the scale, including six cumulative stages: 
transmission (inputs transmitted to policy-makers, stakeholders, citizens,…), cognition (inputs 
read, seen and understood), reference (inputs cited or referred to in public debate and policy 
deliberations), effort (policy-makers have made an effort to adopt recommendations), influence 
(results have influenced policy choice and decision) and application (results gave rise to imple-
mentation and elaboration in policy practice). Other scales (e.g. the Larsen information utilisa-
tion scale, the Hall stages of concern scale, the Hall levels of use scale, the Johnson evaluation 
utilisation scale, the Pelz and Horsley knowledge utilisation index, etc.) also adopt similar con-
cepts and stages (Landry, Amara and Lamari, 2001; Ottoson and Hawe, 2009). Examining 
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knowledge use as various levels or stages in a chain of utilisation (Landry, Amara and Lamari, 
1999) raises the idea of knowledge utilisation as a cumulative process in which, for instance, 
consistent conceptual use may stimulate instrumental forms of utilisation in the long run. An-
other benefit is that a scale operationalises knowledge utilisation as a complex process that goes 
through a number of stages. However, these stage models offer a strictly linear sequence (i.e. a 
next stage of utilisation can only be reached when the previous one is achieved) while utilisation 
is in fact often more iterative. Furthermore, they fail to uncover political/strategic uses of 
knowledge as well as the importance of context (Nutley, Walter and Davies, 2007).  
 
2.5. Models of policy-making and knowledge utilisation 
Numerous definitions attempt to cover the concept of policy-making (Devos, et al., 2009). For 
instance, Howlett and Ramesh (1995) pointed to ‘a complex phenomenon consisting of numerous 
decisions made by numerous individuals and organizations in government. These decisions are 
often shaped by earlier policies and frequently are linked closely with other seemingly unrelated 
decisions’ (p.3). Kingdon (1995) defines this as a ‘set of processes, including at least the setting of 
an agenda, the specification of alternatives from which a choice is to be made, an authoritative 
choice among those specified alternatives and the implementation of a decision’ (pp. 2-3). Alt-
hough authors adopted different perspectives when defining policy-making, all of these defini-
tions include the idea of a set of complex political processes or interactions of which the most 
crucial and final is the choice of a programme or solution to realise goals (Neilson, 2001). The 
complexity of the policy-making process refers to the different interests and diverse range of 
powerful players coming from different perspectives.  
 
In the literature, some models conceptualise how the policy process works as well as the role 
that scientific knowledge might then play (Hanney, et al., 2003). These models of policy-making 
may be useful for understanding how science and policy may connect (e.g. use may differ on how 
the policy-making process is structured) and are thus largely linked with the knowledge utilisa-
tion typologies (Nutley, Walter and Davies, 2007). Generally, these frameworks or narratives are 
grouped in three (overlapping) accounts (Neilson, 2001; Carden, 2004; Stone and Maxwell, 
2005; Nutley, Walter and Davies, 2007; Monaghan, 2009; Stevens and Ritter, 2013). This over-
view is not exhaustive; I focus on the most prominent models. As each of the models below has 
its limitations and specifications, it is interesting to note that some authors developed an alter-
native conceptual framework by combining elements from several of these models (Walt and 
Gilson, 1994; Trostle, Bronfman and Langer, 1999; Liberatore, 2001; Dobrow, Goel and Upshur, 
2004). Given the overview of these models below, I will emphasise which elements have been 
providing input for the conceptual framework of my study.  
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Table 3: Overview of models of policy-making 
 
Models of policy-making Description 
Authoritative choice (rational/vertical) • Policy-makers as single actors confronting a problem 
• Scientific knowledge as instrumental 
• Evidence based policy-making 
Structured interaction (horizon-
tal/pluralist/political) 
• Multiple participants and diffuse authority in the poli-
cy-making process 
• Focus on relationships and interactions 
• Influence scientific knowledge through participation 
in commissions, informal contacts, etc. 
Narrative • Processes of problematisation and social construction 
• Scientific knowledge is part of problem construction 
and framing 
 
Source: adopted from Stevens and Ritter (2013) 
 
2.5.1. Rational or vertical approach: policy-making as authoritative choice 
The rational or vertical approach outlines policy-making as a problem solving process which is 
rational, balanced, objective and analytical. It assumes that policy-makers go through each logi-
cal stage of the process (agenda – alternatives – implementation – evaluation), and carefully 
consider all relevant knowledge (Sutton, 1999). It is also assumed that the authoritative policy 
elites (i.e, government officials) are the only actors involved neglecting actors external to the 
policy-making process (e.g. media, interest groups, …). The role of the researcher is to research 
and present all of the policy options for policy-makers in order to encourage them to examine 
each of the options (Neilson, 2001). This common understanding of the way in which policy-
making process works is consistent with evidence-based policy thinking. In this framework, the 
stage approach towards knowledge utilisation (i.e. chain of utilisation) as well as the instrumen-
tal models of knowledge utilisation (e.g. Weiss’ knowledge-driven model or problem-solving 
model) have obtained significant importance (see also above, §2.4.4.). However, this speaking 
truth to power approach is subject to substantive critique: it is perceived as too simplistic, mech-
anistic sequential for the process of both knowledge utilisation and policy-making which is, in 
reality, much more arbitrary and complex. In other words, truth is contingent and power is dis-
persed and mediated by a wider set of actors (Hird, 2009). Additionally, some authors character-
ise this belief in technocracy as naïve in its assumption that objective knowledge can be pro-
duced (Fraser and Moore, 2011).  
 
2.5.2. Political or horizontal/pluralist approach: policy-making as structured interaction 
Alternative, so-called political/horizontal/pluralist approaches perceive the policy-making pro-
cess as more diffuse as it involves bargaining, conflicts and negotiation and the dispersal of au-
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thority/power through various spheres and levels of the political arena (e.g. in a country, policy-
making is not restricted to the national level; regional and local government are also involved) 
(Monaghan, 2009). For instance, policy-making is not an authoritative process but a theatre 
where a variety of actors interact with each other (Stevens and Ritter, 2013). Accordingly, deci-
sions can be seen as the outcome of the interplay between diverse participants. Scientific 
knowledge is just one of the sources used by these multiple stakeholders.  
 
In this respect, knowledge utilisation may be more problematic or complex when compared to 
the rational model where utilisation is assumed. As will become clear, the politi-
cal/horizontal/pluralist approach can be seen as an umbrella term covering various views on 
the nature of policy-making (and knowledge utilisation) (Neilson, 2001). Focusing on interaction 
and allowing the input of a range of (internal and external) actors in the policy-making process, 
this approach has also been termed governance. The concept points to the growing influence of 
non-state actors and thus, a policy-making process incorporating a greater range of players than 
those traditionally considered policy-makers (Weiss, 2000; Sanderson, 2009; MacGregor, Single-
ton and Trautmann, 2014). These accounts are consistent with my approach of the science-
policy nexus. 
 
Lindblom’s incrementalist model (or the model of mudding through) is an early example of 
alternative approach of the policy-making process (and knowledge utilisation) (Lindblom, 
1959). Policy-making is seen as an interactive process as this approach compels actors to share 
their interests and views amongst each other. In an attempt to reduce uncertainty, conflict and 
complexity, policy-makers take small incremental steps towards policy change (instead of fun-
damental, instrumental changes) (Neilson, 2001). In this respect, they tend to choose options 
that differ only marginally from existing policy (Sutton, 1999). Within this model, a greater role 
for (political) interest, values etc. is acknowledged; scientific knowledge can be one of the many 
sources that influence policy-makers. As the conceptual as well as political/tactical uses of 
knowledge fits with this muddling through process, this interpretation of policy-making con-
trasts sharply with the EBP movement. There are, however, some limitations to this model 
(Monaghan, 2009). For instance, the incrementalist model does not explain how ideas are se-
lected to be put on the agenda (‘agenda setting’). As this model only focuses on small changes to 
policy, another critique is that it leaves researchers just on the side-lines of the policy-making 
process (ignoring any intense involvement of scientists in the policy-making process, see also 
§1.3.; public criminology).  
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Kingdon presented the multiple streams or agenda setting model7 (Kingdon, 2002; Bekkers, 
et al., 2004; Devos, et al., 2010). Kingdon’s model focuses on the flow and timing of policy action. 
It’s the strength of this approach is that it helps to analyse why and how some subjects and/or 
alternatives are considered for the policy agenda (Kingdon, 2002; Nilunger Mannheimer, Lehto 
and Östlin, 2007). In particular, the stream model defines policy-making as the connection be-
tween three streams: the problem stream, the policy stream, and the political stream (Neilson, 
2001; Brans, et al., 2004).  
 
The problem stream includes the process of problem recognition. Various factors may focus at-
tention on a problem or issue of concern and its importance. In other words, it focuses on the 
political recognition of policy problems where problems come to the attention of policy-makers 
(Radaelli, 1995). The political stream comprises elements such as the national mood, organised 
political interests and government through the influence by people, political parties and political 
ideologies, and can either include or exclude certain issues from the agenda. The policy stream 
refers to the process of the presentation of ideas, generated by a policy community, and the de-
velopment of alternatives. Proposals may be selected on the basis of criteria like feasibility, har-
monisation with dominant norms and susceptibility of politicians. Participants such as scientists 
are not directly involved in just one of the three streams but can be involved in each of them. 
Thus, research must be completed in order for policy-makers to pay attention to their ideas, 
proposals and solutions. Knowledge utilisation is rather unpredictable and may enter into poli-
cy-making from a variety of different sources.  
 
The key to understanding agenda setting lies in the connection between the three streams. 
When this connection occurs, Kingdon spoke of the opening of a window of opportunity (Bekkers, 
et al., 2004; Nilunger Mannheimer, Lehto and Östlin, 2007). At such moments, policy entrepre-
neurs (e.g. individuals championing a particular solution or intervention) may play a particular 
role in forging the connection. Sometimes a window closes when the problem is assessed as 
solved, or when there is a change in government. Because of its dynamic, unpredictable view of 
the policy-making process and knowledge utilisation, this model fits with the enlightenment 
model, in which scientific knowledge may gradually influence shifts in thinking or ideas (Nutley, 
Walter and Davies, 2007). A general drawback of this model is that little account is given to the 
actual minutiae of the policy-making process and, in particular, the conflict that occurs in the 
political arena (Monaghan, 2009). Additionally, as windows of opportunities for policy change 
                                                          
7  This model is based on the garbage can model developed by Cohen, March and Olsen (1972). The garbage can 
model assumes that decision-making is neither rational nor incremental and supposes rather coincidental congru-
ence between problems, solutions and choice opportunities. 
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open infrequently and briefly, the impact of research on policy needs to be evaluated over a long 
time period (Lenton, 2004). 
 
Unlike Kingdon, who focused on how issues arise onto the legislative agenda, some modelling is 
concerned with the ways in which power and influence are exercised in policy (Foucault, 1972; 
Dissanayake, 1992; Ritter and Bammer, 2010). For instance, there may be many mechanisms 
used by policy-makers to influence the distribution and consumption of research (e.g. making 
administrative difficulties; requesting to rewrite sections of the report; delaying the release of 
the findings, etc.) (Walters, 2003).  
 
Weiss (1999 and 2001) developed an iterative model of policy-making about the influence of 
Ideology, Interests, Information, and Institutional rules in policy-making. She acknowledged that 
as research findings move into the policy-making process, they are shaped by, and have to con-
tend with competing beliefs and values (Lindquist, 2001). The distribution of power determines 
whose ideology, interests, information and institutional rules will be dominant. By ideology 
Weiss meant policy-makers’ basic values, political orientation, principles, etc. that underlies 
their approach. Policy-makers are expected to act in accordance with their political ideology. 
Interests reflect for the most part self-interests like re-election, budget increases,…. Institutional 
matters refer to the organisation and context where policy-makers function, and may set power-
ful constraints on what is possible. Information may include research evidence, personal experi-
ences, anecdotes, media reportage, etc. Scientific knowledge is just one type of information, 
competing with other types of information as well as ideology, interests and institutional rules 
(Weiss, 2001). The ways in which groups (including politicians, practitioners and researchers) 
represent their membership, their relative power and influence are key to understanding policy-
making process. In sum, power, ideology and interests often stand in the way of scientific 
knowledge being influential (Weiss, 1999; Ritter and Bammer, 2010). 
 
While the models above still focus on the centrality of the policy-making process (and thus have 
a stronger link with the rational/vertical approach), policy networks models have a more plu-
ralist account, being concerned with the powerful role played by a wider range of actors. Net-
works are considered an important means for enabling and encouraging knowledge and infor-
mation sharing. Analysis of policy networks may be particularly useful as it illustrates how 
groups both influence the policy process and reflect the relative status and power of the various 
interests (Duke, 2003). In terms of knowledge utilisation, this model suggests that scientific in-
volvement is important for knowledge utilisation as they may feed more directly into the policy-
making process. In other words, policy networks models can be seen as related to Weiss’ inter-
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active model (Hanney, et al., 2003). The concept of policy network is used as a label for the dif-
ferent types of involvement. Four types of networks are distinguished in the literature: (1) issue 
networks, (2) epistemic communities, (3) policy communities and (4) advocacy coalitions. They 
may be conceived as on a continuum differing in terms of level of integration, type of member-
ship and the role that scientists may play (Sutton, 1999; Neilson, 2001; Nutley, Walter and Da-
vies, 2007).  
 
An issue network, initially put forward by Heclo (1978), is characterised by participants with 
conflicting interests and little consensus in terms of problem definition or the outcomes of policy 
interventions (Nutley, Walter and Davies, 2007). It is their (non-professional) knowledge of the 
issue that makes them an expert in the area under debate and that binds this kind of network. 
Issue networks are the least integrated type of policy networks. They are characterised by a 
large number of participants and members are free to participate and leave almost at leisure 
(Monaghan, 2009).  
 
An epistemic community, defined by Haas (1992), is considered as a network of professionals 
with recognised expertise in a particular domain or issue area. Scientific knowledge is the key 
variable defining epistemic communities (Radaelli, 1995). Policy-makers turn to epistemic 
communities for advice when faced with uncertainties or sensitive matters. In other words, this 
approach focuses on expert actors in the policy-making process who share their belief in the 
legitimacy and value of bodies of knowledge in supporting policy-making. Knowledge is their 
source of power in shedding light on a problem as well as developing policy (Nutley, Walter and 
Davies, 2007).  
 
Policy communities, emerging in Kingdon’s policy stream, consist of specialists from a range of 
backgrounds both inside and outside the policy-making process (e.g. interest groups, practition-
ers, scientists,…). While epistemic communities coalesce around expertise and scientific authori-
ty, policy communities are based on common understandings of problems or the policy-making 
process in a policy domain. They operate independently of the wider political sphere (Nutley, 
Walter and Davies, 2007). 
 
Advocacy coalitions, a concept based on the advocacy coalition framework (ACF) of Sabatier and 
Jenkins-Smith, consist of people (elected and agency officials, interest group leaders, research-
ers, media etc.) who share a set of basic values, causal assumptions, and problem perceptions 
(Sabatier, 1998). Coalitions are characterised by three belief systems: deep core, policy core and 
secondary aspects. The deep core system is comprised by basic ontological and normative be-
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liefs, the policy core is basic commitments and causal perceptions across the entire policy do-
main, and secondary aspects concerns narrowly held beliefs concerning the seriousness of the 
problem. Deep core beliefs are very resistant to change while secondary beliefs are most condu-
cive to change. This model assumes that coalitions seek power to translate its core beliefs into 
policy. Usually, two or four coalitions are part of the political system at any given time. Accord-
ing to this approach, policy change occurs through the interaction between wide external chang-
es or shocks to the political system and the success of the ideas in the coalitions, which may 
cause actors in the advocacy coalitions to shift allegiances (John, 2003). Here, the goal of science 
may not be to directly influence policy but rather to improve the quality of the debate or evi-
dence and introduce a shift in beliefs (which is partly linked with the enlightenment model) (Sa-
batier, 1998). 
 
2.5.3. Policy-making as a narrative 
Perceiving policy-making as a narrative directs attention towards processes of problematisation 
(e.g. how the problem was defined and understood? By whom?). Within this framework, policy-
making is seen as an arena where variety of actors contest meaning, and scientific knowledge 
may contribute to the construction of the problem (Hajer, 1995; Bacchi, 2009; Fraser and Moore, 
2011; Stevens and Ritter, 2013; Lancaster, 2014). Such a social-constructivist perspective (e.g. 
policy is constructed through language and discourses of several actors) is adopted by the policy 
narratives model. 
 
The policy narratives model sees the policy-making as a process constructing a problem rather 
than responding to a problem. In particular, it emphasises how language or discourse shapes the 
policy agenda (Roe, 1991). In this model, centrality is not given to external events that cause 
policy change, but rather how these events are perceived. The stories or discourses help to sim-
plify complex issues on which policy-makers can base their decisions. Such stories even persist 
in the face of empirical evidence to the contrary: counter-narratives are necessary to counter 
policies (Sutton, 1999; Neilson, 2001). Using a policy narrative model may help to gain a deeper 
understanding of how policy is made and which discourses arise, compete and emerge, but is 
less informative about the perceptions of policy-makers and/or scientists as to whether or not 
scientific knowledge is (not) used in the policy-making process, which is focus of this study 
(Neilson, 2001; Bak Jørgensen, 2011).  
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2.6. Knowledge exchange/linkage models 
Following along the lines of the earliest paradigm concerning the science – policy nexus, the two 
communities thesis, models were developed about how to bridge the gap between both. Alt-
hough clearly related to the models of knowledge utilisation (the importance of interaction or 
exchange between both worlds, for example, fits well with the interactive model of Weiss), these 
models focus on knowledge exchange and linking, or in other words, the role of boundary organ-
isations/arrangements (e.g. consultancy, advisory boards, etc.) and the policy-making process 
rather than types of knowledge utilisation as such (Lomas, 2000). In other words, their starting 
point is the view that there is a missing connection between science and policy.  
 
Knowledge exchange/linkage models describe a continuum of boundary arrangements endors-
ing three principles: (1) primacy of policy (e.g. politicians have the first and the last say), (2) 
primacy of science (e.g. science dominates politics; policy-makers are dependent on scientific 
procedures, techniques and thinking) and (3) dialogue or debate between science and policy. 
Even though these models (and terminologies) are rather confusing and overlapping, I tried to 
reconstruct the most important elements alongside two axes: primacy versus dialogue 
(Wittrock, 1991; Hoppe, 2005; Hoppe, 2009; Smet, 2013).  
 
Table 4: Models of knowledge exchange/linkage 
 
Primacy (linear) Dialogue (interactive) 
Primacy for policy • advocacy models  
(adversarial model; dispositional 
or discourse coalition model) 
• learning models (model of pure 
learning; coping model) 
• bureaucratic model 
• organisational interests model 
• engineering model 
• demand pull model 
  
Primacy for science  
• science push model  
• dissemination model  
• enlightenment model 
• technocracy model 
 
 
Source: adopted from Hoppe (2005); Landry, Amara and Lamari (2001); Smet (2013) 
 
In general, according to the principle of primacy, utilisation follows a linear sequence from sup-
ply of research advances to utilisation by policy-makers and practitioners (rational or linear 
model, see also §2.4.1.). Supporting primacy of policy, I generally distinguish the bureaucratic 
model, the organisational interests model, the engineering model and the demand pull model. In 
the demand pull model, knowledge utilisation depends only on the needs of the politicians. The 
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more researchers try to focus on the needs of policy-makers, the more their research will be 
used (Landry, Amara and Lamari, 2001; Ottoson and Hawe, 2009; Cherney and MacGee, 2011). It 
is clear that the emphasis lies on instrumental/rational use of scientific knowledge. A variant of 
the demand pull model is the organisational interests model. This model assumes that organisa-
tional structures, rules and norms are essential determinants of knowledge utilisation (Lampi-
nen, 1992; Oh, 1998). Thus, research needs to fit with these issues in order to guarantee a prob-
lem solving policy-making process which is rational, balanced, objective and analytical. Fur-
thermore, political responsibility and divergence between politics and science are considered in 
the bureaucratic model. In this model, the recruitment and mobilisation of expert knowledge 
from society to policy is highlighted. Here, scientists are often incorporated into state institu-
tions and loyal instrumental input is promoted (Hoppe, 2005; Hoppe, 2009). In a similar vein, 
the engineering model stresses political responsibility. However, unlike the bureaucratic model, 
policy-makers are on top and experts on tap. Scientists are less formally bound to the govern-
ment. Instead, policy-makers formulate knowledge questions and assign detailed research pro-
jects to scientists. Even though the gap between both communities is bridged through con-
tracts/projects, policy-makers still manage the priorities and funding of these research pro-
grammes (Wittrock, 1991).  
 
Primacy of science is considered in several other knowledge exchange/linkage models. The 
science push model stresses the supply of advances in research findings as the major determinant 
of knowledge utilisation. In other words, the central assumption is that scientific knowledge as 
such (and its quality or content) is the determinant of knowledge utilisation in the policy-making 
process. A variant is the dissemination model, which analyses knowledge utilisation with the re-
course to two determinants: the types of research results and the dissemination effort (Landry, 
Amara and Lamari, 2001). Furthermore, the enlightenment model emphasises a gap between 
politics and science and opts for primacy of science. Knowledge slowly trickles down to the po-
litical domain. Politicians walk in darkness and scientists in daylight; science is crucial for pro-
gress. However, it is still the decision of politicians to use scientific knowledge. Scientists reject 
any responsibility for knowledge exchange, dissemination or application. Finally, primacy of 
science and strong convergence between science and policy characterise the technocracy model. 
As their goals are the same, scientific knowledge holds the power and politics legitimises it. In 
this model, scientists act as administrators or central policy-makers on vital positions of power. 
 
Some models do not presuppose primacy but dialogue. The emphasis on dialogue or debate 
between science and policy suggests that knowledge utilisation depends on various interactions 
between researchers and users rather than on linear sequences. The more sustained and intense 
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the interaction between researchers and users, the more likely there will be utilisation. This ap-
proach explains utilisation by types of research and scientific disciplines, needs and organisa-
tional interests of users, dissemination and linkage mechanisms (Landry, Amara and Lamari, 
2001; Ottoson and Hawe, 2009). In the literature, they speak of advocacy models and learning 
models (Hoppe, 2005; Hoppe, 2009).  
 
The advocacy model considers the societal functions of politics and science as analogous but di-
vergent. This model includes two approaches: the adversarial and dispositional approach. In the 
adversarial model, scientific arguments serve as political ammunition to improve the quality of 
the political debate. In other words, science is part of the political struggle in which scientists 
advocate for a particular policy direction. The role of science in the dispositional or discourse 
coalition model is to provide (new) concepts which may function as conceptual bridges between 
knowledge and policy. Boundary arrangements are made by means of producing texts, docu-
ments, procedures, overlapping memberships by experts and policy-makers, etc. Several coali-
tions exist and each of the coalitions in a given policy area share a particular discourse or belief 
system (cfr. advocacy coalition model of Sabatier, see above, §2.5.2.).  
 
In the policy-oriented learning models, politics is a forum for debate (and not an arena, as in the 
advocacy model). Convergence and dialogue are more important than in advocacy models 
(Brans, et al., 2004). All actors, even policy-makers, are considered scientists, in a sense, engaged 
in a process of social learning through social debate. Two learning models are distinguished: the 
model of pure learning and the coping model. The model of pure learning considers the policy 
process as a sort of research process. First, a policy or policy program is viewed as a set of hy-
potheses about the causal links between certain (collective, organisational) acts and a specified 
(desirable) future state of affairs. Second, policy-making is social experimentation: close moni-
toring of the degree of goals achievement can help to eliminate errors gradually. Finally, policy-
makers evaluate the problem-solving capacity of policy programs. In the coping model, the focus 
is on interactive processes of problem coping. Policy change is considered as a search process 
through trial-and-error, threatened by the political inclination to try and the political constraint 
not to fail. While policy-makers, interest groups and the public primarily rely on their common 
sense, only from time to time they allow scientists to have an input (Wittrock, 1991; Hoppe, 
2005; Hoppe, 2009). 
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3. Empirical research unravels conceptual models and relationship prob-
lems 
 
Since the end of the 1960s, various scientists have attempted to conceptualise the science-policy 
nexus into models (Schryer-Roy, 2005), as I discussed in §2. Later on, empirical study began on 
the relationship between science and policy. In particular, social scientists started reviewing the 
policy-making process in an attempt to map and increase the uptake and use of their research by 
policy-makers. Before I discuss the results of those studies, I must investigate the underlying 
(conceptual and) methodological issues and characteristics.  
 
3.1. Product versus process design 
The 1970s and early 1980s can be judged as the starting point of empirical study of and thought 
on knowledge utilisation (Bogenschneider and Corbett, 2010). Scientists gave a great deal of 
thought to the way policy-making was done and how scientific knowledge fit into the policy-
making process. Following the early theoretical assumptions elaborated in detail above (Caplan, 
1979), many early studies viewed knowledge utilisation as a linear pipeline from knowledge 
producers to knowledge users, an instrumental process whereby findings will be used directly 
by policy-makers to adapt their policy or to take action (outcome or product design). Further-
more, there was little recognition that policy-makers had to take into account other knowledge 
from other sources. Although this is a reductive approach, many of the researchers who worked 
on the original empirical studies held such beliefs. These early international studies were 
skewed strongly towards quantitative research methods, thereby focusing on surveys among 
policy-makers and/or scientists or bibliometric analyses of academic citations in policy docu-
ments.  
 
Through these early studies, researchers were finding that research was not having much influ-
ence on policy decisions. Many disillusioned scientists published articles in professional journals 
bemoaning the neglect of their work. Along with these concerns came the recognition that 
measurements of research impact cannot be limited to examples of direct, instrumental use of 
research within a single decision point. Neither can it rely on the traditional mechanisms of 
measuring academic success, such as academic citations or publications and memberships of 
advisory groups (Brambila, et al., 2007). 
 
In the past decade, many researchers have sought to use methods which better reflect the reality 
of the policy-making process and the dynamic role that research plays within it (Ritter and Lan-
caster, 2013) (process design). Leaving aside some exceptions (e.g. Landry, Lamari and Amara, 
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(2003) who examined knowledge use as various levels or stages in the chain of utilisation; 
Mulder et al. (1991) preferred to analyse and count references in policy documents), many au-
thors (i.e., Webber, 1991; Weiss, 1995; Rich, 1997; Oh, 1997; Elliot and Popay, 2000; Linquist, 
2001; Ottoson and Hawe, 2009) left the strict focus on the rational/instrumental model of poli-
cy-making, with its positivistic epistemological foundation, and became sympathetic towards the 
emerging view that recognises the roles of knowledge and context, and acknowledges the diffi-
culties in reconciling them in the context of policy-making processes (O’Dwyer, 2004; Brambila, 
et al., 2007). Therefore, an interactive approach, linked to interpretivism and the critical para-
digm, was recognised as a better approach to the science-policy nexus (Hunter, 2009). Equally, 
regarding utilisation as a process (instead of utilisation as outcome), use may mean that infor-
mation has been received and read, that information is judged to be relevant or valuable. In oth-
er words, as with the enlightenment or conceptual model, this does not imply that information 
has been understood and that action has been undertaken but rather implies that information in 
some way has contributed to a decision, an action or thinking about a problem (Rich, 1997). 
Gradually, the perspectives of and the interactions between policy-makers, as well as research-
ers and the third community (e.g. media, think tanks,…), were also integrated. They argued that 
the dichotomous construction of the science-policy nexus as two communities is not useful in 
analysing and understanding how and when knowledge is used by policy-makers (Brans, et al., 
2004; Bacchi, 2008). Parallel to these reconsiderations came a rethinking of methods for study-
ing research use. Scientists began to realise that the fixed survey form, with its fixed questions 
and constrained choices of answers, was not necessarily the only way to go. As a consequence, 
scientists increasingly favoured qualitative inquiry and interviews in particular (Linquist, 2001; 
Carden, 2004).  
 
3.2. Methods for studying the science-policy nexus 
As a result of the changing conceptual framework, a variety of methodological approaches has 
been employed to measure knowledge utilisation in the policy-making process. I distinguish 
surveys, documentary analysis, case studies, narrative analysis, interviews and ethnographic 
studies. 
 
A common method to measure knowledge utilisation is a survey, which asks respondents (at 
different levels of the government, in different positions of power) to provide what information 
they acquired and used (Sorian and Baugh, 2002; Klein Haarhuis, Hagen and Scheepmaker, 
2009). Surveys may lead to observation of a large number of individuals, at all stages of 
knowledge production and utilisation. (Landry, Amara and Lamari, 1999; Smet, 2013). A survey 
may also help to measure the extent of knowledge utilisation. For instance, Caplan (1979) sur-
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veyed 204 policy-makers about the extent of their interactions with scientists while Landry, La-
mari and Amara (2003) conducted a mail survey of 833 government officials from Canadian 
government agencies. In another study, a survey of 292 policy-makers was used to determine 
policy-makers’ formal and informal methods of acquiring information about health policy issues 
(Sorian and Baugh, 2002). Some studies explored the views of researchers (instead of policy-
makers): Cherney and McGee (2011), for example, replicating the study of Landry, Lamari and 
Amara (2003), surveyed 1,229 Australian academic sociologists and criminologists about the 
different stages of utilisation of their research. In a recent Belgian study about the use of social 
science in the policy-making process, both policy-makers (97) and social scientists (641) were 
surveyed (Smet, 2013). In each of these studies, respondents could say ‘strongly agree’, ‘mostly 
agree’, ‘mostly disagree’, or ‘strongly disagree’; they could give a numerical response; or provide 
other short-form answers. An important critique on this self-report method is that respondents 
use their own definitions of use (Rich, 1997). Other important limitations are that respondents 
may tend to reply in a manner that will be viewed favorably by others (social desirability bias) 
and that the statements about (indirect) knowledge utilisation cannot be measured accurately 
(Weiss and Bucuvalas, 1980; Landry, Lamari and Amara, 2003; Klein Haarhuis, Hagen and 
Scheepmaker, 2009; Smet, 2013).  
 
Analysing (policy) documents/reports (e.g. content/discourse analysis, citation/bibliometric 
analysis) is less prevalent as single method (Rich, 1997). As the availability of such information 
is usually very limited, documentation is more often used as background information (Elliott and 
Popay, 2000; Lindquist, 2001; Daniels and Lewin, 2008; Dobrow, Goel and Upshur, 2006). How-
ever, some authors supported the usefulness of document analysis as a single method, especially 
when a variety of documents is involved such as (1) documents including discussions, debates or 
conversation, (2) documents including formal articulations of policy and (3) media documents 
(Ritter and Lancaster, 2013). 
 
Methods of (in-depth) interviewing are often used to reconstruct processes and depict nuances 
of knowledge utilisation (Trostle, Bronfman and Langer, 1999; Elliott and Popay, 2000). In par-
ticular, interviews may help to explain the perceptions of policy-makers and/or researchers as 
to the extent to which scientific knowledge informs public policy (Neilson, 2001). In most cases, 
only officials from different levels and hierarchies are interviewed (Linquist, 2001; Carden, 
2004). Researchers from different institutions and other relevant actors (i.e. journalists, mem-
bers of interest groups, practitioners) are less frequently interviewed in order to understand the 
science-policy nexus. Exceptionally, Trostle, Bronfman and Langer (1999) interviewed 67 re-
searchers and policy-makers from different institutions and levels of responsibility in order to 
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examine the relationship between health research and policy. Similar, Elliot and Popay (2000) 
conducted 28 interviews with lead health authority managers, researchers and community de-
velopment workers. Haynes et al. (2011b) focused only on researchers, interviewing 36 peer-
nominated and highly influential Australian public health researchers.  
 
Most authors agree that case studies are the approach best suited to understanding the science-
policy nexus (Carden, 2004). Case studies allow to answer how and why questions whereas sur-
veys or other methods mainly help to answer what questions. Although case studies lack exter-
nal validity, a this approach is chosen most frequently (Elliott and Popay, 2000; Landry, Amara 
and Lamari, 2001; Brans, et al., 2004). In most studies, a number of cases are selected where 
there is at least some interaction between researchers and policy-makers. For example, in their 
study on the impact of research on migration on public policies, Brans et al. (2004) selected two 
policy domains: (1) education and (2) labour market. Bak Jørgensen (2011) selected the migra-
tion policy of two countries as two cases, comparing the role of expertise in migration policy in 
Denmark with that of Sweden. Furthermore, the WODC (Wetenschappelijk Onderzoek- en Doc-
umentatiecentrum) as well as the IDRC (International Development Research Centre) conducted 
a study about the utilisation of research results originating from WODC or IDRC projects 
(Carden, 2004; Klein Haarhuis, Hagen and Scheepmaker, 2009). The IDRC study, for instance, 
addressed what constitutes policy influence, to what degree and in what ways research has in-
fluenced policy and what factors and conditions have facilitated or inhibited the potential to 
influence policy. Twenty-five case studies were the heart of the strategic evaluation: they con-
cerned a literature review; a review of project reports and programming documents; an inven-
tory of evaluations conducted; and interviews with senior staff (Linquist, 2001; Carden, 2004).  
 
Few studies examine the science-policy nexus from a narrative analytical perspective (Rich, 
1997; Oliver, et al., 2014), however, such an analysis could assist in studying how discourses can 
be identified as ways of defining and analysing problems. Some examples, however, considered 
how scientific discourse has influenced how policy is made and which policy discourse is adopt-
ed. Their approach was to analyse the effects of discourse (instead of to the content or sources of 
the text). For instance, Bak Jørgensen (2011) focused on the role of social scientists in the social 
construction of policy narratives about migration, particularly its influence on agenda setting 
and conceptual rethinking of immigrant integration policies. In a similar vein, Jacob (2006) ana-
lysed the utilisation of two academic narratives about innovation policy in policy discourse by 
examining policy representations of the problem issued by one Swedish agency. Lastly, Hoppe 
(2009) explored the extent to which policy-makers’ discourses do (not) show similarities to the 
academic typology of boundary work. 
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Finally, and even more exceptionally, an ethnographic study of the use of evidence in policy-
making has been conducted (Petersilia, 2008; Stevens, 2011). As policy process is typically ex-
amined through analysis of its outputs or accounts given by policy-makers, there is a real pauci-
ty of direct examination of the policy process. To illustrate, Petersilia (2008), working as a policy 
advisor on correctional reform in California, observed the work of colleagues and their interac-
tions with other special advisers to the Californian Governor.  
 
3.3. Focus on health domain 
The science-policy nexus can be considered an overarching theme that is of interest in many 
countries and many policy domains (Estabrooks, et al., 2008). As a result of the growth of the 
concepts of evidence-based medicine and evidence-based practice, it is somehow logical that most 
empirical studies on the interface between policy and knowledge focus on the health (clinical) 
domain (Harries, Elliott and Higgins, 1999; Tomson, et al., 2005; Gagliardi, et al., 2008; Hyder, et 
al., 2011). Common policy themes where the science-policy nexus is studied include cancer 
screening, AIDS, cholera, family planning, immunisation, mental health, social care, surgical in-
tervention. The research focus mostly lies in the translation of findings and links among re-
searchers and policy-makers, including the mechanisms which facilitate or impede knowledge 
utilisation (Davis and Howden-Chapman, 1996; Harries, Elliott and Higgins, 1999; Sorian and 
Baugh, 2002; Trostle, Bronfman and Langer, 1999; Tomson, et al., 2005; Brambila, et al., 2007; 
Daniels and Lewin, 2008; El-Jardali, et al., 2012). 
 
More recently, the interface between policy and knowledge has also been studied in social, eco-
nomic and environmental policy domains (Carden, 2004; Hoppe, 2009). In this study, I am for 
the most part interested in the efforts on the criminological domain. Leaving aside the valuable 
analytical reflections of, for instance, Chan (1995), Loader and Sparks (2011), in the (public) 
criminological field, the complex relationship between science and policy, as well as the en-
gagements of scientists in the public and political domain, are rarely approached from within or 
exposed to profound observation by criminologists (Tonry, 2010; Wacquant, 2011). Or, as Load-
er and Sparks (2011) argued: ‘Studies of the recent political uses of knowledge are much needed in 
the field of crime and punishment and […] acquiring a working understanding of the ‘contexts of 
reception of criminological knowledge (and how they are structured and operate)’ is essential to 
effectively gearing criminology and policy.’ (p.12). All too often, criminologists have been observ-
ers after policies are decided and implemented instead of examining to the so-called black box of 
the policy-making process, where the formation of these policies takes place (Rock, 2010). At-
tention to public and policy processes is too rarely given, probably due to the methodological 
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complexity of studying the science-policy nexus (Ritter and Lancaster, 2013) and the fact that 
criminological issues have a rather high symbolic content (Brereton, 1996).  
 
However, I have found some exceptions addressing topics like criminal (juvenile) justice policy 
(Brereton, 1996; Marston and Watts, 2003; Petersilia, 2008; Freiberg and Carson, 2010; Devroe, 
2010; Vande Walle, 2010), the emotional well-being of young people (Ottoson and Hawe, 2009) 
and migration (Brans, et al., 2004; Scholten, 2011). While drug policy has also shared these 
tendencies (Berridge, 2002), studies about the science-policy nexus in the drug policy area are 
discussed in detail in chapter 2.  
 
In a context in which migration issues are often thought of in terms of security and social prob-
lems, the issue of the linkage between science and policy has become topical. For instance, in the 
UNESCO MOST (Management of Social Transformations) programme, the purpose is to transfer 
relevant social science research findings and data to policy-makers and other stakeholders. As a 
result, this programme established a number of research projects in several countries (Brans, et 
al., 2004). In Belgium, a research project was funded by the Belgian Federal Science Policy Office 
and aimed to evaluate the impact of research about migration on public policies. It measured the 
extent to which policy design in the field of migration has rested on the results of scientific 
knowledge (in agenda setting and policy formulation); the role of researchers in the implemen-
tation of policies in the field of migration (policy implementation); and how knowledge utilisa-
tion between scientists, policy-makers and stakeholders may be improved (Brans, et al., 2004). 
The project has followed the framework of inquiry suggested by UNESCO research programme 
and used, among others, the agenda setting theory of John Kingdon (1995).  
 
Scholten (2011) also examined the science-policy nexus in the context of the development of 
immigrant policy. He focused on the role of research in Dutch policy structures by distinguishing 
between various models of knowledge utilisation (Weiss, 1979). The central theme of his work 
was the relationship between various structures of science-policy nexus and the framing of im-
migrant integration policy in the Netherlands over the past three decades. As a final example, 
Bak Jørgensen (2011), adopting the policy narratives model, investigated the role of expert 
knowledge in migration policy in Denmark and Sweden. 
 
Some studies have analysed the use of research evidence in criminal (juvenile) justice policy, 
particularly in the field of crime prevention (Farrington, 2006; Freiberg and Carson, 2010; 
McNeill, et al., 2012). First of all, Brereton (1996) studied the role that scientific knowledge can 
play in shaping policy and practice in the Australian criminal justice system, focusing on the 
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mechanisms of the policy process as well as the utility of scientific knowledge. Marston and 
Watts (2003) criticised the emergence of the evidence-based policy discourse in Australia by 
examining the foundations of the evidence-based claims in policy documents or reports concern-
ing criminal juvenile justice policy. Furthermore, by means of an analytical assessment of the 
youth justice programme, Goldson (2006) also tried to find out if the policy-making in the youth 
justice sphere is evidence-based. Furthermore, Brants (2002) studied the use of criminological 
empirical studies and theories in election programs of political parties in the Netherlands. As a 
public criminologist (contributing to the inner workings of state government), Petersilia (2008) 
studied the relationship between research and policy on the California prison reform, specifical-
ly about how criminologists can utilise knowledge to influence policy choices.  
 
Finally, even though the interest in studying the science-policy nexus in Belgium is rather lim-
ited, three relevant Belgian initiatives are worth mentioning. Vande Walle (2010) studied the 
use of evaluation studies in the Belgian criminal justice policy-making process, reflecting on the 
models of Weiss (1979), while Devroe (2010) analysed the knowledge base of the Belgian crimi-
nal justice policy over a period of 15 years (between 1995 and 2008). Smet (2013) examined the 
extent and nature of the utilisation of social scientific research in general in Flanders.  
 
3.4. Empirical results 
Understanding knowledge utilisation is difficult: it is a complex task to demonstrate how outputs 
such as scientific knowledge affect outcomes and policy impacts (Rich, 1997). Assessments are 
difficult due to the multiplicity of actors and the dynamics of policy processes (Ritter and Lan-
caster, 2013). Empirical studies also often use different terms to refer to similar concepts (e.g. 
the notions knowledge/policy, science/policy or research/policy are used as interchangeable 
concepts) (Berridge and Stanton, 1999; Bekkers, et al., 2004) or a distinction between basic8 
versus applied research is often not made (Weiss, 2001; Smith, 2010). Methodologically, the 
measurement and specification of use (e.g. utilisation as outcome vs. utilisation as process) and 
the checklists of variables (e.g. research products, policy contextual factors, dissemination and 
links between researchers and policy-makers) are diffuse. At the same time, some studies focus 
on particular researches or research programs while others take a policy on a particular topic or 
a particular policy measure to assess knowledge utilisation. Finally, I found a predominance of 
Anglo-Saxon examples (e.g. United States, Canada, Australia and the United Kingdom) which 
suggests that extrapolation of these results to another country or policy domain is limited (e.g. 
                                                          
8  Basic (or fundamental, bottom-up) research is driven by a scientist's curiosity or interest in a scientific question. 
Applied (or top-down) research, on the other hand, is designed to solve practical problems of e.g. policy-makers, 
rather than to acquire knowledge for the scientific community (Devroe, 2002). 
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due to the differences in political system or the sensitivities of the matter) (Tonry, 2010; Hyder, 
et al., 2011; El-Jardali, et al., 2012).  
 
However, while the debate about the methodological framework is still ongoing (Ritter and Lan-
caster, 2013; Tieberghien, 2014b), there is some consistency between empirical results (Landry, 
Lamari and Amara, 2003; Smet, 2013). A distinction can be made between studies focusing on 
knowledge utilisation typologies (knowledge utilisation literature) and studies focusing on the 
concept of the interface between researchers and policy-makers (knowledge exchange litera-
ture). 
 
3.4.1. Results about knowledge utilisation 
Empirical studies measuring the use of knowledge in policy-making in a particular policy do-
main on the local or national level operationalised Weiss’ knowledge utilisation typology by de-
veloping a three-folded classification system distinguishing the instrumental model, the politi-
cal/symbolic model and the enlightenment model (Lester, 1993; Chan, 1995; Brereton, 1996; 
Rich, 1997; Oh, 1997; Sorian and Baugh, 2002; Hanney, et al., 2003; Amara, Ouimet and Landry, 
2004; Smet, 2013; Stevens, 2007; Monaghan, 2008a; Head, 2010; Freiberg and Carson, 2010).  
 
Table 5: Three-folded typology of knowledge utilisation 
 
Three-folded typology  Meanings of utilisation Description 
Instrumental  • knowledge driven model 
• problem-solving model 
This model represents the typical under-
standing, a rather static approach, of the 
science-policy nexus. It assumes that sci-
entific knowledge has a direct bearing on 
policy. 
Enlightenment / conceptual • interactive model 
• enlightenment model 
• intellectual model 
A dynamic perspective of the science-
policy nexus is supported in this model. 
Scientific knowledge can be conceived as 
part of the process of policy-making. Utili-
sation must be considered as a series of 
events or processes which may (not) lead 
to a specific action/decision 
Political/symbolic  • political model 
• tactical model 
Offering a more strategic approach of 
knowledge utilisation, in this model, scien-
tific knowledge is considered as ammuni-
tion for political sides. It can be used to 
silence the arguments of the opposition or 
to support ideas, which the policy-makers 
have already adopted.  
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Even though there is considerable variation between studies, according to the interpretation and 
conceptual framework used, there is generally least evidence for instrumental use of research 
(Chan, 1995; Brereton, 1996; Weiss, et al., 2008). International studies mainly agree about the 
rather incremental impact of scientific knowledge in the policy-making process (enlighten-
ment/conceptual use) and its political/symbolic use (Young, et al., 2002; Bak Jørgensen, 2011). 
For instance, Chan (1995) pointed to Braithwaite’s ‘reintegrative shaming theory’ which has 
been adopted in pre-trial programs aimed at diverting juvenile offenders as an example of the 
enlightenment function. Some Belgian (criminological) studies on the science-policy nexus also 
revealed that although direct use was intended by policy-makers, more examples of indirect 
utilisation were observed (Vande Walle, 2010; Smet, 2013). Furthermore, Marston and Watts 
(2003), analysing the use of research evidence in criminal (juvenile) justice policy, pointed to the 
risk that evidence-based policy becomes a means for policy elites to increase their strategic con-
trol (political/symbolic model). They concluded that the (often causal) assumptions of the juve-
nile justice research preclude what might be considered a reasonable evidence-based approach 
of policy-making.  
 
Equally, Goldson (2010) found arguments that the policy trajectory concerning youth justice 
systems moved in an opposite direction to the route outlined by research knowledge. Likewise, 
Brants (2002), examining the use of criminological empirical studies and theories in election 
programs of political parties in the Netherlands, concluded that criminological insights are used 
selectively by political parties and that criminologists have to be conscious of the normative and 
political implications of theory and research. In terms of the types of utilisation altogether, em-
pirical studies conclude that conceptual use is more frequent than political/symbolic utilisation 
with instrumental use found less frequently. For instance, Landry, Lamari and Amara (2003), 
conducting a mail survey of 833 government officials from Canadian government agencies, con-
cluded that 53% of the research have never influenced decisions, whereas 9% have usually or 
always influenced decisions. Similarly, through a survey of 833 government officials, Amara, 
Ouimet and Landry (2004) found that 12% of the respondents reported instrumental use while 
16% reported symbolic use and 22% conceptual use. Similar results were found by means of 
qualitative inquiry. For instance, Petersilia (2008), taking up the role of an embedded criminolo-
gist, concluded that scientific knowledge does not drive crime policy directly but rather concep-
tually or politically. Each of these studies clearly supports the usefulness of a process design in-
stead of an outcome design. At the same time, these results suggest that the types of utilisation 
must indeed be considered as complementary rather than as contradictory dimensions. 
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Given the typology of the chain of utilisation, most studies make general comments on the policy-
making process. They argue that the complexity of the policy-making process cannot easily be 
divided in particular phases, or that such a focus may lead to an unrealistic simplification of the 
policy-making process and may face the difficulties identifying the transition from one phase to 
another (Teisman, 2001; Devos, et al., 2009). Nevertheless, some studies have attempted to 
study knowledge utilisation in several phases of the policy-making process, taking into account 
the chain of utilisation (Penninx, 1988; Lampinen, 1992; Landry, Amara and Lamari, 2001) or 
have focused on one particular phase, such as agenda-setting (Kingdon, 2002; Brans, et al., 
2004). For example, Lampinen (1992) distinguished (a) awareness, (b) politisation, (c) institu-
tionalisation and (d) evaluation which he respectively linked with knowledge utilisation models 
like (a) conceptual use, (b) political/conceptual use, (c) conceptual/political/instrumental use, (d) 
conceptual/instrumental use. Results of these empirical studies applying the chain of utilisation 
have provided no consensus. While it is sometimes assumed that scientific knowledge can play 
an equal role in each phase, others argue that the degree of knowledge utilisation is the largest 
in the first phases (e.g. agenda setting) and decreases in the final phases of policy-making (Pen-
ninx, 1988; Lampinen, 1992; Landry, Amara and Lamari, 2001; Cherney and MacGee, 2011). In 
this study, I aim to examine the contribution of scientific knowledge at both the parliamentary 
and governmental level, with the expectation that the relationship between science and policy 
may differ across the policy-making process. 
 
3.4.2. Results about barriers and facilitators regarding the science-policy nexus 
The positive or negative interaction between researchers and policy-makers is perhaps the most 
frequently addressed topic in studies of the science-policy nexus, either as part of a knowledge 
utilisation study, or as a knowledge exchange study as such (Mitton, et al., 2007; Head, 2010). 
Exchange or linkage issues incorporate the idea that there are two different worlds or communi-
ties that have to be bridged (two communities thesis) and pay more attention to the contextual 
issues (which are rather lacking in the knowledge utilisation models).  
 
The obstacles to interactions between research and policy are frequently classified into three 
categories: shortcomings/barriers related to research(ers); shortcomings/barriers related to 
policy-makers or the policy-making context; and shortcomings/barriers in the links between 
those two. Both barriers and facilitators are linked with organisational characteristics (position, 
length of career, incentive system) on the one hand, and individual characteristics (individual 
needs and perceptions) on the other (Oh, 1997; Oh, 1998). The question of how research results 
fail to influence policy-making has also led to thinking about the mechanisms to enhance the 
understanding of the dynamics at play (Wagner, 1991; Lavis, et al., 2003; Jacobson, Butteril and 
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Goering, 2003; Schryer-Roy, 2005). As will become clear, some of these barriers/facilitators are 
linked with the knowledge utilisation models as well as models of policy-making.  
 
Many empirical studies highlight barriers for policy-makers to the use scientific knowledge, 
such as limited budgets (e.g. economic context); timing mismatch (i.e. scientific research can 
take years to complete whereas policy issues often rise rapidly to the top of the political agen-
da); and the level and complexity of the policy-making process. From the perspective of the poli-
cy-makers, research findings are but one contributory source that is filtered into policy-making 
(Weiss and Bucuvalas, 1980; Ritter, 2009). Policy-makers take into account the rules of the game 
of which they are at least partially aware (Stevens, 2011).  
 
Other powerful, legitimate elements are at the table too. For instance, policy-makers need to 
deal with values and opinions of political parties (e.g. some parties, especially liberal and socio-
democratic, seem to be more devoted to the value of scientific knowledge than others (Devroe, 
2002)); the characteristics of the policy system (e.g. single-party system, two-party system or 
multi-party system; government party versus opposition); political climate (e.g. moral panic, 
windows of opportunity); elections; affected stakeholders; and the general public (Wagner, 
1991; Kingdon, 2002; Lenton, 2004; Bowen and Zwi, 2005; Mitton, et al., 2007; Ritter, et al., 
2007; Huston, 2008; Klein Haarhuis, Hagen and Scheepmaker, 2009). Each of these elements 
may determine how a social problem is constructed, how questions are asked, what answers are 
expected and if or how scientific knowledge plays a role (Berridge, 2002; Hartnoll, 2004). For 
instance, a multi-party system seems to stimulate more knowledge utilisation than a single or 
two-party system (Weiss, 1999) and findings that fit with ideology and party interests are more 
likely to be used (Nutley, Walter and Davies, 2007).  
 
Next to organisational and political factors, the preparedness of the individual policy-maker to 
use research results, his/her prior knowledge, experience and beliefs are also crucial (Lavis, et 
al., 2003). This so-called tacit knowledge is knowledge acquired by individuals implicitly, 
through performing personal and professional activities (Smet, 2013; Richardson, 2013). For 
instance, policy-makers with more education and experience of research will be more in favour 
of using research.  
 
Research contexts also shape the uptake of research. From the researcher’s perspective, a bar-
rier is the dissonance between what is rewarded within the academic community and what is 
valued by policy-makers (Nutley, Walter and Davies, 2007; Ritter, 2009). As writing policy-
oriented briefings is not recognised as valuable work within the academic world, many academ-
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ics argue that dissemination and engagement with policy-makers is not their role (see also pub-
lic criminology, §1.3.). For instance, a study of Landry, Amara and Lamari (1999) found that 
nearly 50% of the Canadian scholars in social science reported that they usually or always 
transmit their research findings to policy-makers and practitioners. However, due to the de-
creasing research funding nowadays, there is a growing pressure to produce policy relevant 
research. Stronger attachment to the commissioning authorities may diminish the independent 
capacity of academia to provide a space in which innovative ideas can be developed (Smith, 
2010).  
 
Next to the system characteristics in which researchers work, most common complaints are relat-
ed to the characteristics of scientific knowledge: unresponsiveness to policy-makers’ needs (e.g. 
research findings may be not relevant enough for practice-based issues and policy-makers pre-
fer to use findings from the accepted body of knowledge instead of new, recent findings (Weiss, 
et al., 2008)); fragmented data; the academic format of communication (e.g. concise and jargon 
free communication is preferred; actionable messages are preferable to long research reports); 
and evidence that fails to cumulate or yields contradictory findings (an ongoing source of frus-
tration for some policy-makers) (Lavis, et al., 2003; Weiss, et al., 2008). For instance, in the study 
by Sorian and Baugh (2002), policy-makers estimated that 49% of the information they receive 
is not relevant to their current work. Furthermore, conflicting recommendations by different 
authors may lead to uncertainty and this can be exacerbated by, for instance, selective use of 
evidence by powerful interest groups or by the media (Mulder, et al., 1991).  
 
The presence of each of these barriers also depends on the social science discipline and research 
approach. According to Landry, Amara and Lamari (2001) the professional social sciences (so-
cial work, health and employment) lend to higher levels of utilisation than the disciplinary social 
sciences (economics, political science, sociology, criminology and anthropology). The research 
approach (quantitative versus qualitative methodology) also plays a role (Rist, 1981). Even 
though qualitative research may contribute by means of determining the problem definition or 
identifying unintended consequences of decisions (Rist, 1981), politicians usually ask questions 
about the size of the problem and whether this is growing or not, so that prevalence and inci-
dence values are the order of the day (Muscat, 2008). In accordance with what I have discussed 
above, within the evidence-based framework many believe that qualitative research does not 
count as research unless it is embedded in a randomised clinical trial (RCT) (Denzin and 
Giardina, 2008). In a similar vein, many authors have emphasised that systematic reviews of 
relevant evidence must be designed to ensure that policies and practices are informed by rigor-
ous, transparent, up-to-date evaluations of relevant empirical evidence (Sorrell, 2007; Devroe, 
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2002). In light of the barriers above, many facilitating strategies have been documented. In par-
ticular, it has been stressed that scientists have to invest in giving policy-makers briefings regu-
larly, in providing short summaries, in respecting the time frame of policy-makers and in estab-
lishing or maintaining a reputation of objectivity and credibility. 
 
The links between researchers and policy-makers concern the way in which knowledge is 
disseminated and transmitted (linking mechanisms). Knowledge must be distributed from the 
producer to the policy-maker so that it can be used in making policy decisions (Webber, 1991; 
Jacobson, Butteril and Goering, 2003). The critical element is the existence and power of effec-
tive linkage or boundary arrangements among researchers and policy-makers (Van Eijk and 
Hartkamp, 1992; Landry, Amara and Lamari, 1999; Landry, Amara and Lamari, 2001), in which 
strong (e.g. personal, long-term connection, policy networks) and weak (e.g. media, working 
groups, conferences, interest groups,...) links are distinguished (Wagner, 1991; Lampinen, 1992; 
Nutley, Walter and Davies, 2007; Weiss, et al., 2008; Head, 2010). Referring to the latter (weak-
er) links, media or interest groups may be actively involved in underpinning future policy op-
tions with studies that criticise existing policy or suggest alternative policies. Strong factors re-
lated to the links between researchers and policy-makers include relationships of scientists with 
potential users of their research and the scientists’ credibility (National Center for the Dissemi-
nation of Disability Research, 1996; Haynes, et al., 2012). Policy-makers do not always have 
ready access to research results and they tend to accept guidance, information, and ideas from 
sources they know and trust. Accordingly, Hird (2009) and Haynes et al. (2012) emphasised the 
importance of a personal connection (i.e. to talk with each other) instead of focusing on the writ-
ten research. Likewise, Ritter (2009) found that the most common source of research evidence 
in the policy-making process was through the policy-maker directly contacting an expert.  
 
An important aspect of building these relationships is the scientists’ credibility. For instance, 
Sorian and Baugh (2002) reported that a majority of the respondents (84%) said they trust 
some sources of information more than others (e.g. a high-profile scientist). Landry, Amara and 
Lamari (2001) even agreed that the greater the number of publications, the greater the use of 
the expert’s knowledge. While there is a general consensus that interaction and communication 
between researchers and policy-makers are key issues in improving knowledge utilisation, little 
is known about how policy-makers access research concretely and how trust relationships are 
precisely formed (Ritter, 2009; Haynes, et al., 2012). Equally, detailed examples of scientists who 
have effectively operated in this particular way are rather rare (Bammer, et al., 2010). As I focus 
on the utilisation of knowledge, including scientific research as such, as well as the scientific 
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discourse of academics, this study considers the role played by scientists in the processes of pol-
icy-making and the policy-maker’s approach towards researchers.  
 
4. Roles of the media and interest groups 
In this study, I am particularly interested in certain actors (i.e. media and interest groups) stand-
ing alongside knowledge producers (academic world) and knowledge consumers (policy com-
munity). While scientists are considered to be relatively ‘hidden’ actors, the media and interest 
groups are far more public and visible. As the literature about the role of media in the science-
policy nexus is rather lacking, I examine the interplay between the media and policy as well as 
the link between the media and science in order to get a better view of the role that the media 
may play in the science-policy nexus (§4.1.). Finally, the importance of interest groups is dis-
cussed in §4.2.  
 
4.1. Media and the science-policy nexus 
The media, a rather ambiguous concept, may include several forms of communication: newspa-
pers, television, radio, internet, etc. (McCombs and Reynolds, 2009). At the same time, the role of 
the media may depend on the subject (e.g. sensational themes receive most attention), the medi-
um (newspaper, television), period (pre-electoral, non-electoral), concerned politicians, type of 
agenda (government, parliament, party), and so on. Regarding the links between media and poli-
cy/science, I first address the influence of the media on the policy-making process. Existing 
studies have already highlighted a number of roles.  
 
First, according to key media theories, the media can be perceived as a powerful player because 
of its ability to present issues through selection and salience, so called framing, and the ability to 
indirectly shape individual and community attitudes towards risk, known as priming (McCombs 
and Shaw, 1972; Lancaster, et al., 2011). Thus the media can unintentionally, as a result of the 
characteristics of news production (e.g. limited space, driven by publicity and economic con-
cerns), or strategically, make a significant contribution to how people think by influencing what 
they think about (Entman, 1989; Lancaster, et al., 2011).  
 
Second, as policy-makers aim to understand what the public values and considers important, the 
media may also feed into political debate and policy-making (Scheufele and Tewksbury, 2007; 
McCombs and Reynolds, 2009). For instance, some researchers noticed that media has more 
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influence on the symbolic policy agenda9 (e.g. interpellations and oral questions in the parlia-
ment) than on the substantial agenda (e.g. actual decision-making). However, studies about the 
precise role of the media in setting the political agenda often yield contradictory results, as the 
influence of the media in political agenda-setting strongly depends on the type of issue covered, 
the specific media outlet, the kind of coverage and the features of the political system at stake 
(Kingdon, 2002; Walgrave and Van Aelst, 2006). The role of the media in shaping policy is even 
more disputable (Chan, 1995). Nevertheless, some examples suggested that media may play a 
key role in precipitating policy change. They suggest that the media creates the news and pro-
vides images which can lead to widespread public panic (Goode and Ben-Yehuda, 1994). For 
instance, following media-generated panic, newly emerging psychoactive substances (like 
mephedrone and so-called legal highs) shot to prominence in the political agenda in a matter of 
months, demanding action from the government. Eventually, this resulted in a change in the le-
gal status of these substances in some countries (Bright, et al., 2013; Lancaster, et al., 2010; Van 
Hout and Brennan, 2011; Dabrowska and Bujalski, 2013).  
 
Scientific knowledge is just one of the elements at work in the media. As researchers have long 
been interested in the media's coverage of their field and individual work, naturally the question 
of if and how scientific knowledge is really used in the media has received some attention 
(McQuillan and Tse, 1996; Hijmans, Pleijter and Wester, 2003; Reed, 2001). This ranged from 
studies measuring how much and how accurately scientific knowledge was reported in the me-
dia, to the discursive processes involved in the representation of science in the media.  
 
Even though some authors argued that the number of mistakes in media coverage remains small 
and that scientists are too quick to blame the media for inaccurate coverage (Condit, 2004; Bu-
bela and Caulfield, 2004), several authors have stressed the prevalence of technical/graphical 
problems, inaccuracy of data, the lack of contextual information, the urge to sensation, the per-
sonification of science, and so on. Technical/graphical problems refer to the (in)correct presen-
tation of percentages or numbers. Text formatting requires the selection of the most important 
issues with eye-catching titles. In other words, the process of summarising into a limited space 
(with e.g. a suggestive title) may produce a significant shift in the content of the text and the 
public interpretation thereof (Veneu, Amorim and Massarani, 2008). Inaccuracy of data mostly 
results from a lack of clarification of purpose and key concepts, and the level of journalists’ com-
                                                          
9  In the literature, a distinction between two types of agenda is sometimes made: the substantive agenda and the 
symbolic agenda. The substantive agenda deals with law making, budgetary allocations, sanctioning, nominations, 
and so on. In contrast, symbolic agendas have no real policy consequences (Walgrave, Soroka and Nuytemans, 
2008).  
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prehension. The media always have to find an angle for the news item or feature article (Reed, 
2001).  
 
Furthermore, studies have shown that scientific facts are less important than moral beliefs and 
ideological standpoints to journalists and that, as a result, methodological and contextual infor-
mation about the research is commonly omitted (Malone, Boyd and Bero, 2000; Carvalho, 2007). 
Equally, bibliographic information is almost never included, and science is often presented too 
simplistic and one-sided.  
 
Moreover, the media often casts a critical eye over science and assessing the competences of 
some scientists. Additionally, media coverage of scientific knowledge is often reduced to the 
researcher as such. The personification of science results in a focus on the authority of research-
ers more than on the quality of the scientific research (Malone, Boyd and Bero, 2000).  
 
Finally, studies around the media coverage of scientific knowledge revealed that scientific re-
search is often used selectively. For instance, Kennedy and Bero (1999) found that although re-
search on the harmful effects of passive smoking accumulated strongly, media coverage of the 
research maintained that this body of knowledge was controversial. At the same time, tobacco 
industry representatives who criticised the research methods of scientific studies, were quoted 
more often than researchers.  
 
Brossard (2009) tried to clarify this particular relationship between media and science by dis-
tinguishing several selection mechanisms employed by the media. Obviously, geography may be a 
factor in media coverage of a topic. In particular, local, regional or national pride may explain 
why some international studies or other regional studies are not mentioned. Secondly, the 
chance of scientific research being covered depends on the degree of actual interest in the topic. 
The researcher’s individual reputation plays a decisive role too. Selection is often based on the 
nature of the understanding between the scientist and journalist. Fourth, journalism’s focus on 
sensationalism and drama and the direction of its editorial agenda also influences the selection 
of scientific research. Additionally, it is often considered that journalism and science are two 
communities separated by the academic style of research articles which make them inaccessible 
for journalists; the lack of rigor among journalists; the different time frames in the media and the 
scientific world; and so on (McQuillan and Tse, 1996; Maillé, Saint-Charles and Lucotte, 2010). It 
is clear that the barriers and mechanisms that impede and/or facilitate knowledge utilisation in 
the media are similar to those regarding the utilisation of knowledge in the policy-making pro-
cess (see above, §3.4.2.).  
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Given the central role of the media in policy and science, this issue is of considerable importance 
for those who aim to better understand the complexity of the nexus. Even though the im-
portance of the media’s role in the policy-making process is widely acknowledged, the issue of 
whether and how the media actually affects the science-policy nexus remains empirically under-
studied. Some studies (Weiss and Singer, 1988; Wagner, 1991; Lampinen, 1992; McArthur, 1999, 
Lenton, 2004; Lancaster, et al., 2011; Haynes, et al., 2011b; Ritter and Lancaster, 2013; Smet, 
2013) generally suggest that the media may act as a linking or facilitating mechanism between 
those who wish to influence policy (e.g. scientists and interest groups) and the actual policy-
makers, for example, once research findings have been covered by the media, they might be 
harder to ignore. On the other hand, it is also acknowledged that disseminating scientific 
knowledge through the media might entail risk as the media often provides misinformation or 
unbalanced stories, leading to a distortion of perception and the construction of dominant over-
arching narratives (Carvalho, 2007; MacGregor, 2012). For example, media’s distorted attention 
on the crack cocaine epidemic in the late 1980s led to concern about drug abuse nationwide and 
generated support for the radical right-wing political agenda (Hartman and Golub, 1999). While 
scientific knowledge debunked the various myths arising from this media scare and presented a 
rather different picture, media stories did not correct any mistaken claims which led to govern-
ments stepping up its war on drugs, especially towards dangerous groups living in ghettos 
(Reinarman and Levine, 1997). 
 
4.2. Role of interest groups 
The value of community participation in policy and practice has already been recognised in 
(criminological) literature (Tewksbury and Lees, 2007; Beyers, Eising and Maloney, 2008). For 
instance, Kingdon (2002) assessed that an interest group, a group of people with shared beliefs 
and goals in a particular policy area (e.g. a drug user organisation), may have an important role 
in holding the policy-makers accountable by means of trying to insert their preferred alterna-
tives into the discussion.  
 
Central to the challenge of interest groups is the introduction of their real-life experiences into 
the policy debate. Through different mechanisms (e.g. participation in hearings, media involve-
ment, demonstrations), interest groups may directly or indirectly seek to affect the policy-
making process (Leiden, 1995; Chari, Hogan and Murphy, 2010). For instance, by means of the 
media, interest groups may aim for power, public support or opposition, public awareness of the 
issue and finally the formulation and acceptation of a solution to a problem (Becker, 1967; 
Goode and Ben-Yehuda, 1994). If they are part of a policy network (e.g. issue network model; see 
also above, §2.5.2), members of interest groups can be particularly powerful by providing the 
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network with valuable insights (Hanney, et al., 2002). For instance, Epstein (1996) reported 
about the successful participation of activists in the construction of scientific knowledge about 
AIDS. By setting up partnerships with scientists, professionals and policy-makers and learning 
the language of these experts, activists succeeded in presenting themselves as credible advo-
cates. As a result, Members of Parliament may sometimes turn to interest groups for assistance 
in analysing or evaluating bills or resolutions. In this way, interest groups may influence the lan-
guage or direction of bills and subsequent discussions (Leiden, 1995). Nevertheless, it is general-
ly assumed that they have a rather limited ability to influence the policy-making process, espe-
cially as they tend to be less organised, have fewer resources, and may be less familiar with en-
gagement in policy advocacy (Porter and Hicks, 1995).  
 
How the activities of interest groups may, or may not, have an impact on the contribution of sci-
entific knowledge to the policy-making process is still unclear. One general statement on their 
role in the science-policy nexus was made by Weiss (1986) who speculated that interest groups 
may be a key channel for the flow of scientific knowledge, and so may provide an important 
route for research entering into the policy-making process. 
 
5. Conclusion 
The common understanding of knowledge utilisation is that scientific knowledge has a direct 
bearing on the policy-making process (utilisation as an outcome; evidence based policy). Howev-
er, theoretical frameworks and empirical studies have shown that knowledge utilisation is far 
from instrumental. It has been found that different types of knowledge utilisation interact as 
parallel, complementary processes. Scientific knowledge is mostly used in a conceptual way (i.e. 
delayed and diffused use of information in policy-making) and sometimes in a political/symbolic 
manner (Amara, Ouimet and Landry, 2004). Viewing utilisation from the simple dichotomy be-
tween (instrumental) use and non-use does not offer a full explanation of utilisation. Equally, 
breaking down the process of utilisation into linear series of stages/steps (chain of utilisation) 
fails to uncover alternative forms of utilisation. As a result, Weiss’s three-folded knowledge 
utilisation typology (1979), distinguishing rational/instrumental use, conceptu-
al/enlightenment use and political/symbolic use has proven to be very influential in the 
knowledge utilisation literature and has been frequently applied to studies of the science-policy 
nexus. However, it is recognised that Weiss’s typology leaves other questions unanswered. For 
instance, when and why is scientific knowledge used? Which other types of information compete 
with scientific knowledge?  
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The literature review highlighted the factors which influence whether and how scientific 
knowledge is used. Recognising the context of policy-making is imperative to understanding 
how scientific knowledge is used (Flitcroft, et al., 2011). Ways of thinking about policy-making 
have followed the same path as the thinking about knowledge utilisation. The view of the policy-
making process as an authoritative choice, focusing on the outcome of policy-making, has been 
rejected in favour of the examination of policy-making as a structured interaction between inter-
nal and external actors. An interactive approach is considered to be the best guide to understand 
the processes through which scientific knowledge is used in the policy-making process. Hence, it 
is important to study how scientific knowledge may seep into the policy-making process (includ-
ing Parliament as well as Government), not just in the outcome of policy formulation (Govern-
ment). Likewise, examining the role of external actors such as the media or interest groups is 
considered important to better understand the complexity of the nexus. 
 
Following the interactive approach, a substantial body of work has revealed key barriers to and 
enablers of knowledge utilisation. Policy-makers need to deal with institutional barriers such as 
budgets, timing (e.g. windows of opportunity), values and opinions of political parties, type of 
policy system (multi vs. single party system), elections, affected stakeholders and the general 
public. The individual policy-maker’s basic values, political orientation, tacit knowledge are also 
expected to play an impeding role.  
 
The complexity of the knowledge utilisation process is also found to be related to the nature of 
scientific knowledge and the characteristics of the scientific community. For instance, the dis-
sonance between what is rewarded within the academic community and what is valued by poli-
cy-makers, as well as the particular characteristics of scientific knowledge (e.g. unsuitability to 
policy-makers’ needs, fragmented data, academic format of communication, contradictory find-
ings, qualitative vs. quantitative research) may act as important barriers. Even though scientific 
knowledge is commonly perceived as research executed by academics who work in university or 
college departments, the literature review made clear that it is important to examine the differ-
ent levels of engagement of scientists. The two communities thesis, characterising scientists and 
policy-makers as part of opposing but homogenous communities, is no longer supported in the 
literature. Scientists who are concerned with their engagement in the policy-making process can 
potentially perform a variety of public roles within the policy process, such as performing as 
scientific experts, policy advisors, observer-turned players, lonely prophets or social movement 
theorists/activists. However, in the literature it is still unclear how scientists themselves perceive 
and handle these engagements. Therefore, it is necessary to use the notion of scientific 
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knowledge to refer to scientific research as such, as well as to the scientific discourse of an aca-
demic. 
 
Some linking mechanisms through which scientific knowledge may influence the policy-
making process were also discussed. Establishing networks and active (recurrent) engagements 
by scientists in the policy-making process are understood to be strong facilitators of knowledge 
utilisation. Other engagements by scientists (e.g. participation in conferences) as well as the me-
dia and interest groups are considered as weak linking mechanisms between science and policy. 
These mechanisms certainly capture some of the complexities of knowledge utilisation and facil-
itate the better understanding of the science-policy nexus.  
 
A variety of methodological approaches has been employed to measure knowledge utilisation 
in the policy-making process. Along with the changing theoretical framework came the recogni-
tion that measurements of knowledge utilisation cannot be limited to examples of direct, in-
strumental use. Drawing on an interactive approach, many researchers have sought to use 
methods which better reflect the reality and dynamics of the interaction between science and 
policy. Clearly, previous studies favour a qualitative inquiry, interviews, document analysis and 
case studies in particular. 
 
This chapter examined the science-policy nexus and how it has been conceptualised and assessed. 
Several sensitising concepts10 were identified through this literature review and provided the 
first steps in answering the research questions of the study. In the following chapter, I will exam-
ine if and how these concepts can be applied to the drug policy area. The conceptual framework 
of this study will be discussed in Chapter 3. 
 
                                                          
10  Blumer (1969) argues that sensitising concepts “gives the user a general sense of reference and guidance in ap-
proaching empirical instances […] sensitising concepts merely suggest direction along which to look” (p. 148). 
Chapter  2 Science – policy nexus in the drug policy area 
 
Building on the first chapter, I will go on to apply these theoretical and methodological consider-
ations to the drug policy area. Drugs are a politicised and mediatised topic which may lead us to 
believe that the science-policy nexus is even more complicated in this context. Is scientific 
knowledge being used to inform drug policies (reflecting instrumental or conceptual research 
use according to Weiss’s model) or rather to provide support for political ideals (in line with 
Weiss’s notion of political/symbolic use)? Which barriers or facilitators regarding the science-
policy nexus in the drug field are found? What is the particular role of the media and interest 
groups?  
 
In order to answer these questions, I first describe the specificities of the topic of drugs, and of 
drug policy and drug research in particular (§1). Secondly, I address the science-policy nexus in 
the drug policy area (§2). In particular, I will discuss two models of knowledge utilisation in the 
drug field (§2.1.) and the main results of empirical studies on the science-policy nexus in this 
area (§2.2.). The role of media and interest groups is elaborated in §3. 
 
1. Drugs: a politicised and mediatised topic 
Over the past 40 years, drugs and drug use have shifted from marginal phenomena to a situation 
in which they are widely sampled and used (South, 1999). Likewise, awareness of and ideas 
about drugs have also been changing. Clearly, as long as drug use was seen as pertaining to mar-
ginalised and minority groups, it was possible to confine it to a limited place on the policy agen-
da (Gusfield, 1975). Defining social problems in such a fashion is a way of depoliticing problems. 
In other words, the psychologising or medicalising of drug use can draw attention away from 
institutional or structural aspects of the issue (Gusfield, 1975). 
 
In recent years, serious drug problems have become increasingly connected with a number of 
other social issues, such as high crime rates (Garland, 2001; Seddon, Ralphs and Williams, 2008). 
These changes may have played a crucial role in shaping responses to drug use. Drugs pose a 
substantial threat to society, affecting public health but also potentially generating crime, disor-
der, poverty, etc. Accordingly, drug policy debates focused on the prevention or reduction of the 
damage that drug use cause to the public good (Strang, et al., 2012). Gradually, it was also recog-
nised that ‘drugs’ were pervasive in society and particularly amongst young people (instead of 
among marginalised populations only). Drug use moved from exceptional to being part of every-
day life (South, 1999). Subsequently, this was labelled with the of the term normalisation (Par-
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ker, Aldridge and Measham, 1998). Referring to drugs as a problem of everyday life or by magni-
fying existing problems (e.g. crime rates, poverty,…) politicians soon exploited and inflamed 
feelings of unease and made it a political issue (Boekhout van Solinge, 2002).  
 
By creating fear and heightened concern about deviant stereotypes or evil wrongdoers out of 
proportion to the threat posed to society, the media may generate moral panics as well as create 
outsiders in society and, thus, force policy-makers to react even more firmly (Goode and Ben-
Yehuda, 1994; Mosher and Atkins, 2007; UKDPC, 2010) (see also below, §3). Drug policy is con-
sidered to be one of the most polarised areas of public debate, and the media tends to emphasise 
this polarisation (Lenton, 2007). 
 
In the following paragraph (§1.1.), I examine the evolution as well as variation in the way drugs 
are defined as a problem in drug policy, taking into account historical and international issues. 
Then, as policy discourse may reflect (changes in) scientific discourse, the nature of drug re-
search is discussed (§1.2.).  
 
1.1. Drug policies: international perspective 
Drug policy can be seen as a field of government activity, consisting of a set of laws and pro-
grammes, government sponsorship of scientific research, monitoring initiatives, etc. (Babor, et 
al., 2010). While drug use has taken different forms and has been introduced at different times, 
the approval or disapproval of certain types of drugs has differed greatly in time and place. To-
gether with the changes in and spread of drugs in society, awareness and ideas about drugs and 
the ways of how to cope with drug use have been changing. The process of policy-making does 
not occur in a vacuum but is affected by ideological divisions and several domains (i.e. criminal 
justice, health and education) or scientific disciplines (e.g. criminology, public health, sociology 
of deviance, anthropology, etc.) (MacCoun and Reuter, 2001; Bergeron and Fortane, 2010; Sin-
gleton and Rubin, 2014). It is also a policy area which is framed by historical and international 
developments (Tops, 2001; Eisenbach-Stangl, Moskalewicz and Thom, 2009), as I will further 
elaborate below.  
 
By the early 20th century, drug use became a socially unaccepted activity (Boland, 2008). It was 
believed that drug use inevitably leads to addiction as well as crime, and was therefore a dan-
gerous threat to society. Two sets of views on the response to drug use emerged: care through 
health and social care systems (reflecting a medical view on drugs including concepts like addic-
tion, disease), and control through the criminal justice system. However, under enormous pres-
sure from the US government and some powerful allies, law enforcement became practically the 
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only means through which governments attempted to control drug use and trafficking (Levine, 
2003). Medical treatment of those experiencing problems as result of addiction remained lim-
ited. Political leaders and governments throughout the world supported drug prohibition and 
constructed a global drug prohibition system, later on regulated by three UN conventions (the 
1961 Single Convention on Narcotic Drugs, the 1971 Convention on Psychotropic Substances 
and the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances). 
Illustrative too is President Nixon’s use of the concept War on drugs in 1971, which spread all 
over the world. Clearly, at that time, the politically accepted and correct norm was to use harsh 
anti-drug language and rhetoric of a drug free world (Boekhout van Solinge, 2004). Bergeron and 
Griffiths (2006) have noted that scientific knowledge on both the nature and the scale of the 
problem accompanied the prohibition in the first place. But drug prohibition activities were also 
found useful for other agendas: drug prohibition provided governments with the rationale for 
additional police and military powers, and as drug addiction, abuse, and even usage could be 
blamed for any social problem, its prohibition united political opponents (Garland, 2001; Sed-
don, Ralphs and Williams, 2008).  
 
Throughout the 1980s, the War on drugs was seriously called into question by the heroin epi-
demic all around the world, with many new heroin users tending to be young and unemployed. 
Even though this first encouraged support for a policy of strict law enforcement, its close link 
with the outbreak of AIDS among injecting drug users led to a shift in policy. Hence, a harm re-
duction approach (with the installation of methadone substitution programs, needle exchange 
projects, etc.) was incorporated in many countries during that period. Parallel with this devel-
opment, recreational drug use (especially cannabis but also ecstasy, LSD or amphetamines) dur-
ing the 1980s and early 1990s was increasing and changing in youth cultures. Some commenta-
tors even suggested that drug use had become normalised among certain youth groups (Parker, 
Aldridge and Measham, 1998). The fact that the drug situation was no longer restricted to prob-
lematic drug users raised more questions about the effectiveness of the strict prohibitive War on 
drugs (MacCoun and Reuter, 2001). As a result, a growing number of countries began to divert 
the focus away from zero-tolerance towards a better balance between supression and protection 
of public health (Jelsma, 2008).  
 
In particular, at the end of the 20th century, there was a trend among some (European) countries 
towards the development of a public health movement (Reinarman, Cohen and Kaal, 2004). 
Within this framework, Belgium also developed a drug policy based on public health principles 
instead of a simple focus on judicial solutions (Federal Government, 2001; BIRN, 2002). At the 
same time, drug policies in many countries evolved from the criminalisation end of the drug 
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prohibition continuum towards a more regulated and tolerant approach (Shinner, 2009). As an 
example, debates on the depenalisation or decriminalisation of drug use sparked off in several 
countries (e.g. in Spain, Portugal, the UK, …) (Hughes and Stevens, 2012). These debates reflect-
ed the idea that drug users should not be imprisoned because of their use, and that alternatives 
provided by law enforcement were preferable. Despite this trend, nations still adopted a wide 
variety of policies towards the control of illicit drugs. In particular, some nations still treated 
drugs primarily as a problem for law enforcement while others focused on prevention and edu-
cation (Babor, et al., 2010), reflecting the two central narratives of drug policy (i.e. drug use as a 
problem of crime vs. drug use as a problem of health) (Bourgois, 2000). Nevertheless, this 
movement constituted the first step away from the dominant drug policy paradigm advocated by 
the United States, which was prohibition based on punishment.  
 
Nowadays, the variety of approaches still exists. On the one hand, it is argued that the War on 
drugs has failed and that fundamental reforms in national and global drug control policies, such 
as the decriminalisation and destigmatisation of people who use drugs, are urgently needed 
(Global Commission on Drug Policy, 2011). Some new approaches to drug control are being test-
ed: e.g. the legalisation of cannabis supply in Uruguay and some US states (Singleton and Rubin, 
2014). On the other hand, some countries are evolving in the opposite direction. For instance, 
recent developments in cannabis policy in both the UK and the Netherlands seem to show a 
toughening attitude which may indicate a move towards a culture of control (Garland, 2001). 
While cannabis was reclassified from Class B to Class C in 2004, British policy-makers decided to 
revert to the former classification in 2009 (Seddon, Ralphs and Williams, 2008; Monaghan, 
2011). According to Stevens and Measham (2014), the drug policy strengthening recently has 
been extended by the practice of banning new psychoactive substances like mephedrone. In the 
Netherlands, a set of stricter criteria were introduced for coffee-shops in 2012 and 2013 
(Wouters, 2013; Brewster, 2014).  
 
1.2. Drug research: understanding the drug phenomenon 
Scientific knowledge can be seen as a frame within which representations of the reality of drug 
use are depicted (Reinarman, 2005; Noorman, 2005). Just as the interpretation of scientific 
knowledge by policy-makers is influenced by values, ideology or underlying world views, scien-
tific assumptions are intermingled with moral judgments or perceptions. Within this framework, 
policy-making may influence the paradigmatic focus of research, its funding and impact but re-
search results may also further establish the dominance of a particular policy (Allen, 2007; 
Bright, et al., 2008; Moore, 2008). 
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Some decades ago, the knowledge base on the subject of drugs was extremely limited. Drug use 
did not become a significant research topic in Europe until the 1970s, when its importance in the 
policy agenda increased (Hartnoll, 2004). Existing drug research focused on physical or genetic 
deficiencies of individuals as an explanation for the phenomena, such as criminality or mental 
illness (Mosher and Akins, 2007). Drug use (like homosexuality, insanity and criminality) was 
considered a disease. Addiction was viewed in the same way as traditional medical problems 
(Reinarman, 2005; Herzog, et al., 2009). The deterministic concept of disease focused on the 
individual and failed to answer questions about why and how patterns of drug use develop dif-
ferently in various communities under a wide range of social, political and economic conditions. 
As a result, political use of this concept was leading to simplified conclusions about causes and 
claims about potential scientific solutions. Thus, this biomedical and clinical research offered 
little foundation for public policy on prevention, health promotion, etc. (Hartnoll, 2004). 
 
In the late 1960s and 1970s, things started to change: the first attempts to estimate the preva-
lence of drug use (especially cannabis) were made and more concerns were raised about opiate 
addiction, which led to clinical studies on prevention, health promotion or harm reduction. As a 
result, public health and epidemiological perspectives became more important in drug research. 
These paradigms reconceptualise drug use as a socially infectious condition, and focus on both 
risk and protective factors. This approach is linked with a psychiatric understanding of drug use: 
e.g. it was assumed that a psychiatric individual was more susceptible to the infection of addic-
tion (Mold, 2007). Within this framework, epidemiological research played an important role 
and was used to analyse the spread of infectious diseases in a population (e.g. AIDS). Policy re-
sponses were oriented towards control and coercion (e.g. prohibition, stigmatisation drug users, 
compulsory treatment,...). At the same time, from the 1970s onwards, drug use started to be per-
ceived as a social phenomenon among youth culture (instead of a marginalised phenomenon). 
Accordingly, drug research from a sociological approach started to expand too. This paradigm 
assumes that the drug phenomenon is shaped by social reactions to it. For instance, in the devi-
ance and labelling theory drug use (i.e. deviant behaviour) and the characteristics of drug users 
are seen as a consequence of policy rather than as intrinsic to drug use per se (e.g. Becker, 1967; 
Young, 1971; Agar, 1973). 
 
The increase in heroin use and the number of AIDS-infections during the 1980s had an impact 
on the drug research approach. Epidemiological studies became more dominant, introducing 
drug indicators (e.g. treatment demand, deaths, market indicators,…) but also social research on 
risk patterns among hidden populations, for example among injecting drug users, expanded fur-
ther (Hartnoll, 2004). While the dominant methodological approach in drug research remained 
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quantitative, there was an increasing receptivity to the qualitative paradigm emphasising the 
importance of a holistic understanding of drug use, thereby investigating behaviours in their 
natural setting and exploring narratives provided by members of the group (Sloboda, 2005). The 
value of this type of research is that it may help to reach and research hidden populations, to 
understand the experience and meaning of drug use and to understand the social contexts of 
drug use (Korf, 2013). 
 
While drug research continued to focus on heroin, AIDS and hidden populations, gradually, in 
the 1990s, attention was given to other (new) drugs (e.g. cocaine and synthetic drugs) and the 
emphasis has shifted from local (e.g. multi-city study) to national (e.g. national projects), Euro-
pean and international levels. An important milestone for the consolidation and development of 
drug research was the installation of the European Monitoring Centre for Drugs and Drug Addic-
tion (EMCDDA). Becoming operational in 1995, it built on earlier pioneering work at national 
level and launched several projects. The EMCDDA established 5 key indicators: 1) prevalence 
and patterns of drug use among the general population; 2) prevalence and patterns of problem 
drug use; 3) drug-related infectious diseases; 4) drug-related deaths and mortality of drug users 
and; 5) demand for drug treatment. Since then, REITOX National Focal Points are responsible for 
the data collection on ongoing and concluded studies through its network of partners. The na-
tional focal point is enforced yearly to prepare a national report in order to disseminate infor-
mation on drug-related research findings to different audiences.  
 
From the mid-1990s onwards, most (European) countries established a sound empirical (epi-
demiological) basis of research (Stimson, 1997; EMCDDA, 2008). The strong growth and variety 
of drug research is also illustrated by the increasing numbers of addiction journals, career pro-
fessionals, specialised research centres, international conferences and scientific publications 
relevant to drug policy (Muscat, 2008). Much emphasis is still placed on identifying how many 
people use drugs, how often and what they use, as well as on target groups or individuals for 
preventive interventions (groups which show the highest relative and attributable risk for onset 
of a problem are the appropriate targets for primary prevention programs) or the effectiveness 
of interventions for the prevention or treatment of drug abuse (what works?) (Sloboda, 2005; 
Eisenbach-Stangl, Moskalewicz, Thom, 2009).  
 
Next to the strong focus on the public health and epidemiological perspective, drug research has 
been developed in varying ways (Korf, 2013). There has been a growing emphasis on issues like 
crime and public order, accountability and efficiency of policy, harm reduction, drug markets 
and national legislations. Clearly, an amount of drug research has now been carried out from 
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economic and legalistic/repressive perspectives. Within this framework, some drug researchers 
have studied the evolution of political responses to drug use, the historical origins of the interna-
tional conventions and particular national policies and legislations. A substantial part of these 
studies concentrated on cannabis (Korf, 2008; Decorte, Potter and Bouchard, 2011). This focus 
was related to the debates about the national drug strategies towards cannabis which sparked 
off at the end of the 20th century (e.g. in Spain, Portugal, the UK and Belgium). With the growth 
and expanding diversity of drug research, a variety of methodological approaches have been 
further developed and implemented (e.g. experimental studies, survey research, mortality or 
morbidity statistics, qualitative research, online data collection methods, and so on) (Babor, et 
al., 2010; Korf, 2013). Even though epidemiological research still is the predominant approach, 
qualitative research, reporting the insider’s views of their research participants, struggles for 
equal legitimacy.  
 
Given that research on drug use evolved in different ways and at varying rates in different coun-
tries, I would like to make a short note about drug policy and research in Belgium. As I have stat-
ed, the extent and nature of drug research is often linked with how and when drugs came to be 
seen as a topic requiring attention, depending on issues that have dominated the drug policy 
agenda (Bergeron and Fortane, 2010). Unlike most countries where drug research started to 
take off in the 1970s or at least at the beginning of the 1980s, drug research in Belgium started 
slowly, beginning in the 1990s. Or, as an EMCDDA report from the early 1990s, stated, in Bel-
gium, “drug research has a low priority on the political agenda” (Kenis, 1997, p.33). Things really 
started to change when drugs appeared on the political and media agenda in 1996 (e.g. with the 
installation of the Parliamentary Working Group on drugs). Increased attention to the drug phe-
nomenon by policy-makers, scientists and media therefore provides a perfect starting point for 
my case study.  
 
2. Science-policy nexus 
The nature of drug research, their focus, paradigms and methodological approaches developed 
over a long period of time. Until the 1960-70s, drug policy was grounded on moral assumptions 
(Hughes, 2007). Supported by the increasing research efforts of international organisations like 
the EMCDDA, the evidence-based policy thinking also increasingly affected debates about drug 
policy (Hartnoll, 2004; EMCDDA, 2008; Korf, 2013; Lancaster, 2014): on the one hand, questions 
about what works and effectiveness of, for example, law enforcement were raised; on the other 
hand, efforts were made to increase the uptake of scientific knowledge in the policy-making pro-
cess. For example, the current drug strategies and action plans of most Member States include 
references to scientific knowledge (EMCDDA, 2008).  
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Given that debate in the drug policy field is often contested, part of a heated controversy or sub-
ject to rapid change, the notion of evidence-based policy was soon labelled as having less rele-
vance (MacGregor, 2013). In particular, drug policy carries great symbolic value as research find-
ings may become elements in value-based arguments (Ritter, 2009; Room, 2005; Fitzgerald, 
2005). Instead of a strict rational relationship between research and policy, it is assumed that 
evidence-based arguments are more likely to be used as weapons in emotive debates (Head, 
2010). For instance, Dixon (1995) stated that “Drug policy is a prime example of the limited con-
tribution which criminology is currently allowed to make to public policy.” (p.3). Wodak (2008) 
also stated that “in drug policy, what is effective is often unpopular while what is popular is often 
ineffective” (p.227). Such points of view, whereby the policy-making process is considered an un-
evidenced-based mess, are frequently adopted in the drug policy domain (Monaghan, 2008b). 
Therefore, there has been a need for studies which consider the alternative ways of knowledge 
utilisation to move beyond those zero-sum statements of evidence-based policy.  
 
In the following paragraphs, I discuss some theoretical models of knowledge utilisation that 
were developed for the study of knowledge utilisation in heavily politicised policy areas (§2.1.) 
as well as the existing empirical studies of the science-policy nexus in the drug policy area 
(§2.2.). 
 
2.1. Models of knowledge utilisation in the drug policy field 
Stevens (2007a) and Monaghan (2011) argued that existing theoretical models were insufficient 
to conceptualise the science-policy nexus in the drug policy field. Some newer models have been 
advocated: the evolutionary model and processual model.  
 
In a similar vein to the conceptual model (enlightenment), the evolutionary model views utilisa-
tion as a process and not just as an outcome. Unlike the political and tactical model, this model 
tends to focus not only on the policy-makers but also on the social structure as important in 
supporting selection in the use of scientific knowledge. In this respect, there is recognition that 
the media or interest groups may play a role in influencing what is permissible in policy-making. 
Furthermore, one of the strengths of the model is that it pays attention to the power dynamics in 
the policy-making process. Except for an emphasis on power dynamics in Weiss’ iterative model 
on competing interests shaping the policy-making process (see also above, §2.5.), this issue is 
largely neglected in existing models of knowledge utilisation or policy-making. The evolutionary 
model assumes that there is a Darwinian survival of the fittest evidence in the policy-making 
process: e.g. as some evidence may fit the interests of the powerful groups, and others may not, 
evidence without a powerful supporter will not be used. Several arguments and processes of 
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selection of scientific knowledge are distinguished, which may help to explain the (preservation 
of the) relative power of some groups (Stevens, 2007a). A first mechanism is trawling, which 
means that policy-makers select the beneficial evidence and ignore the rest (which is similar 
what others have called cherry-picking). Second, policy-makers can farm for evidence, whereby 
powerful actors focus attention on evidence that supports a given policy. A third mechanism is 
called flak, creating disquiet about evidence which is detrimental to a particular policy direction. 
Finally, a strain mechanism includes the imposition of strain on researchers who produce irrele-
vant evidence. Monaghan (2011) put forward an important downside of this evolutionary mod-
el. He argued that the evolutionary model has an understanding of a linear deterministic form of 
utilisation and policy-making as an authoritative choice. He argues that even evidence that fits 
with the interests of the powerful groups may not be used if the political conditions are not fa-
vourable. In other words, Monaghan refutes that policies move towards a fixed point: evidence-
based or not.  
 
Based on a case study of the (re)classification of cannabis in the UK, Monaghan (2011) tentative-
ly advocated a synthesis of the enlightenment and evolutionary model. Drawing on the evolution-
ary model, the processual model shares the approach of the selection mechanisms (Stevens, 
2007b). However, it does not support the deterministic view of utilisation focussing on the out-
come of policy formulation. Instead, as this model accepts that evidence is not the only player in 
the policy-making process and that the policy process is of an ad hoc, back and forth nature, with 
multiple groups interacting and competing in shaping policy (policy-making as structured inter-
action), the model can be thought of as related to the enlightenment model (Monaghan, 2009). 
Additionally, the processual model also provides a more nuanced account of the nature of evi-
dence. It is put forward that the concept of evidence itself must be seen as contested and in a 
constant state of flux. Taking each of these considerations into account, the science-policy nexus 
in a heavily politicised policy area is described as uncertain and unpredictable.  
 
2.2. Empirical studies 
2.2.1. Design and methods 
Empirical studies focusing on the understanding of the interaction between science and policy 
have long been scarce in the drug field (Bergin, 2013). However, interest in this interaction has 
recently emerged, especially in the UK, Australia and Canada (Musto and Sloboda, 2003; Lenton 
and Allsop, 2010; Macleod and Hickman, 2010; Hughes and Stevens, 2012; Stevens and 
Measham, 2014). In Belgium, research about knowledge utilisation in the drug area is still lack-
ing (Tieberghien, 2013). Most knowledge utilisation literature in the drug policy field clearly 
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originates from countries with a two-party system, and is thus not representative of the science-
policy interaction in a multi-party system as exists in Belgium.  
 
Most studies, except for those focusing on how drug policy-makers access scientific knowledge 
(Bickford and Kothari, 2008; Ritter, 2009), analysed knowledge utilisation in one or more cases 
(case study design) by using a process design. A case may be, for example, the historical develop-
ment of a policy (Duke, 2001; MacGregor, 2013), the policy process at a given time (Stevens, 
2011) or a new policy measure (e.g. new legislation, the implementation of safe injecting rooms 
or treatment of heroin dependence, …) (Erickson, 1998; Lenton, 2004; Hall, 2004; Lenton, 2007; 
Hughes, 2007; Hall, 2008; Monaghan, 2009; Hughes and Stevens, 2010; Zampini, 2014). 
 
Together with growing recognition of the importance of qualitative methods in studying the sci-
ence-policy nexus (see also above, §3.2.), similar interest has developed in the drug field. Analy-
sis of policy and media documents has been regularly conducted. For example, Lenton (2007 and 
2004) discussed the evidence base of changes to the legal status of cannabis in Australia using a 
variety of sources: citations of research publication in government reports or parliamentary 
debates; media statements by members of the government; references in political party policy 
statements; official correspondence and invitations to join government working groups; written 
testimonials from member of parliament and other key stakeholders, and so on. Similarly, Wood, 
et al. (2008) also used documents (policy documents, media,…) to describe the Canadian Gov-
ernment’s rejection of the findings from the evaluation of the safer injecting facility. Finally, 
Bennett and Holloway (2010) analysed the extent to which the UK drug strategy is evidence-
based by examining research evidence cited in policy documents to determine which of the find-
ings were said to have been used and the way in which they were (mis)interpreted.  
 
In addition to document analysis, the method of interviewing key policy players is used frequently 
in order to reconstruct processes and depict nuances of knowledge utilisation (Ritter and Lan-
caster, 2013). The general focus lies on the perceptions of the policy-makers. For instance, Duke 
(2001) analysed the interplay between research and the historical development of prison drugs 
policy within its political, economic and social contexts, drawing on semi-structured interviews 
with key policy players. As another example, Hughes (2007 and 2009) assessed the role of evi-
dence in the development and implementation of the Illicit Drug Diversion Initiative (IDDI) in 
Australia using data from interviews with 16 key informants working in the Australian drug 
policy arena. Clearly, most studies do not take into account the role of scientists, journalists or 
members of interest groups. The study of MacGregor (2013) can be seen as a very valuable ex-
ception: 50 interviews were carried out with MP’s, police officers, journalists, researchers etc. 
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Methodologically speaking, I also observed one ethnographic study acknowledging how policy-
makers use evidence in a range of social policy and criminal justice areas (Stevens, 2011). Un-
doubtedly, such a privileged position provides a unique view of the inner workings of a policy 
department, which is rarely observed. 
 
Finally, taking into account their process design and qualitative methodological approach, most 
studies examine the extent and nature of knowledge utilisation in both the parliamentary and 
governmental policy-making process. For instance, studies involving a document analysis often 
concerned documents and frameworks produced by the Government as well as submissions and 
reports of the Parliament or joint committees (Lenton, 2004; Ritter and Lancaster, 2013). Stud-
ies which took the effort to interview policy-makers often selected respondents with differing 
degrees of involvement in the policy process, some involved in direct decision-making, while 
others are involved in commissions, inquiries or consultation (Monaghan, 2009; MacGregor, 
2013). However, some exceptions focus on just one particular phase: parliamentary processes 
(Erickson, 1998; Tomson, et al., 2005; Reuter and Stevens, 2007) or governmental policy-making 
(Stevens, 2007; Bennett and Holloway, 2010).  
 
2.2.2. Results about the interplay between science and policy 
The role of scientific knowledge in policy development is in drug policy studies mainly studied 
using Weiss’ three-folded typology (Duke, 2001; Monaghan, 2009; Stevens, 2011).  
 
I found some examples of the way in which scientific knowledge has succeeded in being useful 
(instrumental) to policy (Edwards, Strang and Jaffe, 1993; Fountain, 2000). For instance, an epi-
demiological study, published in 1950, that demonstrated the connection between the rise in 
lung cancer and the habit of smoking led to a new policy agenda for smoking. Furthermore, a 
needle exchange evaluation in 1987 gauged whether such approach would be an appropriate 
means of dealing with the threat of AIDS. The research concluded that the exchange worked and 
was an important factor in unlocking governmental support for harm reduction and needle ex-
change services.  
 
Despite these examples of direct use of knowledge, most authors agree that the relationship be-
tween science and policy does not make use of the logical connections between them, and the 
rational application of findings in policy in particular (Edwards, Strang and Jaffe, 1993). I noted 
some examples of conceptual use of scientific knowledge. For instance, Hall (2008) argued that 
the role that research played in the development of a national cannabis policy in Australia in 
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2006 has exemplified the enlightenment model (Weiss, 1995). In particular, evidence has pro-
duced slow changes over three decades in conceptual understandings of cannabis use.  
 
A significant theme that arose in these studies is that scientific knowledge has been used selec-
tively (or not used) to fit the (personal/political) preferences of those in power (Griffiths and 
McKetin, 2005; Stevens, 2007b; Hall, 2008; Monaghan, 2009; Bennett and Holloway, 2010; 
Brewster, 2014). Stevens (2007b and 2010) concludes that evidence is used in a selective, narra-
tive way based on ideology, in that it supports systematically asymmetrical relations of power. 
Similarly, research of Hughes (2007 and 2009), assessing the role of evidence in the develop-
ment and implementation of the Illicit Drug Diversion Initiative (IDDI) in Australia, showed that 
while policy-makers were supportive of the IDDI as a pragmatic response to drug users, they 
contend that implementation has suffered through a selective and variable emphasis upon scien-
tific knowledge. Wood, et al. (2008) also concluded that ideology triumphed over evidence: the 
Federal Government disregarded the recommendations derived from a scientific evaluation 
about injecting facilities. Storbjörk (2014) argued that scientific knowledge was selectively used 
to support arguments both in favour of and opposing the reform of the Swedish substance abuse 
treatment system, in line with the findings above.  
 
The misuse of data also came through. For instance, Rossi (2002) critically analysed a drug re-
port of the United Nations Drug Control Programme. Apparently, the data taken from several 
publications was misinterpreted (Rossi, 2002). Rather similar, Olsson (2009) critically reviewed 
an UNODC report by evaluating the empirical facts referred to and the main conclusions drawn 
about the success of the Swedish drug policy. He concluded that the scientific basis behind the 
report was flimsy, if it existed at all. For instance, prevalence data was presented without distin-
guishing between medical, experimental, occasional and problematic use. The UNODC report 
also claimed that the Swedish drug policy caused a decrease in drug use. Other alternative ex-
planations, like employment rates, health consciousness, etc. were not even analysed. Serving as 
another example, Griffiths and McKetin (2005) described some common misuses of epidemio-
logical research about drug use. Two of the most common misuses reported were generalizing 
from a non-representative sample (for example when researchers generalise from clinical or jail 
samples) and measuring one thing and generalising to another (for instance when researchers 
confuse the epidemiology of drug use with the epidemiology of drug abuse). Equally, Hughes and 
Stevens (2012) highlighted the misuse of evidence in the case of the Portuguese decriminalisa-
tion. They concluded that divergent policy conclusions were derived from selective use of epi-
demiological data, which belied the largely positive implications of the Portuguese decriminali-
sation of illicit drugs.  
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In the light of the political/symbolic model, one study also revealed another challenger of 
knowledge utilisation (and evidence-based policy-making) in the drug policy field. By means of a 
reflection on the debate about the classification of ecstasy in the UK, Monaghan, Pawson and 
Wicker (2012) illustrated that scientific knowledge is sometimes side-stepped by policy-makers 
playing the card of precaution in order to postpone action.  
 
Because the majority of the studies focus on the policy-making process in general without mak-
ing a clear distinction between stages or phases, it is difficult to draw conclusions on this issue. 
The few studies that do reflect on the differences between, for example, the Government and the 
Parliament, have provided contradictory results. An empirical study of alcohol policy-making 
found that research was more influential in the early stages than in the later stages of policy-
making. This finding supports the Kingdon’s agenda setting theory (Johnson, et al., 2004). In 
contrast, MacGregor (2010) found that drug expertise (i.e. scientific experts and practitioners) 
may play an equal but different role in the two worlds of the Government and the Parliament.  
 
Furthermore, the barriers and mechanisms facilitating the utilisation of knowledge as dis-
cussed above, can also be applied to the drug field (Berridge and Thom, 1996; Ritter and Bam-
mer, 2010; Oliver, et al., 2014). The characteristics of the policy-making process most frequently 
identified include the limitations in policy-makers’ capacity to evaluate research evidence; fi-
nancial constraints; political ideology; the policy-maker’s interest; electoral cycle, and; their 
preference for the existing body of knowledge instead of new knowledge. For instance, accord-
ing to Berridge and Thom (1996) and Muscat (2008), the selection of drug policy options seems 
to depend on political ideology and public opinion. Likewise, in the case of treatment of heroin 
dependence (1990-2001) in Australia, Hall (2004) noted that research has a mixed impact on 
policy as the interface between research and policy depends on policy-maker interest and the 
availability of funding. Additionally, Macleod and Hickman (2010) analysed the available evi-
dence on the health effects of cannabis and reviewed the factors that may have influenced public 
discourse and policy decisions. The researchers concluded that the strongest evidence of a pos-
sible causal relation between cannabis and schizophrenia emerged more than 20 years ago, and 
that the strength of more recent evidence may have been deliberately overstated by political 
opponents (as part of the political game). Finally, several authors agreed that the policy-maker’s 
background determines if he/she places more or less importance on a particular subject and its 
evidence base (Zampini, 2014).  
 
Many barriers related to the characteristics of research have also been documented: the ambigui-
ty and uncertainty of research, the lack of notes or short summaries of research or the reputa-
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tion of the researcher (Hall, 2004; Wood, et al., 2008, Bennett and Holloway, 2010). For instance, 
in his commentary from a policy-maker’s perspective, Gregrich (2003), in his position as Chief of 
the Treatment Branch (Office of National Drug Control Policy) pointed to a number of issues that 
limit the usefulness of researchers’ work. One of the issues relates to format. Format issues in-
clude the manner in which research reports are presented (e.g. language) and their often equiv-
ocal nature. Furthermore, it is argued that the relationship between science and policy is fre-
quently linked with quantitative (epidemiological) research. The quantitative domination is of-
ten underpinned and preserved by greater funding, greater scientific credibility of methodologi-
cal approaches and more numerous researchers and projects (Moore, 2008). Reuter (1993) has 
pointed out that “for conscientious policy-makers dealing with drug problems at the national and 
local levels, prevalence estimation ought to be a fundamental element of sensible decision-making” 
(p.167). The role of qualitative research in relation to drug policy is much more uncertain. Ber-
ridge and Stanton (1999) highlighted the fact that policy interests may package a message from 
qualitative research but that qualitative research, by its very nature, is rarely so specific about 
guiding policy (Fountain, 2000; Denzin and Giardina, 2008).  
 
A common challenge is also to establish linking mechanisms in a manner that fosters systematic 
action (Elliott and Popay, 2000; Gregrich, 2003). This refers to taking into account the 
timeframes of both researchers and policy-makers (e.g. research findings are not often present-
ed to policy-makers at the times of greatest receptivity: the beginning of a legislature, budget 
development cycle, etc.). In particular, Gregrich (2003) noted some practical steps researchers 
can take to make their work more accessible, and useful, to policy-makers and practitioners. 
These practical steps involve making effective contact to educate and influence while respecting 
the values, insights and the limited time of policy-makers. Duke (2001) and MacGregor (2013) 
also agreed that drug researchers should become more active agents in all stages of the policy 
process in order to stimulate the interplay between research and (drug) policy. Having long-
standing relationships with key players inside and outside the policy-making process as well as 
participating in fora or committees are also considered to be of great importance (Lenton, 2007; 
Lenton and Allsop, 2010). This is in accordance with the few studies that focus on how policy-
makers get access to sources of research evidence in their drug policy-making, instead of on how 
policy is actually made in terms of interactions between evidence and policy (Bickford and Ko-
thari, 2008; Ritter, 2009). The most popular way through which evidence accesses the policy-
making process is by means of policy-makers seeking advice from an expert and consulting 
technical reports. It has been reported that the advantages of consulting an external expert in-
clude the speed with which the information can be obtained and the ability of an expert to syn-
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thesis the (often contrary) evidence. Consulting academic literature or relying on internal exper-
tise or policy documents are least frequently found approaches.  
 
3. Roles of the media and interest groups 
The diversity of participants in the policy process is widely acknowledged in these empirical 
studies: references are made to politicians, academics, interest groups, media, police, and so on. 
Media is considered to be one of the most important influencing factors in drug policy debates, 
even though whether the media is driving policy or vice versa is rather unclear. For instance, 
several researchers have already argued that the media may fuel drug scares as well as increase 
curiosity in a new drug or stigmatise particular drug users (Goode and Ben-Yehuda, 1994; Len-
ton, 2007; Mosher and Atkins, 2007; Taylor, 2008). The emergence of methamphetamine use 
and production in Canadian media provides one such example. Media coverage was found to 
have fuelled public fear and speculation by using terms such as epidemic and plague to describe 
the prevalence of this drug (Boyd and Carter, 2010).  
 
Even though the role of the media in determining drug discourse is widely acknowledged, lim-
ited research has been conducted in examining the particular role of the media in the science-
policy nexus in the drug area. I would submit that drug research is rather attractive to the media 
because anything related to drugs tends to be automatically newsworthy. However, existing 
studies on the influence of the media on the drug policy-making process have made only general 
statements (Lenton, 2004). For instance, Hall (2008) argued that the impact that research evi-
dence has had on Australian cannabis policy has been largely constrained by the media framing 
the debate as a choice between two competing fields, critics and defenders of prohibition. Given 
the central role of the media in drug policy debates, this issue is of considerable importance for 
those who aim to better understand the complexity of the nexus in the drug policy area.  
 
The idea that interest groups (civil society associations, NGOs or third sector organisations, 
alliances, coalitions and networks of existing organisations, professional associations of lawyers 
or law enforcement officers, or user groups) can play a role in drug policy-making is also recog-
nised (Tops, 2001; Hall, 2004; Bergin, 2013; Lancaster, Ritter and Stafford, 2013; EMCDDA, 
2013). Ritter (2011) explicitly argued that “Drug policy is a perfect example of a complex social 
problem, without obvious solutions, driven by highly emotional arguments and strong interest 
groups.” (p.3). However, as with the role of the media, details about their particular influence 
have been largely missing in the knowledge utilisation studies in the drug policy area. Neverthe-
less, some general statements about associations advocating for drug users’ rights as well as 
groups presenting parents or ex-drug users advocating against drug use, have provided us with 
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an avenue for further investigation of this issue in this study. For instance, Lenton (2004) con-
sidered the support by cannabis users to be one of the many conditions that could be seen nec-
essary for the cannabis law reform in Western Australia. Additionally, of particular relevance is a 
recent EMCDDA report on drug policy advocacy organisations in Europe (EMCDDA, 2013: 
O’Gorman, et al., 2014). This report described the tools used by these groups to influence drug 
discourse: participation in media debates, policy forums or conferences were reported as the 
most useful mechanisms while activist strategies, such as demonstrations and marches, were 
employed less frequently.  
 
4. Conclusion 
Both the compounded social problems associated with drug use (e.g. crime, poverty) and drug 
use becoming normalised instead of being a marginalised phenomenon led to drug use gradually 
becoming a subject of political debates. Accordingly, drug research sparked off in the 1970s and 
has been growing since. The dominant perspectives surrounding drug research moved from the 
frameworks of psychiatry and psychology of dependence (biomedical and clinical paradigms) to 
public health concerns with epidemiology (public health paradigms) and law enforcement prior-
ities concerning control (legalistic/repressive paradigms). An important push for drug research 
was provided with the installation of the European Monitoring Centre for Drugs and Drug Addic-
tion (EMCDDA) during the 1990s. One of its aims was to identify gaps in knowledge in order to 
strengthen the research base for promoting evidence-based policy (Stimson, 1997; Hartnoll, 
2004). Accordingly, theoretical and empirical interest in how the science-policy nexus in the 
drug field actually works has been rapidly expanding in recent years.  
 
The qualitative methodological design of each of these studies, including interviews, document 
analysis and case studies, as well as their interactive approach (policy-making as a structured 
interaction) illustrate their large interest in the policy processes, interactions and engagements 
between policy-makers, scientists and other actors. It is assumed that scientific knowledge may 
play a role in the process of drug policy-making (Parliament and Government) instead of in the 
outcome.  
 
An overview of the existing literature on knowledge utilisation in the drug field indicates that 
the science-policy nexus is more complicated here than in other domains (see Chapter 1). Apply-
ing Weiss’ three-folded typology (1979), studies have shown that the nature of knowledge utili-
sation is mainly politicised: while scientific knowledge is most often used political-
ly/symbolically, illustrations of instrumental or conceptual use were rather limited. Examples 
of the misuse of data as well as the use of the precautionary principle to postpone action also 
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underline the high prevalence of political/symbolic utilisation. Supporting the idea that the po-
litical context is very important in the science-policy nexus in the drug policy area, several au-
thors made useful additions to Weiss’ three-folded typology. It is recommended by Stevens’ evo-
lutionary model (2007a and 2011) and Monaghan’s processual model (2011) that studies about 
the science-policy nexus in the drug field have to examine which powerful selection mechanisms 
are used by policy-makers and how scientific knowledge itself is conceptualised in the policy-
making process.  
 
Furthermore, existing studies revealed that the barriers regarding the utilisation of scientific 
knowledge, which were documented in chapter 1, also apply to the drug policy field. In a similar 
vein, there is consensus that establishing networks or having relationships with key players in-
side and outside the policy-making process are strong facilitators of knowledge utilisation in 
the drug field. In the context of the current study, a profound examination of the role of the me-
dia and interest groups seems important for those who aim to better understand the complexity 
of the nexus in the drug policy area. Media is considered to be one of the most important influ-
encing factors in drug policy debates. The idea that associations advocating for drug users’ rights 
as well as groups representing parents or ex-drug users advocating against drug use play a role 
in drug policy-making is also recognised. In other words, in the drug policy field, the media and 
these interest groups are considered to be strong facilitators of the science-policy nexus. How-
ever, except for some recent work (O’Gorman, et al., 2014), their particular role in the science-
policy nexus has rarely been studied. 
 
Chapter 2 explored the origins of the evidence-based drug policy thinking and how the science-
policy nexus has been defined and assessed in this particular field. The issues proven to be of 
particular relevance in studying the science-policy nexus in the drug field strongly supported the 
construction of the conceptual framework of this study (outlined in Chapter 3). 
 
Chapter 3  Research design and methodology 
 
Previous chapters have detailed the literature on the nature of policy processes and the assess-
ments regarding whether and how scientific knowledge informs (drug) policy. In this chapter, I 
first discuss the conceptual framework of this study, explaining sensitising concepts that were 
identified through the literature review (§1). Then, I turn to the research design and methodolo-
gy. The conceptual framework proved to be particularly helpful, for example in selecting a case 
and in structuring data analysis and interpretation. Subsequently, in this chapter, I address the 
ontological and epistemological assumptions underlying my study (§2) and illustrate why I 
adopted a qualitative approach in order to obtain the kind of data I am looking for (§3). Then, I 
present the technical design of this study (§4) and the two data collection methods (§5). Finally, 
data analysis (§6) and validity and reliability (§7) are discussed.  
 
1. Conceptual framework 
According to Miles and Huberman (1994), “A conceptual framework explains, either graphically 
or in narrative form, the main things to be studied – the key factors, constructs or variables – and 
the presumed relationships among them.” (p. 18). Below, I explain the sensitising concepts that 
were identified through the literature review and will be studied in this dissertation in order to 
answer the three research questions. 
 
 
1/ How has Belgian drug policy been developed between 1996 and 2003? 
2/ How did scientific knowledge contribute to the development of Belgian drug policy between 1996 and 
2003? 
2.a./ Through which modalities did scientific knowledge contribute to the drug policy-making  
process? 
2.b./ What has counted as scientific knowledge in this particular drug policy-making process? 
2.c./ Is there a difference in the role played by scientific knowledge within the main  
political institutions (i.e. Parliament and Government)? 
2.d./ Which other types of information competed with scientific knowledge in this particular  
drug policy-making process? 
3/ What is the particular influence of the media and interest groups on the contribution of scientific 
knowledge to the development of Belgian drug policy between 1996 and 2003? 
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Theoretical analyses and empirical studies have shown that the knowledge utilisation process is 
neither rational nor instrumental. Different types of knowledge utilisation interact as parallel, 
complementary processes. In this study, I examine through which modalities scientific 
knowledge contributed to the development of Belgian drug policy between 1996 and 2003. I 
draw on Weiss’ three-folded typology (rational/instrumental; political/symbolic; conceptu-
al/enlightenment) because of the high usage in the knowledge utilisation literature inside and 
outside the drug field. Therefore, the studies which recently emerged in the drug field may serve 
as interesting cases for making (careful) comparisons with the findings of this study. 
 
Based on existing studies, I expect political/symbolic utilisation to be particularly prevalent in 
the context of drug policy given the strong emotions and opinions surrounding the use of illicit 
drugs and the high media profile that drug use attracts. Therefore, in addition to Weiss’ politi-
cal/symbolic model, I examine if and how power mechanisms play a role in the knowledge utili-
sation process (evolutionary model) and how scientific knowledge itself is conceptualised in 
the policy-making process (processual model; e.g. how do policy-makers see the role of scien-
tific knowledge? what counts as scientific knowledge?). Likewise, I will examine the misuse of 
scientific knowledge and other political/symbolic strategies (e.g. precautionary principle) that 
were observed in previous empirical studies.  
 
The literature review also made clear that different models of policy-making correspond to the 
different types of knowledge utilisation. It highlights how scientific knowledge can be used dif-
ferently depending on whether the policy process is conceived as an authoritative choice (ra-
tional/instrumental) or as interactive, with multiple (f)actors influencing the policy-making pro-
cess (rational/instrumental; political/symbolic; conceptual/enlightenment). This study adopts the 
framework of policy-making as a structured interaction, as I am interested in the different mo-
dalities through which scientific knowledge contributed to the policy-making process (includ-
ing Parliament as well as Government). Little is known about whether and how the main politi-
cal institutions (i.e. Parliament and Government) in a parliamentary democracy such as Belgium 
use scientific knowledge in the drug policy-making process and which (f)actors are at play.  
 
A focus on policy processes and interactions between policy-makers, scientists and other actors 
assumes that scientific knowledge may be just one of a multitude of factors to influence the poli-
cy-making process. This study fits into the knowledge exchange literature in that I seek to de-
scribe and understand the barriers and facilitating mechanisms regarding knowledge utilisa-
tion in the Belgian drug policy-making process. In addition to Weiss’ three-folded typology, I 
take into account the institutional and individual characteristics of policy-making (e.g. budgets, 
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windows of opportunity, values and opinions of political parties, the type of policy system, tacit 
knowledge of individual policy-makers). The complexity of the knowledge utilisation process is 
assumed to be related to the nature of scientific knowledge and the levels of engagement of scien-
tists too. Therefore, in this study, scientific knowledge refers to scientific research as such as 
well as to scientific discourse of an academic. Scientists may take different public positions in the 
policy-making process (scientific experts, policy advisors, observer-turned players, lonely prophets 
or social movement theorists/activists) which may influence the ways in which their findings or 
knowledge are utilised. This study will examine how scientists themselves perceive and handle 
these engagements. In accordance with the literature, I expect to find that establishing networks 
or having relationships with key players inside and outside the policy-making process are strong 
facilitators of knowledge utilisation.  
 
The media and interest groups are also expected to play a decisive role. Previous studies have 
shown that media and associations advocating for drug users’ rights as well as groups present-
ing parents or ex-drug users advocating against drug use may act as strong facilitators of 
knowledge utilisation in the drug policy field. However, details about their particular influence 
have been largely missing in the knowledge utilisation studies in the drug policy area. This study 
aims to offer a modest contribution towards this understanding. 
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Figure 2: Conceptual framework 
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2. Ontological and epistemological assumptions 
2.1. A diversity of paradigms 
Guba and Lincoln (in Denzin and Lincoln, 1994) distinguished several competing paradigms (e.g. 
positivism, critical theory, constructivism,...) which can be placed on a continuum. Paradigms are 
viewed as basic belief systems based on ontological (What is the form and nature of reality?), 
epistemological (What is the nature of the relationship between the knower or would-be knower 
and what can be known?) and methodological (How can the inquirer go about finding out what-
ever he or she believes can be known?) assumptions (Walliman, 2011).  
 
There are several broad and diverse traditions but, while sharing several assumptions, I discuss 
them in terms of two broad traditions. In a positivist view of the world, reality exists inde-
pendently of what anyone knows, thinks, or believes about it (Rubin and Rubin, 2005). Science is 
seen as the way to get at truth, to understand the world well enough so that we might predict 
and control it (Mortelmans, 2009). In this context, positivists deal with explaining causal rela-
tionships and most importantly direct cause and effect relationships. The positivist paradigm 
also denies the historical and social context (e.g. existing power relations in society). Scientific 
inquiry is seen as the core knowledge production process. Positivism is not valuable in studying 
complex, changeable social processes containing a variety of actors. It strips away context and 
meaning (Rubin and Rubin, 2005). Another claim made in these traditions is that research pro-
duces objective and value-free knowledge. Knowledge obtains the status of truth which is sepa-
rated from the opinions and values of the researcher. 
 
A contrasting composition of traditions is associated with a (social) constructivist or interpretive 
perspective. This tradition views knowledge as socially constructed and dependant on circum-
stances. According to Schwandt (2000), “Knowledge is not disinterested, apolitical, and exclusive 
of affective and embodied aspects of human experience, but in some sense ideological, political, 
permeated with values.” (p.198). This perspective assumes that social reality is produced and 
reproduced through actions and interactions between people and their world, and developed 
and transmitted within an essentially social context. Social reality is not determined, it is socially 
constructed (Hebberecht, 2002). Multiple versions of the same event can be true at the same 
time (Rubin and Rubin, 2005). In other words, this approach values multiple realities that peo-
ple have in their minds (Golafshani, 2003). It also maintains that scientific research is not the 
result of an objective understanding of the natural world. Rather, science has a social compo-
nent, which makes it subject to an array of influences (e.g., demographic characteristics of scien-
tists, organisational processes, social and cultural context in which research is developed, etc.) 
through which knowledge is certified (Davies, 1997; Guston, 2000). In this view, knowledge ob-
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tained by research can be considered as partial and relative (to the researcher’s view and val-
ues) (Rubin and Rubin, 2005).  
 
Alternative approaches, taking a position between both main traditions, provide arguments for a 
critical framework: there is no objective or value-free knowledge (the researcher and the object 
of research are assumed to be interactively linked; (social) constructivist perspective) and pow-
er inequities and value systems have to be acknowledged (Guba and Lincoln, 1994). The social 
reality is historically shaped through the social, political, cultural and economic context and is 
the result of human action. This framework assumes that some interpretations (i.e. those of the 
more powerful and dominant groups) are taken as more valid than others. The focus is on the 
role of the state, society and the public at large which offers a framework for analysing how be-
haviour is problematised and controlled by the government through different kinds of actions 
and reactions (Hebberecht, 2002). In other words, the critical framework adds the view that all 
perspectives are ideologically influenced. It is their epistemological position that most differen-
tiate the critical framework and the constructivist approach from the positivist view (Guba and 
Lincoln, 1994). 
 
2.2. Choosing an approach 
This study does not put a primacy on scientific knowledge as the source of truth but regards 
social science research as disassociated from reality, and the findings of research as an abstrac-
tion. Ontologically, I doubt the existence of an objective reality. Social reality is not given or de-
termined, it is socially constructed: there are only socially bound perspectives on reality (Guston, 
2000; Hebberecht, 2002). This approach provides a helpful perspective to understand the be-
liefs, values and perceptions of different actors and the processes of interactions among these 
individuals. I do not separate the world of research and the world of policy-making but see 
knowledge and policy as interrelated. The very idea of two autonomous communities (Caplan, 
1979) has not captured how the policy process shapes and modifies how or why scientific 
knowledge is used, abused or ignored (Stone, 2001). Simple linear models, studying the rational 
or instrumental approach of policy (and the science-policy nexus), have also been criticised be-
cause the social context in which the process occurs is neglected (Sutton, 1999; Neilson, 2001; 
Devos, et al., 2009). Most interestingly, they criticise the current notion of evidence-based policy 
which relies on positivist, rationalist assumptions (Bacchi, 2009). Thinking about the science-
policy nexus from a social constructivist tradition is valuable to explore different perspectives of 
knowledge utilisation as well as how particular kinds of knowledge come to be seen as useful 
and valid, by whom and in what contexts. Constructivist researchers address the multiple mech-
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anisms and avenues for informing the policy process (even from the sidelines) (Lancaster, 
2014).  
 
Furthermore, I regard drug use, the focal theme of the study, as a social construct. The concept of 
drug use is constructed by socially institutionalised definitions. Debates about drug use are not a 
simple reflection of the properties of the drug itself but they rather reflect the nature of society 
(Dingelstad, et al., 1996). Scientists, the media and policy-makers play a role in constructing 
drug use. On the one hand, while the scientific world aims to discover and name the problem and 
construct ‘proof’ through appeal to scientific knowledge, the media may be responsible for the 
process of commanding attention and legitimating the claim. On the other hand, policy-makers 
are able to invoke action and mobilise support (White, 2008). 
 
In general, this study is essentially applying an interpretive approach (social constructivism), 
including critical concerns. The process of policy-making is concerned with the power to make 
decisions, to control resources or to control people’s behaviour (Watkins, 1994; Stevens, 2011). 
Similarly, the choice of what counts as scientific knowledge and who is considered as authorita-
tive or trustworthy involves acts of power (McNay, 1994). Hence, I acknowledge the likelihood 
that scientific knowledge may be used strategically by dominant groups (Huberman, 1994). Poli-
cy can be seen as an ideological construct in favour of particular powerful groups and scientific 
arguments may help to reproduce this (Letherby and Jewkes, 2002).  
 
3. Qualitative methodological approach 
Traditionally, a (social) constructivist or interpretive approach implies the application of qualita-
tive methods, as opposed to quantitative methods (Morgan, 2007; Mortelmans, 2009). Qualita-
tive methods allow us to explore a phenomenon in order to generate a richer understanding of 
the full range of opinions and experiences on this phenomenon (Mortelmans, 2009; Decorte and 
Zaitch, 2010). In other words, these methods seek to understand a given topic from the perspec-
tives of the population it involves (insider’s view – emic perspective) while capturing the histori-
cal and social context, instead of taking an outsider (etic) perspective. The distinction between 
qualitative and quantitative research methods has also been classified as the distinction be-
tween subjective versus objective, between idiographic versus nomothetic, between exploration 
and understanding versus prediction and control (Creswell, 2009).  
 
This study adopts a qualitative methodological approach in order to understand the complexity 
of the knowledge utilisation process. Qualitative measures may provide us with information or 
access to meanings and choices regarding the knowledge utilisation process and allows us to 
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delve into parts of this process. Previous studies on knowledge utilisation in the drug field also 
argued that these how and why questions are best answered through qualitative research meth-
ods. Quantitative methods would reduce knowledge utilisation to variables and causal relation-
ships, without providing insight into the experiences, beliefs, values that actors and networks 
attribute to the science–policy nexus (Landry, Lamari and Amara, 2003). Then, the object of 
study would be quantified: the focus would be on the frequency and extent of knowledge utilisa-
tion and the phenomenon would be cast into categories (assuming that it is a homogenous, un-
changing, or static concept). Furthermore, answers to questions in a quantitative questionnaire 
may be expected to be unreliable because the firm structuring of questions may influence the 
answers received (Huber and Power, 1985). Respondents may tend to reply in a manner that 
will be viewed favourably by others (e.g. about political utilisation of scientific knowledge; social 
desirability bias). Statements about (indirect) knowledge utilisation cannot be studied adequate-
ly as each respondent has his/her own definitions of use (Rich, 1997; Landry, Lamari and Amara, 
2003; Klein Haarhuis, Hagen and Scheepmaker, 2009). However, qualitative methods have their 
disadvantages as well: it is more difficult to determine the validity and reliability of data (e.g. it is 
tricky for qualitative researchers to make generalisations from a sample to a population; re-
searchers’ bias (like e.g. subjectivity) are unavoidable) and qualitative research methods often 
require a lot of time and/or money while a rather small number of respondents is reached 
(Hammersley and Gomm, 2008; Decorte and Zaitch, 2010).  
 
4. Technical design: Case study 
A case study design is an appropriate strategy of research to obtain an in-depth view of a social 
phenomenon in its (naturally occurring) context, over a certain period and by means of the de-
scriptions and explanations of the population under study (Bloor and Wood, 2006). As I will 
elaborate below, this design is particularly useful to describe and understand how scientific 
knowledge contributed to the development of Belgian drug policy between 1996 and 2003. 
 
4.1. Why a case study design? 
A case study serves the purpose of identifying complex processes (Yin, 2003; Bloor and Wood, 
2006). In particular, a case study design provides a thick description that is essential for a de-
tailed and holistic understanding of the context and processes within a particular setting and 
time period (Gerring, 2007; Swanborn, 2008). This is very suitable for this study, as the science-
policy nexus involves complex and dynamic interactions between policy-makers, scientists and 
other key players like the media or interest groups. Likewise, in the literature, I found that it is 
difficult to adequately trace the flow of information from the time it enters the policy-making 
process to the time that some action/decision is taken, unless the policy domain is monitored for 
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at least a long period (Sabatier, 1998; Lindquist, 2001; Kingdon, 2002). A case study allows us to 
study the phenomenon intensively over a long-term time period.  
 
Second, a case study design is preferred when how and why questions are posed. I have argued 
earlier that I want to describe how scientific knowledge contributed to the Belgian drug policy-
making process. In particular, I will explore how actors (i.e. members of the Parliament, mem-
bers of the Government, media, scientists, interest groups) and factors (i.e. characteristics of 
scientific knowledge, political context, budget, etc.) influence why (or why not) scientific 
knowledge contributed to this process (Yin, 2009).  
 
Furthermore, previous research on the science-policy nexus also showed that a case study de-
sign is an approach highly suited to understand the nexus (Landry, Amara and Lamari, 2001; 
Brans, et al., 2004; Elliott and Popay, 2000; Carden, 2004; Monaghan, 2009; Zampini, 2014; 
Brewster, 2014). As stated above, most of these studies analyse knowledge utilisation in one or 
more cases. An example of a case may be the historical development of a policy (e.g. prison poli-
cy, cannabis policy, migration policy, …) (Duke, 2001; Brans, et al., 2004) or a new policy meas-
ure, for example the establishment of new cannabis legislation; the implementation of safe in-
jecting rooms or treatment of heroin dependence; the implementation of the Illicit Drug Diver-
sion Initiative (IDDI),… (Lenton, 2004; Lenton, 2007; Hughes, 2007; Hughes and Stevens, 2010; 
Hall, 2008; Hall, 2004; Monaghan, 2009; Macleod and Hickman, 2010). Some researchers prefer 
to study more than one case. Two or more research projects are sometimes selected as cases 
(Elliott and Popay, 2000; Carden, 2004). Similarly, Bak Jørgensen (2011) investigated the role of 
expert knowledge in migration policy in two countries (cases): Denmark and Sweden. 
 
Finally, no matter how many cases are included in a study (e.g. a single or limited number of 
cases), a case study design always runs the risk that the number of cases will not be sufficient to 
reduce the generalisation problem. However, advocates of the case study have responded to this 
criticism by claiming that the kind of generalisation is rather analytical or theoretical. Yin (2003) 
states that “case studies […] are generalisable to theoretical propositions and not to populations or 
universes. In this sense, the case study […] does not represent a 'sample', and in doing a case study, 
your goal will be to generalise theories (analytical generalisation) and not to enumerate frequen-
cies (statistical generalisation)" (p.10). In contrast with statistical generalisation that demon-
strates the validity of an argument for statistical populations or universes, analytical generali-
sation aims to create and expand theoretical frameworks that should be useful in analysing sim-
ilar cases (Swanborn, 2003; Bloor and Wood, 2006; Gerring, 2007). Thus, case studies, by 
providing a depth and richness that are indispensable to social sciences, have a general rele-
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vance and are able to generate ideas and theoretical conclusions about the science-policy nexus 
in the drug field. 
 
4.2. The development of Belgian drug policy between 1996 and 2003: why this case? 
The selection of case(s) is crucial to the purpose of each case study design (Swanborn, 2003; 
Bloor and Wood, 2006; Gerring, 2007). Whereas much research focuses on a single case, often 
chosen because of its unique characteristics, the multiple-case study design allows the research-
er to explore the phenomena under study through following a replication logic. The conceptual 
framework, identified through the literature review, assisted me in selecting a case for my 
study.11  
 
First of all, existing studies on the science-policy nexus sometimes focus on a type of research 
(e.g. evaluation research) or on studies conducted within a research institute or programme. 
However, it is difficult to measure the impact or influence relative to a single, research project. 
As research projects generate several effects, it is rather impossible to distinguish the impact of 
a particular research project from that of other influences with which the findings get mixed 
(Hanney, et al., 2003; Ritter and Lancaster, 2013). Selecting a policy area, policy debate or policy 
measure may facilitate some assessment of the science-policy nexus because it may identify how 
far the policy-making process has been informed by scientific knowledge taking into account 
contextual issues.  
 
While some researchers studied a historical case (e.g. the (re)classification of cannabis in the UK 
(Monaghan, 2009), or the historical evolution of prison drug policy (Duke, 2002)), others exam-
ined contemporary issues in the science-policy nexus, such as the perception of policy-makers or 
researchers about the way research results are used under the present circumstances. Choosing 
a historical case has however some methodological advantages. Leaving aside the reality that 
some information may be lost due to memory bias, retrospective recalls about a historical, heavi-
ly politicised case offer the researcher a clear cut-off point for analysis and undoubtedly ensure 
that the answers of interviewees are less influenced by the current (political and public) context 
(cfr. social desirability) (see also below, §5.3.3.). A study about the perceptions regarding current 
use of scientific knowledge in the Belgian drug policy-making process would have been biased 
by the political developments when I started my PhD. Belgium was locked in a political impasse 
                                                          
11  Next to the case of the development of Belgian drug policy between 1996-2003, we, initially, selected a second 
case (i.e. the development of the local drug policy in the city of Antwerp) but the aim of achieving a manageable 
case for detailed analysis brought this study back to one case. 
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between 2010 and 2011. After the elections in June 2010, policy-makers failed to produce a new 
government until the end of 2011.  
 
Furthermore, the specific period of the development of Belgian drug policy (1996-2003) pro-
vides a critical case12 for examining the contribution of scientific knowledge in the drug policy 
area. In other words, the case can be seen as useful in replicating or extending theory by filling 
conceptual categories (Denzin and Lincoln, 2003). The aim is to understand through which mo-
dalities scientific knowledge contributed to the Belgian drug policy-making process (and not just 
in the outcome of policy formulation). Additionally, according to the literature, windows of oppor-
tunities may open infrequently and briefly. These key arguments supported the selection of this 
particular case. I have chosen the period between 1996 and 2003 because drugs appeared on 
the political and media agenda in 1996 (window of opportunity opened) and increasingly attract-
ed the attention of policy-makers, scientists and media until 2003. Processes of interaction and 
engagement between these actors have been observable in this case. Between 1996 and 2003, 
drug policy has been the subject of debate and interaction between the majority and the opposi-
tion parties within the Belgian Federal Parliament13 and Government14 and between policy-
makers, scientists, the media and interest groups. Clearly, this case allows the detailing of the con-
tributions of scientific knowledge to both processes (parliamentary and governmental). Similar-
ly, as the drug phenomenon quickly and repeatedly gained media attention between 1996 and 
2003, the selection of this case also makes it possible to study the role of the media (and interest 
groups) in improving or hampering the science-policy nexus. Likewise, a respondent mentioned 
that the development of the drug policy in Belgium (1996-2003) can be seen as a case in which 
each of those actors were explicitly engaged. 
                                                          
12  Nevertheless, I am aware that choosing a case that has the greatest amount of discussion about the topic under 
study might bias the results in favor of showing the strongest links between science, policy (and media or interest 
groups). 
13  The Federal Parliament (consisting of two assemblies, the Chamber of Representatives and the Senate) is an oblig-
atory point of passage as it performs several important functions: e.g. law-making and political control. In the 
Chamber of Representatives as well as the Senate several commissions and meetings are held. Important issues 
like voting on bills, amendments and motions or deliberations on bills and budgets are almost always dealt with in 
plenary meetings, consisting of all elected members of the Parliament. Obviously, members of the Parliament in an 
oppositional position may play a very active role here (and their statements might even be slightly overrepresent-
ed). Standing Commissions can decide to set up a working group charged with hearing experts, conducting 
searches and seizing documents. An example of a working group is, for example, the Parliamentary Working 
Group on drugs (PWG).  
14  The so-called Copernicus reforms of the Government (1999-2003) aimed to decrease the powerful (political) role 
of the Ministerial Cabinets and to give the civil servants of the Administration (‘Federal Public Services’ (FPS) at 
the federal level or ‘Departments’ at the federate level) a more decisive role. As a result, the Ministerial cabinet 
was replaced by a personal secretariat of the Minister, a policy council (‘beleidsraad’) and a policy cell 
(‘beleidsvoorbereidende cel’), which together formed the policy-making bodies of the member of the Government. 
The secretariat is situated on the level of the Minister while the cell is situated on the level of the Administration. 
The policy council forms the bridge between the Minister and the Administration. However, the neutral cell situat-
ed in the Administration remained the powerful and political player of the Minister (cfr. Ministerial Cabinet). In 
practice, it just meant a change of name (Devos, 2006). 
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“I think you selected a perfect time period. At that time, the political debate was very vivid, politi-
cal parties had contacts with interest groups, the issue got a lot media coverage, etc. Now, the at-
tention is rather absent on each level” (Respondent 29, policy-maker). 
 
5. Data collection methods 
In a case study design, researchers often use a variety of data collection methods in order to 
reach a holistic understanding of the phenomenon (Swanborn, 2003; Kohlbacher, 2006: Cre-
swell, 2009). In this study, two data collection methods are used. The objective is not so much to 
place one kind of data against another but to use them in conjunction with one another. 
 
Critical Discourse Analysis (§4.1.) is concerned with the contribution of scientific knowledge pre-
sent in recorded talk (e.g. media, official statements of the parliamentary/governmental debate). 
It has benefits in drawing a critical but rich picture of an issue (e.g. use of scientific knowledge) 
within a particular setting (e.g. media, policy debates), and in revealing taken-for-granted and 
hidden values, positions and perspectives (McLaughlin and Muncie, 2013).  
 
Retrospectively exploring experiences of policy-makers, scientists, journalists and members of 
interest groups by means of semi-structured interviews (§4.2.) further enhanced our understand-
ing of the processes of knowledge utilisation, and the (informal) interactions between the multi-
plicity of actors, networks and contextual issues in particular.  
 
5.1. Critical Discourse Analysis of policy and media documents 
The analysis of documents (i.e. letters, notes, invitations, meeting reports, newspaper articles, 
etc.) is described as a major method of social research (Mason, 1996). Documents are of particu-
lar importance for qualitative research because access can (sometimes) be easy and at low cost, 
because the information provided may not be available in oral form and because documents may 
give historical insight (Hodder, 2003). According to Mortelmans (2009), documents may be used 
as background information or as source of information about incidents and events. Although 
documents are a non-negligible source, they are never a complete representation of the real dis-
cussion or activity (Silverman, 2006; Mortelmans, 2009). Documents are always written with a 
specific purpose and for a particular audience in a specific setting.  
 
In this study, I use documents as a source of background information to explore the chronology 
of the development of the Belgian drug policy between 1996 and 2003. Secondly, I acknowledge 
that documents represent rather partial accounts which require critical assessment. Such analy-
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sis may assist in critically examining the policy and media discourse about drug policy and if and 
how the central actors used scientific knowledge or other types of information. 
 
Before I focus on the general characteristics of a Critical Discourse Analysis (§5.1.2.) and the 
particular approach that I have adopted to study the science-policy nexus in the development of 
Belgian drug policy between 1996 and 2003 (§5.1.3.), I briefly address the definition and the 
different types of discourse analysis (§5.1.1.).  
 
5.1.1. What is a discourse and a discourse analysis? 
Discourse is a complex term, and is not defined consistently.15 Generally speaking, it is assumed 
that discourse is not a neutral communicative resource which reflects reality in transparent 
ways. The concept of discourse implies that truth is socially constructed through talk (McLaugh-
lin and Muncie, 2013). The focus of discourse analysis16 is any form of written or spoken lan-
guage, such as a conversation (e.g. interview), a newspaper article or policy document. A dis-
course analysis is suitable for looking at what is said but also at how something is expressed (emic 
perspective or insider’s view).17 The emergence of meaning is always considered a matter of in-
teraction processes between people and texts (intertextuality; the use of text in other texts such 
as a newspaper article referring to a scientific report; see also below, §5.1.3.). These interaction 
processes may in some cases focus on the micro-level of conversations (e.g. Discursive Psycholo-
gy (DP)18, Conversational Analysis (CA)19) but sometimes also on the broader (social or historical) 
                                                          
15  While some authors understand discourse as the “language that is structured according to different patterns that 
people’s utterances follow when they take part in different domains of social life” (Jørgensen and Phillips, 2002, p.2), 
others offer a critical approach considering causes and consequences of broader, historical, contexts and changes 
(Wodak and Krzyzanowski, 2008). According to Michel Foucault (1972): “we shall call discourse a group of state-
ments in so far as they belong to the same discursive formation […] Discourse is made up of a limited number of 
statements for which a group of conditions of existence can be defined. Discourse in this sense is not an ideal, timeless 
form […] it is, beginning to end, historical – a fragment of history […] posing its own limits, its divisions, its transfor-
mations, the specific mode of its temporality” (p.117). 
16  The general label of discourse analysis is mostly applied to both formal linguistic techniques as well as theoretical 
propositions of, for example, Laclau and Mouffe or Foucault (Torfing, 1999). However, a distinction is sometimes 
made between discourse analysis and discourse theory, with the latter notion particularly referring to the theoreti-
cal propositions. In the following paragraphs, I will use the general label discourse analysis. 
17  Offering a different perspective of theorising and analysis, content analysis is essentially seen as a quantitative 
method consisting of counting the numbers of occurrences per category. This type of analysis assumes that there 
is a relationship between the frequency of content and meaning and, therefore, fits more within the positivist re-
search tradition (Krippendorff, 2013). 
18  Discursive psychology (DP) considers that human thinking (e.g. reasoning, emotions) is an inherently social activi-
ty ingrained in one’s use of language. For instance, reasons are seen as mental constructions made within the con-
text of a person’s larger social and cultural world view and his or her need to convey a particular image of the self 
(Bagozi and Dabholkar, 2000). In other words, DP studies the identities, minds and selves within naturally occur-
ring discourse. As discursive psychology also analyses talk between people, it has similar assumptions like Con-
versation Analysis (CA) (Wetherell, Taylor and Yates, 2001a). 
19  Conversation Analysis (CA) is frequently used to study discourse in speeches or talks because this method focuses 
on discourse in social interactions or day-to-day conversations. This type concentrates on the talk itself and what 
people do when they talk while context is relatively unimportant. 
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context (e.g. Critical Discourse Analysis (CDA), Foucauldian discourse analysis) (Wetherell, Tay-
lor and Yates, 2001b; Wodak and Meyer, 2001).  
 
5.1.2. Critical Discourse Analysis (CDA)  
Taking into consideration the conceptual framework (and research questions) of this study, a 
Critical Discourse Analysis can be very useful. It is a critical mode of analysis: a researcher 
should exercise a high degree of scepticism in the reading and interpretation (Mason, 1996). 
Foucault (1981) stated that: “a critique does not consist of saying that things aren’t good the way 
they are. It consists of seeing on what type of assumptions, of familiar notions, of established, unex-
amined ways of thinking the accepted practices are based” (p.456). Drawing on a (critical) social 
constructivist approach, documents are properly used as a topic, not as a resource. Analysing 
and understanding the science-policy nexus does not only require a textual analysis of what an 
individual says or writes (e.g. are references to scientific knowledge made?, how is scientific 
knowledge used?). I also aim to explore how scientific knowledge itself has been conceptualised 
in the policy-making process (e.g. which scientific research is considered useful? who is consid-
ered as knowledgeable expert?). As argumentation and persuasion are involved, scientific 
knowledge may (or may not) find its way into policy through power struggles (Szarka, 2004). 
 
A central notion in most critical work on discourse is that of power, and more specifically on 
how power relations are exercised and negotiated in discourse (Bacchi, 2009). Van Dijk (2003) 
argues that all levels and structures of context, text, and talk may be controlled by powerful 
groups. For instance, dominant groups may play a prominent role in determining crime and 
crime control where the power of dominant groups may be integrated in laws or rules and, thus, 
control the acts and minds of the dominated groups (Van Dijk, 2003). In a similar vein, drug poli-
cy can be considered as a political-ideological construction (Hebberecht, 2009). While policy-
makers dominate or control political discourse, the same can also be said for other discourses: 
e.g. journalists control media discourse and academics control scientific discourse. “Power does 
not belong to particular agents such as individuals or the state or groups with particular interests; 
rather, power is spread across different social practices” (Jørgensen and Phillips, 2002, p.13). Each 
powerful position does presuppose a privileged access to a particular resource such as money, 
status or knowledge/information. For instance, rich people may obtain and maintain power be-
cause of their money whereas professors may achieve power based on their knowledge or cred-
ibility (Van Dijk, 2003). In relation to the science-policy nexus, this may work in two ways: on 
the one hand, deciding who is trustworthy or qualified to advise in the policy-making process 
involves acts of power (Van Dijk, 2003; Acevedo, 2007). For instance, a medical policy discourse 
may come to constitute particular objects as distinct and factual as well as to qualify a doctor as 
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a particular trustworthy individual with knowledge and authority (processual model; Monaghan, 
2011). On the other hand, within the struggle between different knowledge claims, it is assumed 
that scientific knowledge that is structured and institutionalised through policy discourse is like-
ly to attract the support of powerful groups (evolutionary model; Stevens, 2007b).  
 
The relationship between text and context is also an important theme in a Critical Discourse 
Analysis. Meyer (2001) mentions that the notion of context is crucial for CDA as this includes 
historical, political and ideological components. As a result, to understand the text, it is im-
portant to incorporate elements of context into the analysis of texts. For instance, the character-
istics and procedures of the Federal Parliamentary debate may influence and affect what consti-
tutes scientific knowledge and how it is used (e.g. in submitting questions or interpellations, one 
may expect that MPs of opposition parties will use scientific knowledge selectively to support 
their case and disprove that of others). 
 
Furthermore, a Critical Discourse Analysis allows one to make a bridge between micro level 
and macro level instead of focusing on the micro-level (e.g. this is the focus in Conversation 
Analysis) or on the macro-level (e.g. Foucauldian discourse analysis assumes that discourses can 
only be understood with reference to their historical context). For instance, a CDA focuses on 
speeches or interactions in the Parliament (discourse at the micro-level), while taking into ac-
count that this may enact or be a constituent part of legislation or the reproduction of power at 
the macro-level as well.  
 
Leaving aside these general characteristics, some criticisms towards the method and perspective 
of Critical Discourse Analysis (CDA) are worth mentioning. Carvalho (2008) criticised the large 
focus on policy discourse while media discourse is frequently ignored. Furthermore, it is argued 
that the concept of Critical Discourse Analysis is in itself an abstract label that is relatively open-
ended.20 Rogers (2004) mentioned that “Approaches to CDA may vary at the ‘critical’, ‘discourse’ 
and ‘analysis’ sections of the method, but must include all three parts to be considered a CDA.” 
(p.1). Despite these differences, the work of Foucault had a significant influence on the general 
framework of Critical Discourse Analysis. Foucaults’ archaeology (What are the rules for the 
                                                          
20  Different types of Critical Discourse Analysis exist. Some critical analysts focus on linguistic details (e.g. patterns in 
vocabulary, intertextuality) (Wodak and Meyer, 2001) or on the cognitive basis of representations (e.g. Van Dijk). 
According to Van Dijk (2001) “Cognition involves both personal as well as social cognition, beliefs and goals as well 
as evaluations and emotions, and any other “mental” or “memory” structures, representations or processes involved in 
discourse and interaction.” (p.97-98). A critique of this approach is that such mental states and processes are pri-
vate or personal and that a study of discursive social interaction should attend to the public dimensions of text and 
talk. Others (e.g. Norman Fairclough) are interested in the relationship between different levels of social practices.  
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formation of a discourse?) and genealogy21 (How do discourses change historically? What role 
do these discourses play in the political decision?) focused on the identification of a number of 
typical discourses and, in particular, on which thoughts underlie these problem representations. 
Foucault’s way forward was to examine the effects of discourses (and less the content and 
sources of discourse) (Bacchi, 2009). Furthermore, his macro-sociological analysis of social 
practice was rather abstract and did not provide a particular methodology for the close analysis 
of specific texts (Fairclough and Fairclough, 2012). 
 
5.1.3. Critical Discourse Analysis framework of Norman Fairclough 
In this study, I apply the Critical Discourse Analysis framework of Norman Fairclough. This 
approach oscillates between a textually oriented analysis (content) and a focus on macro-
sociological analysis (context) (Fairclough, 2003). In particular, with the aid of the approach of 
Fairclough (2003), discourse is seen as the use of language as a form of social practice, meaning 
that discourse is inherent in every social action and interaction. The dialectical relationship 
between different levels of social practices (e.g. media coverage, parliamentary/governmental 
decisions, academic discourse) and between discourse and other elements of social life (e.g. 
relations of power) are two of his main points (Fairclough and Fairclough, 2012). For Fairclough, 
a textual analysis alone is not sufficient for discourse analysis as it does not shed light on the 
links between texts and societal and cultural processes (Jørgensen and Phillips, 2002). Discourse 
is also seen as the product of power because it embodies what is understood to make sense, to be 
true or to yield authority (Burchell and Foucault, 1991; Fraser, et al., 2004). Likewise, his focus 
on intertextuality (i.e. the use of text in other texts such as a newspaper article referring to a 
scientific report; see also below) may allow one to identify which texts and voices are included 
(and excluded) in a given text (Fairclough, 2003). Such an approach systematically describes the 
various strategies of text, and relates these to the social or political context (Hajer, 1995; 
Vianello, 2011). Therefore, in the literature, this approach is identified as a suitable way for 
analysing policy as well as media discourses (Fairclough, 1998; Mautner, 2008; Thomas, 2009). 
 
Furthermore, Fairclough’s approach represents the most developed methodological framework 
for CDA (Jørgensen and Phillips, 2002). In a search for a methodological framework suited to 
systematically structure and analyse the multitude of data included in the policy and media doc-
uments, it appeared that few Critical Discourse Analysists developed clear methodological tools 
                                                          
21  The work of Michel Foucault developed from the early text on madness (‘Madness and Civilization’) over the stud-
ies ‘Order of Things’ and ‘Discipline and Punishment’ to the final study of sexuality (‘History of Sexuality’). The first 
period has been described as a period of archaeological investigations, while the later studies have been seen as 
genealogical analyses. This evolution considered a transformation from a descriptive/historical perspective on 
discourses towards a greater critical and explanatory consideration of the interface between discursive and non-
discursive practices and the power-knowledge nexus (e.g. why and how discourses occur). 
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for empirical research of specific texts (Jørgensen and Phillips, 2002; Bacchi, 2009). Critical Dis-
course Analysts generally agree that a discourse analysis consists of detailed and repeated read-
ing of the text in an attempt to identify categories, themes, ideas, views, roles, and so on, within 
the text itself. The analysis may then result in an overview of structuring concepts, ideas and 
categorizations, story lines, metaphors, etc. (Wetherell, Taylor and Yates, 2001a). A clear meth-
odological framework can be perceived as a fruitful starting point, especially because interpreta-
tions of the data are always subjective: another researcher may interpret the same documented 
data differently (Wetherell, Taylor and Yates, 2001b, Fairclough, 2003). 
 
Fairclough’s method of CDA consists of a 3-dimensional framework: (1) textual analysis (e.g. 
description of the content, sentence structure and text structure, vocabulary, social actors (who 
speaks?), … ); (2) discursive practices (e.g. production and interpretation of the meaning of the 
text, context of the author, intertextuality, … ), and; (3) social practices (e.g. relation between the 
text and discursive practices and the wider society). Some refer to this framework as exercises 
in description, interpretation and explanation where the last phase refers to the dialectical rela-
tionship between discourse and society, for which Fairclough claims affinity with Foucault (Fair-
clough, 2003).  
 
Figure 3: Fairclough's three-dimensional framework 
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Source: Fairclough (1992, p.73) 
 
Fairclough (2003) developed a checklist of 12 analytical tools. These tools are: social events, 
genre, difference, intertextuality, assumptions, semantic or grammatical relations between sen-
tences and clauses, speech functions and grammatical mood, discourse, representation of social 
events, styles, modality and evaluation. Here, a dichotomy of internal relations to text and exter-
nal relations to text is often used to make a distinction between an internal analysis rather fo-
cusing on the (linguistic aspects of the) text and an external analysis rather paying attention on 
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the context (Fairclough, 2003). In particular, analysis of the internal relations includes analysis 
of linguistic details as semantic, grammatical, vocabulary, phonological relations. External rela-
tions refer to relations between one text and other texts which are external to it: social events, 
genre, difference, assumptions, discourse, representation of social events, intertextuality, 
styles, modality and evaluation. A researcher must make his/her own choice in applying these 
tools depending on the research questions and the topic under study (Joye, 2011). In our study, 
of the twelve tools, I will only focus on the 10 tools related the external relations of texts (i.e. 
relations with other elements of social events, practices and structures). I did not focus on inter-
nal relations such as semantic, grammatical, vocabulary, phonological relations or speech func-
tions as applied by the purely linguistic tradition of discourse analysis (Wodak and Meyer, 
2001). According to Jacobs (1998), a focus on internal elements in e.g. parliamentary debates 
may reveal bias. Parliamentary documents are written representations of oral debates which 
means that some spoken details may have been changed while writing these down. Hesitations 
or slips of the tongue are removed. Thus, a better strategy is to examine the content of the text, 
the general discursive patterns and social context rather than linguistic details as semantic, 
grammatical, vocabulary, phonological relations. Below, while focusing on three aspects (the 
source of the document, its context and the text itself), I elucidate each of the selected 10 tools in 
more detail (see also Appendix I). 
 
Source of the document refers to the type of publication/document, title, publication date, au-
thor(s) and the authority of the author(s) (i.e. who says it and on what grounds?).  
 
Context refers to the nature of the document, its goal(s)/objective(s), the target population (au-
dience), publication form, role in the parliamentary/governmental debate, etc. Documents and 
texts always need consideration of the social context as they do not exist separately from the 
rest of the social world. They are embedded in social events (Fairclough, 2003). The central 
issue is: to which social event or chronology of social events does the particular text belong? For 
example, in this case, a distinction can be made between parliamentary and governmental ac-
tions where texts are considered as elements of these social events. Within this framework, I 
also consider the genre of the text or document. A genre is a type of text or language used in the 
performance of a particular social practice. In other words, how does the text or interaction fit 
within and contribute to social action and interactions in social events? For instance, the genre 
of media texts, following Norman Fairclough, may recontextualise the arguments which policy-
makers have put forward (Wodak and Krzyzanowski, 2008). Also the discursive genre of par-
liamentary/governmental debates has its specificity: on the one hand, politicians aim for mobi-
lising the public (to achieve a lot of votes) and on the other hand they aim for positioning them-
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selves towards professional opponents (Jacobs, 1998). Both genres are therefore linked: for ex-
ample, members of the Parliament know that they always speak on the record and that the press 
is keeping an eye on them.  
 
In studying and analysing texts I will consider several elements. A discourse is a particular way 
of representing some part of the world. As stated above, different social groups often have dif-
ferent (alternative or competing) discourses. Related to the topic under study, I look for several 
competing discursive systems: e.g. biomedical/clinical discourse, public health discourse, socio-
logical discourse, legalistic/repressive perspectives (Hartnoll, 2004). Difference is fundamental 
to social interaction. For instance, in this study, differences may exist regarding terminology or 
discourse about drug use/cannabis. Within the policy-making process, the orientation of differ-
ence in the text may vary too: an openness to difference, an accentuation of difference and con-
flict or power, an attempt to resolve difference, a focus on solidarity or a consensus. Similarly, a 
discourse contains certain (implicit) assumptions. There are different types of assumptions: 
existential assumptions (i.e. assumptions about what exists, characterised by using classificatory 
categories), prepositional assumptions (i.e. assumptions about what is or may be), value as-
sumptions (i.e. assumptions about what is good and/or bad) and ideological assumptions.  
 
It is also important to examine which persons are represented in the text and from which per-
spective or viewpoint (e.g. whether they present themselves in support of or against a state-
ment/discourse, or where no clear position is taken). The tool styles are linked to social identi-
ties. Using this tool, I will study the way people present themselves (e.g. do they perceive them-
selves as experts or as having authority? are they part of a network?) and which position they 
take (e.g. dual roles: a policy-maker may use his role a parent to support some arguments; a pub-
lic role ranging from scientific experts to policy advisors, observer-turned players, lonely proph-
ets, or social movement theorists/activists). 
 
Representations of scientific knowledge are also studied. It is interesting to consider the choices 
made in describing, quoting and portraying scientists, scientific knowledge and the interpreta-
tion of scientific research. Regarding to the tool evaluation, my analysis focuses on statements 
concerning good/bad or (un)desirable, affective attributes of scientific knowledge (e.g. qualita-
tive – quantitative data; theme/topic; terminology; quality judgments). Similarly, the tool mo-
dality concerns the question: how do texts assess scientific knowledge in terms of truth and 
necessity? is more power and authority attributed to scientists than to other actors? which voic-
es are included and excluded? A particular discourse may come to constitute particular experts 
or type of experts with authority. 
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Furthermore, the emphasis also lies on the representation of social events. It is relevant to 
examine which contextual elements (e.g. political context, international discussions), related to 
the social events under study, are represented in the texts and which are the most salient, in this 
case, in the development of Belgian drug policy between 1996 and 2003.  
 
Examining how texts draw upon, incorporate, (re)contextualise and dialogue with other texts, is 
called intertextuality (Fairclough, 2003). In other words, this refers to making use of text in 
other texts (e.g. a newspaper article refers to or makes use of results in a scientific report). The 
meaning and content of any text or statement is shaped by what has happened before (e.g. the 
dissemination of scientific research findings, the publication of a newspaper article, a particular 
policy decision or debate), as well as in anticipation of future responses. Focusing on intertextu-
ality allows one to identify if and how scientific knowledge is used (rational/instrumental, con-
ceptual/enlightenment and political/symbolic) and which other types of information competes 
with scientific knowledge (Fairclough, 2003). 
 
Generally, my analysis consisted of a detailed and systematic reading of the policy and media 
documents in an attempt to identify the external relations of the texts (i.e. the role of scientific 
knowledge in argumentative structures as well as the practices through which these utterances 
were made) (Burchell and Foucault, 1991; Hajer, 1995). It is a way of moving beyond the actual 
words to draw a rich and critical picture of an issue (e.g. use of scientific knowledge) within a 
particular setting (e.g. governmental/parliamentary debate) and of the emphasis it is given with-
in a group or community (Wetherell, Taylor and Yates, 2001a). I particularly focused on: the 
textual elements that characterise (differences between) discourses (e.g. the terminology and 
definition(s) of drug use or drug policy options used and the use of existential, prepositional, 
value assumptions); how players are represented in the text and from which perspective or 
viewpoint; how scientific knowledge was represented: e.g. statements about the nature, type 
and quality judgements of this researches, the relationship of scientific knowledge to other 
forms of information available, the players/networks referring to or discussing these scientific 
results and their motivations, and the various types of knowledge utilisation.  
 
5.1.4. Sample of documents 
My case study, of the development of Belgian drug policy covering the period between 1996 and 
2003, offers many examples of communication activities (interviews, press conferences, leaks, 
leaflets, parliamentary interpellations) of which I study its reflection in documents. Of course, I 
had to clearly select the documents involved in the discourse analysis. According to Phillips and 
Di Domenico. (2009) this choice is difficult but decisive: “The difficulty for discourse analysts, 
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then, is how to identify a manageable, relatively limited corpus of texts that is helpful in exploring 
the construction of the object of analysis.” (p.560).  
 
The work in collecting and analysing the policy and media documents was completed by one 
researcher over a thirteen month period (between July 2011 and October 2012). Successively, I 
analysed the parliamentary/governmental discourse (first phase) and the media discourse (sec-
ond phase). 
 
Parliamentary/governmental discourse (Phase 1) 
Policy documents included formal, publicly available expressions of strategy and statements of 
intent made by the Federal Government, as well as parliamentary discussions. Given the selected 
case, the databases of the Federal Government and Parliament were searched22, first using gen-
eral key words like drugs, drug use, substance use, but eventually refined key words such as drug 
policy, Parliamentary Working Group on Drugs, Federal Drug Policy Note, and drug/cannabis law 
reform. A strategy used to ensure that all relevant documents were retrieved for analysis, to pre-
vent the exclusion of documents that might be marginally important, and to balance the narra-
tives selected included an additional search with the keywords legalisation, decriminalisation, 
depenalisation, as these words were included in most of the initially selected documents. This 
search resulted in a total of 164 policy documents, which I have analysed. Governmental docu-
ments involved are rather scarce (due to the unpublicised character).  
 
Media discourse (Phase 2) 
Print media are rich sources of data for social scientists (Mautner, 2008). Print offers real practi-
cal advantages (e.g. easier to collect than audio-visual data, more permanent than web material) 
as well as benefits related to the method (e.g. if you are interested in the content and sources of 
discourses, the major newspapers and magazines are obvious sources to turn to). In this study, 
media analysis examined Belgian (including Flemish as well as Walloon) newspaper articles. In 
particular, the analysis covered the main Belgian newspapers and magazines: Gazet Van Ant-
werpen, De Morgen, De Standaard, De Tijd, Het Belang van Limburg, Het Laatste Nieuws, Het 
Nieuwsblad, Het Volk, Knack - Le Vif/L'express, Trends – Tendances, L’Avenir, La Dernière Heu-
re, L’Echo, Les Echos, Grenz Echo, La Libre Belgique, Libération, La Meuse, La Tribune, Le Soir.  
 
Most of the articles published in the Flemish or Walloon newspapers were collected from online 
media databases. In particular, the articles published in the Flemish newspapers were collected 
                                                          
22  The documents of the Senate and Chamber of Representatives are available online since, respectively, 1995 and 
1988. 
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from the Mediargus database and articles published in the Walloon newspapers were collected 
from the Pressbanking database. However, as these databases have only been available since the 
end of the 1990s, the search was completed by examining archives (which was a very time-
consuming process). A total number of 1,067 articles were selected (using the same search 
strategy as with policy documents) and analysed.  
 
5.2. Semi-structured interviews with elites 
Entering the worlds of those involved in the debate and engaging them in an interview is seen an 
appropriate way to the understanding of the knowledge utilisation process. Interactions be-
tween actors, contextual developments, informal initiatives, networks, conflicts and strategies 
also have to be taken into account (Trostle, Bronfman and Langer, 1999; Elliott and Popay, 
2000). 
 
Interviewing is a qualitative research technique that involves conducting individual face-to-face 
conversations with a number of respondents, to explore their perspectives on a particular idea 
or phenomenon (Decorte and Zaitch, 2010; Creswell, 2009). Interviews are useful to get detailed 
information about a person’s thoughts or to explore new issues in-depth. They provide much 
more detailed information than through other data collection methods, such as quantitative sur-
veys. Furthermore, interviews also provide a more confidential atmosphere: people may feel 
more comfortable having a personal conversation as opposed to filling out a survey (see also 
above, §3). However, conducting a number of interviews is a time-consuming activity because of 
the time it takes to contact respondents, conduct interviews, transcribe them, and analyse the 
results (Mortelmans, 2009). 
 
5.2.1. Definition of elites 
Social scientists rarely study up, they have traditionally identified with the disadvantaged or un-
derprivileged, believing that to understand the latter will eventually empower them (Hertz and 
Imber, 1995; Smith, 2006). Likewise, drug research has tended to focus on the objects of policy 
like drug users (e.g. Becker, 1967; Young, 1971; Agar, 1973; Parker, Aldridge and Measham, 
1998) instead of on those involved in the development of drug policies such as policy-makers, 
scientists or professionals working in the drug field (Duke, 2002; Hartnoll, 2004). Exceptions are 
analyses of drug markets or law enforcement and evaluations of interventions that have sought 
to involve or engage stakeholders such as police officers, judicial agencies and/or staff in treat-
ment organisations etc. (e.g. Ruggiero and South, 1995; Hartnoll, 2004; Korf, et al., 2005). 
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Elites have been the focus of definitional squabbles that vary across a range of domains and, as a 
result, there is much confusion and debate surrounding this concept (Littig, 2009). In economics, 
elites are sometimes regarded as occupying positions at the top of the employment and income 
pyramid (Woods, 1998; Harvey, 2010). Others define elites as persons who hold strategic posi-
tions within a social network like, for example, senior management positions or leading consult-
ants (Welch, et al., 2002), or people occupying positions of influence within policy and political 
networks (Neal and McLaughlin, 2009). Common elements comprise: having direct or indirect 
decisional power, having great insight in specific knowledge and/or holding information difficult 
to explore by other methods. However, in this way, a different range of people may be perceived 
as elites: policy-makers, scientists and professionals. In other words, what constitutes an elite is 
socially and, in case of elite interviewing, scientifically constructed (Bygnes, 2008).  
 
While I do not believe, in line with Rice (2010), that it is possible to clearly segregate people into 
dualistic categories of elite and non-elite, I agreed to the use of the term to give some meaning to 
those who can best answer my particular research questions. In this study, I use the term elites 
to describe those people who are in positions of power in relation to the processes of drug poli-
cy-making. This rather broad definition, adopted from Duke (2002), acknowledges that in addi-
tion to overt indicators of power (e.g. policy-makers) there are also more hidden sites/actors of 
power and influence (e.g. police officers, judges, prevention workers, journalists, scientists or 
interest groups) (Cochrane, 1998). Existing studies mostly engage policy-makers from different 
levels and hierarchies while the thoughts and experiences of researchers or other relevant per-
sons (i.e. media, interest groups) are less frequently involved (Carden, 2004; Lindquist, 2001). 
 
5.2.2. Sampling 
The discourse analysis allowed us to identify which actors played an important role in the de-
velopment of Belgian drug policy. Respondents were selected on the basis of what they might 
know to help the researcher fit in pieces of a puzzle (Aberbach and Rockman, 2002). A selection 
on the basis of the researcher’s own judgment about which will be the most useful, is called the-
oretical sampling or purposive sampling (Bloor and Wood, 2006). According to Strauss and 
Corbin (1998) theoretical sampling may be defined as “data gathering driven by concepts de-
rived from the evolving theory and based on concept of ‘making comparisons’, whose purpose is to 
go to places, people, or events that will maximize opportunities to discover variations among con-
cepts and to densify categories in terms of their properties and dimensions” (p.201). In other 
words, theoretical sampling evolves during the process of a research, rather than being fully 
predetermined at the beginning of a research. It is a suitable technique for exploring new or un-
chartered areas. 
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Initially, 62 actors were identified and selected by means of the analysis of policy and media 
documents. However, 8 respondents23 explicitly refused to cooperate, 3 respondents has already 
passed away since and the contact details of one respondent (who was part of an interest group) 
were not found. Most refusing respondents felt they were not sufficiently knowledgeable about 
the subject (anymore) while two respondents refused because of their medical health condi-
tions. In case a respondent refused to cooperate or at the end of each interview, I always asked 
them to provide names and contact details of others they thought were important for me to in-
terview. By means of using the snowball technique (Farquharson, 2005) I succeeded in contact-
ing 5 additional respondents who worked on a lower level (e.g. ministerial cabinets/ employees 
of MPs). This simple question not only helped me to snowball but also generated interesting data 
on who knew who, who valued who and who networked with who (which is important when 
studying the science-policy nexus). Experts on a lower level also appeared to have much detailed 
knowledge.  
 
Eventually, a total of 55 individuals were interviewed over an eight-month period between 
January and December 2013, including fifteen members of Parliament, two employees of mem-
bers of Parliament, eight members of the Federal (and Regional) Government, eight employees 
of members of the Federal (and Regional) Government, six scientists, six journalists, four mem-
bers of interest groups, and six professionals working with drug users. Taking the selection into 
account, a clear limitation of this sample (and a recommendation for further research) is the 
underrepresentation of civil servants of the Federal Administration (Federal Public Services 
(FPS)). As civil servants of the FPS do not come and go with the Minister but have a permanent 
tenure (regardless of the political colour of the Minister), their perceptions could also have been 
very interesting.  
 
Theoretical sampling, a hallmark of grounded theory methodology, is a useful technique which 
continues until the point of theoretical saturation (Bloor and Wood, 2006). The literature talks 
about theoretical saturation when no new data is emerging from the data collection tools but 
rather confirms previous ideas. In my study, theoretical saturation occurred after about 50 in-
terviews (which was more or less consistent with my sample of 55 interviews). At the same 
time, it gradually became clear that the most important actors involved in my case had been in-
terviewed. The request to provide names and contact details of others they thought were im-
portant for me to interview directed me more and more to the same individuals already included 
in the study. 
                                                          
23  These eight respondents concern 1 practitioner and 7 policy-makers. Four of them were French speaking and four 
Dutch speaking actors. 
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5.2.3. Topic list 
In this study, I conducted semi-structured interviews with open-ended questions. About 54 re-
spondents were interviewed face-to-face; I had to resort to a telephone interview with one re-
spondent as he was working abroad.  
 
According to Conti and O’Neil (2007), semi-structured interviews seem the most appropriate 
approach in studying elites, as this may focus their responses on the specific topics of interest 
and accommodate the short amount of time offered for the interview. These semi-structured 
interviews were guided by a topic list which was prepared beforehand, and which provided a 
framework for the interview. My topic list or interview guide was based on the topic list used in 
the study of Monaghan (2008a) and Duke (2002) and augmented by themes raised during the 
analysis of the policy and media documents. In this study, the topic list was available in both 
languages (Dutch or French) and tailored (but still comparable) for each type of actor: members 
of the Government, members of the Parliament, scientists, journalists, members of interest 
groups. The interview schedule covered key themes such as the particular role of the interview-
ee in the debate, the content of the debate, the role played by scientific knowledge, ideologi-
cal/political motives, media and interest groups in the parliamentary and governmental debates, 
and their perception about the evidence-based/evidence-informed characteristic of the develop-
ment of Belgian drug policy (see also Appendix II). Following a cyclic-iterative process, the topic 
list was sometimes slightly adapted based on new information from previous interviews.  
 
5.3. Challenges of access, knowledge and power in interviewing elites 
5.3.1. Retrospective accounts 
Prior research shows that retrospective recall of events and attitudes yields reliable data despite 
errors attributable to faulty memory (memory bias) (Golden, 1992; Mortelmans, 2009). Indeed, 
it often appeared that it was difficult for the respondents to remember exact dates or names 
over such a long period of time. When conducting the interviews, respondents often made re-
marks such as “I do not know, it has been a long time” or “It is history for me, it is amazing how 
much detail is gone”. Accordingly, many interviewees asked for some clarification from the inter-
viewer. Of course, when I was asked this question, I tried to avoid any suggestive information 
focusing on the description of facts or dates retrieved from the documents (e.g. the participation 
of an interviewee in parliamentary commissions). Nevertheless, talking about the historical case 
seemed to be very helpful in refreshing their memories. As the interview progressed, interview-
ees started to remember more and more details and examples.  
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5.3.2. Negotiating and maintaining access 
Following advice established in the literature (Duke, 2002), a formal letter was sent introducing 
the research project and requesting their cooperation with the research. I did not contact all 
participants at the same time (I contacted them when I was free for the next few days as some of 
them may have replied to me straightaway). Neither did I start with the most central key actors, 
in order to gain experience and confidence. However, this way of making contact proved unsuc-
cessful, given the popularity of the internet and social media. Except for retired policy-makers 
and the most senior active policy-makers, most respondents did not respond to my request until 
I contacted them by e-mail or telephone.  
 
“I received your letter but it got lost between the other mail. Is there a particular reason why you 
contacted me by means of a letter?” (Respondent 11, practitioner). 
 
On one occasion, my institutional affiliation had explicit negative implications in gaining access. 
However, I succeeded in convincing the respondent to participate by stressing my academic neu-
trality.  
 
“I really do not agree with the viewpoints of your supervisor and your institute and I have ques-
tions about the usefulness of my contribution to your research.” (Respondent 3, member of interest 
group). 
 
For this project, I selected elites on the basis of their privileged knowledge and ability to best 
answer my questions. Even though Welch, et al. (2002) warn researchers not to go only for the 
most senior or top-level people, my discourse analysis only revealed the most visible (and 
most powerful) respondents, for example, Ministers. Gaining access to these top policy-
makers was an ongoing process throughout the fieldwork and involved multiple levels of barri-
ers such as personal secretaries or spokespersons. As it is critical not to be put off by spokesper-
sons or secretaries (Peabody, 1990; Harvey, 2010), I tried to personalise the research problem 
without academic jargon by making it clear why I was interested in their views and experiences. 
 
On making contact with respondents, I left open the possibility to view the topic list prior to the 
interview as this could stimulate access and trust (Duke, 2002). Some respondents (especially 
policy-makers) asked me to send the topic list in advance in order to prepare themselves. In 
combination with their lack of time, these short but well-prepared interviews often resulted in a 
high quality and focused interview which filled in some parts of the puzzle. In one case, I felt that 
the topic list was checked out carefully in order to identify any critical questions. A personal 
secretary (of a still active Minister) asked me to specify some of my questions from the topic list. 
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She was particularly interested in the questions focusing on the ideological and political motives 
(see Appendix II).  
 
Even though respondents agreed to participate, actually meeting them proved difficult. Very 
often the interview was cancelled or rescheduled at the last minute. The use of a smartphone 
proved to be very useful. As elites are expected to be available 24/7, they naturally assumed this 
of the researcher. On a number of occasions, for example, interviewees turned up late (e.g. one 
respondent let me wait for 1.5 hours) which challenged my ability to be flexible (e.g. to attend a 
subsequent interview) and not to become distracted. However, in general, it is my opinion that 
the problems around negotiating and maintaining access to elites often have been exaggerated 
in the literature. Gaining access was in some cases difficult but mainly because some of the indi-
viduals involved in the development of Belgian drug policy-making process had retired or 
changed jobs. This difficulty is linked with the problem of getting contact details and not with 
gaining access as such. 
 
5.3.3. Interview setting and knowledge 
Firstly, as a researcher, it frequently appeared useful to keep abreast of current (political) 
events. As stressed by Hunter (1995), news items may form a useful lead for the interview. Sev-
eral issues actually permeated through informal discussions within the interviews and provided 
further insights into the politics and dynamics of the way in which policy processes work. For 
instance, newspaper articles about hundreds of young Europeans fighting with rebel forces in 
Syria led to discussions about political responsibility, parliamentary questions and representa-
tions of policy-makers in the media. 
 
Secondly, the interview venue, i.e. where interviews are conducted, may determine the level of 
formality and the type of information respondents are prepared to disclose (Harvey, 2010). In-
deed, in my experience, when the interview was held outside the respondents’ office, the con-
versation tended to be more informal and the respondents were more prepared to disclose de-
tails. When the interview took place in a more formal setting, it was useful to avoid behind-the-
desk scenarios and to hold the interview either around a table or on comfortable chairs or sofas 
in the room. This helped to place myself and the respondent in more physically equal and neu-
tral positions.  
 
Although qualitative methods are attractive to addressing complex and personal issues, per-
suading them to tell me something about their personal view was indeed not easy. These re-
spondents (especially active ones) are still part of the societal debate in which they experience 
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direct or indirect decisional power. For instance, I am aware that the period of conducting inter-
views (between January - December 2013) was marked by a number of political and policy dis-
cussions and/or changes (i.e. local elections were held in October 2012 and federal/regional 
elections were held in May 2014). This could have been an important reason why responses 
given may have been ‘guarded’ and represent the views of a political party or institution rather 
than of the individuals themselves. In some interviews, I generally felt that a (still active) re-
spondent shut down questions and emphasised certain matters and neglected others. Retired 
interviewees or those who stepped down from their powerful positions were clearly less reti-
cent to talk to me. 
 
“I can easily talk about the issues and networks as I am no longer part of the ‘game’.” (Respondent 
16, practitioner). 
 
A good solution to avoiding errors in interpretation and to get as complete, honest and nuanced 
a story as possible from the respondent was a thorough preparation for the interview and re-
search into the background of the interviewees. Likewise, I often tried to put forward the focus 
on an intellectual discussion instead of an organisationally or politically oriented dialogue, and 
changed the scale of my question in order to move away from the somewhat public view to-
wards more personal narratives. 
 
5.3.4. Role of interviewer 
As described by Duke (2002) and Hertz and Imber (1995), the researcher may have to oscillate 
between knowledgeability and naivety. In my study, interviews were organised around cen-
tral themes, but individually tailored and crafted for the respondent. My honesty about gaps in 
my knowledge and my willingness to draw on the expertise of respondents had consequences 
for either being dismissed or taken seriously by elites. 
 
“The interview is finished? I want to congratulate you. It is an extensive and complex case but 
you’ve mastered it.” (Respondent 41, policy-maker). 
 
Nevertheless, I found it difficult to correct errors in the stories of respondents without appearing 
to be arrogant or suggestive. In those examples, I replied in a careful way, appearing to be a 
knowledgeable insider balanced against being an amateur outsider who is keen to learn. Only 
one respondent really got their facts wrong. This respondent provided wrong information and I 
politely tried to point to the chronology of the debate, analysing if the respondent was 
(un)consciously providing wrong information. As an interviewer one has to anticipate and have 
good knowledge of the case and the respondent’s role within the event being studied. In my ex-
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perience, this approach not only makes the interviewer appear credible, it also ensures that the 
respondent cannot offer a completely false account of events without it being queried. In one 
case, however, I was called unexpectedly and asked if the interview could take place within 30 
minutes. This meant that I had limited time to prepare the interview and formulate my specific 
questions. It was a stressful moment but my flexibility and my detailed knowledge of the field of 
research were appreciated and therefore helped to conduct a rather high-quality interview.  
 
Secondly, interviews were held with the oral informed consent of the participants. An informed 
consent ensures that respondents’ participation is voluntary and informed, based on adequate 
briefing given to the participants about the details of the project (e.g. purpose of the study, pri-
vacy, anonymity and confidentiality, identity of the researchers, etc.). Even though every re-
searcher has a responsibility regarding anonymity and confidentiality (Decorte and Zaitch, 
2010), these assurances are more difficult when researching a well-defined but small-scale poli-
cy system. Elite respondents are particularly interested in knowing ‘who else you have spoken 
to?’ (Hunter, 1995). When I was asked this question, I tried to give vague answers because I felt 
that any information of this nature would impair my assurances of confidentiality and anonymi-
ty. In many cases, the respondents already knew who I had interviewed and had discussed my 
research and its value with other participants, putting me in a rather awkward and powerless 
position. For example, some respondents clearly stated that they had contacted someone (who 
turned out to be another respondent). 
 
“I called X this morning and he told me that you already interviewed him and Y. I wanted to rec-
ommend those people, but you already found them.” (Respondent 37, policy-maker). 
 
Finally, respondents were asked if I could record the interview in order to facilitate the conver-
sation and to minimise loss of information. Respondents mostly talked freely about their experi-
ences. However, there were some who showed extreme caution. They often mentioned “this is 
off the record now” or “don’t quote me on that”. In one case, a respondent clearly felt uncomforta-
ble in answering the questions. After the recording, he started to talk more openly. Only two 
respondents (a policy-maker and a member of an interest group) were unwilling to talk on the 
record even if anonymity was assured. They did however want to impart information to me. 
These two interviews were reconstructed by means of notes that I tried to complete as soon as 
possible. Additionally, some respondents provided me some confidential documentation after-
wards which also gave me the impression that they did trust me sufficiently. 
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5.3.5. Power mechanisms 
In qualitative methodological discussions, it is often said that there is an imbalance of power 
between the researcher and the participants. The question is: does the researcher still hold 
power over his participants when studying up? (Aguiar, 2012). First of all, the practice of check-
ing out the researcher appeared to be a common feature of research on elites. Several respond-
ents made some remarks during the interview which revealed that they (or their spokesperson) 
had reviewed my profile on the university website. They also tested me as a researcher by ask-
ing and examining whether I had read various documents. My honesty and knowledgeability 
helped me to gain their trust and get to their personal accounts of the case.  
 
“Your research is already in the final stage, I saw it on the website […]. I noticed you already 
checked those documents. OK, then you know what the important issues were. I don’t need to elu-
cidate them anymore.” (Respondent 27, policy-maker). 
 
Furthermore, I was aware of the real danger that respondents may take over control of the in-
terview, thinking that whatever they said would be relevant or important to my research (Conti 
and O’Neil, 2007; Neal and McLaughlin, 2009). Indeed, elites sometimes dictated the interview 
with only anecdotal and illustrative information. Furthermore, it appeared to be common that 
elites start posing the researcher tricky questions about the findings or made remarks about the 
research or researcher.  
 
“You already analysed a lot of pages. The art will be to make a selection and draw a line. You will 
have to find a point of view by which you demonstrate you know the particular domain and the 
domains that are linked.” (Respondent 17, policy-maker). 
 
Only on a few occasions did my attempts fail to steer the interviewee back to the relevant topics. 
Although much of what the respondent was saying was interesting and relevant to my research, 
my core set of topics was not covered in any systematic way on those occasions.  
 
Elites, even those who had stepped down from official duties, are busy and value their time 
(Peabody, et al., 1990). Elites clearly felt they donated their precious time to me, which demon-
strated the power relationship between interviewer and interviewee. For example, as most of 
the respondents work within tight time frames, some interviews were held during lunch breaks 
or between meetings in the evening. Similarly, even though time limitations were part of the 
process in negotiating getting in, they sometimes directly dictated the end of the interview even 
though there was some time left. In one case, a spokesperson was attending the interview in 
order to keep an eye on time; she made the interviewee aware when 15, 30 and eventually 45 
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minutes had passed. The effective strategy here is to create a set of priorities as to what to focus 
on if unexpected situations emerge where time is up. 
 
Finally, some emphasised their powerful position by mentioning that I had to be grateful that 
they were able to talk to me. Pointing to the interruptions by phones ringing, employees or col-
leagues with urgent questions, one respondent said to me at the end of the interview: 
 
“You are lucky that I found some time to participate in your research. As you have seen, I am very 
busy and, actually, I really don’t have time for things like this.” (Respondent 27, policy-maker).  
 
5.3.6. Language 
Another difficulty was related to the language of the interviewer and the respondents. Eleven 
respondents were French-speaking while forty-four interviewees spoke Dutch, which is the na-
tive language of the researcher. The selection of a larger amount of Dutch-speaking experts oc-
curred purposefully (based on the discourse analysis) and not because of pragmatic reasons. 
Although French is not the researcher’s mother tongue, her French-speaking abilities as well as 
the use of a translated topic list assured the quality of the interviews.  
 
6. Data analysis 
Data analysis is the most crucial aspect of qualitative research (Miles and Huberman, 1994). By 
means of analysing the data, qualitative researchers continually must attempt to gain a deeper 
understanding of the phenomenon they have studied in order to refine their interpretations. The 
analysis phase is a cyclic, continuous process (Noaks and Wincup, 2004).  
 
It is important to classify the data analysis approach in terms of whether it is inductive or deduc-
tive or both (Creswell, 2009; Decorte and Zaitch, 2010). Deductive analysis starts with theoreti-
cal perspectives or concepts as the basis for data analysis, while inductive analysis lets the ana-
lytic themes emerge from the study of the data. The current study is shaped by using both induc-
tive and deductive perspective. The theoretical perspectives (theoretical sensitivity) together 
with the existing body of knowledge provided me with sensitising concepts like, for example. 
types of scientific knowledge utilisation (instrumental, conceptual, political/symbolic, evolu-
tionary, processual), linking mechanisms/facilitators, institutional or individual barriers, the 
media or interest groups (deduction). I am aware that an extensive literature review that pre-
cedes the collection and analysis of data may lead to certain preconceptions. However, I tried to 
apply a rather exploratory perspective (instead of a confirmatory perspective) in which I ex-
plored which themes emerged from the documents or the interviews. Thus, alongside the deduc-
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tive approach, I strived to look at the data for undiscovered patterns or emergent understand-
ings (inductive approach). As stated by Corbin and Strauss (2008), “At the heart of theorizing lies 
the interplay of making inductions (deriving concepts, their properties, and dimensions from data) 
and deductions (hypothesizing about the relationships between concepts).” (p.56). 
 
The analysis of the documents (i.e. policy documents and media articles) used traditional man-
ual methods of examining the data. Practicalities apart (e.g. while some files were secured from 
editing, others were too large to import into a qualitative data analysis programme), qualitative 
data analysis programmes (e.g. NVivo, MAXQDA) are only considered useful in the early stages 
of a discourse analysis (e.g. to structure texts, to search them and to assist in rudimentary cod-
ing). It is assumed that software cannot assist enough to get to the deep level of analysis that is 
required for a discourse analysis (MacMillan, 2005). 
 
The documents were printed and I read through them with a highlighter in my hand. Reading 
printed texts instead of reading on the screen made the task of analysing and coding easier. My 
analysis consisted of a detailed (re)reading of the documents. Relevant fragments were high-
lighted and given one or more corresponding codes. Subsequently, patterns and explanations in 
these codes were derived. During the coding process, I also regularly wrote down some memos 
for certain sections of the text (e.g. notes of how a paragraph in the text is linked with the sensi-
tising concepts or methodological issues). Data were then organised chronologically (from 1996 
to 2003) and thematically according to the central (theoretical) concepts of the study (e.g. types 
of scientific knowledge utilisation, representation of scientific knowledge and experts, other 
types of information, barriers and facilitating mechanisms). As will become clear in the following 
Part, segments of actual data are presented in the form of citations in the text.  
 
The digital recording from each interview was transcribed in full. While the full transcription of 
all interviews was a time-consuming process, it engaged the researcher in the process of deep 
listening, analysis and interpretation right from the beginning. In contrast with the discourse 
analysis, qualitative data analysis software NVivo was used to analyse these interview data. 
When an interview was transcribed, the transcript was immediately imported in Nvivo in order 
to start with the coding. Adopting an open or exploratory perspective, none of the codes I re-
trieved from the manual discourse analysis were imported in Nvivo in advance. Data was subse-
quently coded and categorised to eventually find links with the sensitising concepts (e.g. types of 
scientific knowledge utilisation, representation of scientific knowledge and experts, other types 
of information, barriers and facilitating mechanisms, media, interest groups). Thoughts on how 
fragments or codes were linked with the sensitising concepts, methodological issues or results of 
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the discourse analysis were written down in memos. Analysis of the interview data followed a 
cyclic process in which an accumulation of interview data and of codes was supported. Data 
were eventually also organised chronologically (from 1996 to 2003) and thematically according 
to the central (theoretical) concepts of the study.  
 
The findings from the interviews are also supported by narrative statements (i.e. quotes). I do 
not give details of the institution respondents were working in, or the particular topics they 
were working on, where that could lead easily to their identification. Therefore, a number and a 
general typology (policy-maker, journalist, scientist, member of interest group) has been as-
signed to each respondent as a means of protecting identities in line with relevant ethical obli-
gations in conducting social research (Decorte and Zaitch, 2010). 
 
7. Reliability and validity of the empirical results 
Qualitative research is always a matter of interpretation (Yin, 2003), even more so since the reli-
ability and validity of this study depended entirely on the cogency of one researcher’s argu-
ments. Transparency regarding data analysis strategies is necessary to ensure reliability and 
validity of data. Reliability is the extent to which research produces the same results when rep-
licated (Bloor and Wood, 2006). In particular, this refers to the following questions: would an-
other researcher on reanalysing the data come to the same conclusion? (internal reliability) or 
would another researcher obtain similar results when replicating the original study? (external 
reliability). For this study to be reliable, I reported about my methodological/theoretical choices, 
analytical procedures and processes as completely and truthfully as possible (see above).  
 
Furthermore, each (qualitative) researcher aims to say that the final conclusions accurately re-
flect what they were studying (internal validity). External validity refers to the way in which 
empirical results can be applied to other situations, contexts, populations, etc. A case study de-
sign aims for analytical generalisation (see also above, §4.1.). Several strategies were employed 
to strengthen the validity of the empirical results. First, during the coding of the documents and 
interviews, I constantly wrote memos about the codes and their definitions. This is to avoid any 
shift in meaning of the codes during the process of coding.  
 
Second, I provide thick descriptions (e.g. by using quotes or narrative statements) to allow trans-
ferability of the findings to other studies (case-to-case transferability). However, choosing 
quotes involves an element of subjective judgment. A researcher must be aware of cherry-
picking quotes that support their personal views instead of theoretical concepts (Sandelowski, 
1994; Wodak and Kryzyzanowski, 2008). I tried to counterbalance any subjective judgment by 
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means of checking for negative, contradictory proof as well as selecting representative quotes 
(from various participants) as evidence of a prevailing opinion or trend.  
 
I am also reflexive about other researchers’ bias. My age and gender may have played a role in 
conducting elite interviews (Walford, 1994). I am aware that being a female (pregnant) re-
searcher may have been an advantage in being perceived as harmless, especially because I am 
relatively young, not in a senior position, and my key actors were predominantly older men. 
Additionally, as the study is based on a case study in a policy field consisting of a rather limited 
pool of researchers, the research activities of my supervisor and some members of the guidance 
committee were included in my analysis. I tried to maintain neutrality by not favouring one re-
search project or researcher above the other. To discuss research projects and researchers in 
terms of good or bad would be to miss the point, because the goal of the study is not to distin-
guish the impact of particular research projects (see also above, §4.2.). This study aims to exam-
ine and understand how far and through which modalities the policy-making process has been 
informed by scientific knowledge, taking into account contextual issues.  
 
Finally, different methods have different strengths and weaknesses, but if these methods result 
in converging findings then a researcher can be reasonably confident that one is getting a valid 
result (Swanborn, 2003; Kohlbacher, 2006). Triangulation includes the use of multiple meth-
ods, data or investigators which may lead to a higher validity (Creswell, 2009). The case study 
consists of two data collection methods used in conjunction with one another. Discourse analysis 
of either policy documents or newspaper articles, is very useful for analysing historical material 
and may become an even more powerful tool when combined with other research methods such 
as interviews. Interviews may provide information about what is not publicly available (e.g. in-
formal discussions or debates that are held behind closed doors) or may reveal implicit uses of 
(scientific) research or experts (as the absence of a reference does not simply imply that a par-
ticular research is not used). Interpretations resulting from the discourse analysis were gradual-
ly tested against associated literature about the case and the results of the interviews. Similarly, 
the data retrieved from interviews were continuously contrasted with the results from the dis-
course analysis. 
 
8. Conclusion 
I argue that taking a (critical) constructionist view on reality is a helpful approach in examining 
complex, changeable social processes containing a variety of actors. It allows the researcher to 
understand how beliefs, values, problem perceptions of different actors and networks as well as 
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power mechanisms influence the ways that scientific knowledge is used within policy processes, 
what constitutes scientific knowledge and who is designated as qualified to know.  
 
Based on this assumption, a qualitative methodological approach is most suitable. I intend to 
approach the science-policy nexus as an interactive process where several actors construct 
meaning and actions. A quantitative methodological approach would focus on the frequency and 
extent of knowledge utilisation ignoring the historical and social context (e.g. existing power 
relations in society) and the phenomenon would be casted into fixed categories (assuming that 
scientific knowledge is a homogenous and static concept). 
 
In order to contribute to knowledge utilisation literature in the drug field, a case study is an ap-
propriate technique for intensively studying complex processes and interactions within a par-
ticular setting and time period and for answering how and why questions. Making use of this 
conceptual framework, identified through the literature review, the case of the development of 
Belgian drug policy between 1996 and 2003 was chosen. During the specific episode of the de-
velopment of Belgian drug policy (1996-2003) drugs appeared on the political and media agen-
da (a window of opportunity opened) and increasingly attracted the attention of policy-makers, 
scientists, media and interest groups.  
 
I used two data collection methods. First, the Critical Discourse Analysis consisted of a detailed 
and systematic reading of 164 policy documents including formal, publicly available expressions 
of strategy and statements of intent made by the Federal Government, as well as parliamentary 
discussions. Media analysis examined a total number of 1,067 Belgian (including Flemish as well 
as Walloon) newspaper articles. In both cases, I used the methodological framework of Norman 
Fairclough because it has been proven to be useful for the analysis of policy and media docu-
ments and provides clear methodological tools. In particular, this study focused on the textual 
elements that characterise (differences between) discourses, how players are represented in the 
text and from which perspective, how scientific knowledge was represented, the relationship of 
scientific knowledge to other forms of information available, and the various types of knowledge 
utilisation. Nevertheless, I argued that discourse analysis is always a matter of interpretation, 
especially because it depends entirely on the cogency of one researcher’s arguments and bilin-
gual abilities. 
 
Therefore, additionally, semi-structured interviews with policy-makers, scientists, journalists and 
members of interest groups allowed the researcher to be more reflective of the reality of the 
policy-making process and the dynamic role scientific knowledge plays within it. A total number 
Chapter 3  Research design and methodology 
116 
of 55 elite interviews helped to better understand the interactions between multiple actors, con-
textual developments, informal initiatives, networks, conflicts and strategies. In my experience, 
however, there also seem to be some important challenges in interviewing elites. Usually in the 
relationship between researcher and interviewee, the researcher is the one with the higher sta-
tus. On the contrary, elites tend to reverse the power relationship between researcher and inter-
viewee by indirectly trying to subvert the position of the researcher. For example, elites, being 
used to speak in public and defending their views, tried to take control over the conversation by 
starting to pose the researcher tricky questions about the findings or by making remarks about 
the research or researcher. Moreover, elites, their power structures and the issues with which 
they deal, do not stand apart from their organisational or political context. An interviewer is 
hostage to different agendas and power struggles in the course of fieldwork.  
 
Finally, it is important for qualitative studies, not at least for case studies, to emulate reliability 
and validity. In this study, several strategies were employed to strengthen the (inter-
nal/external) reliability and validity of the empirical results. For this purpose, reflexivity and 
sensitivity towards the individual research processes was shown. I reported about my concep-
tual framework, methodological choices, analytical processes and researcher’s bias as complete-
ly and truthfully as possible. Furthermore, by using both data collection methods (Critical Dis-
course Analysis and elite interviews) in conjunction with one another, the information gathered 
has been contrasted and reinterpreted constantly.  
  
 
 
 
 
 
 
 
 
 
 
 
Part II Results of the empirical study 
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Prologue 
 
In this part we outline the empirical results of our case study with an in-depth view of the devel-
opment of Belgian drug policy between 1996-2003, with particular focus on the role of scientific 
knowledge and which other (f)actors were at play. 
 
The description of the results detailed in the subsequent chapters follows the structure of the 
development of Belgian drug policy, taking into account three milestones. In order to contextual-
ise the development of Belgian drug policy, chapter 1 focuses on the history of Belgian drug 
policy and its legislative framework before 1996. While the drug issue entered the legislative 
framework with Belgian law criminalising certain drugs and drugs possession (1921), the foun-
dations of modern Belgian drug policy were laid down in the first half of the 1990s. 
 
Chapter 2 discusses the first milestone: the Parliamentary Working group on drugs (1996-
1997), which was established by the Federal Parliament in order to develop a clear and timely 
view on all aspects of the Belgian drug phenomenon. The Parliamentary Working Group asked 
national and international experts, working in all domains of drug policy, to convey their analy-
sis and to give clear recommendations to the Federal Government.  
 
Chapter 3 focuses on the turbulent intermezzo between 1997 and 2000. At the end of the nine-
ties, the entire Belgian drug debate was overshadowed by the Dutroux case (i.e. a paedophilia 
scandal) as well as by the resulting focus on reform of the judicial authorities and the police (‘Oc-
topus reforms’). Meanwhile, in 1999, Belgian voters rejected the longstanding Coalition Gov-
ernment of Christian Democrats and Socialists and voted a six-party Coalition into power con-
sisting of the Flemish and Francophone Liberals, Socialists and Greens led by Flemish Liberal 
Leader Guy Verhofstadt (1999-2003). 
 
Gradually, the drug issue re-entered the political agenda in Belgium. The Belgian Government 
further elaborated the principles and recommendations of the Parliamentary Working Group 
and established the first (and current) national drug strategy (Federal Drug Policy Note) in 
2001. The Federal Drug Policy Note is considered as the second milestone in the development of 
the Belgian drug policy between 1996 and 2003 and is addressed in chapter 4. 
 
As the direction of Belgian drug policy determined the policy priorities and thus the legislative 
and prosecution framework, we assess the reform of Belgian drug law (2003) as the third mile-
stone in the development of Belgian drug policy (Chapter 5). This reform is one of the major 
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initiatives, and definitely the one most discussed by MPs, members of the Government, media 
and others (and therefore relevant for this study).  
 
Figure 4: Brief overview of the developments of Belgian drug policy and the composition of the 
Coalition Governments between 1996 and 2003 
 
 
Chapter 1  History of Belgian drug policy and its legislative 
framework before 1996 
 
Before focusing on the period of our interest (1996-2003), we briefly elaborate the historical 
evolution of Belgian drug policy and the Belgian legislative framework. Some important political 
and/or scientific impulses have had certain consequences for both. The Belgian legislative and 
prosecution framework (e.g. Laws, Ministerial Circular Letters,...) addresses the enforcement 
and prosecution of the drug phenomenon. Belgian drug policy has no juridical value but deter-
mines the policy priorities (and thus the legislative and prosecution framework).  
 
1. From 1921 until 1975: early developments 
The basic Belgian law concerning the traffic in toxic substances, hypnotics, narcotics, disinfecting 
and antiseptics dates back to 24 February 1921. The criminalisation of drugs and drug posses-
sion was largely influenced by the international developments (Guillain, 2003), the Belgian anti-
alcoholic movement supported by Minister of Justice Emile Vandervelde and the social defence 
framework (De Ruyver, 1988).  
 
At the end of the 19th and the beginning of the 20th century, policy-makers started to believe in 
scientific rationality as a key to solving problems (Hoppe, 1999). The positivist school (e.g. Lom-
broso), who adopted a more empirical, scientific approach, claimed to have discovered the exist-
ence of criminal types whose behaviour was determined by their biological, psychological, and 
social environment rather than based on a rational calculus (individual responsibility). Positiv-
ists concentrated upon the criminal rather than the crime. The criminal justice system had to 
determine whether or not the offender was the perpetrator of an act and then to apply to him 
measures to protect the society from dangerous and habitual criminals (social defence). The 
Belgian criminal justice system owes much to the influence of Adolphe Prins, who embodied this 
movement in Belgium. The doctrine of social defence focused on crime as a human (individual) 
as well as social problem, not easily addressed by legal regulation. Punishment should not only 
deter criminal offenses but should also aim for the resocialisation (and re-education) of the of-
fender (Christiaensen, 1993). This doctrine influenced several Belgian Ministers and was at the 
origin of the first Belgian drug law. Within the framework of the state’s responsibility to protect 
the community (at the end of the 19th century), as an elected member of the Parliament, Emile 
Vandervelde’s opinion was that alcoholism perpetuated the social misery of the working classes 
and immobilised social and economic relations. This prepared the ground for future legislation 
in Belgium (De Ruyver, 1988). The Law of 29 August 1919 (also known as the Vandervelde Law) 
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prohibited the sale and consumption of alcohol in drinking-houses, while consumption at home 
was allowed (under certain circumstances). Concerns were soon raised that the alcohol prohibi-
tion had led to a shift to the use of other drugs like cocaine and morphine even though studies 
showed that the increase in drug taking was rather a consequence of World War I and appeared 
among the higher classes (De Ruyver, 1988; Fijnaut and De Ruyver, 2014). Nevertheless, Minis-
ter Emile Vandervelde also supported a strong response to the use of other drugs than alcohol, 
which directly led to the realisation of the new Belgian Law of 24 February 1921 (De Ruyver, 
1988; Fijnaut and De Ruyver, 2014).  
 
In the same period, international attention focused on the drug phenomenon at the Opium Con-
ferences in Shangai and The Hague (De Ruyver, 1988). Like several other countries, Belgium 
ratified the International Opium Convention in 1912 because of the moral value inherent in this 
international commitment and the importance of being associated with it. Although there was 
little anxiety about a drug use problem at the time of the International Opium Convention in 
1912, some concerns were raised at the time of the ratification (De Ruyver, 1988; Todts, 2004). 
For instance, some registrations showed that 2-3% of Belgian prisoners (in some prisons: 6%) 
were addicted to cocaine. As a result, for the first time emotions were running high in the par-
liamentary debate : “The Government is almost completely disarmed by the fatal drug abuse that 
occurs in all classes of our population." (Hand. Kamer 1920-1921, 21 December 1920, 108/1). 
Ratification required Belgium to take action, which it did with the Law of 24 February 1921 and 
the Royal Decree of 31 December 1930 (Cesoni, 2008; Fijnaut and De Ruyver, 2014).  
 
For several years, the Law of 24 February 1921 was an instrument against drug trafficking and 
drug addiction. However, more than alcohol use, the drug phenomenon is a complex, interna-
tional phenomenon. The internationalisation of the production of drugs continued to grow and 
there was an increasing mobility on the demand side (De Ruyver, Vermeulen and Vander Beken, 
2002). During the following period, influenced by the strong prohibitive advocacy by the United 
States, several multilateral drug control treaties were established. The United Nations Single 
Convention on Narcotic Drugs (New York, 1961) was an important consolidation of these multi-
lateral drug control treaties and the prohibitionist international drug control system. In other 
words, this convention streamlined and tightened the controls on the production, use and distri-
bution of illicit narcotics (De Ruyver, Vermeulen and Vander Beken, 2002). In particular, posses-
sion of cannabis was placed under the strictest control regime in the Convention (similar to co-
caine and heroin), on the basis that it was widely abused. The 1961 treaty also created the Inter-
national Narcotics Control Board (INCB) to collate the parties' legal drug requirements and to 
monitor legitimate trade.  
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In the 1960s, drug use exploded around the world, most notably in developed Western nations. 
As the increase was closely related to the pervasive use and availability of synthetic, psycho-
tropic substances such as amphetamines, barbiturates, and LSD, the United Nations Convention 
on Psychotropic Substances (Vienna, 1971) was established. Dealing with psychotropic sub-
stances next to narcotics, it formed a companion instrument of the 1961 Convention (De Ruyver, 
Vermeulen and Vander Beken, 2002).  
 
In Belgium, media increasingly reported about the surprising rise in drug use among the popula-
tion (De Ruyver, 2005). In his analysis of the criminal policy of Socialist Minister of Justice Alfons 
Vranckx (SP, Flemish Socialists), De Ruyver (1988) showed that drug policy-making was primar-
ily based on emotional and political motivations inspired and stimulated by the media. Scientific 
input into the policy-making process received less attention mainly because, in this period of 
social and economic reconstruction (after two World Wars and an economic crisis), it was ar-
gued that scientific knowledge was fallible (De Ruyver, 1988). For instance, the stepping stone 
theory (Cohen and Sas, 1997), which argues that people who use alcohol or marijuana will prob-
ably go on to use drugs such as cocaine or heroin, was the basis of the framework regarding 
drugs. Although this theory was widely rejected by scientists because of the lack of evidence 
supporting any causality claim, it won a lot of support among policy-makers, media and the pub-
lic opinion (De Ruyver, 1988; De Ruyver, 2005). Furthermore, other initiatives taken by crimi-
nologists to discuss and improve the relationship between science and policy were largely ig-
nored. For instance, a Dutch working group, under the leadership of professor Louk Hulsman, 
discussed the direction of the drug policy in 1971. The working group expressed their concerns 
about the misinformation generated by the selective attention put forward by media, public 
opinion and policy-makers (De Ruyver, 1988). As a second example, in 1978, a conference enti-
tled ‘Criminal law and scientific research’ was organised by several scientists in order to get a 
view of and to improve the existing cooperation between science and police, justice and the 
prison system (Geeroms, 1978). Another important initiative was the publication of the book 
‘Drugs: substances, people and society’ during the emotional polemic about drug use in the 
1960-1970s. Casselman, De Schepper and Nuyens (1971) strongly believed in relevance, utility 
and application of academic wisdom. The authors provided an innovative, multidisciplinary pol-
icy perspective on drugs taking into account: the drug, set and setting (instead of a pure repres-
sive approach) (Zinberg, 1984; Goethals, Hutsebaut and Vervaeke, 2005). Nevertheless, during 
the 1960s and 1970s, the problem of drug use in Belgium was mainly created and maintained by 
media and policy-makers as well as inspired by the War on drugs framework of the United States 
(De Ruyver, 1988). Panicked reactions had no profound scientific base, except for some official 
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statistics which simply represented the criminal justice system’s ability to detect, define and 
process criminal action (Fijnaut and De Ruyver, 2014).  
 
Except for some small modifications (i.e. penalising some new products like LSD or ampheta-
mines), few changes were made to the Belgian legislative, prosecution or policy framework be-
tween 1921 and 1975. However, due to an increasing fear of an uncontrollable drug epidemic at 
the international level and Belgium’s ratification of the United Nations Single Convention on 
Narcotic Drugs (New York, 1961) as well as the United Nations Convention on Psychotropic Sub-
stances (Vienna, 1971), Belgian policy-makers decided to implement a more severe legislative 
framework in the 1970s (Todts, 2004). In Belgium1, there was litte discussion about the idea 
that all illegal drugs had to be treated in the same way (Fijnaut and De Ruyver, 2014).  
 
The basic Belgian law of 1921 was modified by the Law of 9 July 1975 due to a growing concern 
by the judicial authorities about drug use and its punishment. Possession of drugs remained 
prohibited; the concept of aggravating circumstances (i.e. drug use by minors; drug use in group, 
etc.) was implemented; a denunciation clause was integrated; cannabis was classified like other 
illicit drugs, and; a strong enforcement of drug trafficking was the main focus (De Ruyver, 1988). 
Minister of Justice Alfons Vranckx (SP, Flemish Socialists), who submitted the original proposi-
tion together with Minister of Public Health Louis Namèche (PS, French-speaking Socialists), did 
question the point of punishing drug use, looking into the socio-cultural factors behind use and 
advocating treatment solutions for users. In particular, by means of the introduction of some 
amendments, he aimed for the adoption of compulsory treatment strategy for drug users in the 
criminal justice system (De Ruyver, 1988). However, eventually, the amendment establishing 
compulsory treatment was rejected and replaced by an extension of the modalities of the Law of 
29 June 1964 regarding probation towards drug users.2 As a result, the Law of 9 July 1975 was 
somehow caught between two stools: a stronger enforcement agenda, and a desire for a differ-
ent approach – that of treatment and rehabilitation for drug users (Cesoni, 2008).  
 
Despite international and national efforts, drug problems seemed to increase all over the world 
during the 1980s. In Belgium, a growing fear of the rising drug problem was caused by an enor-
mous increase in prosecutions across several jurisdictions, the fast spread of infectious diseases 
                                                          
1  At that time, the Netherlands took the first step in the opposite direction. The debate about the Dutch drug policy 
sparked off and resulted in the Opium Act (1976) making a distinction between soft drugs and hard drugs. 
2  While, according to art. 3 and 8 of the Law of 29 June 1964, the person concerned should not have been earlier 
sentenced to a criminal sentence or a prison sentence of more than 12 months, art. 9 of the Law of 9 July 1975 
noted that, in case of offences for personal use or of drug use in group, judicial antecedents were no impediments 
for probation (Mahieu, 2004; Wet van 29 juni 1964 betreffende de opschorting, het uitstel en de probatie, B.S. 17 
juli 1964). 
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(HIV, hepatitis B and C) among intravenous drug users, increasing feelings of insecurity for the 
criminal consequences of drug use and a decreasing belief in justice (e.g. because of the lacking 
police and judicial actions towards the Gang of Nijvel3) (Todts, 2004). In other words, drug use 
was increasingly considered as a major cause of crime and social infectious diseases and a 
source of fearfulness in some neighbourhoods (Cartuyvels and Hebberecht, 2002). 
 
In this context, in 1988, the United Nations Convention against illegal traffic in narcotic drugs 
and psychotropic substances was established (Vienna, 1988). This Convention provided addi-
tional comprehensive measures against drug trafficking, including provisions against money 
laundering and the diversion of precursor chemicals. Additionally, in 1985, the Schengen 
Agreement, which was directed towards the free movement of persons, goods and services, was 
established. One of the goals of this Agreement was to improve the cooperation between judicial 
and police services in the EU. Some elements focused specifically on the drug issue (Guillain and 
Marchand, 1998). In particular, the 1985 Schengen Agreement stipulated that the five original 
Schengen countries (Belgium, Luxembourg, the Netherlands, Germany and France) had to target 
illegal drug traffic vigorously as well as to coordinate their actions efficiently. In this context, the 
Schengen Agreement also aimed to harmonise the legislation on drugs among the Schengen 
countries. However, this original compromise proved to be inadequate: the harmonisation of 
legislation on drugs appeared to be a stumbling block as it was not clear which national legisla-
tion or practice should be adopted as the standard (e.g. a Liberal policy of the Netherlands or a 
stricter policy of France). Ongoing debate, with France taking the lead, speculated about the neg-
ative consequences of Dutch drug policy (Fijnaut and De Ruyver, 2008; De Ruyver, et al., 2010). 
As a compromise, the 1990 Schengen Convention, applying the 1985 Schengen Agreement, 
adopted some new stipulations (Articles 70-76). For instance, a permanent working group was 
set up in order to monitor the situation in the Schengen area. Furthermore, a political solution to 
the harmonization issue was found by invoking the former UN drugs conventions. In particular, 
Member States were expected to take criminal and/or administrative measures to tackle illegal 
production and trafficking of drugs (including cannabis) as well as possession for the purpose of 
illegal sale or export. At the same time, a general agreement was included stating that if a coun-
try’s drugs policy deviates from that of others, all parties must take measures to limit the impact 
of this discrepancy on those other countries.4 Here, only an implicit link was made to the coffee-
                                                          
3  During the 1980s, the Gang of Nijvel carried out a number of very violent and bloody raids on supermarkets in 
which a total of 28 people were killed. The unsolved killings by this criminal gang together with the poor and cha-
otic communication between police and justice, threatened the legitimacy of the entire police and justice system 
and caused a moral panic. 
4  The possible (negative) impact of the liberal policy of the Netherlands on the drug policy in Belgium is a frequently 
heard argument in the debate about the drug policy in Belgium during the nineties. For example, it was argued 
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shop model of the Netherlands. Nevertheless, until the Schengen Convention was formally rati-
fied in 1995, the discussions continued, especially regarding the (negative consequences of the) 
divergent policy of the Netherlands and its formal recognition by the other Schengen countries. 
As an interviewee argued, these international debates certainly influenced the further develop-
ments of Belgian drug policy. 
 
“The Benelux discussions, the Schengen discussions, the European discussions, etc. all had an influ-
ence on the development of the policy. They created a kind of awareness, insight and pressure to 
undertake things. In particular, to make decisions that comply with the international framework.” 
(Respondent 39, policy-maker).  
 
2. Beginning of the 1990s: focus on insecurity 
The report of the Parliamentary Inquiry Commission on the struggle against banditism and ter-
rorism5 had prompted the Federal Government Martens VIII (1988-1991), a coalition of 
CVP/PSC, SP/PS, VU (i.e. Coalition of Flemish and French-speaking Christian Democrats, Flemish 
and French-speaking Socialists and Flemish Nationalists), to take action. In 1990, the pro-
gramme for maintaining order, the safety of the citizens and curbing crime (i.e. Pinksterplan or 
Whitsuntide Plan) was announced. Within this framework, the Federal Minister for Internal Af-
fairs, Louis Tobback (SP, Flemish Socialists), outlined a prevention policy under which the local 
administrative authorities were held responsible for the expansion and implementation of an 
integrated, local prevention policy (Beyens, et al., 2001; Cartuyvels and Hebberecht, 2002). The 
implementation of the Pinksterplan was facilitated by the Federal elections of 24 November 
1991 (so-called black Sunday). The rise of the extreme right parties (Vlaams Blok (Flemish ex-
treme right party), Front National (French-speaking extreme right party)) in the large and me-
dium cities was a tangible illustration of the growing political legitimacy problem. As a result, 
the 1992 Federal Government Policy Statement, put forward by the new Prime Minister Jean-Luc 
Dehaene (CVP, Flemish Christian Democrats) in the House of Representatives, emphasised the 
importance of securing the safety of the citizens (Federal Government, 1992). An improvement 
of the relations of the community with the police was seen as one of the major means to restore 
confidence. Shortly thereafter, security contracts (hinged on a prevention section as well as a 
police section) were drawn up with the country’s five largest cities (e.g. Antwerp, Brussels, Char-
leroi, Liege, Ghent) and prevention contracts (only a prevention section) were implemented in 23 
                                                                                                                                                                                     
that an explosion in the coffee-shop market and a Europe without borders (according to the Schengen Convention) 
has led to an increasing amount of foreign (Belgian) drug tourism to the Netherlands (Fijnaut and De Ruyver, 
2014). 
5  A combination of the unsolved killings of the Nijvel Gang and the acts of terrorism of the ‘Cellules Communistes 
Combattantes’ (CSC) in the 1980s posed problems for the entire criminal law system. This resulted in the creation 
of a Parliamentary Inquiry Commission on the struggle against banditism and terrorism in 1988.  
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towns that were less problematic when it came to security. By means of subsidising projects, the 
Federal Government (i.e. Ministry of Internal Affairs) aimed to help the cities fight insecurity and 
to improve living conditions in neighbourhoods. Within this framework, the Permanent Secre-
tariat for Prevention Policy6 was established in 1994. This body was put in charge of supporting, 
coordinating and evaluating these security and prevention contracts. (Cartuyvels and Heb-
berecht, 2002). The security and prevention contracts were renewed and the number of con-
tracts grew during the following years.  
 
Interest in the use of illegal substances was one key element of the security policy as envisioned 
by the 1992 Government Agreement. In the 1992 Government Agreement, put forward by the 
new Prime Minister Jean-Luc Dehaene (CVP, Flemish Christian Democrats), it was stated that 
“Drug use causes an increasing amount of criminality. The struggle against drug traffic must be 
oriented towards the supply and demand of drugs and must contain a better prevention, a more 
efficient repression and a better medical treatment in prisons.” (p.8). Some large cities (especially 
in the French-speaking part of Belgium: Liege, Charleroi, Mons) were confronted with a steep 
increase of frequently occurring crime which seriously affected the quality of life in a number of 
neighbourhoods (Guillain, 2003). Even though this was not backed up by scientific data, police 
officers supported the idea that problematic drug users were responsible for the increase in 
crime and in public nuisance. A statement of a respondent illustrates this point: 
 
“Based on a lot of discussions with police officers it was assumed that drug problems were the un-
derlying cause of many burglaries, car thefts,… which were hot topics at that time.” (Respondent, 
25, policy-maker). 
 
At the same time, drug use (especially new drugs like XTC) became more visible in certain 
(youth) cultures (BIRN, 2000). Accordingly, media attention focused on drug use in mega-clubs 
as well as on the link between drug use and crime due to the high political attention to crime and 
insecurity at that time (Guillain, 2003).  
 
There was an increasing pressure for a comprehensive drug policy caused by the intensification 
of the supply of both legal and illegal drugs (in quantity as well as variety), an increasing mobili-
ty of the demand side, and the supposed increase in drug-related property crimes. This particu-
lar pressure together with the availability of government funds inspired the formalisation of 
drug prevention and security contracts between the Federal Government and the cities. Accord-
                                                          
6  The Permanent Secretariat for Prevention Policy was integrated in the ‘Algemene Directie Veiligheid- en Preven-
tie’ in 2003.  
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ingly, a new development was that localities could request additional subsidies to finance new 
projects linked to the security contract, such as support for alternative criminal sentences (sec-
tion justice) or the prevention of drug addiction (section drugs) (Hebberecht, 2004). In particu-
lar, the municipalities were allowed to install projects with regard to drug prevention, drug 
treatment and local drug coordination (Verslag namens de Parlementaire Werkgroep belast met 
het bestuderen van de drugproblematiek, Parl.St. Kamer, 1996-1997, 1062/1-3; De Ruyver, et 
al., 2004). For instance, the emergence of local medical-social treatment centres for drug users 
(MSOC), ambulant drug treatment centres and outreach projects were financed through con-
tracts with the Ministries of Interior and Social Affairs. Also (smaller) municipalities without a 
security (or prevention) contract had the opportunity to implement projects related to drug 
prevention or drug treatment and to recruit staff like outreach workers or prevention workers 
(these contracts were called drug plans or drug plan contracts) (Hebberecht, 2009). The Gov-
ernment began to fund more services in response to research findings related to e.g. the efficien-
cy of distribution of methadone to heroin addicts (De Ruyver, Van Bouchautte and Reisinger, 
1993) or the link between poverty, drug use and criminality (De Ruyver, et al., 1992). While 
these contracts were financed by the Belgian Federal Public Service Home Affairs as responses 
to crime and delinquency, drug treatment and prevention logically became part of the security 
discourse applied by the Federal Government. Initially, this caused some commotion among 
drug treatment and prevention workers. 
 
“These drug plans […] at first, the whole (especially Flemish) drug treatment and prevention sector 
was highly outraged because of the link with security. Eventually, they realised that the Govern-
ment offered a golden opportunity to strengthen the treatment and prevention field.” (Respondent 
25, policy-maker). 
 
Generally, for the first time, attention was paid to the problem of drugs as a social and health 
problem. Due to the increase in problematic drug use in major cities (often linked with intrave-
nous use, HIV, mortality), political interest raised in low threshold harm reduction initiatives 
like medical-social treatment centres for drug users (MSOC) (BIRN, 2002; Todts, 2004), needle 
exchange projects (e.g. a pilot project was set up in 1993 in Antwerp; Kinable, et al., 1994)7 and 
maintenance therapy for drug addicts (i.e. methadone)8. All respondents acknowledged the im-
portance of this change in discourse, as one of them illustrated in this point: 
                                                          
7  The results of this pilot project were very positive, but the legal context and the political climate at that time im-
peded the implementation of the project in Flanders. In 2000, needle exchange projects were formalised by a Roy-
al Decree (5 July 2000) and finally operationalised in 2001.  
8  At that time, there were large differences between the more liberal practices in Brussels and the French-speaking 
part on the one hand, and the more cautious Flemish region, where maintenance treatment was still exceptional 
and where therapeutic communities were still influential, on the other hand. 
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“Those drug plans included a very important movement, not only towards developing drug treat-
ment, methadone substitution and MSOC’s but also towards stimulating the cooperation between 
drug treatment centres.” (Respondent 16, practitioner). 
 
Exemplary too is the initiative of senators Lallemand and Erdman. They proposed a bill in 1991 
altering Article 3 of the drug law to state explicitly that substitution treatment prescribed by a 
physician cannot be punished.9 Likewise, a conference was set up in 1994 by the Minister of 
Public Health, Jacques Santkin (PS, French-speaking Socialists), together with the medical (and 
academic) world, in order to reach a consensus about methadone maintenance. According to 
conditions included in the Consensus document, substitution treatments had to be perceived as a 
responsible and effective approach to opiate dependence. In particular, the conference agreed 
on what should be expected during treatment: a reduction in the consumption of drugs and the 
use of needles; an improvement of therapeutic ‘compliance’, and; an improvement of the socio-
professional skills of drug users and a reduction of delinquent activities (Hoge Gezondheidsraad, 
2000). Furthermore, a reduction in HIV transmission risks as well as a decrease of overdoses, 
hepatitis, complications and mortality was expected. This conference played an important role 
in opening up the discussion about the organisation of legal substitution treatments. The actors 
involved turned progressively towards a more positive approach of this kind of treatment, but it 
was only in 2002-2003, with the Law of 22 August 2002 and a Royal Decree of 28 March 2003, 
that a definition and practice of substitution treatments as well as the goals they should pursue 
were formalised.  
 
Another initiative also showed that drugs gradually became a topic on the policy agenda. In 
1993, Minister of Justice Melchior Wathelet (PSC, French-speaking Christian Democrats) took a 
more severe approach, pointing to increasing drug use, fear of the escalation of soft drugs to 
hard drugs (Guillain, 2003) and feelings of insecurity. He issued guidelines pertaining to a com-
mon prosecution policy with regard to narcotic substances (De Ruyver, et al., 2004). By means of 
the Ministerial Circular Letter of 5 May 1993, the Minister of Justice instructed Public Prose-
cutors to respond to every instance of (problematic) use regardless of type of drugs. Although 
Belgian law had not penalised the use of drugs as such, the Public Prosecutors had to proceed on 
the assumption that possession is the prerequisite for use, and possession of drugs (irrespective 
of type and quantity) is in itself an offence constituting valid grounds for prosecuting the user 
(Vander Laenen, 2001). Increasing workloads and creating an increasing number of conscien-
tious objectors (i.e. social workers, prosecutors), the implementation of these guidelines ap-
                                                          
9  Voorstel van wet tot wijziging van de wet van 24 februari 1921 betreffende het verhandelen van de giftstoffen, 
slaapmiddelen en verdovende middelen, ontsmettingsstoffen en antiseptica (ingediend door Mr. Roger Lallemand 
and Mr. Fred Erdman), Parl.St. Senaat 1991-1992, nr. 447/1.  
Chapter 1  History of the Belgian drug policy and its legislative framework before 1996 
130 
peared unsuccessful (Dienst Strafrechtelijk Beleid, 1996). Additionally, many cannabis users 
ended up in prison, and there was a lack of uniformity in the application of the prosecution poli-
cy.  
 
The legitimacy of the criminalisation of drugs gradually entered the parliamentary debate 
(Chamber of Representatives and Senate)10 too (Kaminski, 2003b). From the beginning of the 
1990s there had been an increasingly widespread clamor on the international level for a change 
in the laws controlling drugs, with cannabis the most plausible candidate for reform (MacCoun 
and Reuter, 2001). In the Belgian context, two members of the Parliament, Mr. Frans Lozie and 
Mr. Michiel Maertens (AGALEV-Ecolo, Flemish and French-speaking Greens), launched a bill in 
the Parliament in 1993 concerning the revision of the Drug law of 1921 and the decriminalisa-
tion11 of cannabis possession (Hand. Senaat 1993-1994, 30 november 1995, 871/1). Similarly, 
another MP, Mr. Johan Van Hecke (CVP, Flemish Christian Democrats), submitted a proposal to 
establish a parliamentary working group charged with studying the drug problem in Belgium 
and developing an appropriate and coordinated drug policy (Hand. Kamer 1992-1993, 30 april 
1993, 989/1).  
 
3. Federal Action Plan Toxicomania-Drugs (1995)12 
On 3 February 1995, the Government approved the Federal Action Plan Toxicomania-Drugs 
(ten-point plan) in order to offer a reply to the complex and changing drug phenomenon. This 
ten-point plan was intended to define action priorities on drugs, which could then serve as a 
starting point for the establishment of concrete initiatives (Kabinet van de Eerste Minister, 
1995). However, surprisingly, the plan did not propagate an integrated or global perspective. A 
respondent clarified: 
                                                          
10  Like the Chamber of Representatives, the Senate is a forum for reflection. Members of the Senate may take the 
initiative to put forward written or oral questions, resolutions and bills. Both assemblies exercise similar powers, 
but only the Chamber can sanction the Government politically. For example, the members of the Senate do not 
have the power to control the Federal Government by means of interpellations (Van der Hulst, 2010). 
11  The concept decriminalisation is often confused with the concept depenalisation. In this study, we follow Room et 
al. (2010) by using the term decriminalisation to refer to ‘prohibition with civil penalties’. Thus, criminal penalties 
are removed from the law while administrative penalties are still possible (e.g. Portugal). Depenalisation involves 
maintenance of criminal penalties in the criminal law, yet removing or shortening the periods of incarceration, or 
reducing fine amounts, as possible sanctions (e.g. Belgium, Germany, Denmark and the Netherlands). Legalisation 
means that the specified forms of behaviour are no longer offences dealt with under the law, yet it is often still 
governed by different tools of regulatory law.  
12  The concept toxicomania refers to the security discourse that was common at that time (Guillain, 2009). 
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“Those 10 points… If you have read them, then you know that they are not the product of a clear 
vision on drug policy. The plan rather includes an enumeration of ‘points that they have to take 
care of’. The installation of medical-social treatment centres for drug users is just one example.” 
(Respondent 50, scientist). 
 
The 10 action points of the Federal Action Plan Toxicomania-Drugs were (1) to allocate to social 
security the material benefits that were confiscated in the fight against drug trafficking, (2) to 
improve the training of prison personnel with regard to the problem of drug addiction, (3) to 
develop needle exchange programmes, (4) to extend the power to close down establishments 
where drug crimes are committed, (5) to establish medical-social treatment centres for drug 
users (MSOC’s)13, (6) to combat recreational drug use, (7) to extend scientific research (e.g. epi-
demiological research and the scientific evaluation of the medical-social treatment centres for 
drug users), (8) to optimise the treatment of drug users, (9) to extend the measures to reduce 
the supply of drugs and (10) to establish research into the consequences of drug use for road 
safety.  
 
Only six of these action points were realised, with differing success (De Ruyver, et al., 2004). 
The training of prison personnel was financially supported in 1995 and 1996 and afterwards 
rather ad hoc (caused by a lack of continuity in funding). Applying the harm reduction approach, 
an exchange programme for syringes was formally organised in November 1998. Furthermore, 
the programme to combat recreational drug use was not fully developed. Some local projects 
focusing on the prevention of experimental and recreational use among youth in nightlife were 
established in 1998, but not continued. Research into the consequences of drug use for road 
safety was developed in 1995 with the Belgian Toxicology and Trauma study (Charlier and 
Plomteux, 1998). Likewise, in 1999, a study into the consequences of drug use for road safety 
(ROSITA) was conducted. A law (9 April 1999) regarding drug use in road traffic was imple-
mented as a result of both studies. The Belgian Institute for Road Safety also started to organise 
prevention campaigns about the consequences of drug use (especially alcohol) in road traffic (e.g. 
BOB – Wodca).  
 
Additionally, some medical-social treatment centres for drug users (MSOC’s) to treat problematic 
drug users were established in 1997. The Federal Action Plan Toxicomania-Drugs (1995) advo-
cated for a sharp increase in public expenditures for drug treatment centres (within the frame-
                                                          
13  The installation of medical-social treatment centres for drug users (MSOC’s) was largely inspired by the network 
of low-threshold (methadone) programs in Amsterdam. Mr. Johan Vande Lanotte is considered as the driving force 
of the ten-point plan and the installation of medical-social treatment centres for drug users (MSOC’s) in particular 
(Fijnaut and De Ruyver, 2014). 
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work of social security standards) (De Ruyver, et al., 2004). Next to funding for residential care, 
more diversity was stimulated by supporting day centres, crisis centres and low threshold ser-
vices. These low threshold services were initially located in Antwerp, Brussels, Charleroi, Genk, 
Ghent, Liege, Mons and Ostend.14 The establishment of the medical-social treatment centres for 
drug users can be seen as one of the most important policy engagements in the development of 
Belgian drug policy between 1996 and 2003. 
 
Finally, an increased credence was given to scientific knowledge as an instrument of developing 
drug policy. While drug research became internationalised (EMCDDA was installed in 1993 and 
operationalised in 1995)15, the importance of a scientific base was explicitly underlined in the 
Federal Action Plan Toxicomania-Drugs. Soon, this action point resulted in policy-funded re-
search (i.e. useful inventory of drug research in Belgium and its neighbouring countries; Van 
Daele, et al., 1996). An evaluation of the activities of medical-social treatment centres for drug 
users (MSOC’s) followed: research teams from the universities of Ghent and Liège prepared a 
manual with uniform methodology and evaluation criteria for an assessment and, in 1998, the 
assessment took place on the basis of this manual (Pelc, et al., 2001). The plan can be perceived 
as one of the first explicit steps in the development of an interest in (and influence of) policy-
funded research and evaluation research about drugs in particular. 
 
The realisation of those six action points was stimulated by the 1995 Federal Government Policy 
Statement (Vander Laenen, 2001). The same centre-left Coalition of Flemish and French-
speaking Christian Democrats and Socialists (CVP/PSC, SP/PS) was re-installed in June 1995 and 
corresponding with the 1992 Federal Agreement, Prime Minister Jean-Luc Dehaene (CVP, Flem-
ish Christian Democrats) re-emphasised the need for a comprehensive national drug policy in 
Belgium in his 1995 Federal Government Policy Statement. In particular, the increasing effort to 
prevent drug use among youth, the extension of treatment for drug users (e.g. medical-social 
treatment centres for drug users), the increase of repression against drug traffic and the devel-
opment of a scientific base for drug policy were stressed as important elements. Anticipating the 
media focus on cannabis policy (and on the usefulness of the criminalisation of drugs in particu-
                                                          
14  After an evaluation of the MSOC’s (1999), an MSOC in Vlaams-Brabant was established. 
15  The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) played an important role in initiating 
the science – policy debate. Established in Lisbon in 1993, the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) was given the task of providing the EU and its Member States with a factual overview of Eu-
ropean drug problems and a solid evidence base to support the drugs debate (Stimson, 1997; Hartnoll, 2004). Un-
der the influence of this movement, most European countries gradually started to establish an empirical basis of 
(epidemiological) research (Stimson, 1997; EMCDDA, 2008). As a result, more and more, references of research 
were introduced into the drug policy documents (i.e. national drug strategy or action plan) in many European 
countries (EMCDDA, 2008). 
Chapter 1  History of the Belgian drug policy and its legislative framework before 1996 
133 
lar), the 1995 Federal Government Policy Statement explicitly emphasised that the legalisation 
of drugs was not an acceptable solution and that a legal framework around the medical prescrip-
tion of methadone had to be developed.  
 
4. Scientific knowledge: still lacking but on the increase during the nineties 
For a long time, drug use was confined to a limited place on the policy agenda (Gusfield, 1975). 
During the nineties, throughout Europe (and the rest of the world) more and more initiatives 
were taken to identify gaps in knowledge and to strengthen the research base (Stimson, 1997; 
Hartnoll, 2004). In Belgium, the Federal Action plan Toxicomania-Drugs (1995) gave the first 
important impulse to the extension of the scientific research base. However, studies about drug 
use in Belgium remained rather scarce and fragmented (Van Daele, et al., 1996).  
 
So far, existing Belgian studies described (some aspects of) the drug situation in Belgium, mainly 
focusing on etiological and epidemiological questions (Kaminski, 2003a). Worth mentioning are 
several school population surveys at the regional and local level (e.g. Casselman, et al., 1984; 
Goyvaerts, Van Hal and Teugels, 1992; De Ruyver, Van Daele and Coolsaet, 1991) next to the 
official statistics (e.g. number of drug overdoses, number of confiscations, number of prisoners 
because of drug-related crimes) and some utilisation (registration) studies (e.g. Bijnens, Nie-
landt and Hauglustaine, 1985; Vandenbroele, et al., 1989). In particular, the reported growth of 
cannabis (and ecstasy) use among youth and adolescents16, and the observed increase in the 
demand for treatment of problematic cannabis use increased the interest in epidemiological 
studies and risk factor research focusing on cannabis initiation and intensive use of cannabis 
(VAD, 2000; BIRN, 2000). Several risk factors were identified: parent-child relationship, peer 
influence, academic integration, etc. Following the increasing number of youth population sur-
veys, information on the situation of drug use in the general adult population started to develop 
in 1995, especially after a CATI health monitoring survey was conducted in Flanders (in 1996 
the survey started in the French Community).17 Ethnographic studies were limited in Belgium.  
 
Another stream of (often policy-funded) research included studies focusing on the trajectories of 
drug users within the criminal justice system or on the state of the art and the efficiency of dis-
                                                          
16  Cannabis was the most commonly used illegal drug in Belgium in the mid-nineties. About 14.9% of the school 
population had at least tried the drug in 1994. Increases of the use of cannabis were reported in 1996 (19.6%). A 
major issue for young people’s drug use was the emergence of so-called ‘dance drugs’, including ecstasy. Lifetime 
prevalence of ecstasy use increased from 4.1% in 1994 to 5.6% in 1996 (BIRN, 2000). 
17  Regarding cannabis use, one observed that the Flemish life-time prevalence of 1994 (5.8%) followed the global 
increasing trend during the nineties (as observed in other European countries). Information on use of other drugs 
by adults was limited (BIRN, 2000). 
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tribution of methadone to heroin addicts (De Ruyver, Van Bouchautte and Reisinger, 1993).18 
Other important initiatives included a study of the link between poverty, drug use and criminali-
ty (De Ruyver, et al., 1992); a study of the goals and mission of street work (De Ruyver, et al., 
1996); a study focusing on discotheques, house music and nuisance (Vercaigne and Walgrave, 
1995), and; (qualitative and quantitative) studies of the judicial actions towards drug users (or 
secondary criminalisation) (De Pauw and Lempereur, 1990; Christiaensen and Goethals, 1994).  
 
A very important initiative came from a scientist in his capacity as a policy advisor (Minstrom, 
1997; Loader and Sparks, 2011)19. Prof. Dr. Brice De Ruyver picked up the growing need to es-
tablish a comprehensive national drug policy in Belgium. From 1993, an annual conference 
‘Drug policy 2000’ was organised in order to develop and stimulate the interaction between 
practice, science and policy (De Ruyver, et al., 1995). The scientific organisation committee was 
composed of several scientists, practitioners and a representative of the Government. During 
these national conferences several drug-related topics were discussed. The topics addressed 
clearly followed the main interests of the media and policy-makers. Because of the importance of 
the international framework, comparisons with Dutch drug policy were made regularly (De 
Ruyver, et al., 1996). The first conference was organised in 1993 and stimulated discussions 
about epidemiology, prevention, justice and treatment from a variety of perspectives. In 1994, 
the central themes were more specified and included: integrated drug policy, recreational drug 
use, international struggle against drug traffic, development policy and drug production, drug 
treatment, police and justice. The third conference ‘Drug Policy 2000’ (held in October 1995) 
was mainly devoted to the action points of the Plan Toxicomania-Drugs: outreach work; recrea-
tional drug use; drug tourism and nuisance; harm reduction initiatives (which was also linked 
with the 1994 Consensus Conference); driving under the influence of medication and illegal 
drugs; registration and monitoring; drug treatment during detention; the development of an 
integrated and integral drug policy, and; the difficulties with regard to the cooperation between 
the criminal justice system and treatment services (De Ruyver, et al., 1996). The problems with 
the application of the 1993 Ministerial Circular were also addressed for the first time.  
 
Such conferences encouraged a greater role of scientific knowledge in the policy-making pro-
cess. On the one hand, the conference was attended by several actors (policy-makers, scientists, 
practitioners, journalists) which made it possible to stimulate debate about (different) ideas as 
                                                          
18  As studies showed rather high prevalences of hepatitis B and C (while HIV-seroprevalence among drug users 
remained low in Belgium), the set-up of low threshold centres was considered as a possibility to improve access to 
treatment (including methadone substitution) and to support risk reduction interventions (EMCDDA, 2000). 
19  The role of scientists in the public/political debate is part of a heated discussion among scientists (cfr. public soci-
ology or public criminology).  
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well as cooperation between (Dutch-speaking and French-speaking) practitioners, scientists, 
policy-makers and journalists. These important and highly attended conferences set and kept 
this particular issue high on the political and public/media agenda. Those conferences can be 
perceived as one of the incremental steps opening a policy window (Kingdon, 2002). They lead to 
the widespread attention and shared concern that some type of action was required. On the oth-
er hand, these conferences provided some interesting multidisciplinary input for the Parliamen-
tary Working Group on drugs (1996-1997). 
 
“Those conferences were the mecca of politicians, scientists and practitioners. It was a kind of 
movement of people who had finally found each other. The conferences also gave a lot of input to 
the debate in the Parliamentary Working Group on drugs as it can be considered as a sort of pro-
longation of these debates.” (Respondent 9, practitioner). 
 
Additionally, some scientists acted as policy advisors through the attendance of study groups 
from political parties. From the beginning of the 1990s, when interest in the drug issue gradually 
increased, several study groups from political parties invited scientists (and practitioners) to 
develop a party policy on drug policy (which was then integrated in parliamentary and govern-
mental actions). Such engagement of scientists goes behind the public scenes but can be seen as 
another (successful) route to bringing scientific knowledge to the policy-making process and to 
establish an interaction between science (and practice) and policy. For instance, as will become 
clear, many participating scientists (and practitioners), were also picked up in the PWG (see 
below, Chapter 2). 
 
“Experts did not have to be members of the party but they had to express their sympathy with our 
points of view […] In a study group, they try to influence the conclusions and notes from their per-
spectives […] Of course, they search for a study group from a political party that is most compati-
ble with their vision. […] It is more effective to take part in a study group when you want to influ-
ence policy-making.” (Respondent 29, policy-maker). 
 
Even though the technical skills and know-how of scientists were brought into the debate, this 
engagement was also influenced by the political context. For instance, a scientist who participat-
ed in the study group from two majority parties simultaneously, ended his engagement when 
one of the political parties became part of the opposition. Likewise, due to their link with the 
Catholic ‘Brothers of Charity’, members of the organisation ‘De Sleutel’ tended more to engaging 
in the study group from the Flemish Christian-Democratic party (CVP). 
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5. Conclusion 
The drug theme entered the Belgian legislative framework at the beginning of the 20th century. 
In particular, the basic Belgian law relating to the traffic in toxic substances, hypnotics, narcotics, 
disinfectants and antiseptics dates from 24 February 1921. The first steps in developing a Bel-
gian drug policy were, however, laid in the 1990s. The increase of the supply of both legal and 
illegal drugs (in quantity as well as variety), an accumulative mobility of the demand side, and 
the supposed increase in drug-related property crimes led to a need for a comprehensive drug 
policy. This particular pressure together with the availability of government funds led to the 
creation of drug prevention and security contracts between the Federal Government and the cit-
ies. Even though projects initially were set up from a crime prevention perspective, these con-
tracts gradually broadened the discourse on drug problems and treatment. For the first time, 
drugs were considered as a social and health problem and a harm reduction approach was in-
corporated. Support for initiatives like needle exchange, methadone maintenance (as a result of 
the 1994 Consensus Conference) and medical-social treatment centres for drug users demon-
strated this change.  
 
The Federal Action Plan Toxicomania-Drugs (1995) can be considered as another move towards 
the development of a comprehensive Belgian drug policy. On 3 February 1995, the Government 
approved this ten-point plan in order to define action priorities on drugs, which could then serve 
as a starting point for the establishment of concrete initiatives. However, so far, the 10 action 
points of the Federal Action Plan Toxicomania-Drugs has not yet propagated an integrated or 
global perspective.  
 
While the theme of drugs was increasingly prominent in the political forum from the beginning 
of the nineties, the contribution of scientific knowledge into the policy-making process remained 
limited. Several barriers to the integration of scientific knowledge in the policy-making process 
are observed. On the one hand, drug research in Belgium was rather fragmented and restricted 
to a small number of epidemiological youth studies and policy-funded studies. On the other 
hand, feelings of insecurity (as a result of a steep increase of frequently occurring crime and nui-
sance), an increasing visibility of drug use in certain (youth) cultures and increasing fear for a 
uncontrollable drug epidemic at the international level dominated the debates. Stimulated by 
attentive media coverage and the aftermath of the election victory of the Flemish extreme right 
party Vlaams Blok in 1991 (Black Sunday), emotions largely determined the policy-making pro-
cess until then.  
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Several initiatives served as an important breakthrough regarding the contribution of scien-
tific knowledge to the drug policy-making process. An increased attention to scientific 
knowledge as an instrument of developing drug policy was evident in the Federal Action Plan 
Toxicomania-Drugs (1995). This initiative can be seen as one of the first explicit steps in the 
development of an interest in (and influence of) policy-funded research and evaluation research 
about drugs in particular. At the same time, scientists themselves, taking up their public role as 
policy advisor (Loader and Sparks, 2011), made efforts to bring available scientific knowledge to 
conversations and debate on issues of drug policy. For instance, the highly attended national 
conferences ‘Drug Policy 2000’ engaged the debate between scientists, practitioners and policy-
makers with their criticism and enthusiasm for knowledge about the drug phenomenon and 
possible policy solutions. Those conferences can be seen as one of the initiatives improving the 
utilisation of scientific knowledge in the policy-making process. The participation of some scien-
tists in study groups from political parties may have encouraged the input of scientific 
knowledge in the policy-making process as well. Clearly, those scientists – who had the skills to 
carry scientific knowledge into the public and political debate – facilitated the interaction be-
tween science and policy.  
 
With this history in mind, we will discuss the Parliamentary Working Group on Drugs (1996-
1997), the first milestone in Belgian drug policy between 1996-2003, in the next chapter.  
 
  
Chapter 2  Parliamentary Working Group on drugs: 1996-
1997 
 
The debate about the development of Belgian drug policy has several roots. Firstly, the emer-
gence of drug use and drug problems among small groups started to affect the lives of youth and 
general populations. Throughout the European Union, cannabis was the most commonly used 
illegal drug in the nineties. Depending on the country, from 5.8% to 20.30% of the population 
had at least tried the drug. Increases in the use of other drugs like ecstasy, amphetamines and 
LSD were also reported (EMCDDA, 1995). Secondly, the multidisciplinary and complex nature of 
drug problems demanded a nationally coordinated response incorporating prevention, treat-
ment and law enforcement. Each of the previously mentioned events in Belgium (e.g. Federal 
Action Plan Toxicomania-Drugs; national conferences ‘Drug Policy 2000’) and elsewhere (e.g. 
international trend to review national drug strategies; EMCDDA, 1997) provided the background 
for some (even though rather isolated) incremental steps gradually opening a policy window20 
(Kingdon, 2002). As a result, around mid-1990s, Belgium engaged in a profound debate on the 
development of a national drug policy with the creation of the Parliamentary Working Group on 
drugs (PWG).  
 
1. Installation of the Parliamentary Working Group on drugs (PWG) 
The Belgian drug policy window was opened by Mr. Patrick Moriau, a MP of the French-speaking 
Socialist party (PS). He emphasised publicly in the French-speaking newspaper Le Soir (17 No-
vember 1995) that he would submit a proposal to depenalise (and in a later stage legalise) can-
nabis possession (in contrast with the repressive Belgian law). This initiative was inspired by his 
personal experiences as mayor (of the city Chapelle-les-Herlaimont in the Walloon Region), by 
the public awareness of a still increasing drug phenomenon as well as by the fact that the im-
plementation of the Ministerial Circular Letter of 5 May 1993, which instructed Public Prosecu-
tors to add a consequence (e.g. prosecution, praetorian probation,…) to every violation (making 
no distinction between types of drugs), impeded a uniform prosecution policy among Public 
Prosecutors (De Ruyver, et al., 2004). Although it was only a threat (in the end, he did not submit 
his proposition), his statement opened up the debate on drugs and drug policy in Belgium. 
 
                                                          
20  The Multiple Streams model (Kingdon, 2002) seeks to explain policy changes by means of, respectively, the pres-
ence of powerful and competing policy networks or the importance of context like political climate, timing (e.g. 
when a window of opportunity (policy window) opens) and changing realities. Even though incident or crisis-
driven policy-making regularly occurs (Beyens, et al., 2001), remarkable incidents have not been decisive in shap-
ing political action in this particular case. 
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“The idea of a proposal was launched but it was never the goal to submit the proposition. The only 
goal was to create a debate and this turned out well […] Actually, it has advanced this political and 
public debate […] Sometimes, in politics, you have to force things […] I am also convinced that 
without media, there wouldn’t have been a debate nor a Parliamentary Working Group.” (Re-
spondent 41, policy-maker). 
 
Several newspapers picked up the decisive article and published the core of it the day after. With 
headlines like “PS wants to legalise cannabis” (18 November 1995, Flemish newspaper Gazet van 
Antwerpen), they immediately created a climate in which concepts like ‘danger’, ‘death’ or ‘dis-
ease’ were linked with the concept of legalisation of cannabis (instead of depenalisation which 
was argued by MP Moriau). In presenting their particular thesis, journalists tended to prefer 
finding an authority who confirmed their analysis, often citing football players or musicians. In 
this case, the whole issue of what media regards as a so-called authority on drugs is questiona-
ble. 
 
At that time, several (ex-)drug users (together with some like-minded practitioners and scien-
tists) were united in interest groups advocating for drug users’ rights. For instance, the BCCO 
(Belgian Cannabis Consumers’ Organisation) played an active role in the Flemish part of Belgium 
while in the French-speaking part of Belgium, interest groups A citizen just like any other and 
Association against the prohibition were active. These interest groups took advantage of media 
attention in an attempt to publicise their ideas and to persuade the public and policy-makers to 
share their point of view. For instance, BCCO showed up in the newspapers as several protests 
were organised in order to promote legalisation of cannabis. In hoping to stimulate the discus-
sion, they also published their own magazine ‘The Paper’, and forwarded international newspa-
per articles (e.g. concerning the opinion of the Beatles towards cannabis) to the Flemish news-
papers.  
 
“One of the reactions on our appeal came from the Belgian Cannabis Consumers’ organisation 
(BCCO). The Bond sent us some newspaper cuttings from which we chose the two most supportive.” 
(21 November 1995, Flemish newspaper Belang van Limburg). 
 
Additionally, they took advantage of the ‘Kim Saadeldin’ incident. This 16-year old youngster 
and member of the BCCO, Kim Saadeldin, who was locked up in a youth institution because of 
cannabis possession, died of natural causes during his imprisonment. While the Flemish media 
falsely linked the death of youngster Kim Saadeldin with the dangers of cannabis use, the inter-
est group BCCO used this incident to plead against imprisonment of recreational users of canna-
bis.  
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“Obviously, there was a need for a public debate and we forced it by means of our actions […] His 
death caused a lot of indignation and the media attention which followed gave us a boost in popu-
larity. We were invited for television programmes, debates, etc. everywhere in Flanders.” (Re-
spondent 23, member of interest group). 
 
At the same time, interest groups tried to influence the parliamentary debate on the drug issue 
by making some (often selective) contacts with MPs (scientists or practitioners were hardly con-
sulted). 
 
It is clear that the media (and interest groups) played a significant role in empowering the en-
lightenment function of scientific knowledge in our particular case (Tieberghien and Decorte, 
2013). In particular, media coverage initially shaped political action (and a focus on scientific 
knowledge) in Belgium. The media succeeded in placing (and keeping) an item on the political 
agenda, which in turn increased the likelihood of action on the part of the Federal Parliament 
and the Government. In accordance with Lenton (2004), it seems that once a topic is covered in 
the media, it is harder to ignore for policy-makers. 
 
“If a topic gets a lot of media attention, it is really not done for the MPs to not pay attention to this 
issue in the parliamentary debates.” (Respondent 6, policy-maker).  
 
Accordingly, some MPs formulated and submitted particular questions and interpellations. Oth-
er MPs wrote a letter to the President of the Chamber of Representatives (Letter of MP Claude 
Eerdekens (French-speaking Socialists (PS)) regarding the drug problem in Belgium, 27 Novem-
ber 1995) or submitted a proposition to establish a Parliamentary Inquiry Commission or a 
temporary Commission (Hand. Kamer 1995-1996, 13 november 1995, 230/1) by referring to 
the 1995 Federal Agreement (which re-emphasised the need of a comprehensive and efficient 
national drug policy in Belgium) and the evolving drug phenomenon. Vague references to scien-
tific knowledge were used as ammunition (political/symbolic utilisation): “We have a mass of 
scientific information, legal data and advice from professionals working with drug users and the 
public” (Hand. Kamer 1995-1996, 13 november 1995, 230/1). Although these initiatives applied 
to all legal and illegal drugs, an underlying focus on cannabis was identified (in line with the high 
media coverage of the cannabis issue and the ongoing discussion in the Netherlands): “A tempo-
rary Commission should decide whether a tolerance policy or a legalisation/regulation of (1) 
use/possession or (2) use/possession/sale/production is most appropriate” (Hand. Kamer 1995-
1996, 13 november 1995, 230/1). 
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Eventually, the Conference of Presidents21 decided to establish a Parliamentary Working Group. 
A working group has the task of collecting information about the state of the art of a phenome-
non as well as to formulate some recommendations which may change the state of the art 
(Staelraeve, 2003). In accordance with the political/symbolic model (Weiss, 1979; Nutley, 2003), 
some respondents considered this action by the Parliament as a strategy of the majority to keep 
the political responsibility away from the Government (and thus for delaying real decision-
making).  
 
“The use of hard or soft drugs in our country is a highly topical issue. A major public debate on 
drugs, particularly on soft drugs, sparked off in the last few days [...] The Parliament should take a 
prominent role in discussing a topic which arouses a great deal of emotions and anxiety in society 
[...] Some initiatives were taken by individual MPs. The Parliament has the task to examine the 
drug phenomenon, without presupposing any legal actions22 (my emphasis).” (Memorandum of the 
Parliamentary Working Group).  
 
“It has been a trick to keep the discussions away from the Government […] The Government had an 
excuse not to take any initiatives or measures in one or another direction as the Parliament was 
working on the topic.” (Respondent 4, policy-maker). 
 
The creation of a Parliamentary Working Group on drugs was approved on 17 January 1996 by 
the Conference of Presidents based on the advice of the Presidents of the (standing) Commis-
sions of Justice, Internal Affairs and Public Health.23 After the approval, the working group was 
established on 25 January 1996. 
 
The chairman of the working group was Mr. Louis Vanvelthoven (SP, Flemish Socialists). First 
and second vice-president were respectively Mr. Daniel Bacquelaine (PRL-FDF, French-speaking 
Liberals) and Mr. Marc Verwilghen (VLD, Flemish Liberals) who was replaced by Mr. Jef 
Valkeniers (VLD, Flemish Liberals) on 30 January 199724. Secretary of the Parliamentary Work-
ing Group was Mr. Jacques Lefevre (PSC, French-speaking Christian Democrats). Both Mr. Mau-
                                                          
21  The Conference of Presidents is one of the most important bodies of the Chamber of Representatives. It consists of 
the President and the Vice-Presidents of the Chamber, former Presidents of the Chamber who are still members of 
the Chamber, the fraction leaders and a member of each fraction. The Conference meets weekly to discuss the day-
to-day business and the work of the Chamber (Devos, 2006). 
22  ‘without presupposing any legal actions’: refers to the 1995 Federal Government Policy Statement which empha-
sised explicitly that the legalisation of drugs was not an acceptable solution in a search for the development of an 
efficient drug policy. Likewise, an underlying focus on cannabis can be identified here. 
23  President of the Commission of Justice: Mr. Marc Verwilghen (VLD, Flemish liberals), president of the Commission 
Internal Affairs: Mr. Charles Janssens (PS), president of the Commission Health Affairs: Mr. Louis Vanvelthoven 
(SP, Flemish Socialists). 
24  Mr. Marc Verwilghen was appointed to the Parliamentary Inquiry Commission Dutroux. 
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rice Minne (PS, French-speaking Socialists) (as he replaced Mr. Charles Janssens (PS, French-
speaking Socialists) on 22 April 1996) and Mr. Jo Vandeurzen (CVP, Flemish Christian Demo-
crats) were responsible for the writing up of the report. The Parliamentary Working Group on 
drugs was further composed of representatives of several political parties seated in the Commis-
sions of Justice, Internal Affairs and Public Health.25  
 
2. Bottom-up approach 
The PWG aimed to study the complexity and multidisciplinary nature of the drug phenomenon 
to determine the future orientation of Belgian drug policy. It was the first time that the drug 
phenomenon was studied thoroughly, focusing on prevention, treatment and repression. Mem-
bers of the PWG relied on experts to get an idea of good practices as well as of scientific findings 
regarding the drug phenomenon. Through a bottom-up approach, the PWG aimed to translate 
the advice of experts into useful policy recommendations. 
 
2.1. Composition of the PWG 
In the Parliamentary Working Group on drugs (1996-1997), a total of 59 national and interna-
tional experts26, working in various domains of drug policy (epidemiology, prevention, treat-
                                                          
25  One member of each fraction in these Commissions was involved: Mr. Jan Van Erps and Mrs. Ingrid Van Kessel 
(CVP, Flemish Christian Democrats), Mr. Patrick Moriau (PS, French-speaking socialists), Mr. Willy Cortois (VLD, 
Flemish liberals), Mr. Dany Vandenbossche (SP, Flemish socialists), Mr. Filip De Man (Vlaams Blok, Flemish ex-
treme right party), Mr. Frans Lozie (AGALEV, Flemish Greens). Each of these members were qualified to vote. 
Some non-voting members (e.g. Mrs. Anne-mie Vandecasteele (VU, Flemish Nationalists) also participated in the 
PWG. 
26  The following experts were consulted in the PWG: Prof. Dr. M. Bogaert (Heymans Institute for Pharmacology, 
UGent), Prof. Dr. A. De Leenheer (Toxicology, UGent), Prof. Dr. A. Noirfalise (Toxicology and Bromatology, ULG), 
Prof.Dr. J. Casselman (Academic Psychiatric Centre Bierbeek, KULeuven), Prof. Dr. I. Pelc (University Hospital 
Brugmann), Prof. Dr. G. Reginster-Hanneuse (ULG), Mr. R. Hartnoll (EMCDDA), Mr. M. Morival (Doctor, WHO), Mr. 
A. Perissino (Doctor, EMCDDA), Prof. Dr. B. De Ruyver (Institute for International Research on Criminal Policy, 
UGent), Mr. A. Labrousse (Director Observatoire géopolitique des drogues), Mr. Willy Bruggeman (Assistant coor-
dinator EUROPOL), Prof. Dr. C. Fijnaut (KULeuven), Mr. A. Morel (Medical Director Le Trait d’Union), Prof. Dr. P. 
Cohen (Department Social Geography, University of Amsterdam), Mr. P. Duinslaeger (National magistrate), Mr. B. 
Dejemeppe (Public Prosecutor Bruxelles), Mr. C. De Winter (Director Programme Drugs Police), Mr. T. Marchan-
dise (Public Prosecutor Charleroi), Mr. M. Vansnick (Belgian Institute for Road Safety), Mr. I. Carmen (Public Pros-
ecutor Louvain), Mr. D. Delhauteur (Director Safety Contracts, City of Liege), Mr. J. Vanwingh (Director Prison Sint-
Gillis), Mr. F. Van Mol (Medical Director, Algemeen Bestuur Strafinrichtingen), Mr. R. Mertens (Director Prison 
Dendermonde), Mr. V. Libert (Director project Praxis-Verviers), Mr. R. Bosmans (Administrator CAP-ITI, aide psy-
chologique et sociale aux toxicomanes incarcérés et sortants de prison), Mr. J. Spreutels (Advocate and President 
Cel Financiële informatieverwerking), Mr. B. De Bie (Officer Police, Departement economical criminality and fi-
nance), Mr. J. Doraene (Officer Police, Director OfficeCentral chargé de la lutte contre la Délinquance Economique 
et Financière Organisée (OCDEFO)), Mr. F. Lequarré (Doctor, Centre d’analyses transdisciplinaires drogues), Mr. P. 
Bastin (Director Infor-drogues, Association qui offre de l'information, de l'aide, des conseils à tout un chacun con-
fronté d'une façon ou d'une autre, de près ou de loin, à la problématique des drogues), Mr. S. Todts (Doctor, MSOC 
Free Clinic), Mr. G. Vanhalle (Vice president Algemene Pharmaceutische Bond), Mr. F. Buntinckx (Doctor Weten-
schappelijke Vereniging voor Geneeskunde), Mrs. I. Montulet (Febecoop, expertise centre social economy), Mr. J. 
Lafontaine (Doctor and coordinator Wetenschappelijke Vereniging voor Geneeskunde), Mr. G. Cahuana (Vice Pres-
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ment, repression) were asked to convey their analysis and their recommendations. The experts 
can be divided into three categories: 12 scientists, 44 practitioners and 3 representatives of in-
terest groups of ex-users.27 The first category included national and international scientists, se-
lected from different countries (related to the importance given to the international framework) 
and different angles: pharmacology, epidemiology, criminology, etc. Practitioners were selected 
from police (6), justice (9), treatment services (19) and prevention services (10). Some of these 
practitioners occupied a dual position in the PWG. Practitioner Mrs. Jacqueline Paisse contribut-
ed twice: once as a member of the department prevention of the treatment service ‘Clips Liège’, 
and a second time as a representative of the treatment service Association Francophone des In-
tervenants en Toxicomanie (AFIT). Mr. Eric Picard occupied an official role as an individual medi-
cal expert as well as an unofficial one, as a member of the interest group CORA (Radical Anti-
Prohibitionist Coordination).  
 
Next to these experts, some members (and 3 of their representatives) of the Federal and Feder-
ate Government28 were also invited and heard in the PWG. Both levels were represented due to 
the complexity of competences related to drug policy (e.g. prevention actions are situated at the 
federate level).29 In particular, 6 members of the Federal or Federate Government were heard in 
the discussion: Mrs. Wivina Demeester-Demeyer (Flemish Minister of Health, CVP, Flemish 
                                                                                                                                                                                     
ident Andesraad van cocaproducten), Mrs. M.Geirnaert (Coordinator Vereniging voor Alcohol en andere 
Drugproblemen), Mr. L. Bils (Director CCAD, Comité de Concertation sur l'Alcoolet les autres Drogues (CCAD), Mr. 
E. Servais (Coordinator ASL, ArbeitsgeMaynschaft [ûr Suchtvorbeugung und Lebensbewaltigung), Mr. F. Curtet 
(Psychiatrist), Mr. Marcel Van Hex (Director CAD, Centrum voor Alcohol en andere Drugproblemen Limburg), Mr. 
P. Van der Kreeft (Director vzw Leefsleutels voor jongeren), Mrs. J. Paisse (member Clips Luik, Centrum Gees-
telijke Gezondheidszorg), Mrs. M. Dal (Prospective Jeunesse Bruxelles, centre d’étude et de formation actif dans le 
domaine de la prévention des risques liés aux usages de drogues, dans une dynamique de promotion de la santé), 
Mr. A. Figiel (Neuropsychiatrist and Director ALFA, Centrum Geestelijke Gezondheidszorg), Mr. E. Picard (Doctor 
Midrasch Brussel, Drug Rehabilitation Clinic), Mr. D. Van de Putte (Doctor Psychiatric Hospital Ziekeren), Mr. M. 
Firket (Doctor START, Service Transdisciplinaire d'Aide à la Réadaptation des Toxicomanes Liège), Mr. M. Reisin-
ger (Psychiatrist In-dépendance absl), Mr. C. Coenegrachts (Pluralistisch Overleg Welzijnswerk (POW)), Mr. H. 
Wolf (VLASTROV), Mr. P. Terreyn (Belgian Cannabis Consumers’ Organisation), Mr. J. Blanquaert (Belgian Canna-
bis Consumers’ Organisation), Mr. D. De Vleesschouwer (A citizen just like any other), Mr. G. Vereecke (Doctor –
inspector RIZIV - social security administration), Mrs. J. Paisse (Vice President AFIT, Association francophone des 
intervenants en toxicomanie), Mr. J. VanRusselt (Director FEDITO, Fédération wallonne des institutions pour toxi-
comanes ), Mr. J. Bertels (Prevention Assistant FJIAC, Federatie Jongeren Informatie en Adviescentra). 
27  In order to use a clear terminology, I will make a distinction between categories of experts (scientists, practition-
ers, representatives of interest groups) when applying a quotation. 
28  Mr. Kris Van Limbergen (Secretary Prevention Policy of Ministery of Internal Affairs), Mr. Claude Debrulle (Gen-
eral Director Administratie van de strafwetgeving en van de rechten van de mens van het departement justitie), 
Mr. Lucien Nouwynck (Adviser Criminal Policy Service, Ministry of Justice), Mrs. Wivina Demeester-Demeyer 
(Flemish Minister of Health), Mr. Stefaan De Clerck (Minister of Justice), Mr. Johan Vande Lanotte (Minister of In-
ternal Affairs), Mr. Laurette Onkelinx (Minister-president French-speaking Community), Mr. Yvan Ylieff (Minister 
of Science Policy) and Mr. Karl-Heinz Lambertz (Minister of Youth, Media and Social Affairs of the German speak-
ing Community). 
29  There are a lot of key actors and departments involved in the drug issue on the federal level and federate levels 
(Federal Government, 2001a). 
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Christian Democrats), Mr. Stefaan De Clerck (Federal Minister of Justice, CVP, Flemish Christian 
Democrats), Mr. Johan Vande Lanotte (Federal Minister of Internal Affairs, SP, Flemish Social-
ists), Mrs. Laurette Onkelinx (Minister-president of the French-speaking Community, PS, French-
speaking Socialists), Mr. Yvan Ylieff (Federal Minister of Science Policy, PS, French-speaking So-
cialists) and Mr. Karl-Heinz Lambertz (Minister of Youth, Media and Social Affairs of the German 
speaking Community, PS, French-speaking Socialists). Although it was the goal of the PWG to 
study the phenomenon thoroughly, this selection is in accordance with the prevailing discourse 
in studying the drug phenomenon during the 1990s: a focus on (in)security and a predominance 
of domains like Interior Affairs and Justice. Both the federal Minister of Social Affairs and the 
federal Minister of Public Health were not heard in the PWG. 
 
“The working group heard the colleagues of the Federal Government, responsible for the depart-
ments of Justice and Internal Affairs, for a good reason. Unfortunately, the PWG failed to obtain the 
advice of the Ministers of Social Affairs and Health. That surprised me a little bit. I think we could 
have made an important contribution.” (Mr. Marcel Colla, Federal Minister of Public Health, SP, 
Flemish Socialists; Hand. Kamer 1996-1997, 24 juni 1997, 175). 
 
The members of the PWG also selected 3 additional members during their first meetings: 2 
(so-called external)30 experts (Prof. Dr. Brice De Ruyver, scientist Ghent University; Mr. Claude 
Stoclet, director of treatment services NPO Consult (Bureau d’études et d’interventions en toxi-
comanie) and AFIT (Association Francophone des Intervenants en Toxicomanie) and the advisor 
of the Cabinet of the Prime Minister (Mr. Jérôme Glorie). The two (so-called ‘external’) experts 
had the task of attending the hearings, reporting on them and exploring possible ways of think-
ing about the drug phenomenon in Belgium. The selection of a Dutch-speaking and a French-
speaking external expert was inspired by the need for parliamentary equilibrium as well as by 
their complementary expertise: Prof. Dr. Brice De Ruyver applied a scientific approach from a 
juridical and criminological angle while Mr. Claude Stoclet represented the practitioner’s focus 
on prevention and treatment. 
 
“In the French-speaking part, we were most concerned with the social, educational dimension of 
the phenomenon and Stoclet was selected from this perspective. The juridical dimension was more 
part of the debate in Flanders which was the approach of De Ruyver.” (Respondent 38, practition-
er). 
                                                          
30  Although each of the selected experts were external, the report of the PWG made a distinction between the invited 
experts. While scientists, practitioners, etc. were called experts in the report, Prof. Dr. Brice De Ruyver (Ghent Uni-
versity) and Mr. Claude Stoclet (Director of NPO Consult and president of AFIT) were called ‘external experts’. 
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2.2. Selection of expertise 
2.2.1. Personal networks/contacts 
The selection and non-selection of expert advice can be seen as an integral part of the policy 
process. Or, according to McCann (2008) and Miller (1999), what counts as expertise is a ques-
tion of power. In the PWG, the selection was made by the external experts (Prof. Dr. Brice De 
Ruyver and Mr. Claude Stoclet) as well as by the members of the PWG. Indeed, a lot of care was 
given to political (i.e. party policy, majority vs. opposition) and cultural/linguistic (e.g. Flemish 
MPs preferred the selection of Flemish experts) issues. Who was invited and heard, and who 
wasn’t, also said something about the functional specialisation of the policy-maker involved. For 
instance, MPs with a medical background (e.g. qualified as a doctor) more often tended to select 
doctors or professors in toxicology or pharmacology. Several interviewees acknowledged that a 
thoughtful (but political) selection of experts was made. 
 
“We selected people that we knew […] Some were obvious, other were picked selectively. You 
search for authorative experts […] you have to select some issues and enlarge them, that is the 
trick. It is a game, which is the political side of such a PWG. We select those who suit us the most.” 
(Respondent 4, policy-maker). 
 
“We found some people who were to a lesser extent involved in the drug phenomenon but who 
were willing to support our position. Other parties also tried to select experts supporting their po-
sition.” (Respondent 1, policy-maker).  
 
Generally, it appeared that personal contacts/networks were at least as important (maybe 
even more) as the expertise and competence of experts. Policy-makers describe it as a funda-
mental task of scientists to make contacts and to establish networks with policy-makers. Once an 
expert appeared on the political stage (and his ideas and opinions were shared by one or more 
political families), often a (permanent)31 relationship with policy-makers is elaborated. Estab-
lishing networks and active (recurrent) engagements by scientists in the policy-making process 
are considered as facilitators of knowledge utilisation.  
 
“You are not selected because of your knowledge and experience but because you know people and 
have several personal contacts.” (Respondent 48, scientist).  
 
“Everyone makes a list of experts and those who are mentioned on several lists are invited auto-
matically. Yes…mostly one knows one or more experts personally […] It is not only about the exper-
tise of an expert but, yes, the access to policy or the contacts with policy-makers, both elements I 
think.” (Respondent 35, policy-maker). 
                                                          
31  Or at least temporarily taking into account the duration of the legislature. 
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Therefore, it comes as no surprise that we observe a certain degree of overlap between the sci-
entific organisation committee32 of the conference ‘Drug Policy 2000’ and the PWG. It works in 
both ways: participating experts become well-known among policy-makers but attending these 
conferences also allow experts to get to know the key policy players and to empathise with 
them. 
 
“These conferences did build up a strong network (…) We had a good idea of who, in the French-
speaking part as well as in the Dutch-speaking part, was involved in several domains.” (Respond-
ent, 50, scientist). 
 
The selection is also linked with the attribution of research projects. If we look at the policy-
funded research projects which were commissioned and funded by the Government in the 1990s, 
these research projects were allocated to the same pool of university professors as those who 
were selected as expert in the PWG (cfr. policy advisors; Loader and Sparks, 2011). As they were 
granted policy-funded studies, they were obviously perceived (and known) as experts in this 
domain by policy-makers. For instance, the studies ‘Poverty, drugs and criminality’ (1992) and 
‘Desirability of methadone maintenance treatment’ (1993) were allocated to Prof. Dr. Brice De 
Ruyver (UGent) and another study ‘Inventory of epidemiological data in Belgium and in some 
neighbouring countries’ (1996) to Prof. Dr. Brice De Ruyver (UGent), Prof. Dr. Joris Casselman 
(KULeuven) and Prof. Dr. Alfred Noirfalise (ULg). A study creating a manual for the evaluation of 
the medical-social treatment centres for drug users (MSOC) (1997) was also allocated to Prof. 
Dr. Brice De Ruyver (UGent) and Prof. Dr. Alfred Noirfalise (ULg). The evaluation of the MSOC’s 
(1999) was allocated to Prof. Dr. I. Pelc (ULB), Prof. Dr. B. De Ruyver (UGent), Prof. Dr. J. Cassel-
man (KULeuven), Prof. Dr. A. Noirfalise (ULg) and Prof. Dr. C. Macquet (ULg) (Bullens, et al., 
1999). 
 
Interviewees also argued that when media pushes forward certain public credible experts, they 
may have a greater chance of being integrated in the personal networks of the policy-makers. 
For instance, activities such as protests by interest groups as well as extensive media coverage in 
the period before the PWG resulted in more progressive policy-makers selecting these interest 
groups. Respondents also stressed the role of media in selecting scientists. 
                                                          
32  Some members of the scientific organisation committee were not invited and heard in the PWG: Dr. Stan Ansoms 
(Association for Alcohol and other Drug Problems, VAD), Mr. Jean Bertrand (Comité de Concertation sur l’Alcool et 
les Autres Drogues, CCAD), Mr. Ruud Bruggeman (employee Trempoline), Mr. Freddy Carlier (Director Police 
Academy), Mr. Wim Depreeuw (Inspector Prison administration), Mr. Christian De Vroom (Judicial Police), Mr. 
Guy Goyvaerts (SODA), Dr. Jean-Pierre. Jacques (Director ‘Le projet Lama’), Mr. Albert Schleiper (Centre Universi-
taire de Liège, CUNIC), Mr. Karl Van Cauwenberghe (Public prosecutor Antwerp), Mrs. Nadine Van Coppenolle (Di-
rector Police Charleroi, section youth), Baron Paul Van der Straten Waillet (Director Trempoline), Mrs. Ann 
Vandesteene (Advisor Prison Administration), Mr. Patrick Zanders (Director Police). 
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“It is logical that the people who pose statements in media will be heard in advisory commissions. 
In that way the selection of experts is influenced by the media.” (Respondent 40, policy-maker). 
 
2.2.2. Types of public engagement 
In accordance with Loader and Sparks (2011), scientists performed a variety of influencing roles 
in the PWG. Prof. Dr. Brice De Ruyver can be seen as a privileged member of the PWG which is 
linked with the particular public role of an observer-turned player. On the one hand, he was in-
troduced and heard as an expert of European drug policy and of the drug phenomenon as na-
tional and international security problem. On the other hand, Prof. Dr. Brice De Ruyver, together 
with Mr. Claude Stoclet, was also appointed to integrate the findings from the hearings into a 
report and, secondly, to write a draft of the final conclusions and recommendations. This draft 
served as a starting point in the political discussion about a Belgian drug policy among the 
members of the PWG (see also below, §5). Based on his expertise (e.g. coordination of (policy-
funded) research projects) and networks (e.g. through the organisation of the annual confer-
ences, the participation in the study group from the Flemish Socialists (SP)), he was given the 
opportunity to participate directly in the development of the drug policy, and in particular in the 
activities of the Parliament.  
 
In addition, some scientists, stressing the independent characteristics of science, did not go be-
yond their participation in the PWG. These so-called scientific experts only gave a presentation 
and replied to questions for information but were not proactively seeking for engagement out-
side the formal advisory structure (PWG). 
 
“I tried to formulate clear recommendations. Maybe this is not good enough and maybe I should 
participate in the policy-making process. The question is then, to what extent is your scientific re-
search compromised or does one have the impression it is compromised?” (Respondent 24, scien-
tist). 
 
Social movement theorists/activists took up a similar role as scientific experts. However, in par-
ticipating in the PWG, these scientists put forward a more critical, alternative discourse towards 
the drug phenomenon and drug policy (see also below, §4).  
 
Several policy advisors aimed to inform (public and political) debate (Loader and Sparks, 2011). 
They were doing a large part of their research on (short-term) contracts for the Government 
(see above) and perceived it as their task to bring scientific knowledge into parliamentary de-
bates or Commissions and/or to become advisors of MPs. These policy advisors also established 
good contacts with professionals (e.g. police, outreach workers, …). Some of this engagement 
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also goes behind the public scenes: e.g. those scientists also participated in a study group from a 
political party (see also above, §1.3., Part I).  
 
“First, I tried to influence the highest level of the policy-making process but that was not successful. 
It is better to work bottom-up, talking with associations and MPs in order to climb up. I also have 
found other ways to distribute information, I have attended a lot of conferences, etc. That is the 
role of a scientist. Of course, I understand that some scientists do not do this […] Eventually, I 
played a role.” (Respondent 52, scientist). 
 
3. Hearings of experts and members/representatives of the Government 
Experts were asked to make an inventory (status questionis) of the multidimensional aspects of 
the phenomenon, such as: health risks; implications for security and public order; judicial ele-
ments, such as (inter)national drug trafficking and drug-related criminality, and; social and eco-
nomic factors (Verslag namens de Parlementaire Werkgroep belast met het bestuderen van de 
drugproblematiek, Parl.St. Kamer, 1996-1997, 1062/1-3). Several references to the action points 
of the Federal Action Plan Toxicomania-Drugs (1995) were made.  
 
It is important to note here that the hearings of the 59 experts (over a period of 2 years) were 
alternated with some working visits and a demonstration of a drug detection device. At the 
meeting of 18 February 1997, Dr. Luc Beaucourt (University Hospital Antwerp) demonstrated 
the Barringer drug-detection device. This device can quickly detect both drugs and explosives. 
Furthermore, working visits to Amsterdam (9-10 April 1996), Bern-Zürich (15-16 April 1996), 
Ghent –Oosterzele –Ruislede (20 May 1996), Brussels (21 May 1996) and Charleroi (28 May 
1996) were organised. At each working visit, the MPs had the opportunity to talk with some 
practitioners and/or local policy-makers. Respondents evaluated these working visits as very 
informative towards the discussion. 
 
3.1. Content of the hearings 
In the expert hearings, it was recognised that we live in a drug-taking society. The (internation-
al) increase of the prevalence rates of drug use (cannabis and ecstasy in particular)33, the in-
crease of registrated drug addicts and the diversification of the supply were reported. Based on 
the diverse contributions of scientists and practitioners, it became clear that the drug problem 
had to be perceived as a complex phenomenon covering various aspects of life and has multiple 
                                                          
33  Cannabis remained the most frequently used substance (18 % of those aged 15 to 64 have tried cannabis at least 
once; about 6 % of those aged 15 to 64 have used cannabis in the past 12 months). Amphetamine, ecstasy and co-
caine use increased moderately over the 1990s as a whole, with ecstasy use more evident than amphetamine or 
cocaine use among young adults (EMCDDA, 2000). The trends observed in Belgium were very similar to those no-
ticed in other countries of the European Union. 
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dimensions: health problems (e.g. health risks), social problems (e.g. unemployment, poverty) 
and security problems (e.g. relationship between drug use and criminality). Repeated references 
were made to the relationship between drug use and truancy, family situation, violence, traffic 
accidents, criminality, marginalisation and poverty. In accordance with the Federal Action Plan 
Toxicomania-Drugs (ten-point plan), a number of scientists and practitioners pointed to the 
need for an integral and integrated policy, with a focus on a social and health approach. Mem-
bers/representatives of the Government were also in favour of an integrated and integral Bel-
gian drug policy. They acknowledged the complexity of the drug phenomenon (as a social and 
health problem; see also security and prevention contracts) and confirmed the recommenda-
tions of the experts to develop a realistic approach (regarding prevention, methadone treatment, 
etc.). The Minister of Internal Affairs Johan Vande Lanotte (SP, Flemish Socialists), in his (rather 
conservative) contribution ‘Freedom - Happiness’, discussed the several pillars of an integrated 
drug plan separately (i.e. prevention, treatment and repression) and acknowledged that a coher-
ent and homogenous drug policy may succeed in decreasing drug use in society. Each of the ele-
ments discussed were rather similar to those appointed by scientists and practitioners. 
 
In terms of the demand for drugs, several (inter)national epidemiological/pharmalogical ex-
perts, practitioners and members/representatives of the Government raised concerns about the 
lack of reliable numbers or registrations and the lack of (funding for) epidemiological studies on 
drug use. They stressed the fact that more epidemiological studies were necessary in order to 
produce the necessary reliable and comparable data. Furthermore, the development of a better 
and uniform registration system among treatment centres was strongly recommended. They 
also regularly referred to the necessity of the creation of the Belgian Monitoring Centre for 
Drugs and Drug Addiction (BMCDDA) in order to assemble all registrations, evaluations, scien-
tific researches or related information on the drug phenomenon in Belgium (even though a 
sound epidemiological base seems to be a prerequisite here). Epidemiological experts, consulted 
within the framework of the PWG, also underlined the need to study the drug phenomenon 
comprehensively, focusing on drug, set and setting. Here, it was stated, ethnographic research 
methods could introduce valuable, qualitative information. 
 
By means of a detailed overview of the prevention initiatives and projects in Belgium, the im-
portance of prevention was stressed by several practitioners from prevention services and 
members/representatives of the Government. It was stated that total abstinence was not a fea-
sible goal in a drug taking society. Realistic goals of prevention, such as increasing initiation age 
(e.g. they argued that the use of alcohol-tobacco was initiated at the age of 11 years while the age 
of initiation of other drugs (now 15 years) is decreasing) and decreasing the incidence of driving 
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under influence were put forward. For this purpose, several practitioners and mem-
bers/representatives of the Government supported the need for a full professional statute for 
prevention workers as well as the elaboration of prevention projects. A wide range of person-
centered (general health promotion and education, increase social skills and learning to deal 
with risks) and structural (poverty reduction, social policy) measures were recommended.  
 
Regarding treatment, the need for more initiatives, a diversification of the supply and an inten-
sive network approach (also between social services and specialised drug services) was 
stressed. Many practitioners, as well as the members/representatives of the Government, rec-
ommended the establishment of a wide range of facilities ranging from low threshold, harm re-
duction initiatives to high-threshold, drug-free therapeutic programs. Representatives of inter-
est groups also added their preference of establishing consumption rooms. Opting for a multi-
disciplinary approach, it was argued by treatment practitioners that the specialised drug abuse 
treatment had to be integrated into the existing network of social and medical facilities. The im-
portance of the medical and psychological support and social reintegration through e.g. em-
ployment, sport or culture was also emphasised. Furthermore, many practitioners, representa-
tives of interest groups and members/representatives of the Government underlined the need 
for a legal basis of, for example, methadone treatment and needle exchange. In case of metha-
done treatment, these practitioners recommended involving doctors, psychiatrists, pharmacists, 
etc. supported by training as well as by expertise from the medical-social treatment centres for 
drug users (MSOC’s). Additionally, it was argued by several practitioners that heroin-addicted 
inmates should also have access to substitution treatment and that primary and secondary pre-
vention had to be extended given the large size of drug use in prison. The need for a prison drug 
policy was stressed. 
 
Regarding the supply of drugs, several scientists and practitioners stated that international drug 
production and traffic increased and diversified (e.g. links with weapon traffic) strongly the last 
decades. They found support for these statements in the reports of Europol and Interpol as well 
as in the reports of the International Narcotics Control Board (INCB), a control organ which 
monitors the implementation of the United Nations drug control conventions (1961, 1971, 
1988). Belgium was perceived as production and transit country being confronted with drug 
tourism, local production, users as well as dealers and criminality/nuisance. As a result, the ex-
perts (scientists and practitioners) as well as members/representatives of the Government rec-
ommended a good international cooperation, an involvement of Belgium at international fora, an 
increased police-justice cooperation, etc. To tackle local nuisance, it was suggested that a consul-
tation between police, justice and the Government was necessary. Finally, to tackle drug traffic, 
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there needed to be more effective targeting of the criminal profits from money-laundering and a 
legal framework for special investigation methods. The results of the Dutch Commission Van 
Traa34 which were presented in the PWG by expert Prof. Dr. Cyrille Fijnaut provided some input 
about the possibilities and limitations of special investigation methods in Belgium. 
 
The hearings also addressed the debate on criminal interventions towards drug users and 
small-scale production and traffic. Several Public Prosecutors presented the number of ar-
restees, confiscations and drug cases in their district. Clearly, there was a lack of uniformity in 
prosecuting drug users. A person who was prosecuted for the possession of 500 grams of canna-
bis in one district may have not been prosecuted in another district. Furthermore, other practi-
tioners (e.g. directors of prisons) stated that there had been a strong increase in the number of 
drug users/addiction among the prison population since the seventies (from 1% until 40-50% in 
the mid-1990s). Practitioners from social services and prisons also emphasised overpopulation, 
degrading circumstances and the lack of care for and supervision of drug addicted prisoners. 
Eventually, many practitioners, scientists as well as members/representatives of the Govern-
ment recommended that prison be the ultimum remedium and that alternative measures (as well 
as the cooperation between justice and treatment) had to be supported in order to guide prob-
lematic drug users more easily towards treatment.  
 
Particular attention was paid to the criminalisation of cannabis possession. This topic was heavily 
discussed by scientists, practitioners, representatives of interest groups and mem-
bers/representatives of the Government. The bottom line was that most scientists, practitioners 
and representatives of the interest groups nuanced the dangers and risks of cannabis use. Like-
wise, the Minister of Internal Affairs Johan Vande Lanotte (SP, Flemish Socialists) placed canna-
bis in the first (least dangerous) category of drugs. Presenting cannabis as a relatively harmless 
substance was a tactic deployed in the debate on the (anti-)prohibition of cannabis possession. 
Several practitioners stated that prohibition of cannabis possession had rather negative conse-
quences on prevention. In particular, it was argued that prohibition did not allow any distinction 
between drugs, the relationship between drug user and drug and the level of addiction. During 
the discussion, several scientists elucidated that this debate was strongly directed by interna-
tional UN and European conventions and the 1995 Governmental Declaration. Similarly, learning 
                                                          
34  In 1994, the Dutch Parliament decided to establish a Parliamentary Inquiry Commission under the supervision of 
Maarten Van Traa. The so-called Van Traa Commission examined the complexities of criminal investigation meth-
ods in the field of organised crime in the Netherlands. Its aim was to develop a general legal and organisational 
framework for investigations with regard to organised crime. Within this framework, an external research team, 
chaired by Prof. Dr. Cyrille Fijnaut, was asked to present a well-founded picture of the problems of organised 
crime in the Netherlands (Black, et al., 2001; Woodiwiss, 2014). 
Chapter 2  Parliamentary Working Group on Drugs: 1996-1997 
153 
from the Dutch experience, agreement grew among several scientists and practitioners that in-
troducing coffee-shops in Belgium should never be an option. The flood of foreign drug tourists 
resulted in an increase of the number of coffee-shops as well as in their development into com-
mercial enterprises that did not respect the tolerance criteria. Moreover, this resulted in an in-
crease of nuisance in the major Dutch cities and municipalities at the boarders (which was 
against article 71 of the Schengen Convention), an explosive growth of the illegal cannabis pro-
duction and a spread of illegal selling points for drug tourists. The Dutch Government acknowl-
edged the adverse implications and changed direction in 1995 with the Drug Note ‘The Dutch 
drug policy, continuity and change’. Priority was given to the control of and fight against these 
unforeseen effects of the tolerance policy (Fijnaut and De Ruyver, 2008). The working visit of the 
PWG to Amsterdam further revealed that the Netherlands took some additional measures to 
counter the effects of the coffee-shop model: a harsher approach of drug traffic, nuisance and 
criminality; the quantity of soft drugs was reduced from 30 grams to 5 grams; the number of 
coffee-shops was decreased, and; a more intensive prevention and treatment policy was estab-
lished, etc.  
 
“A solution like the Dutch coffee-shop model is not recommended as a part of the traffic and profits 
are not controlled by the Government (which is an opportunity for mafia).” (Mr. Philippe Bastin, 
practitioner; Report of the PWG, p.466). 
 
“Dutch policy-makers are aware of the negative consequences of their tolerance policy. Gradually 
they closed coffee-shops as they were not able to control the demand.” (Prof. Dr. Brice. De Ruyver, 
scientist; Report of the PWG, p.126).  
 
However, differentiation between cannabis and other illegal drugs and between possession for 
personal use and possession for profit, was perceived to be necessary to increase the effective-
ness and credibility of prevention initiatives and to decrease the number of prisoners arrested 
for cannabis possession for personal use. Several practitioners were in favour of a depenalisation 
of cannabis possession.35 
 
“I am neither in favour of a legalisation nor a decriminalisation […] The opportunity principle of-
fers the possibility to focus on individualisation. This seems preferable.” (Mr. Willy Bruggeman, 
practitioner; Report of the PWG, p.135). 
                                                          
35  The concept decriminalisation is often confused with the concept depenalisation. In this study, we follow Room, et 
al. (2010) by using the term decriminalisation to refer to ‘prohibition with civil penalties’. Thus, criminal penalties 
are removed from the law while administrative penalties are still possible. Depenalisation involves maintenance of 
criminal penalties in the criminal law, yet removing or shortening the periods of incarceration, or reducing fine 
amounts, as possible sanctions. Legalisation means that the specified forms of behaviour are no longer offences 
dealt with by (criminal or civil) law, yet it is often still governed by different tools of regulatory law. 
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“I plea for a depenalisation of the use of soft drugs. If soft drugs are used in group, the users can be 
imposed with a prison sentence. Prison only makes it worse, they will get addicted […] Prison sen-
tences have to be abolished.” (Mr. Geert Vanhalle, practitioner; Report of the PWG, p. 519). 
 
In his elucidation, Minister of Justice Stefaan De Clerck (CVP, Flemish Christian Democrats) sup-
ported the prohibition of cannabis possession as a kind of threshold. A revision of the 1993 Min-
isterial Letter - which did not make any distinction between types of drugs - or, ideally, a law 
reform was, however, supported by the Minister of Justice Stefaan De Clerck (CVP, Flemish 
Christian Democrats).36 The Minister of Internal Affairs Johan Vande Lanotte (SP, Flemish Social-
ists) perceived the drug problem as a problem of social inequality. He assumed that the Govern-
ment always has the responsibility to offer opportunities to youngsters. In pursuing this, it was 
argued that a criminal approach had to be retained (as part of prevention and giving the correct 
signal). Accordingly, differentiation in the prosecution of cannabis possession was recommend-
ed by the Minister (a harsh approach of drug traffic and avoiding a criminal reaction against 
drug users). It was noted that a risk assessment should not only look at the type of product, but 
also at the personality of the user, the environment, the amount and frequency of use and the 
potency of the product.  
 
Finally, some scientists and practitioners recommended the decriminalisation or legalisation of 
cannabis possession. The representatives of the interest groups claimed to be in favour of de-
criminalisation as well (based on their personal experiences and some vague references to sci-
entific knowledge). For example, on 21 January 1997, Mr. Michel Hancisse (interest group Radi-
cal Anti-Prohibitionist Coordination (CORA)) submitted a petition for a plea for the decriminali-
sation of the possession and use of drugs. Remarkably, the Flemish Minister of Health Wivina 
Demeester-Demeyer (CVP, Flemish Christian Democrats) - while recommending a multidiscipli-
nary approach and pleading against a tolerance policy like in the Netherlands (because of the 
link with hard drugs) - was in favour of a decriminalisation as this makes it possible for drug 
users to talk about problems. 
 
“Decriminalisation does not mean that cannabis users will start to use other drugs. This is not sup-
ported by our data.” (Prof. Dr. Peter Cohen, scientist; Report of the PWG, p.175). 
 
“Removing the illegal status of cannabis, giving it an acceptable social dimension, should be the – 
bold – road that our policy-makers have to take.” (Mr. Rene Bosmans, practitioner; Report of the 
PWG, p.345). 
                                                          
36  A new drug law was not realised in the 1995-1999 legislature but instead a new Ministerial Circular was pub-
lished in May 1998 (which replaced the 1993 Ministerial Circular Letter). 
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“The Minister pleads for an integral and integrated approach of the problem together with a de-
criminalisation of experimental and soft drug use.” (Mrs. Wivina Demeester-Demeyer, Flemish 
Minister of Health, CVP, Flemish Christian Democrats; Report of the PWG, p.792).  
 
3.2. Contribution of scientific knowledge to the hearings 
3.2.1. Deconstructing scientific discourse: truth? 
Scientists’ discourses in the PWG were largely fed by (foreign) epidemiological data and insights 
based on the most visible groups and indirect indicators. In presenting their knowledge in the 
Parliamentary Working Group on drugs, scientists typically adopted a rather technocratic objec-
tivist manner: by means of numbers/statistics. It referred to what the police or justice system 
discovered or/and those groups who are known by treatment: crime statistics, conviction statis-
tics, emergency unit statistics, number of alcohol and drug controls, etc. This means that the fo-
cus was on a disproportionately large number of serious and chronic cases. Accordingly, a lot of 
attention was paid to risks and causality. Next to epidemiological studies, some Belgian policy-
funded studies also provided data about the nature and extent of drug use in Belgium. For exam-
ple, the ongoing inventory of the drug research in Belgium and its neighboring countries like the 
Netherlands, Great Britain and France (Van Daele, et al., 1996), the study of Prof. Dr. Brice De 
Ruyver (Poverty, drug use and criminality; 1992) and the research project of Mrs. Conny Ver-
caigne and Prof. Dr. Lode Walgrave (Youth between (sub)cultures and business: a study focusing 
on discotheques, house music and nuisance; 1995) were frequently mentioned in the PWG and 
were used to describe the percentages of cannabis and XTC use and drug-related crimes. Finally, 
which scientific knowledge was presented during the hearings also depended on cultural and 
linguistic differences. For instance, French-speaking scientists more often referred to scientific 
knowledge produced and advocated by French-speaking scientists from Belgium or abroad. 
 
In line with Jasanoff (1990) and Boland (2008), we observed that scientists presented their 
knowledge as ‘speaking truth to power’. For example, we found that scientists mostly used prep-
ositional assumptions (i.e. assumptions about what is or can be or will be the case; ‘truth’) and 
active verbs without any references. For instance, ‘cannabis use leads to...’, ‘it is determined that 
90% of the drug addicts…’, ‘the prevalence of poly drug use has increased’, ‘the war against 
drugs caused a lot of suffering’, ‘50% of youth has experimented with drugs’. This presentation 
does not allow of course any independent judging of the quality and scope of the research used. 
Practitioners added nuance to their own knowledge/experience in making a distinction between 
personal experiences with the target groups (e.g. parents, addicts) or other practitioners (e.g. 
police officers, treatment experts) and scientific research. They explicitly stated that they do not 
have the goal of a scientific study or analysis. Practitioners often presented themselves as taking 
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into account (international) literature when elaborating their ideas. By means of a bibliography 
or a lot of footnotes, they tried to speak truth, just as much as scientists. In other words, scien-
tific knowledge was seen as something more accurate and authoritative. A particular factual 
claim of a scientist was often regarded as true because it has been put forward by those who are 
considered competent to speak the ‘truth’. 
 
“I do not pretend to provide a scientific analysis. I’ll try to prove everything on the basis of facts, 
numbers and especially daily contacts with prisoners and staff members.” (Mr. Jef Vanwingh, prac-
titioner; Report of the PWG, p.309). 
 
3.2.2. Misuse of scientific knowledge 
In their efforts to possess and speak truth, we found that we must be cautious regarding the 
knowledge some scientists brought into policy debates. Although scientists regularly expressed 
their awareness of the importance of a careful presentation and interpretation of scientific re-
sults (especially numbers)37, some seem to jeopardise their credibility. Uggen and Inderbitzin 
(2010) called scientists, criminologists in particular, flying around as consultants and experts 
while losing sight of their scientific research base, airport scientists. During the hearings, some 
scientists neglected the main principles of scientific research by not taking into account, for 
example accurate methodological designs or unambiguous terminologies. Terminological impu-
rities (e.g. a comparison of percentage users of hashish and percentage of users of cannabis, a 
comparison of drug prevalence rates while neglecting that some rates only focused on cannabis 
use and others on the use of cannabis, ecstacy and cocaine) and neglecting statistical significance 
in studying the relationship between cannabis use and truancy were two such problems. In an-
other example, studies using different methodologies were compared. In particular, a scientist 
compared an opinion poll of a newspaper to a population survey among youth in order to get 
comparable and valuable results. He mentioned that ‘a school population survey can be compared 
to the opinion survey carried out by the newspaper Le Soir in 1980 as this research was set up in a 
similar method’. Another scientist stated: ‘These numbers are the result of a methodological ap-
proach that is not really satisfactory from a scientific point of view. Nevertheless, they show that 
the use of multiple illicit substances has increased’. Juggling numbers or scientific results was also 
found. Scientific results were distorted in several ways, which were often very subtle: e.g. mak-
ing blunt interpretations, false generalisations and causalities. For instance, one scientist made a 
false interpretation regarding poly drug use. In particular, he mentioned that ‘90% of drug ad-
dicts uses several substances‘ while the original research concluded that ‘90% of the daily heroin 
                                                          
37  They criticised official numbers as they tell more about the activities of the service instead of real in-
crease/decrease. Population surveys (i.e. opinion polls and surveys among the general population and school 
populations) were criticised due to their limited methodological quality and/or comparability. 
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users are poly drug users’. Another scientist replied to the questions of the members of the PWG 
‘We found that truant youth use twice as many illegal drugs’ while he originally stated in the hear-
ing that ‘non statistical significant numbers showed that 28,5% of truant youth ever used canna-
bis’.  
 
We also found that, in attempting to support their case and demonstrate their credibility, scien-
tific results were distorted by practitioners in several ways. For instance, a practitioner stated 
that  
 
“Surveys show that 20% of young students aged between 12 and 18 in the Brussels Region use ille-
gal drugs. Assuming that most users are adults between 18 and 45 years old, it is therefore appro-
priate to double 20% to 40%. In this way one may conclude that at least 40% of the population of 
the Brussels Region smoke cannabis.” (Mr. Philippe Bastin, practitioner; Report of the PWG, p.426). 
 
Sometimes prevalence data was presented in another way to how it was originally found. For 
instance, a practitioner heard in the PWG, Mr. Jef Vanwingh, stated that  
 
“As drug users constituted 1 to 1.5% of the total population of prisoners in the beginning of the 
1970s, their share increased up to 40 and 50% (original source mentioned: up to 40%), depending 
on the sources (my emphasis).” (Mr. Jef Vanwingh, practitioner; Report of the PWG, p.307).  
 
3.3. Other factors at play in the hearings 
3.3.1. Political context 
Members of the PWG regularly asked the experts about their perception on the ‘best’ policy op-
tion or the option leading to the ‘best results’. The ‘right’ policy option was conceived by the 
members of the PWG as the option that could deal the most with their concerns about preva-
lence rates, overdoses, drug-related criminality and overcrowded prisons. Within this discourse, 
attention was often given to the causal relationships between e.g. drug use and criminality, drug 
use and etnic minorities, etc. Representatives of the Government also attached importance to 
(foreign) scientific knowledge. Generally, references were made to (criminal) statistics and Bel-
gian policy-funded studies or publications of Belgian scientists (for instance, De Ruyver, et al., 
1992; Vercaigne and Walgrave, 1995). Also references to foreign studies (especially regarding 
the Dutch situation), the application of international conventions or the consequences of prohi-
bition were made. The focus of policy-makers is mostly on numbers or statistics, (wrongly) 
assuming that this type of scientific knowledge always represents objectivity and authoritative, 
truth-producing data. For instance, the Federal Minister of Justice Stefaan De Clerck (CVP, Flem-
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ish Christian Democrats) mentioned that “numbers may illustrate the importance of a phenome-
non” (p.798). The importance of numbers was also mentioned in the interviews:  
 
“Numbers are the only objective source which can provide data for policy-makers.” (Respondent 
51, policy-maker). 
 
“Numbers are religious; if you present these, you are telling the truth regardless whether these 
numbers are correct.” (Respondent 11, practitioner). 
 
“Exact science, numbers and statistics, are science. Sociology, human rights, law, etc. are no science 
in my opinion.” (Respondent 14, policy-maker). 
 
Whereas scientists may be familiar with the conditions of scientific uncertainty (e.g. in the PWG, 
the scientific uncertainty about the link between cannabis and dependence was stressed by Prof. 
Dr. Alfred Noirfalise), members of the PWG sought certainty and deterministic solutions. Even 
though scientific knowledge was considered as authoritative, it was also criticised in the PWG as 
being weak, contradictory, too late and still evolving, and thus producing uncertainty (which is 
supportive of the ‘two communities thesis’ and its barriers between two different worlds; 
Caplan, 1979). Additionally, interviewees also stressed the lack of neutrality of scientific 
knowledge. They pointed to the inherent (technical) limitations of scientific studies and the ex-
istence of deceptive studies. It became clear that some policy-makers had difficulties in handling 
the contradictions in research or the lack of adequate (Belgian) data.  
 
“There is a large spectrum of viewpoints within scientific research […] Scientific knowledge is im-
portant but each scientist has his own opinion. Scientists often have the presumption to think they 
know best.” (Respondent 44, policy-maker).  
 
“It is not because a professor supports an opinion that you automatically have to believe that the 
particular opinion is completely true.” (Respondent 10, policy-maker). 
 
“Scientific research is not always available or methodologically correct. It also does not always al-
low us to answer questions clearly or to draw conclusions.” (Respondent 34, policy-maker). 
 
As a result, in the PWG, representatives of the Government easily distorted some scientific ar-
guments by criticising them as irrational or incorrect (a tactic of creating 'flak'; evolutionairy 
model; Stevens, 2007a; see Part I, Chapter 2). For instance, the Minister of Internal Affairs Johan 
Vande Lanotte (SP, Flemish Socialists) stated that “There is no rational argument to determine 
the line between innocent and dangerous drug use” (p.827). Similarly, even though several scien-
tists underlined the disproof of the stepping stone theory in the hearings, the Minister of Justice 
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Stefaan De Clerck (CVP, Flemish Christian Democrats) noted: “It is a real danger that youngsters 
would start with other illegal drugs, if cannabis became freely available ....” (Report of the PWG, 
p.795). Mr. Kris Van Limbergen, the advisor of the Cabinet of the Minister of Internal Affairs, also 
ignoring the scientific disproof of this theory, argued that “recreational drugs may be very tempt-
ing as so-called step-up drugs” (Report of the PWG, p.668).  
 
Furthermore, the contribution of the members/representatives of the Government in the PWG 
influenced the final direction of the policy debate. Members of the PWG reported that they al-
ways had to take into account their party policy when asking questions to the experts involved. It 
is important to note that the hearings of the members/representatives of the Government as 
such can be seen as highly influential towards the (final) direction of the debate. Those particular 
hearings dictated the opinions and direction of the members of the PWG (who were of the same 
political color). Party policies were carefully considered and weighed during the hearings of the 
PWG (and following political debate). Several respondents underlined the limited power of the 
Parliament (in comparison with the Government) in directing or developing policy. They ex-
plained:  
 
“Eventually, the party had to take a position which is supported by its party members […] An ex-
pert is rather ‘independent’, we always have to take into account our political background.” (Re-
spondent 35, policy-maker). 
 
“There was a lot of interaction between MPs and members of the Cabinet. Yes, the Ministers more 
or less determined our speech.” (Respondent 7, policy-maker). 
 
Exemplary too is the discussion about the contribution of Mr. Lucien Nouwynck, the advisor of 
the Minister of Justice Stefaan De Clerck (CVP, Flemish Christian Democrats). Based on the find-
ings of the French Commission Henrion38, he provided a more moderate view and pleaded for a 
pilot project which would implement a controlled regulation for a short time period. His pro-
gressive perspective was rather remarkable, taking into account his membership of the rather 
conservative Christian Democrats and the 1995 Governmental Declaration. This position was 
not at all appreciated by the Flemish Christian Democrats (and hampered the relationship with 
the Minister):  
 
“The Flemish Christian Democrats were furious, really furious about his intervention because he 
was the representative of the Minister of Justice at that time.” (Respondent 25, policy-maker). 
                                                          
38  In 1994, the Minister of state for social, health and urban affairs, Mrs. Simone Veil, appointed a Commission, head-
ed by Robert Henrion, to examine and reconsider the French drug policy (Boekhout van Solinge, 1996; Nathanson, 
2009). 
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In their discourse in the PWG, policy-makers made use of several political tactics to attain great-
er authority, or a higher position or to favour certain electorates. For instance, members of the 
Government (consciously) made incorrect interpretations in order to find support for their opin-
ion in the PWG. Cannabis is not legalised in the Netherlands, in contrast to what was frequently 
stated. Minister of Internal Affairs Johan Vande Lanotte argued: “In the Netherlands, they make 
complaints about the consequences of hasty legalisation” (p.853). The misuse of terminology has 
fuelled clear misconceptions about the reform. An interviewee described that: 
 
“A differentiation in the political discourse is not simple. Differentiation among academic discus-
sions is not at all absorbed in policy debates.” (Respondent 22, policy-maker).  
 
Finally, Belgian policy-makers are also responsible for the international aspects of their policy 
competences. Given the elucidation of the international UN and European framework in the PWG 
by several scientists, the significance of some (alternative) approaches of scientists, practition-
ers or representatives of interest groups was rather limited. For instance, right from the begin-
ning, the argument of a thorough liberalisation of cannabis policy was refuted as this was pro-
hibited by several international drug control treaties, strongly supported by the international 
community (see also above, §3.1.).  
 
3.3.2. Media coverage 
Even though media coverage ignited the political debate, media interest decreased slightly dur-
ing the hearings in the PWG. A journalist explained: 
 
“I wanted to attend all the hearings but it was not possible. At that time, we had to write two or 
three articles each day. A devastating pressure to achieve.” (Respondent 8, journalist).  
 
Several excerpts of the hearings were provided by Flemish as well as French-speaking newspa-
pers. We found some differences in the type of information presented. The Flemish newspapers 
detailed the epidemiological data put forward by Prof. Dr. Joris Casselman and Prof. Dr. G. Re-
ginster-Hanneuse as well as the scientific research regarding the European drug policy conduct-
ed and presented by Prof. Dr. Brice De Ruyver. The French-speaking newspapers mostly report-
ed about the hearings of the Federal Ministers (e.g. Federal Minister of Justice Stefaan De Clerck 
(CVP) and Federal Minister of Internal Affairs Johan Vande Lanotte (SP)) and the opinion of sev-
eral French-speaking practitioners, like Mr. Christian Figiel (Neuropsychiatrist and Director Cen-
tre L’Alfa, Centrum Geestelijke Gezondheidszorg) and Mr. Jacques Van Russelt (Director FEDITO, 
Fédération wallonne des institutions pour toxicomanes). Also French-speaking ‘external expert’ 
Claude Stoclet (before he was sacked by the PWG) and instigator MP Patrick Moriau (also called 
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‘Monsieur Drogue’ in the French-speaking media) repeatedly reported in the media on their par-
ticipation and experiences. The French-speaking newspapers clearly applied another (more pro-
gressive) attitude towards the drug phenomenon. MPs and experts, presented in these newspa-
pers, rejected the rather conservative statements of Federal Minister of Justice Stefaan De Clerck 
(CVP, Flemish Christian Democrats) and Federal Minister of Interior Affairs Johan Vande Lanotte 
(SP, Flemish Socialists). A newspaper clearly worked as a powerful selection device in determin-
ing what is scientific knowledge, and who are the authorised agents of knowledge (Carvalho, 
2007; Tieberghien, 2014a). Interviewees pointed to the different political landscape (which was 
largely linked with the popularity of the rather progressive party PS in the Walloon region and 
the rather conservative party CVP in Flanders) as well as the language difference. 
 
“That is the way it works. As a Flemish journalist, you will cite Flemish experts instead of French-
speaking experts. This situation led to an enlarging gap between both parts. That is a reflex of 
journalists. If you can choose between a Flemish and French-speaking expert, you pick the Flemish 
one because it is more linked with your audience.” (Respondent 8, journalist). 
 
Alongside the selective representations of the hearings, media also informed the public (and 
thus policy-makers) in a rather ‘coloured’ way. For instance, media included naked statements 
which fell short because they provided no contextual elements: although numbers were pre-
sented in the PWG, it was only stated in the press that cannabis was used the most widely. Fur-
thermore, drugs were very often spoken about in terms of ‘soft drugs’ versus ‘hard drugs’, and 
often the general concept ‘drugs’ was used to refer to one drug like cannabis. In addition, con-
cepts like ‘legalisation’, ‘depenalisation’, ‘decriminalisation’ and ‘tolerance policy’ were regularly 
used without differentiating between each of them. Equally, media did not make a distinction 
between the use and possession of cannabis, in spite of the important juridical difference: in 
Belgium, drug possession is prohibited while drug use is not. A journalist explained: 
 
“Newspapers, media, are more in favour of explicit opinions so, as a result, the debate is narrowed: 
is it allowed or not? Can my son smoke joints? Can it be sold?” (Respondent 45, journalist). 
 
Nevertheless, in the hearings of the PWG, MPs and representatives of the Government often re-
lied on the media coverage. These framings seemed to be an important resource in supporting 
assumptions. For instance, Federal Minister of Internal Affairs Johan Vande Lanotte (SP, Flemish 
Socialists) used a newspaper article from Mr. Pino Arlacchi (former Director-General of the 
United Nations Office, current member of the European Parliament) in the Italian newspaper 
L’Espresso as a support for his statements about the drug policy in the United States. Flemish 
Minister of Health Policy Wivina Demeester-De Meyer acted similarly.  
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“Drugs in the United States (the end of fatalism). The following data are to a large extent derived 
from the article of the rather famous ‘Pino Arlacchi’ in ‘L’espresso’ of 16 April 1996 (my empha-
sis).” (Mr. Johan Vande Lanotte, Federal Minister of Internal Affairs, SP, Flemish Socialists; Report 
of the PWG, p.815). 
 
“Ms Demeester-De Meyer declares that the way the drug problem is shown in the media often goes 
together with a lot of sensation. For example, a daily newspaper recently published a brochure in 
which a direct plea was made for the legalisation of drugs. However, the Minister acknowledges 
that the arguments used for that purpose make her believe even more that legalisation is not a so-
lution (my emphasis).” (Mrs. Wivina Demeester- De Meyer, Flemish Minister of Health Policy, CVP, 
Flemish Christian Democrats; Report of the PWG, p.791). 
 
4. Report of the hearings 
Together with the end of the activities (hearings as well as the working visits) of the PWG in June 
1996, attention to the drug issue sharply decreased. The explosion of the Dutroux paedophilia 
case in August 1996 caused a great deal of feelings of insecurity among the Belgian people and 
changed the focus of the political and media debates (see also Chapter 3, §1.2.). Nevertheless, 
‘external experts’ Prof. Dr. Brice De Ruyver and Mr. Claude Stoclet started their task of integrat-
ing the opinions and statements of the experts and members of the Government in a report and 
(in a second phase) to present a draft of the final conclusions and recommendations to the 
members of the PWG.  
 
Rather quickly, a discussion was generated regarding the working document by Mr. Claude Sto-
clet. According to the French-speaking media, his draft was assessed too inadequate and too 
much in favour of the anti-prohibitionist approach. Similarly, some interviewees expressed that: 
 
“He was too progressive and as such not acceptable for some of them. He failed in finding a consen-
sus among the Flemish members.” (Respondent 29, policy-maker). 
 
A letter from MP Frans Lozie directed to the president of the PWG, Mr. Louis Van Velthoven, con-
firmed that the report of Mr. C. Stoclet got two unsatisfactory reviews. The report was consid-
ered too vague and inconcrete regarding the current state of the art and potential solutions (Let-
ter of MP Frans Lozie (Flemish Green party AGALEV) regarding the working document of Mr. 
Stoclet, 6 december 1996). The document also contained a large (and rather progressive) focus 
on cannabis policy (prohibition versus anti-prohibition) while mainly holding back on other 
issues such as prevention and treatment (Working document on the PWG provided by Mr. 
Claude Stoclet, n.d.). In the end, ‘external expert’ Mr. Claude Stoclet was sacked and the task of 
reporting on the expert hearings was assigned solely to the other ‘external expert’ Prof. Dr. Brice 
Chapter 2  Parliamentary Working Group on Drugs: 1996-1997 
163 
De Ruyver. Nevertheless, when looking at the final conclusions (see also below, §5), we found 
references to issues addressed by Mr. Claude Stoclet in his first draft. For instance, the notion of 
a third way was originally stated by Mr. Claude Stoclet in his first draft: “We need to find a third 
way between security and a controlled liberty” (Working document on the PWG provided by Mr. 
Claude Stoclet, n.d.). 
 
The summarising report and its bibliography provided a clear and careful integration of most of 
the good practices and recommendations of the scientists, practitioners and members of the 
Government. The new frameworks for the understanding of the drug problem provided during 
the hearings clearly altered the language and the discourse. Generally, an integral and integrated 
perspective, taking into account prevention, care and repression, was adopted. The hearings 
generated a clear expression of the social and health discourse with the emergence and devel-
opment of the harm reduction movement and the ultimum remedium philosophy instead of a 
strict security discourse: “the working group believes that it is neither useful nor effective to apply 
a criminal procedure in case of violations of the drug law” (p.1004).  
 
Through the hearings of the PWG, scientific knowledge involved really enlightened the develop-
ment of Belgian drug policy. In other words, scientific knowledge contributed to the percolation 
of (new) ideas and concepts and the development of a substantial body of knowledge. For in-
stance, the policy-funded study of De Ruyver et al. (1992; Poverty, drug use and criminality) and 
the study of Vercaigne and Walgrave (1995; Youth between (sub)cultures and business: a study 
focusing on discotheques, house music and nuisance) both served as strong support for, respec-
tively, the argument that (problematic) drug users in the criminal justice system had to be ori-
ented more towards treatment, and the argument that prevention initiatives have to pay special 
attention to youth, smart drugs and the consequences of drug use for road safety.  
 
The summarising report also addressed the debate on the criminalisation of cannabis posses-
sion. Clearly, scientific knowledge played a role. Supported by the framework of the internation-
al UN-conventions, the 1990 Schengen Convention, the (scientific) evaluations of the Dutch poli-
cy and various kinds of (academic) reports from abroad (mostly referring to the situation in 
France and the Netherlands, but also focusing on the War on drugs in the United States), it was 
argued that a differentiation and individualisation of the criminal intervention, taking into ac-
count the specific situation (cannabis versus other illegal drugs; experimenting, problematic use, 
personal use, dealing with profit), could help to increase the effectiveness and credibility of pre-
vention initiatives and to decrease the number of prisoners arrested because of cannabis pos-
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session for personal use. Accordingly, a de facto depenalisation39 of the possession of cannabis 
for personal use was proposed.  
 
However, if we perceive use as simply pointing to the names of and references used by the con-
sulted practitioners and scientists, the bibliography of the summarising report displayed a lack 
of sensitivity to the views of critical contributors focusing on the largely unproblematic charac-
teristic of drug use, the usefulness of self-control strategies or the decriminalisation of cannabis 
possession (e.g. Prof. Dr. Peter Cohen, scientist (domain sociology); Mr. Alain Morel, practitioner 
social/health; Mr. Peter Terreyn, third community; Mr. Jean Blanquaert, third community; Mr. 
Lucien Nouwynck, advisor of Minister of Justice Stefaan De Clerck, CVP) or contributors who did 
not articulate their points of view (e.g. Yvan Ylieff, Federal Minister of Science Policy, PS, French-
speaking Socialists; Karl-Heinz Lambertz, Minister of Youth, Media and Social Affairs of the Ger-
man speaking Community, PS, French-speaking Socialists).  
 
This finding fuels the debate about the role of an observer-turned player in the policy-making 
process (Loader and Sparks, 2011).40 As this public role of a scientist seems by far a very effec-
tive means to advance evidence-informed drug policy-making, it clearly is a thin line between the 
role of a neutral/external expert and a policy-advocating expert. While we certainly agree that 
the draft of the final conclusions and recommendations (see below, §5) needed to provide a suf-
ficient base for policy debate, we do think that the summarising report with the findings from 
the hearings had to retain autonomy/neutrality completely explicating the alternative, critical 
voices too. Several respondents tried to clarify why critical discourses (of e.g. social movement 
theorists/activists; Loader and Sparks, 2011) only succeeded in heating up the political climate 
and, accordingly, why the summarising report tended to offer and tailor advice in accordance 
with the preferences of the policy-makers (cfr. evolutionary model).  
 
“Scientific research is not always usable for policy-makers. For instance, there were some critical 
voices […] if there are too many differences in opinion with the leading policy-makers, it is difficult 
to play a role.” (Respondent 5, policy-maker). 
                                                          
39  Depenalisation involves maintenance of criminal penalties in the criminal law, yet removing or shortening the 
periods of incarceration, or reducing fine amounts, as possible sanctions. An important distinction between differ-
ent types of alternatives is the differentiation between de facto and de jure, or in other words, between changing 
the law that applies (de jure), or by modifying the way the law is used or applied in the various stages of the crimi-
nal justice system (de facto) (Room, et al., 2010). 
40  Loader and Sparks (2011) colloquially describe the role of an observer-turned player as an expert who is getting 
his hands dirty. 
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“Of course, this report is to a certain extent coloured. Political conclusions were already deter-
mined from the beginning. Some elements need to be stressed, others were rejected. It makes no 
sense to integrate findings that are supporting a totally different view than the view policy-makers 
want to end with […] The expert has to take a neutral point of view […] but some issues indeed 
have been left out.” (Respondent 4, policy-maker). 
 
“Policy-makers have followed the debates, they know the sensitivities and possibilities and, within 
this framework, the expert has to write a report […] If the expert does the proper thing by includ-
ing critical voices too, the political discussion is certainly hampered. It is his task to elucidate the 
political debate […].” (Respondent 50, scientist). 
 
5. Draft of final conclusions and recommendations discussed by the PWG 
Mid-February 1997, ‘external expert’ Prof. Dr. Brice De Ruyver presented a draft of the final con-
clusions and recommendations aiming to find political support among the members of the 
PWG.41 While the hearings of the experts were public, the working group met behind closed 
doors. One of the respondents described: 
 
“After the hearings, a report was produced and the final conclave started. The PWG met behind 
closed doors […] From the morning until the evening, a debate took place. The debate was inspired 
by a draft of conclusions made by the professor.” (Respondent 1, policy-maker). 
 
Meeting behind closed doors was appreciated by MPs involved as this allowed a profound dis-
cussion instead of a mediatised discussion (given the rather strong link between media and the 
parliamentary process). 
 
“It was a good thing that those meetings were not public because when the attendance of journal-
ists is allowed, politics certainly would prevail.” (Respondent 7, policy-maker). 
 
5.1. Political struggle 
In debating the final conclusions and recommendations, the political context clearly prevailed. 
The majority (Government Dehaene II) was composed of a Coalition between Christian Demo-
crats and Socialists (CVP-PSC-SP-PS). The electoral power of the conservative Christian Demo-
crats together with the viewpoint of Flemish Socialist party which was largely marked by indi-
vidual (rather conservative) statements of Minister of Interior Affairs Johan Vande Lanotte (see 
                                                          
41  The presentation of the final draft took until mid-February 1997 as Prof. Dr. Brice De Ruyver was appointed as an 
expert in the Parliamentary Inquiry Commission Dutroux on 26 October 1996. The House of Representatives in-
stalled a Parliamentary Commission on 17 October 1996 to examine what had gone wrong with the Dutroux en-
quiry. After a 17-month questioning of police officers and examining of magistrates in public hearings, the Com-
mission uncovered a lot of deficiencies and judicial flaws. 
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also his contribution to the PWG, §3.1.)42, made that the Flemish political scene represented a 
rather conservative approach. On the contrary, in the French-speaking part of Belgium, the (ra-
ther progressive) Socialists were the largest majority party. Eventually, this particular composi-
tion of the political scene (majority versus minority; Dutch-speaking part versus French-
speaking part) played an influential role in the final parliamentary debate about conclusions and 
recommendations. In other words, debate over the objectives of Belgian drug policy was inher-
ently political. Some respondents described this as follows: 
 
“The draft became subject of discussion due to the characteristics of the political decision-making 
process […] it is always a struggle about symbols and sensitivities of the political parties.” (Re-
spondent 29, policy-maker). 
 
“The Flemish Christian Democrats (CVP) could not agree with certain elements (…) The draft of 
Prof. Dr. De Ruyver created a lot of discussions. I know that Flemish Christian Democrat Van-
deurzen rejected some paragraphs (…) CVP was apprehensive about a too liberal direction.” (Re-
spondent 42, policy-maker). 
 
Amendments on the draft of Prof. Dr. Brice De Ruyver concerned remarks with respect to 
grammatical changes as well as content. Inherent to the political context is the (even more) diffi-
cult discussion about the wording and formulations. For instance, some small phrasings about 
e.g. the installation of Houses of Justice, the definition and interpretation of prevention, the inef-
ficiency of forced treatment, etc. were discussed and revised (CVP-Kamerfractie, 1997). 
 
Remarks concerning content included the importance of developing a policy regarding legal 
drugs like medication, alcohol and tobacco (next to illegal drugs) and smart drugs, the continuity 
of prevention initiatives, the elaboration of the cooperation between justice and treatment ser-
vices, etc. However, in line with the persistent43 focus on cannabis, most political discussion was 
again centralised around the (formulation of the) criminal interventions on drug use and canna-
bis in particular. Initially, the report of Prof. Dr. Brice De Ruyver recommended a de facto de-
                                                          
42  Minister Johan Vande Lanotte took a more conservative point of view in comparison with the rather progressive 
voices of the Flemish Socialists. Policy-making largely depends on individual policy-makers (their interest, educa-
tion, research receptivity, …). See also Weiss (1999) and Landry, Lamari and Amara (2003). 
43  A focus on cannabis was already elaborated from the beginning. Initially, the policy debate (and the installation of 
the PWG) was provoked by a statement in the media focusing on the criminalisation of cannabis (see also above, 
§1). Furthermore, several elements generated a continuation of this fixation on cannabis: it appeared to be the 
most commonly used illegal drug in the nineties, it was part of the discussion at the international level, it provoked 
a highly emotional public and media debate (with an increasing power of interest groups), it was part of many po-
litical/cultural discussions between different political parties (who were very concerned with how their electorate 
would perceive their position), it became a topic on the agenda of the fourth conference ‘Drug policy 2000’ (1996) 
and a need for a change was underlined during the hearings of the PWG (e.g. the 1993 Ministerial Circular proved 
to be not efficient at all).  
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penalisation of cannabis possession for personal use by means of issuing a new Ministerial Circu-
lar Letter (in substitution for the 1993 Ministerial Circular Letter of Minister of Justice Melchior 
Wathelet (PSC, French-speaking Christian Democrats)). However, the original message was 
weakened as a result of the discussion among the members of the PWG. The concept de facto 
depenalisation was removed and the final conclusion only mentioned the lowest prosecution pri-
ority for cannabis possession for personal use, unless it causes public nuisance or in case of a 
problematic user. Members of the CVP-PSC (Flemish and French-speaking Christian Democrats) 
took the lead in deleting the ambiguous phrasing in order to avoid discussion about the (anti-
)prohibition of drug use (within the framework of the international conventions) as well as any 
comparisons with the criticised Dutch drug policy of tolerance.  
 
“The elimination of depenalisation was supported by the CVP because of its connection with the 
concept of legalisation. Of course, both concepts mean different things but their demand was relat-
ed to communication issues and public opinion.” (Respondent 7, policy-maker). 
 
Within this framework, members of the CVP-PSC (Flemish and French-speaking Christian Demo-
crats) suggested including the concept and definition of problematic use44. Accordingly, the final 
conclusions and recommendations defined problematic use as “the problematic nature of use 
depends on the drug and the nature of use” (p. 1004). Another recurring issue during the devel-
opment of Belgian drug policy relates to the determination of number of grams for personal 
cannabis use. At that time, Flemish and French-speaking Christian Democrats refused to deter-
mine a quantity for personal use (even though Prof. Dr. Brice De Ruyver initially argued that 
“obviously, it is necessary to determine what amount can be considered as quantity for personal 
use” (p.19, De Ruyver, 1997). A respondent clarified: 
 
“The number of grams… CVP refused to determine the number of grams. If one decided to limit the 
use to five grams, this should mean that four grams is not harmful. CVP rejected any quantifica-
tion.” (Respondent 42, policy-maker). 
 
Scientific knowledge (mainly including epidemiological data and policy-funded studies) some-
times was used as a resource in this political struggle. However, it was prone to politi-
cal/symbolic utilisation. In particular, interviewees underlined that the broad spectrum of views 
involved in the PWG permitted policy-makers to select or misuse studies or expertise for their 
own purposes. 
                                                          
44  A concept which was discussed heavily in the following years because of its lack of clear definition, even by the 
Christian Democrats themselves when they ended up in the opposition after 1999. 
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“I think it is difficult to find a direct connection between science and policy. MPs do listen to those 
experts but rather selectively. However, in general, those hearings had an important influence on 
the general direction of the debate […] Contradictions are not heard depending on your point of 
view. You listen selectively […]  you search for the scientist who supports your arguments. Yes, ex-
pertise is often used in a tactical, selective way.” (Respondent 7, policy-maker). 
 
“Many points of view were presented in those hearings: from the international context to the pre-
vention policy. These elements really informed the drug policy debate in working towards an inte-
grated drug policy with different pillars such as repression, treatment and prevention […] Howev-
er, the huge amount of documentation and the different points of view among selected experts also 
determined that each of the members heard what they wanted to hear.” (Respondent 40, policy-
maker). 
 
Furthermore, we can say with certainty that scientific knowledge competed with other sources 
of information in this struggle. The expertise of practitioners was very influential because of 
their practical hands-on experience and close ties with MPs. The fact that scientific knowledge is 
not focused on the practical day-to-day issues but is considered abstract and fragmented (not 
multidisciplinary) might explain the use of knowledge produced by other groups (see also Mac-
Gregor, 2010). It was clearly assumed that huge gaps in scientific knowledge remain and that 
practitioners may have a better sense of crucial real-world information (and practice-based re-
search)45 that scientists do not fully appreciate. 
 
“Policy-makers attach more importance to a report of practitioners than a scientific report. They 
easily argue that these viewpoints are just developed by unworldly scientists. Scientists are often 
labelled as people working in an ivory tower, which makes it easier to take scientists less serious-
ly.” (Respondent 29, policy-maker). 
 
This political struggle was indirectly aggravated by media coverage at that time. In particular, 
Belgian cannabis policy was described as a tolerance policy, making an incorrect comparison 
with the Dutch cannabis policy (coffee-shop model). This media coverage provoked the reactions 
of several politicians (e.g. Louis Tobback, SP, Flemish Socialists) and MPs (e.g. Jef Valkeniers, 
VLD (Flemish Liberals); Dany Vandenbossche, SP (Flemish Socialists); Anne-mie Vandecasteele, 
VU (Flemish Nationalists)). Members of the Christian Democrats (e.g. MP Jo Vandeurzen, CVP, 
Flemish Christian Democrats) reacted furiously in the Flemish media against any tolerance poli-
cy and the terminology de facto depenalisation as they were very concerned with how their elec-
torate (and the public opinion in general) would perceive and respond to this direction (even 
                                                          
45  This type of research does not meet the traditional scientific research standards but rather standards related to its 
usefulness for practitioners. 
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though there were no elections)46. Likewise, the power of the media can be blamed because of its 
assumption of a 5 grams limit in line with the Dutch policy. 
 
“In order to have some sort of policy alignment with the Dutch policy, the five grams limit could be 
used as a criterion. The last Dutch drug note of September 1995 allows the same amount.” (19 
February 1997, Flemish newspaper De Morgen). 
 
A smaller response came from interest groups. A demonstration was announced by interest 
group Association against the prohibition together with many French-speaking treatment centres 
(also supported by MPs Patrick Moriau (PS, French-speaking Socialists) and Vincent Decroly 
(Ecolo, French-speaking Greens) as well as by French-speaking scientists, practitioners, etc. in 
order to advance the drugs debate and to plead in favour of a legalisation of cannabis. It became 
clear that interest groups may be perceived as rather isolated (and local) initiatives. There never 
appeared to be mutual connections between Flemish and French-speaking interest groups even 
if they were like-minded (e.g. BCCO and Association against the prohibition). A limited (policy) 
power of interest groups may be one of the results. Several respondents explained that even 
though interest groups were not decisive in the policy-making process, public debates obviously 
influenced the arguments taken up in the debates of the PWG (especially by progressive political 
voices).  
 
“If interest groups take some action by a public demonstration, you are touched. You listen to these 
representatives as they have public and media attention. As you know, a problem only exists when 
media coverage is generated.” (Respondent 35, policy-maker).  
 
5.2. Final conclusions and recommendations 
The final conclusions and recommendations of the PWG reflected how the thinking about the 
drug phenomenon has evolved. The compromise among most parties47can be seen as an out-
come of a powerful discursive struggle between social and public health concerns and of law en-
forcement considerations, and international obligations concerning control. On the one hand, 
arguments were related to concerns about the health of youth, the stepping-stone theory and the 
compliance with the Conventions of the United Nations (1961-1971-1988) and the 1990 Con-
                                                          
46  The next elections were held in 1999. 
47  Nine members agreed and two withheld their support for these final conclusions and recommendations. Motiva-
tions of both of these members of the PWG concerned the recommendations regarding the substitution of metha-
done, the usefulness of compulsory treatment and the lowest prosecution priority for cannabis and its future di-
rection (i.e. member of Vlaams Blok (Flemish extreme right party) argued in favour of total prohibition, the mem-
ber of AGALEV (Flemish Greens) did plead for more steps in the direction of legalisation, regulated by the Gov-
ernment). As will become clear below, topics like methadone and cannabis prosecution policy will also be part of 
the discussion in the following phases. 
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vention of Schengen. On the other hand, it was commonly argued that prohibition leads to stig-
matisation and is counterproductive to public health and well-being. Eventually, the decision to 
develop a normalisation policy48, a so-called third way between prohibition and anti-prohibition, 
was representative of the compromise. The PWG marked a trend towards the emergence and 
the development of drug use as an issue of public health rather than of criminal justice (which 
included an important formalisation of the change in discourse raised by the 1995 Federal Ac-
tion Plan Toxicomania-Drugs). Prevention had to be the first goal and a criminal approach to-
wards drug users was supported by a so-called ultimum remedium philosophy. This approach 
was a more rational and human alternative to the former repressive War on drugs approach. 
 
As one of its main conclusions and recommendations, the PWG set out some guidelines for an 
integral and integrated drug policy as fragmentation of powers between the Federal, community 
and regional, provincial and local levels required both vertical and a horizontal policy coordina-
tion (which is the precursor of the 2002 cooperation agreement between the Federal Govern-
ment and the federate entities and the establishment of the General Drugs Policy Cell; see also 
below). 
 
Concerning epidemiology and evaluation, the need for quantitative and qualitative studies among 
the general population and among special and at risk populations was re-emphasised.49 The 
PWG also recommended a better use of the available epidemiological studies. Evaluation of im-
plemented measures (e.g. treatment methods, health care institutions, cares circuits and preven-
tion techniques) was also recommended. 
 
The recommendations regarding prevention focused on the reduction of drug use and the de-
crease of the number of drug users by means of structural and person-oriented prevention. They 
paid special attention to youth, psychoactive medicines, smart drugs and the consequences of 
drug use for road safety. The final conclusions of the PWG also emphasised the need for a pro-
fessional statute for prevention workers. As prevention workers are employed at several levels, 
also some form of coordination was recommended.  
 
Moreover, according to the final conclusions and recommendations of the PWG, the provision of 
care to drug users needed to be customised. For this purpose, they recommended the extension 
                                                          
48  A policy where the drug phenomenon is considered to be a permanent social reality (Parl.St. Kamer, 1996-1997, 
1062/3, p.992). 
49  The need to extend scientific research such as epidemiological studies and evaluations (e.g. evaluation of the med-
ical-social treatment centres for drug users) was already stressed in the Federal Action Plan Toxicomania-Drugs 
(ten-point plan) (1995). 
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and development of good practices ranging from low-threshold facilities to therapeutic pro-
grams. Besides, these facilities needed to collaborate, they had to be coordinated and integrated 
in the existing network of facilities and had to be equipped with a uniform registration system. 
Other related elements were the promotion of the cooperation between justice and treatment 
and the stimulation of harm reduction initiatives other than substitution treatment.  
 
The main issue of repression in these recommendations was the fight against illegal drug produc-
tion and traffic. Supported by the so-called ultimum remedium philosophy, problematic drug 
users in the criminal justice system had to be oriented more towards treatment (e.g. alternative 
measures must be stimulated). Measures to combat the use of drugs in prison also had to be 
instituted. For instance, the PWG agreed that the organisation of substitution treatments for 
addicted prisoners and the creation of drug free units in prison needed to be elaborated. The 
final conclusions and recommendations of the PWG also supported the distinction between can-
nabis and other illegal drugs by giving the lowest prosecution priority for the possession of can-
nabis for personal use, unless it causes public nuisance or in case of a problematic user.  
 
6. Aftermath of the PWG: plenary meeting 
On 5 June 1997, the PWG reported its final conclusions and recommendations to the Chamber of 
Representatives (Verslag namens de Parlementaire Werkgroep belast met het bestuderen van 
de drugproblematiek, Parl.St. Kamer, 1996-1997, 1062/1-3). As a result, a plenary meeting was 
organised on 24 June 1997 (Hand. Kamer 1996-1997, 24 juni 1997, 175). In this plenary meet-
ing, each member of the Chamber (majority as well as opposition) had the opportunity to ask 
questions and make some remarks about the final conclusions and recommendations of the 
PWG. Members of the PWG also had the opportunity to discuss their vote. Even though MPs from 
the opposition parties (like Vlaams Blok and AGALEV/Ecolo) took the opportunity in the plenary 
meeting to stress once again why they withheld their support50, the real policy power of this 
parliamentary debate remained limited. The importance of the multidimensionality of the drug 
                                                          
50  Both the Greens (AGALEV-Ecolo) and the Flemish extreme right party Vlaams Blok submitted a motion. The 
greens (AGALEV-Ecolo) submitted a ten-point reasoned motion in order to plea in favour of a more liberal canna-
bis policy (e.g. with a controlled distribution of the government), a reinforcement of the international struggle 
against drugs production and traffic and an integration of drug policy in other policy domains (e.g. education, cul-
ture,..). In his reasoned motion, Mr. Filip De Man (Vlaams Blok, Flemish extreme right party) pointed to his aver-
sion to methadone treatment and to the negative consequences of a more liberal cannabis policy. He argued that a 
liberalisation of cannabis will lead to more (problematic) users, that teenagers buying and using drugs will be-
come younger, that a liberalisation will lead to an increase of traffic victims, that the large majority of our citizens 
is against legalisation, depenalisation or decriminalisation, and that a liberalisation is against international obliga-
tions, etc. 
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phenomenon requiring an integrated and integral approach was largely supported by the major-
ity of the MPs in the PWG.  
 
Accordingly, a poor turnout in the plenary meeting resulted in a discussion between members of 
the PWG.51 Only 3 additional people attended the meeting: Mr. Michel Moock (PS, French-
speaking Socialists), Mrs. Martine Schüttringer (Ecolo, French-speaking Greens) and Federal 
Minister of Public Health and Pensions Marcel Colla (SP, Flemish Socialists). After an introduc-
tion to the main conclusions and recommendations of the PWG, several members took the op-
portunity to ask questions and make some remarks. The debate ended with a short contribution 
of Minister of Justice Stefaan De Clerck (CVP, Flemish Christian Democrats) stressing his aim to 
further elaborate the conclusions and recommendations of the PWG regarding judicial matters 
(which would, among other things, result in a new Ministerial Circular in 1998; see below, Chap-
ter 3, §2). 
 
7. Conclusion 
The Parliamentary Working Group on drugs can be perceived as the first milestone in the de-
velopment of Belgian drug policy. It was the first time the drug phenomenon was studied seri-
ously by policy-makers. Priority was given to a systematic approach with a proper assessment of 
existing and new alternatives. The PWG aimed at translating the needs and aspirations as well as 
good practices discussed by (inter)national experts (i.e. scientists, practitioners, representatives 
of interest groups, representatives of the Government) into useful policy recommendations. Next 
to topics such as drug epidemiology, prescription and substitution of methadone and/or heroin, 
prison policy, international drug production and traffic, a large part of the discursive struggle 
between social and public health issues and law enforcement concerns and international obliga-
tions concerning control considered the legitimacy of the criminalisation of drugs. Eventually, 
the PWG led to an agreement among most parties about the development of an integral and in-
tegrated approach, where multiple and different actors (prevention, care, repression) need to 
integrate and work together. It was for the first time that it was formally stated that the drug 
problem had to be perceived as a complex, multidimensional phenomenon that covers various 
aspects of life. The final conclusions and recommendations of the PWG expressed that preven-
                                                          
51  Many members of the PWG attended the plenary meeting: Mr. Louis Vanvelthoven (SP, Flemish socialists), Mr. 
Maurice Minne (PS, French-speaking socialists), Mr. Jo Vandeurzen (CVP, Flemish Christian Democrats), Mr. Jan 
Van Erps, Mrs. Ingrid Van Kessel (CVP, Flemish Christian Democrats), Mr. Willy Cortois (VLD, Flemish liberals), Mr. 
Jef Valkeniers (VLD, Flemish liberals), Mr. Danny Vandenbossche (SP, Flemish socialists), Mr. Daniel Bacquelaine 
(PRL-FDF, French-speaking liberals), Mr. Jacques Lefevre (PSC, French-speaking Christian Democrats), Mr. Filip De 
Man (Vlaams Blok, Flemish extreme right party), Mr. Frans Lozie (AGALEV/Ecolo), Mrs. Anne-mie Vandecasteele 
(VU, Flemish nationalists) and Mr. Vincent Decroly (AGALEV, Flemish Greens). Also Minister of Justice Stefaan De 
Clerck (CVP, Christian Democrats) joined the plenary debate. 
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tion had to be the first goal and a criminal approach towards drug users was supported by the 
so-called ultimum remedium philosophy. 
 
This episode in the development of Belgian drug policy has shown how scientific knowledge 
contributed to a formal advisory structure at the parliamentary level. Through the PWG, it be-
came clear how scientists (so-called scientific experts and policy advisors) managed the relation-
ship between their academic activities and policy-making. While scientific drug research was 
still rather scarce in Belgium, scientists’ discourses in the PWG were largely fed by data (num-
bers and statistics) derived from (foreign) epidemiological and policy-funded studies. Scientists 
were speaking truth to power by using prepositional assumptions (i.e. assumptions about what is 
or can be or will be the case; truth) and active verbs without any references. However, we found 
that we must be cautious regarding the knowledge that scientists brought into policy debates. A 
nuanced account of the nature of scientific knowledge is necessary (i.e. processual model). Sever-
al forms of misuse of science by scientists were distinguished during the hearings (e.g. using 
ambiguous terminologies or ignoring statistical significance). As participating in a formal advi-
sory structure allow scientists to control which message is provided and how it is absorbed in 
the political setting, it is important that scientists involved in the policy-making process take the 
responsibility of providing correct information and to be aware of becoming so-called airport 
scientists who are flying around as consultants while losing sight of their scientific research base 
(Uggen and Inderbitzin, 2010). If scientists misrepresent their expertise they are involved in, 
there is less hope for well-informed coverage in the policy-making process.  
 
Policy-makers attached importance to policy-funded studies or (foreign) academic research giv-
ing a quantified view on the drug phenomenon (numbers or statistics) assuming that scientific 
knowledge represents authoritative, truth-producing data. In this context, scientific knowledge 
contributed to the PWG through different modalities. The new frameworks for the understand-
ing of the drug problem provided by scientists (and practitioners as well) clearly altered the 
discourse in the drug policy-making process. In other words, scientific knowledge enlightened 
the development of Belgian drug policy: it contributed to the percolation of common ideas and 
concepts (e.g. related to the prevention projects towards youth or related to the orientation of 
(problematic) drug users in the criminal justice system towards treatment) and the develop-
ment of a substantial body of knowledge. An important role was played by an observer-turned 
player, a scientist who wrote the summarising report of the hearings as well as prepared the 
draft of the final conclusions and recommendations. Such a public role is by far the most effec-
tive means of advancing an evidence-informed drug policy, but also raises questions about the 
thin line between the role of a neutral/external expert and a policy-advocating expert. The ‘ex-
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ternal expert’ could not retain his autonomy/neutrality completely: in order to provide a suffi-
cient base for policy debate, the summarising report with the findings from the hearings tended 
to offer and tailor advice in accordance with the preferences of the policy-makers (cfr. evolution-
ary model). For instance, if we perceive use as simply pointing to the names of and references 
used by the consulted practitioners and scientists, the report and its bibliography provided a 
clear and careful integration of most of the good practices and recommendations of the scien-
tists, practitioners and members of the Government but displayed less sensitivity to the views of 
more critical accounts (of e.g. social movement theorists/activists). 
 
Simultaneously, findings also match the theoretical assertions about policy-makers’ politi-
cal/symbolic knowledge utilisation (Weiss, 1979; Stevens, 2007a). Vague references to scientific 
knowledge were used as ammunition to support the installation of the PWG. Furthermore, ac-
cording to some respondents, the creation of a PWG (and thus a thorough study of the phenom-
enon) has to be seen as a strategy of the majority to keep the political responsibility away from 
the Government (and thus for delaying real decision-making). Additionally, during the debate of 
the final conclusions and recommendations, the broad spectrum of views of experts involved 
permitted policy-makers involved in the PWG to select studies or expertise to support their ar-
guments (as an instrument to enact power).  
 
Scientific knowledge has been just one element in the PWG competing with other types of infor-
mation. Barriers to knowledge utilisation can be attributed to the institutional characteristics of 
the political setting (e.g. political party instructions, majority versus minority issues, the interna-
tional framework (i.e. Dutch drug policy, the international drug control conventions), etc.) as 
well as to the individual experiences (their interest, education, research receptivity) of policy-
makers. One clear example is the adaptation of the recommendation regarding cannabis policy. 
Members of the conservative parties took the lead to delete the phrasing ‘de facto depenalisation 
of cannabis possession for personal use’ in order to avoid discussion about the (anti-)prohibition 
of drug use as well as any comparisons with the Dutch drug policy of tolerance. Accordingly, the 
final report of the PWG recommended the lowest prosecution priority for the possession of can-
nabis for personal use, unless it caused public nuisance or in the case of a problematic user. 
Likewise, it became clear that the selection of (inter)national experts in the PWG strongly de-
pended on political (i.e. majority versus opposition, party policy) and cultural/linguistic (e.g. 
Flemish MPs preferred the selection of Flemish experts) motives and the functional specialisa-
tion of MPs (e.g. MPs with a medical background tend to select doctors or professors in toxicolo-
gy or pharmacology). The characteristics of scientific knowledge also seemed to operate as a 
barrier of knowledge utilisation. In the PWG as well as by several interviewees, it was clearly 
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assumed that scientific knowledge is often inconclusive or fragmented and not focused on the 
practical day-to-day issues (which reflects the two communities thesis assuming a fundamental 
gap between science and policy; Caplan, 1979), while practitioners may have a better sense of 
crucial real-world information (and practice-based research)52 that scientists do not fully appre-
ciate. In a similar vein, the utilisation of data derived from other non-academic sources: e.g. offi-
cial (prison or police) statistics or reports supplied by an international organisation (e.g. 
EMCDDA, WHO) was observed. 
 
An important facilitator to knowledge utilisation includes the relationships and networks be-
tween scientists and policy-makers. In selecting scientists to be involved in the PWG, it appeared 
that personal contacts/networks were at least as important (maybe even more) as the expertise 
and competence of experts. It also became clear that, due to the importance of personal con-
tacts/networks, once a (scientific) expert appeared on the political stage (and his ideas and 
opinions were shared by one or more political families) a relationship with policy-makers was 
established. If scientists want to play a role in the policy-making process, they have to make 
themselves visible and create networks outside the academic world. Attending conferences 
(where a mix of expertise is invited), building contacts with (employees of) policy-makers 
through research projects (e.g. guidance committees) or attending study groups from political 
parties may be seen as important ways to be selected in formal advisory structures at the par-
liamentary level.  
 
A strong role of the media is noted. The public and political commotion regarding the newspa-
per article presenting the story of MP Patrick Moriau (PS, French-speaking Socialists), increased 
the likelihood of the Federal Parliament taking action (i.e. the establishment of a PWG). Media 
coverage, therefore, succeeded in generating public reaction (e.g. several interest groups were 
established), setting as well as keeping an item on the political agenda and, most importantly, in 
empowering the enlightenment function of scientific knowledge (via the PWG). Unfortunately, 
right from the start, media coverage reduced the complexity of the discussion in the PWG to one 
topic: cannabis policy (which persisted during the whole period). Furthermore, newspapers 
worked as a powerful selection device in determining the authorised agents of knowledge. In 
particular, it became clear that when media pushes forward certain experts, they may have a 
greater chance of being integrated in the personal networks of the policy-makers and of being 
selected as expert in formal advisory structures at the parliamentary level. In addition, media as 
such also seemed to be an important resource in supporting assumptions or ideas. MPs as well 
                                                          
52  This type of research does not meet the traditional scientific research standards but rather standards related to its 
usefulness for practitioners. 
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as representatives of the Government frequently used media statements in supporting their 
view or advancing certain policy initiatives. 
 
Finally, several associations advocating for drug users’ rights (Belgian Cannabis Consumers’ Or-
ganisation; A citizen just like any other; Association against the prohibition) took advantage of the 
media attention preceding the PWG in an attempt to spread their ideas and to persuade the pub-
lic and policy-makers to share their point of view. Initiatives, ranging from huge media coverage, 
the organisation of demonstrations, making contacts with MPs, etc. even led to some members of 
the PWG selecting these interest groups as experts to be invited to the hearings. It is clear that, 
together with the media, they have played a role in the empowerment of the enlightenment func-
tion of scientific knowledge and that they have influenced the arguments taken up in the political 
struggle (especially by progressive political voices). However, the discourse of the members of 
interest groups was mostly supported by personal experiences instead of references to scientific 
knowledge. Thus, these interest groups were not important linking mechanisms in the science-
policy nexus during this period.  
By detailing the first milestone in the development of Belgian drug policy between 1996 and 
2003, the Parliamentary Working Group on drugs, we have documented through which modali-
ties scientific knowledge contributed to the PWG and which other types of information compet-
ed with scientific knowledge. The following chapter will illustrate how these issues apply during 
an era in which other topics than drugs became more central to the political agenda.  
Chapter 3  Intermezzo: 1997-2000 
 
After the Parliamentary Working Group on drugs (PWG), the general attention to the drug issue 
decreased. The Dutroux case and ensuing reforms of the judicial authorities and the police (‘Oc-
topus reforms’) as well as the creation of a new governmental Coalition led to a turbulent time 
period. Simultanuously, at the international level, several interesting debates developed.  
 
1. General (inter)national context 
1.1. International frameworks 
Internationally, while continuing (modest) rises of drug use (i.e. cannabis, amphetamines, ecsta-
cy, cocaine and heroin) were observed53, the drug problem was increasingly viewed in a broader 
social context including drug prevention, reduction of drug-related harm and crime deterrence 
(EMCDDA, 2000). 
 
For a long time, drugs were scarcely discussed within the framework of the European Communi-
ty.54 It was not until the Treaty of Maastricht (1992) that drugs, along with many other new sub-
ject areas, were brought within the European Union’s competence (Boekhout van Solinge, 2002). 
The European Union focused on the consolidation of common measures for combating drug ad-
diction and drug trafficking, for promoting international cooperation and for supporting the 
efforts of the United Nations. The 1997 Amsterdam Treaty was a reconfirmation of the 1992 
Maastricht Treaty but also determined for the first time that the highest priority should be given 
to the reduction of drug-related harm (De Ruyver, Vermeulen and Vander Beken, 2002). Article 
152 aimed at cooperation in order to stress the objective to reduce the drug-related health dam-
age alongside the traditional cooperation in the prevention field. This article provided a judicial 
basis for the Member States to implement harm reduction strategies. Following the UN conven-
tions, these provisions also required the application of criminal sanctions on the supply side. On 
                                                          
53  Cannabis remained the most frequently used substance (18% of those aged 15 to 64 had tried cannabis at least 
once; about 6% of those aged 15 to 64 had used cannabis in the past 12 months). Amphetamine, ecstasy and co-
caine use increased moderately over the 1990s as a whole, with ecstasy use more evident than amphetamine or 
cocaine use among young adults (EMCDDA, 2000). Between 1 and 5% of those aged 16 to 34 had taken ampheta-
mines and/or ecstasy. Between 1 and 6 % of those aged 16 to 34 and 1 to 2% of schoolchildren had tried cocaine 
at least once. Several studies and evaluations of treatment or prevention programmes, on effectiveness of repres-
sive measures, studies of specific risk-groups (prisoners, youngsters out of school), ethnographic research were 
running (see also §6). The trends observed in Belgium were very similar to those noticed in other countries of the 
European Union (BIRN, 2000). 
54  This is in spite of some interesting initiatives preceding the formal decision that drugs should indeed be an EU-
issue (Treaty of Maastricht): the Stewart-Clark Committee (1985-1986) and the European Committee to Combat 
Drugs (CELAD) (1989) (Boekhout van Solinge, 2002; Fijnaut and De Ruyver, 2014). 
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the demand side, there were no explicit requirements in relation to the criminalisation of the use 
and possession for personal use.  
 
Furthermore, following the implementation of the 1990 Schengen Convention, the Inter-
parliamentary Advisory Council of the Benelux countries provided a report about drug policy in 
Benelux in November 1998. While describing the different drug policies, the Dutch coffee-shop 
model was not openly discussed in the report as the organisation of the supply of cannabis still 
appeared to be a huge stumbling block. However, in accordance with the conclusions of the Par-
liamentary Working Group on drugs (1996-1997) in Belgium, the recommendations of the Bene-
lux report clearly showed agreement about the importance of a normalisation policy, as a third 
way between a prohibitionist and anti-prohibitionist policy (Inter-parliamentary Advisory 
Council of the Benelux countries, 1998; Fijnaut and De Ruyver, 2008). The notion ‘normalisation 
policy’ has been decisive for the further developments of Belgian drug policy (see below, Chap-
ter 4). 
 
In addition to the Drug Note of 1995 (‘The Dutch drug policy, continuity and change’), the Dutch 
Government published its official paper ‘Pathways to the back door’ in April 2000 which ad-
dressed the problems of drug tourism, the professionalisation and commercialisation of home 
growers and organised crime (and the problem of the supply side of the coffee-shop model) pub-
licly. For the first time, it was also acknowledged that these side effects were not just a national 
issue but resulted in negative consequences for neighbouring countries (cfr. Article 71 Schengen 
Convention). The international pressure on the Dutch liberal drug policy increased and this situ-
ation confirmed the rejection of this model by Belgian policy-makers (Fijnaut and De Ruyver, 
2008; De Ruyver, et al., 2010). An interviewee described: 
 
“The negative consequences of the Dutch policy became more and more visible: drug tourism, in-
creasing drug supply, crime and nuisance. Belgium decided not to copy the drug policy of the Neth-
erlands […] The discussion about coffee-shops was immediately finished. Around 2000, the paper 
‘Pathways to the back door’ confirmed the scale of the problem once more.” (Respondent 50, scien-
tist). 
 
1.2. Turbulent time period in Belgium 
At the end of the nineties, the entire Belgian drug debate was overshadowed by the ‘Dutroux 
paedophilia case’.55 The failure of the Belgium's political and criminal justice system was dis-
                                                          
55  Marc Dutroux kidnapped, tortured and sexually abused six girls aged between 8 and 19. He was arrested in August 
1996: two girls were rescued from an underground dungeon and four were found buried in his garden. This case 
led to intense criticism of the Belgian police and justice system. Causing anguish among the Belgian people, a pro-
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cussed at length. A Parliamentary Inquiry Commission, also referred to as the Dutroux Inquiry 
Commission (October 1996-April 1997)56, was created to investigate possible police and judici-
ary incompetence and corruption. In the political (and media) discussion, the focus shifted to 
reforms of the judicial authorities and the police. This debate gained new momentum with the 
escape of public enemy number one, Marc Dutroux, on 23 April 1998. Although Marc Dutroux 
was caught within a few hours, the political world felt that quick and decisive action was neces-
sary to restore trust in police and justice. Dutroux’s escape not only prompted the resignation of 
three officials: the Belgian State Police Chief, Willy Deridder, the Minister of Justice Stefaan De 
Clerck (CVP, Flemish Christian Democrats) and the Minister of Internal Affairs Johan Vande 
Lanotte (SP, Flemish Socialists). At the same time, the leaders of the four governing parties and 
of the four opposition parties started the so-called Octopus negotiations under the presidency of 
Prime Minister Jean-Luc Dehaene (CVP, Flemish Christian Democrats).  
 
2. Ministerial Circular Letter of 8 May 1998: answer to the recommenda-
tions of the PWG 
The Parliamentary Working Group on drugs (PWG) revealed several negative consequences of 
the 1993 Ministerial Circular Letter which did put some pressure on the Minister of Justice 
Stefaan De Clerck (CVP) to take action. Initially, the Minister of Justice Stefaan De Clerck (CVP), 
together with the College of Prosecutors-General, developed a new Ministerial Circular Letter 
modifying the action of the judicial authorities. However, after the Minister of Justice Stefaan De 
Clerck (CVP) resigned his place was taken by his fellow party member Tony Van Parys. He 
launched the Ministerial Circular Letter in May 1998 (also called ‘De Clerck-Van Parys’ Ministe-
rial Circular Letter). This initiative kept the drug issue on the political agenda within the turbu-
lent time period.  
 
“Despite of the turbulent period, the Minister of Justice was more or less obliged to adapt the Min-
isterial Circular Letter of 1993. The PWG had clearly pointed at several problems.” (Respondent 50, 
scientist). 
                                                                                                                                                                                     
test march was held through Brussels by 300,000 people. In 2004, Marc Dutroux was convicted and imprisoned 
for life (Cartuyvels, Delpérée and Delwit, 1997). 
56  In a Parliamentary Commission of Inquiry (e.g. Dutroux Inquiry Commission, Parliamentary Inquiry Commission 
on the Gang of Nijvel), witnesses, as well as interpreters and experts, take an oath and are subject to the same obli-
gations as when questioned by a so-called investigation judge. A Parliamentary Committee of Inquiry can also 
conduct searches and seize documents. Commission of inquiry at which witnesses or experts are heard are public, 
unless the committee decides otherwise. Furthermore, the committee is obliged to report in a given time to the 
plenary meeting. The plenary meeting then votes on motions submitted in the report of the Commission of Inquiry 
(Fijnaut, Huyse and Verstraeten, 1998; Devos, et al., 2009). 
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The new directive (of 8 May 1998) replaced the guidelines of the Ministerial Circular Letter of 5 
May 1993 which did not distinguish between types of drugs and was based on the premise that 
every violation had to lead to a consequence (e.g. prosecution, praetorian probation, etc.). Fol-
lowing the final conclusions and recommendations of the PWG, the Ministerial Circular Letter of 
8 May 1998 pursued a more realistic and contemporary drug prosecution policy. For the first 
time a distinction was made between the prosecution policy with regard to cannabis and other 
illicit drugs. It was argued that “cannabis products are substances that cause fewer health prob-
lems” (Ministerial Circular Letter of 8 May 1998, nr. COL 5/98, p.2). The Ministerial Circular Let-
ter instructed Public Prosecutors to give the lowest priority to the prosecution of cannabis pos-
session for personal use57, unless the use causes public nuisance (defined as environmental pol-
lution, noise, verbal aggression, use or being under the influence of drugs in public space)58 or in 
case of problematic use (defined as sustained regular use, dependence, addiction, lack of socio-
economic integration or crises; in such a case, orientation towards treatment is recommend-
ed)59. Provided there were no aggravating circumstances, the police officer (taking his subjective 
assessment into account) had to make a simplified process-verbal. A list of these records was then 
sent to the Public Prosecutor biweekly or monthly. The 1998 Ministerial Circular further asked 
the Public Prosecutors to be severe in the case of retail sale but to take into consideration (by 
reducing the punishment) the case in which the only purpose of the sale was to finance one’s 
own use.  
 
The 1998 Ministerial Circular followed the conclusions of the PWG by reemphasising that the 
possession of illegal drugs remained punishable and that the lowest prosecution priority was 
given to the possession of cannabis for personal use. However, the details about the application 
of the Ministerial Circular Letter (e.g. a clear definition of concepts) remained unclear. The new 
directive ignored the fact that vague notions like public nuisance and problematic use were heavi-
ly criticised by both the academic world and practitioners (Kaminski, 1998). At the same time, 
regular registrations by the Public Prosecutor formed the main criterion to determine persistent 
regular use of cannabis. Problematic use was therefore rather linked with the risk of being con-
trolled by the police. As we will discuss in detail below, an evaluation study demonstrated these 
problems clearly (see Chapter 4).  
                                                          
57  Generally defined as the limited possession for personal (single or occasional) use (Ministerial Circular Letter nr. 
COL 5/98, p.4). 
58  Public nuisance is defined for the first time (no definition was integrated in the final conclusions and recommen-
dations of the PWG). 
59  Even though the final conclusions and recommendations of the PWG vaguely defined problematic use as “the prob-
lematic nature of use depends on the drug and the nature of use”, the 1998 MC did not succeed in obtaining a more 
clear definition of problematic use.  
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The new Ministerial Circular Letter, presented in May 1998, resulted in a slight (but short) in-
crease of the public (and political) attention to the drug issue (see also below, §5; Hand. Senaat 
1997-1998, 7 mei 1998, 1-183; Parl.St. Kamer 1997-1998, nr. 1571/1). We also observed that 
information was released to the media in advance of an official press release. On 18 April 1998, 
French-speaking newspaper Le Soir (the same journal that provoked the debate by the article 
about Patrick Moriau’s proposition) reported a scoop regarding the stipulations of the new Min-
isterial Circular:  
 
“Cannabis: room for a little tolerance. Stefaan De Clerck reveals new circular letter about drugs.” 
(18 April 1998, French-speaking newspaper Le Soir). 
 
The news scoop was then picked up by several Flemish and French-speaking newspapers. As a 
result, the Ministerial Circular Letter was already extensively discussed and criticised in the 
Flemish and French-speaking newspapers before the official presentation on 21 April 1998. This 
situation complicated the debate. On the one hand, the media provoked some wrong assump-
tions. For instance, French-speaking newspaper Le Soir as well as Flemish newspaper De Morgen 
both wrongly reported that the quantity for personal use was determined to be five grams, simi-
lar to the Dutch policy.  
 
“It was the responsibility of the policy-makers to develop a clear Ministerial Circular Letter […] 
The press translated the Ministerial Circular Letter and added a certain number of grams, which 
was never included in the first place. As a result, the public discussion and confusion arose.” (Re-
spondent 22, policy-maker). 
 
On the other hand, we found almost each newspaper guilty of using false terminology (and thus 
increasing confusion among the public). Many times it was mistakenly argued that cannabis 
(mostly called soft drugs) was tolerated (expressed as tolerance policy) and, in other words, that 
cannabis users were not to be prosecuted anymore. Clearly, in media coverage, scientific defini-
tions were less important than facts and clear messages. An interviewee explained: 
 
“I am a lawyer but the public debate has to be simple. In many newspapers, these concepts were 
used wrongly. A juridical nuance is not interesting. The bottom-line is: is it allowed or not?” (Re-
spondent 45, journalist).  
 
3. Federal elections: June 1999 
With Federal (and regional) elections on 13 June 1999 lying ahead and the power and status of 
political actors at stake, media coverage and parliamentary activity increased. Accordingly, some 
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MPs used the media to favour electorates and attain a higher authority. The main focus of the 
election campaign (and accordingly media coverage and parliamentary debate) was mainly on 
the Dioxin Affair60 which was revealed only two weeks before the elections (Dewachter, 2001; 
Frognier and Aish, 2003).  
 
Nevertheless, in order to win some votes, MP Van Quickenborne said that he would smoke a 
joint in the Senate if he got elected. “Vincent Van Quickenborne enjoys smoking a joint. He promis-
es to smoke a joint if he got elected. He invites his colleagues to do the same” (28 May 1999, Flemish 
newspaper Het Laatste Nieuws). Others used the media to place themselves in a positive light by 
demonstrating the importance they afforded to scientific knowledge. For example, efforts in 
stimulating scientific knowledge regarding drug use were regularly emphasised in the media. 
”Flemish Minister W. De Meester aims to take these numbers into account. She commissioned a 
survey among youngsters in secondary schools” (30 October 1998, Flemish newspaper Belang van 
Limburg). This is linked with the status model of Cross et al. (2000) which assumes that policy-
makers use a well-stocked portfolio of commissioned research as a kind of status symbol. Given 
this kind of references, it seems necessary to differentiate Weiss’s political/symbolic model 
(Weiss, 1979). Favouring evidence-informed policy can be seen as a rather strategic stance. 
 
Furthermore, an initiative worth mentioning is the common strategy of both Dutch- and French-
speaking practitioners of drug treatment and prevention of developing a Policy Memorandum 
(Memorandum group, 1999). This document described the bottlenecks of each organisation and 
the cooperation between the organisations as well as their wish list for the future. In this docu-
ment, obviously linked with the final conclusions and recommendations of the PWG, they plead-
ed for the clarification of the 1998 Ministerial Circular Letter, the development of a uniform reg-
istration system, the improvement of the collaboration between justice and treatment, the estab-
lishment of a prison policy, the establishment of a forum for a better cooperation and coordina-
tion between different policy actors, and so on. One French-speaking organisation, Fedito Wal-
lonia, emphasised 3 additional elements: (1) a debate about legalisation should be reopened; (2) 
prison life should be improved; and (3) pros and cons of therapeutic communities should be 
reassessed in detail. This exemplified the rather different discourses between the (rather pro-
gressive) French-speaking part of Belgium and the (rather conservative) Dutch-speaking part of 
                                                          
60  Dioxins (i.e. by-products of industrial chemical processes) were introduced into the Belgian food supply through 
contaminated animal fat used in animal feed. This animal feed was supplied to Belgian, French and German farms 
and, accordingly, resulted in a Belgian (and European) food safety scandal. Public and media criticism towards the 
Belgian Government was raised (Casey, Lawless and Wall, 2010). 
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Belgium. On the threshold of the federal elections, the document61 was first provided to the MPs 
who took part in the PWG (which resulted in the endorsement of Mrs. Ingrid Van Kessel (CVP, 
Flemish Christian Democrats) and Mr. Dany Vandenbossche (SP, Flemish Socialists)) and sec-
ondly, to all outgoing MPs in the Chamber of Representatives and Senate (in order to get some 
issues in the party programmes and the new Governmental Declaration). After the new Govern-
ment had taken place, the document was sent to the Ministerial Cabinets62. The Policy Memo-
randum can be considered as an important lobbying instrument, as was described in the accom-
panying letter: 
 
“This Memorandum is endorsed by almost every organisation. The drug issue is a public concern. 
There is need for a repressive as well as for a curative and preventive component. When establish-
ing the latest, this Policy Memorandum can be an important policy instrument.” (1999 Policy 
Memorandum Drug treatment and prevention).  
 
Scientists were not explicitly involved. However, if we assume that personal contacts/networks 
exist between practitioners and scientists (e.g. through attendance of study groups or confer-
ences), some scientists may have influenced the development of the Policy Memorandum indi-
rectly. 
 
4. First Verhofstadt Government (1999-2003): a historical switch 
An important change was established on 13 June 1999. Although the Prime Minister had come 
from the Christian Democratic Party for many years, in the 1999 Federal elections, a Coalition 
led by Flemish Liberal Leader Guy Verhofstadt was voted into power. The first Verhofstadt Gov-
ernment (1999-2003) was a six-party Coalition between the Flemish and French-speaking Liber-
als, Socialists and Greens. The green parties moved to the majority for the first time. Conversely, 
Christian Democrats moved from a long-standing majority position towards the opposition. At 
the same time, an increased availability of finances (De Ruyver, et al., 2004) and political and 
                                                          
61  Even the preliminary version of the document was sent to a member of the Chamber of Representatives in order 
to get some feedback and stimulate parliamentary acceptance.  
62  The so-called Copernicus reforms of the Government (1999-2003) aimed to decrease the powerful (political) role 
of the Ministerial Cabinets and to give the Administration a more decisive role. As a result, the 'Ministerial cabinet' 
was replaced by a personal secretariat of the Minister, a policy council (‘beleidsraad’) and a policy cell 
(‘beleidsvoorbereidende cel’) , which together formed the policy-making bodies of the member of the Government. 
The secretariat is situated on the level of the Minister while the cell is situated on the level of the Administration. 
The policy council is the bridge between the Minister and the Administration. However, Verhofstadt II changed 
some fundamental Copernicus decisions (Royal Decree 19th July 2003). The ‘neutral’ cell situated in the Admin-
istration remained the powerful and political player of the Minister (cfr. Ministerial Cabinet). In practice, it just 
meant a change of name (Devos, 2006). 
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public attention for ‘new’ themes were observed. Many respondents felt that a historical switch 
was introduced. This has largely influenced the development of Belgian drug policy.  
 
“Euphoria prevailed: ‘it will be better’. Regarding the drug issue, we had the feeling that we finally 
could make some progress towards a more efficient policy.” (Respondent 20, policy-maker). 
 
“I am convinced that the outcome of the drug policy and the drug law in particular would not have 
been the same with another Coalition led by the Christian Democratic Party.” (Respondent 51, pol-
icy-maker). 
 
Table 6: Composition of the Belgian Government and Parliament (1996 – 2003) 
 
 Government Dehaene II Government Verhofstadt I 
Start date 23 June 1995  12 July 1999 
End date 12 July 1999  12 July 2003 
Number of parties 4 6 
Composition Coalition CVP 
PSC 
PS 
SP 
VLD 
PS 
PRL-FDF-MCC 
SP 
Ecolo 
AGALEV 
MPs majority 82 MPs  94 MPs 
MPs opposition 68 MPs  56 MPs 
 
The 1999 Federal Government Policy Statement, put forward by the new government, addressed 
a number of so-called ‘ethical topics’, including drugs (alongside e.g. euthanasia). The new Gov-
ernment expressed their intention to develop a coherent drug policy. Even though it has long 
been the exclusive domain of Justice, the drug issue was clearly addressed from a public health 
approach (Federal Government, 1999). Likewise, it was underlined that science was an im-
portant resource in policy-making (as an answer to the lack of scientific research in Belgium, 
highlighted in the PWG). Within this framework, the Verhofstadt I Government stressed that the 
Federal Government had the task of presenting an evaluation report to the Parliament regarding 
the current drug policy within six months. This report had to include an evaluation of (1) the 
implementation of the Ministerial Circular Letter of 8 May 1998, (2) the implementation of the 
final conclusions of the PWG and (3) some experiences of other countries (see also §4.1.). Its 
final goal was to allow the Federal Government to develop, together with the Federal Parliament, 
a coherent (evidence-based) drug policy in Belgium. In this way, the 1999 Federal Government 
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Policy Statement, a powerful guiding tool in a legislature, already announced some important 
steps towards the realisation of a coherent drug policy. 
 
“The 1999 Federal Government Policy Statement played an important role. If this document in-
cludes certain measures, the Government feels obliged to execute these during the legislature.” 
(Respondent 52, scientist). 
 
As another example, Prof. Dr. Brice De Ruyver became the security advisor to Prime Minister 
Guy Verhofdstadt in April 2000. Assistance in the development of a coherent Belgian drug policy 
was one of his main assignments. His prominent role in the policy-making process (at the gov-
ernmental level in particular) is quite unique in the Belgian (drug policy) context (see also be-
low, Chapter 4) and confirms the intention of the new Government to allocate a larger role to 
scientific knowledge in the policy-making process. 
 
4.1. Evaluation report 
With regard to the development of Belgian drug policy, the policy-funded evaluation study aim-
ing at studying the progress of Belgian drug policy as well as the experiences of other countries 
(De Ruyver, et al., 2000) was one of the most important realisations during the intermezzo. The 
Minister of Justice Marc Verwilghen had to coordinate the evaluation described in the 1999 Fed-
eral Government Policy Statement (Federal Government, 1999). In particular, he outsourced the 
evaluation of the implementation of the final conclusions of the PWG, and of the experiences of 
some other countries, to an external research team63 while the evaluation of the implementation 
of the Ministerial Circular Letter of 8 May 1998 was commissioned to the Criminal Policy Service 
[Dienst Strafrechtelijk Beleid] (Hand. Kamer 1999-2000, 13 juni 2000, 716/1, p.81).64 The alloca-
tion of this evaluation to Prof. Dr. Brice De Ruyver (and Prof. Dr. Joris Casselman) can be seen as 
a reflection of his expertise and networks (due to the organisation of the national conferences 
‘Drug Policy 2000’) as well as of his large role in the PWG (observer-turned player; see Chapter 2, 
§2.2.2.). The evaluation study (De Ruyver, et al., 2000), handed over on 12 January 2000, con-
cluded that some priorities of the 1995 Federal Action Plan Toxicomania-Drugs as well as a 
small number of recommendations of the PWG (1996-1997) were elaborated. While we ad-
dressed the realisations of the action points of the Federal Action Plan Toxicomania-Drugs above 
                                                          
63  The external research team conducting this evaluation research consisted of Prof. Dr. Brice De Ruyver (Ghent 
University) and Prof. Dr. Joris Casselman (KULeuven).  
64  The Criminal Policy Service (Dienst Strafrechtelijk Beleid) is responsible for advice and support regarding the 
drug policy matters in the field of Justice (e.g. drug-related crime, drug use in prisons). It is also responsible for 
collecting and analysing scientific research as well as guiding (and sometimes conducting) research projects re-
garding criminal policy topics.  
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(Chapter 1, §3), in the following, we discuss to what extent the recommendations of the PWG 
were met.  
 
At the local level, some structures of consultation and coordination were developed. For 
example, the city of Antwerp (i.e. Local Coordination Drugs Antwerp) played a leading role (De 
Ruyver, et al., 2000, p.9). 
The collaboration between justice and treatment required cooperation protocols and 
agreements considering and respecting the different goals and principles of both sectors (e.g. 
professional confidentiality). Some protocols were already developed by the Centra voor Alcohol 
en andere Drugsproblemen (CAD-Limburg) together with the local justice officers in order to 
improve the collaboration without compromising confidentiality (De Ruyver, et al., 2000, p.26-
27). At the same time, it was stated that the ‘houses of justice’ (established in 1999, but not fully 
operationalised yet) increasingly played a connecting role in the collaboration between the 
criminal justice system and drug treatment (De Ruyver, et al., 2000, p.38).  
In zooming in on the development of epidemiological and evaluation research and regis-
tration systems, attention on the drug phenomenon in Belgium increased slowly. While registra-
tion systems (e.g. ‘Flemish registration of drug use’ by the VAD) were initiated, some research 
initiatives were established: the development of a model framework for alternative measures 
towards (problematic) drug users in the criminal justice system (1997-1998) and a qualitative 
(ethnographic) study of cocaine users in Antwerp. However, knowledge about of the drug phe-
nomenon (e.g. about drug consumption and drug-related problems) remained rather incomplete 
(De Ruyver, et al., 2000, p.20). 
As noted above, on 8 May 1998, a new Ministerial Circular Letter (also called ‘De Clerck-
Van Parys’ Ministerial Circular Letter)65 was published. The evaluation report demonstrated 
several problems. This new Ministerial Circular Letter served as an illustration of the compro-
mise between a public health and repressive/legalistic discourse. On the one hand, it was recog-
nised that drug use is a matter of public health while on the other hand, justice (instead of social 
workers) had the responsibility of ‘objectively’ measuring the problematic66 nature of drug use. 
Furthermore, the study stressed that the inclusion of vague notions like ‘public nuisance’ and 
                                                          
65  The Minister of Justice Stefaan De Clerck (CVP) developed the Ministerial Circular Letter of 1998. However, he 
resigned after the escape of Marc Dutroux in April 1998. His place was taken by his fellow party member Tony Van 
Parys who eventually launched the Ministerial Circular Letter in May 1998. 
66  “Problematic use includes, among other things, sustained regular use, dependence, addiction, lack of social-economic 
integration or crisis situations” (p.4). 
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‘problematic use’ and ‘limited possession for personal (single or occasional) use’67 as well as a 
wide range of possible interventions (dismissal, referral to court, alternative options like praeto-
rian probation, mediation, …) resulted in arbitrariness and a lack of uniformity in prosecutions 
by different Public Prosecutor’s offices. The prosecution of cannabis possession ranged from five 
grams in one district to fifty grams in another (De Ruyver, et al., 2000, p.41-48). Even though the 
number of police records related to drugs decreased from 20.400 in 1999 to 14.225 in 2000, the 
qualification ‘use and possession of drugs’ was still applied in 60% of the police records related 
to drugs. About 70% of these records were referring to cannabis (De Ruyver, et al., 2004). 
 
Other recommendations of the PWG were not yet met entirely, including the establishment of an 
integral and integrated drug policy with a vertical and a horizontal policy coordination; address-
ing the fragmentation of funding; a legal framework for methadone treatment; the increase of 
interest in psychoactive medicines or smart drugs within the framework of prevention; the de-
velopment of scientific research about drug-related criminality and nuisance, and; the develop-
ment of a prison drug policy, etc.  
 
4.2. Federal Safety and Detention plan: drug nuisance and criminality (2000) 
Despite the aim of providing a public health approach, drug policy was initially classified under 
the competences of the Minister of Justice, Marc Verwilghen (VLD, Flemish Liberals). On 1 Octo-
ber 1999, the new Government appointed Minister of Justice Marc Verwilghen to develop a Fed-
eral Security plan68. An Inter-Cabinet Working Group (ICWG) was installed (see also below, 
Chapter 4, §2) and took the advice of scientists (e.g. Prof. Dr. M. Cools, Ghent University) and 
practitioners for granted. For instance, the Minister of Justice Marc Verwilghen invited some 
practitioners.  
 
“I contacted the employees of the Ministerial Cabinet of Minister of Justice Marc Verwilghen. They 
were prepared to arrange a meeting to discuss the memorandum and to elucidate the Federal 
Safety and Detention plan.” (Internal communication Memorandum group, 6 December 1999). 
 
When presenting his 2000 Budgetary Note, Minister of Justice Marc Verwilghen, specified that 
the highest priority had to be given to (individual and social) drug prevention, in particular in 
the field of health, education, research and training (Hand. Kamer 1999-2000, 12 november 
                                                          
67  These notions had been heavily criticised by both the academic world and practitioners (Kaminski, 1998). For 
instance, it was not at all clear what amount had to be considered as possession for personal use (De Ruyver, et al., 
2000; p.41). 
68  In the Government Policy Statement, the preliminary name ‘Federal Safety plan’ was used. In a following stage, the 
‘Federal Safety and Detention plan’ was developed.  
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1999, 198/13, p.52). However, the first version of Federal Safety and Detention plan included 
several measures and projects regarding drug-related nuisance and crime and reflected a legal-
istic/repressive discourse (instead of a public health approach) (Guillain, 2003). Respondents 
illustrated this point too: 
 
“The initial Federal Security plan focused on issues of security like e.g. drug supply. There were no 
links with an integral approach taking into account the premise of public health.” (Respondent 50, 
scientist). 
 
The French-speaking Socialists as well as the French-speaking and Dutch-speaking green parties 
reacted furiously and, accordingly, on the Council of Ministers of 27 January 2000, the develop-
ment of a coherent drug policy was entrusted to the Minister of Public Health Magda Aelvoet 
(Flemish Green party AGALEV). 
 
“The Minister of Justice wrote a Note and presented it to the Council of Ministers. However, this 
Note did not follow the public health approach put forward by the PWG and the Federal Govern-
mental Declaration. The Council of Ministers did ask Minister of Public Health to write another 
Note […]They blew the whistle on Verwilghen.” (Respondent 20, policy-maker). 
 
The final version of the 2000 Federal Safety and Detention plan of the Federal Government 
summed up the priorities for Belgian integral security policy (Hand. Kamer 1999-2000, 13 juni 
2000, 716/1; Devroe, 2002). In the section on drug-related nuisance and drug-related crime, it 
was stressed that an Inter-Cabinet Working Group (under the coordination of Federal Minister 
of Public Health) had to develop an integrated and integral drug policy69. The goal was to launch 
the first national drug strategy in November 2000; it was finally established in January 2001 
(see also below, Chapter 4, §3). Alongside the section on drug-related nuisance and drug-related 
crime, the theme of drugs also came to the forefront by discussions on topics like international 
cooperation in the struggle against drug trafficking, prevention of drug use in schools, in traffic 
or among hooligans, secondary and tertiary prevention of drug addicts, extension of alternative 
measures towards drug users, analysis and prevention of supply and traffic of drugs at metro-
politan level (Hand. Kamer 1999-2000, 13 juni 2000, 716/1). Clearly, the 2000 Federal Safety 
and Detention plan was inspired by some of the conclusions and recommendations of the PWG. 
The fact that the attention given to the drug issue remained rather limited and, particularly, did 
not reflect a public health discourse, increased the pressure on the Government to develop the 
first national drug strategy.  
                                                          
69  The importance of the development of an integrated and integral drug policy was already stressed in the PWG. 
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“About 99% of that plan concerned the implementation of the recommendations of the Parliamen-
tary Inquiry Commission (Dutroux Inquiry). Some topics were related to the drug issue but that 
was really a minimum […] Drugs were no priority for Public Prosecutors, their focus lied on organ-
ised crime.” (Respondent 17, policy-maker). 
 
“The Federal Safety and Detention plan was finished in 2000. If this plan would have been the only 
initiative based on the PWG, it would be terrible. The only focus was on the supply and the profit. 
These limitations did put some pressure on the Government to develop a Federal Drug Policy 
Note.” (Respondent 50, scientist). 
 
5. Attention for drugs and drug policy in parliamentary activities and media 
Within this turbulent framework, we observed some parliamentary and media activity regarding 
the drug issue. Even though the general attention to the drug issue decreased, the aftermath of 
the Parliamentary Working Group on drugs, the launch of the new Ministerial Circular Letter of 
8 May 1998, the 1999 Federal Government Policy Statement and the 2000 Federal Safety and 
Detention plan grabbed the attention of the MPs and journalists.  
 
Making use of their capacity to monitor and control the activities of the Government and aiming 
for (individual) recognition among the public (and their electorate), the opposition MPs posed 
questions70 or submitted interpellations67, resolutions71 or bills72. Within this framework, 
                                                          
70  Members of the Chamber of Representatives may submit written questions as well as oral questions. In contrast 
with interpellations, these questions are always directed to one Minister and cannot lead to the resignation of the 
Government or a particular Minister (Devos, 2006; Van der Hulst, 2010). In the plenary meetings as well as in the 
standing Commissions of the Chamber of Representatives (not in the Senate), members may intervene with a par-
liamentary interpellation. An interpellation requires one or more Ministers or the Government to explain some act 
or policy. Interpellations can be followed by a motion (Devos, 2006). (Hand. Kamer 1996-1997, 24 juni 1997, 175; 
Hand. Kamer 1996-1997, 26 juni 1997, 178; Hand. Kamer 1996-1997, 22 september 1997, 393; Hand. Kamer 
1997-1998, 22 maart 1999, 774, 1-2; Hand. Kamer 1998-1999, 15 juli 1999, 003, 63; Hand. Kamer 1998-1999, 16 
juli 1999, 005, 135; Hand. Kamer 1999-2000, 15 december 1999, 0025/037; Hand. Kamer 1999-2000, 15 decem-
ber 1999, COM 074, 9-13; Hand. Kamer 1999-2000, 25 januari 2000, COM 094, 5-9; Hand. Kamer 1999-2000, 15 
juni 2000, 061, 16; Hand. Kamer 1999-2000, 4 juli 2000, COM 255, 18; Hand. Kamer 1999-2000, 9 november 2000, 
081, 12; Hand. Senaat 1997-1998, 7 mei 1998, 1-183; Vr. en Antw. Kamer, 9 oktober 1998, nr. 49/B152 (Vr. nr. 951 
F. Van den Eynde); Vr. en Antw. Senaat, 12 januari 1999, nr. 1-90, 4733 (Vr. nr. 1479 M. Olivier); Vr. en 
Antw. Senaat, 4 januari 2000, nr. 2-6, 201 (Vr. nr. 170 V. Van Quickenborne); Vr. en Antw. Senaat, 4 januari 2000, 
nr. 2-6, 203 (Vr. nr. 171 V. Staveaux-Van Steenberge); Vr. en Antw. Senaat, 18 januari 2000, nr. 2-7, 236 (Vr. nr. 191 
V. Van Quickenborne); Vr. en Antw. Kamer, 4 februari 2000, nr. 50/22, 2415 (Vr. nr. 67 F. Van den Eynde); Vr. en 
Antw. Senaat, 20 juli 2000, nr. 2-67, 11 (Vr. nr. 2-333 V. Van Quickenborne); Vr. en Antw. Senaat, 20 juli 2000, nr. 2-
67, 15 (Vr. nr. 2-334 L. Caluwé). 
71
  Submitting a resolution can be seen as a general instrument of a member of the Chamber of Representatives to 
express his/her view point about a topic about which one has little to say. Mostly, a resolution concerns a reaction 
regarding a foreign political situation or event (Devos, 2006; Van der Hulst, 2010). For instance, a resolution was 
submitted by members of the green parties: Mr. Vincent Decroly (Ecolo, French-speaking Greens), Mrs. Martine 
Schüttringer (Ecolo, French-speaking Greens), Mr. Frans Lozie (AGALEV, Flemish Greens), Mr. Olivier Deleuze 
(Ecolo, French-speaking greens) and Mr. Jef Tavernier (AGALEV, Flemish Greens). They provided arguments in fa-
vor of a revision of the international conventions (Voorstel van resolutie waarbij de Belgische regering wordt ver-
zocht op de Algemene Vergadering van de VN in juni 1998 te bevorderen dat de internationale verdragen op het 
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the discursive struggle with the different interpretations of the drug problem was demonstrated 
again. By some MPs, drugs was seen as deviant and a threat for society. They referred to a legalis-
tic definition of drugs included in the international conventions and national legislation. Con-
versly, some progressive voices argued that drug taking is a self-regarding act, and accordingly 
not a matter for governments. The parliamentary focus was clearly on the most controversial 
topic: the cannabis prosecution policy. We found that scientific knowledge/experts as well as the 
media and the political context played a role in the arguments provided in these interpellations, 
questions, bills and resolution. 
 
5.1. Scientific knowledge and scientists 
Those who participated in the parliamentary debates often stressed their aim of taking into ac-
count scientific knowledge (cfr. status model). Two MPs introduced their bill as follows: 
 
“It is our intention to develop a coherent policy based on objective scientific research, independent 
of ideologies […] The claim that cannabis use causes a loss of motivation is disproven by recent sci-
entific research.” (Mr. Vincent Van Quickenborne and Mr. Patrik Vankrunkelsven, MPs VU&ID, 
Flemish Nationalists; Parl.St. Senaat 2000-2001, nr. 2 - 585/1). 
 
Scientific knowledge mostly concerned numbers (from policy-funded studies or epidemiological 
research), completed with non-academic reports of international organisations (e.g. EMCDDA, 
WHO) or conclusions of international Commissions (e.g. British Wooton Commission (1969), 
Canadian LeDain Commission (1970), Dutch Baan Commission (1972), French Roques Commis-
sion (1997)…).  
                                                                                                                                                                                     
gebied van drugs worden herzien (ingediend door Mr. Vincent Decroly, Mrs. Martine Schüttringer, Mr. Frans Lozie, 
Mr. Olivier Deleuze and Mr. Jef Tavernier), Parl.St. Kamer 1997-1998, nr. 1571/1). 
72
  Voorstel van wet tot regeling van de teelt, de distributie en de verkoop van cannabis (ingediend door Mr. Vincent 
Decroly, Mrs. Martine Schüttringer and Mr. Frans Lozie (Flemish and French-speaking Green party)), Parl.St. Ka-
mer 1996-1997, nr. 1186/001; Voorstel van wet tot wijziging van de wet van 24 februari 1921 betreffende het 
verhandelen van de giftstoffen, slaapmiddelen en verdovende middelen, ontsmettingsstoffen en antiseptica, ten-
einde het gebruik van cannabis uit het strafrecht te halen (ingediend door Mr. Patrick Moriau and Mr. Thierry Giet 
(both PS, French speaking socialists)), Parl.St. Kamer 1999-2000, nr. 0727/001; Voorstel van wet tot wijziging van 
de wet van 24 februari 1921 betreffende het verhandelen van de giftstoffen, slaapmiddelen en verdovende midde-
len, ontsmettingsmiddelen en antiseptica, ten einde het bezit van cannabis en derivaten ervan gedeeltelijk uit het 
strafrecht te halen (ingediend door Mr. Daniel Bacquelaine and Mr. Olivier Chastel (both PRL-FDF, French spea-
king liberals)), Parl.St. Kamer 1999-2000, nr. 0461/001; Voorstel van wet tot verstrenging van de straffen zoals 
bepaald in de wet van 24 februari 1921 betreffende het verhandelen van de giftstoffen, slaapmiddelen en verdo-
vende middelen, ontsmettingsstoffen en antiseptica (ingediend door Mr. Filip De Man and Mr. Gerolf Annemans 
(both Vlaams Blok, Flemish extreme right party)), Parl.St. Kamer 1999-2000, nr. 0389/001; Voorstel van wet tot 
regeling van de teelt, de distributie en de verkoop van cannabis (ingediend door Mr. Vincent Decroly, Mr. Paul 
Timmermans, Mrs. Zoé Genot and Mrs. Simonne Leen (Flemish and French-speaking Green party)), Parl.St. Kamer 
1999-2000, nr. 0780/001; Voorstel van wet tot wijziging van de wet van 24 februari 1921 betreffende het verhan-
delen van de giftstoffen, slaapmiddelen en verdovende middelen, ontsmettingsstoffen en antiseptica (ingediend 
door Mr. Vincent Van Quickenborne and Mr. Patrik Vankrunkelsven (both VU&ID, Flemish Nationalists)), Parl.St. 
Senaat 2000-2001, nr. 2 - 585/1. 
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"A recent study of smoking behavior among young people, carried out by the University of Ghent, 
confirms the survey conducted by OIVO in 1995 […] According to the French Roques Commission 
only few cannabis users are problematic users […] Taking into account the recent report of the 
EMCDDA and Europol statistics, cannabis appears to be the most commonly used illicit drugs in 
the EU.” (Mr. Vincent Decroly, Mr. Paul Timmermans, Mrs. Zoé Genot and Mrs. Simonne Leen, MPs 
Flemish and French-speaking Green parties; Parl.St. Kamer 1999-2000, nr. 0780/001). 
 
As in the example above, scientific research was often presented without naming the author or 
institution (‘research shows’, ‘research confirms’, ‘some authors mention’, ‘the literature shows’, 
etc). Footnote references and bibliographies were rarely included and often incomplete (wrong 
order, no author, no place of publication, no page numbers, etc.) or out-of-date. 
 
“All the research that in recent years has been conducted (including in the annual police statistics ) 
points in the  same direction” (Mr. Filip De Man and Mr. Gerolf Annemans, MPs Vlaams Blok, Flem-
ish extreme right party; Parl.St. Kamer 1999-2000, nr. 0389/001).  
 
“All researchers and clinicians agree on some points, namely […], but on no medical ground. (Foot-
note): CONNER C., « Marijuana and alcohol use in pregnancy », Drug Intelligence and Clinical 
Pharmacy, 18(3): 233-4, Mars 1984; « Encyclopédie médicochirurgicale , Toxicologie, Pathologie 
professionnelle, Dépendance vis-à-vis des drogues illicites » 16-001-G-60, pp. 8,9; ESCOHOTADO A., 
« Histoire élémentaire des drogues. Des origines à nos jours », Ed. Du Lézard, Paris, 1995 ; DEWEY 
W., « Cannabinoid pharmacology », Pharmacol. Rev., 1986, 38, pp. 151 - 178 ; FRIED P., MAKIN J., 
«Neonatal behavioural correlates of prenatal exposure to marijuana, cigarettes and alcohol in a 
low risk population », Neurotoxicology and Teratology, 9(l): 1-7, 1987, Jan-Feb , HOLLISTER L., 
«Health aspects of cannabis », Pharmacol, Rev., 1986, 38, pp. 1-20, JOHNSON M., MELVIN L., « Can-
nabinoids as therapeutic agents », CRC Press, 1986, pp. 121-145 […]”(Mr. Patrick Moriau e and Mr. 
Thierry Giet, MPs PS, Walloon socialists; Parl.St. Kamer 1999-2000, nr. 0727/001). 
 
These footnotes also revealed that the reports of those studies were not consulted in detail and 
that the Internet was an easy source in the search for supporting research. This finding is in ac-
cordance with Ritter (2009) who found that the third most frequently mentioned source used by 
policy-makers was the Internet (notably Google and websites of national research centres). The 
most common way of getting access to scientific knowledge was through contacting an expert. 
Indeed, in this study, MPs mentioned to turn to scientists for advice or background information. 
Consulting archives or libraries was considered too time-consuming.  
 
“Cannabis can be distributed by pharmacies (1) […] Inhalation of marijuana smoke relaxes the 
muscles within the body (5) (Footnote): See www.maripharm.nl.” (Mr. Vincent Van Quickenborne 
and Mr. Patrik Vankrunkelsven, MPs VU&ID, Flemish Nationalists; Parl.St. Senaat 2000-2001, nr. 2 
- 585/1). 
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“After a while, you have a network of experts that you can consult. You can ask these scientists 
questions but they also send you information. That is the way it works.” (Respondent 35, policy-
maker). 
 
Purposefully searching for scientific knowledge or scientific advice provoked political/symbolic 
utilisation. The selection of scientific knowledge or scientific advice tended to depend on the 
political ideology of the MP and the personal preferences/networks/education (similar to the 
selection of experts in the PWG). For instance, an MP with a medical background was more in 
favour of consulting and referring to doctors or psychiatrists, while former academics more 
tended to consult scientific experts. 
 
“I had to search everything that was in favour of our point of view. It was no objective, scientific 
study, no […] MPs have to impress and present themselves as capable […] Parliamentary work ra-
ther involves ‘action-reaction’ instead of a long-term study […] Everyone has his side of the story 
and his truth […] you hear want you want to hear and you use it in your story.” (Respondent 42, 
policy-maker). 
 
“I worked as an academic, I knew most of the professors. Of course, then, you know who to consult.” 
(Respondent 22, policy-maker). 
 
There were some examples of cherry-picking (or trawling; Stevens, 2007a) of scientific 
knowledge. For instance, although scientists, practitioners and MPs agreed in the PWG that there 
was no scientific evidence in favour of the stepping stone theory, this argument was ignored by 
some MPs. They assumed that there was a quite strong link between alcohol use and cannabis 
use and between cannabis use and the use of other illegal drugs. The existence of a connection 
between the use of cannabis and the use of other illegal drugs was one of the most cited argu-
ments in favour of a repressive approach.  
 
“We are starting to find some indications, concerning alcohol, for possible genetic predisposition, 
but it is certainly not enough to claim that there is or isn’t a steppingstone theory. It is too early to 
say.” (Mr. Jan Van Erps, MP CVP, Flemish Christian Democrats; Hand. Kamer 1996-1997, 24 juni 
1997, 175). 
 
Furthermore, there were some examples where scientific knowledge was misused or misin-
terpreted. First of all, juggling with numbers or scientific results was a common practice. For 
instance, the prevalence rates of cannabis use among young people were used to argue about the 
prevalence of cannabis use among the Belgian national population.  
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“Cannabis use in Belgium. The use of cannabis in Belgium is lower than the European average. […] 
one out of five European youngsters has experimented with cannabis.” (Mr. Vincent Van Quicken-
borne and Mr. Patrik Vankrunkelsven, MPs VU&ID, Flemish Nationalists; Parl.St. Senaat 2000-
2001, nr. 2 - 585/1). 
 
Additionally, conclusions from ongoing or finished studies in other countries were fully or par-
tially transposed to the Belgian situation, without taking into account the different contextual 
elements. The only condition was that these studies have proven the particular point of view.  
 
“The conclusions of international studies, quoted by the respected Member, can be transposed 
completely or partly to the Belgian situation […] the studies conducted abroad are useful and the 
side effects are acceptable.” (Mr. Marcel Colla, Federal Minister of Public Health SP, Flemish Social-
ists; Hand. Kamer 1996-1997, 24 juni 1997, 175). 
 
5.2. Political setting 
The parliamentary process is a political game between majority and opposition where party 
policies and internal party hierarchies play a role73. Political tactics/strategies are often used 
to enhance or disprove the credibility of the opinions or sources offered. For instance, MPs made 
use of rather extravagant vocabulary and metaphors. Members of the Flemish extreme right par-
ty Vlaams Blok were regularly termed as preachers, while members of the green parties 
(AGALEV/ECOLO) were called drug prophets. Similarly, some MPs used personal (ad hominem) 
insults. An interviewee explained: 
 
“The drugs prophets played tactically very well. Something that would not have been thinkable one 
or two years ago […] Mr Lozie, you are a very intelligent person and you have developed all your 
arguments in a very constructive, premeditated and sophisticated way. I can’t cope with this level” 
(Mr. Filip De Man, MP Vlaams Blok, Flemish extreme right party; Hand. Kamer 1996-1997, 24 juni 
1997, 175). 
 
“It is indeed insulting, that is correct. But that is part of the parliamentary culture. I succeeded in 
dealing with it because it is just part of it.” (Respondent 7, policy-maker). 
 
Furthermore, since the concept de facto depenalisation was replaced by the lowest prosecution 
priority for cannabis possession for personal use, MPs confusingly (and often consciously) re-
ferred to the liberalisation of cannabis as a de jure depenalisation, a decriminalisation and even a 
legalisation. For instance, MP Filip De Man (Vlaams Blok, Flemish extreme right party) argued 
                                                          
73  For instance, so-called backbenchers (i.e. they sit in the rows of seats behind the frontbench including the more 
powerful and experienced MPs and Ministers) have less power than frontbenchers and get less opportunity to 
submit a question or interpellation. 
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that “Regarding soft drugs, expert Arlacchi agrees that the proposed legalisation of cannabis use is 
a bad solution” (Hand. Kamer 1996-1997, 24 juni 1997, 175). Accordingly, one of the primary 
talking-points of the Federal Minister of Justice in answering the questions and the interpella-
tions involved clarifying that the Belgian Government was not talking about legalisation or de-
criminalisation.  
 
The strategy of projecting the effects of criminalisation or legalisation based on analogies of ex-
periences of other places (e.g. the Dutch coffee-shop model policy versus the American War on 
Drugs), so-called policy platonism (MacCoun and Reuter, 1997), was also commonly used. For 
instance, it was stated by some MPs that the depenalisation of cannabis possession will increase 
the demand (Hand. Kamer 1999-2000, 13 juni 2000, 716/1). Arguments were supported by the 
1997 Amsterdam Treaty, the report of the Inter-parliamentary Advisory Council of the Benelux 
countries as well as the Dutch policy paper ‘Pathways to the back door’. 
 
Additionally, an appeal to emotions was another important strategy. It involved inciting emo-
tions in people in order to persuade them that a particular statement or argument is true or 
false, independent of the scientific evidence. As in the example below, drug use was often linked 
with committing suicide, HIV, death and criminal organisations.  
 
“Drugs are the direct cause of crimes and social or health problems (absenteeism, car accidents, 
HIV)[…] Important enough to break the taboo and think about solutions” (Mr. Filip De Man and 
Mr. Gerolf Annemans, MPs Vlaams Blok, Flemish extreme right party; Parl.St. Kamer 1999-2000, 
nr. 0389/001). 
 
Equally, cannabis use was repeatedly presented as society's enemy victimising young people.  
 
“In the Parliament, the game is played in a political way. Children or youngsters are often involved 
in the arguments.” (Respondent 29, policy-maker). 
 
Finally, the use of personal opinions or experiences (so-called tacit knowledge) rather than ra-
tional arguments was common practice. Many Members of Parliament complemented their role 
as MP with other roles (dual role). For instance, participants made references to their role as a 
doctor, as a parent or as a practitioner (e.g. health worker, animator). 
 
“As a physician, I also believe that...” (Mr. Jef Valkeniers, MP VLD, Flemish Liberals; Hand. Kamer 
1996-1997, 24 juni 1997, 175). 
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“When I was a youth worker, I often participated in debates with parents, to talk about drugs” 
(Mrs. Martine Schüttringer, MP Ecolo, French-speaking Green party; Hand. Kamer 1996-1997, 24 
juni 1997, 175). 
 
5.3. Media coverage and interest groups 
Internal conflicts and financial disputes rapidly decreased the power of the interest group Bel-
gian Cannabis Consumers’ organisation (the interest group was set up in 1994 and ceased to exist 
in 1998). Other interest groups (e.g. A citizen just like any other and Association against the pro-
hibition) were not as vigorous anymore in promoting their ideas and persuading policy-makers 
through the media. 
 
The media continued to provide the context for (public and) political discussion about Belgian 
drug policy: the time and the space spent on the cannabis issue resulted in (the public and) poli-
cy-makers evaluating the development of Belgian drug policy along the cannabis dimension 
(priming; McCombs and Shaw, 1972). For instance, MPs (and the public) believed that there 
were two positions: either cannabis use is harmless (or at least less harmful than alcohol), and 
hence it should be decriminalised (if not legalised); or cannabis is harmful to health, and there-
fore its use should continue to be prohibited.  
 
The media coverage of the debate depended on which part of the country one lived in or which 
newspaper one read. The Flemish media paid far more attention to the drug phenomenon than 
the French-speaking media. At the same time, both parts of the country presented the debate 
differently. The Flemish media discourse was largely informed by a biomedical/clinical dis-
course (see Part I, Chapter 2) inspired by articles focusing on health problems (e.g. the relation-
ship between cannabis use and cancer or the risks of heart attack). For instance, the Flemish 
newspaper De Morgen reported “14.000 drug addicts end up in hospitals each year” (23 December 
1998, De Morgen). Likewise, the Flemish newspaper De Standaard implied that “Cannabis also 
contains more carcinogens than tobacco. Three joints are equivalent to 20 cigarettes.” (1 December 
2000, Flemish newspaper De Standaard). On the other hand, the French-speaking media had ra-
ther a more nuanced but critical approach, largely focusing on the unproblematic nature of per-
sistent (cannabis) use. “The challenge is to speak the truth [...] It was previously demonstrated that 
there are a lot of myths [...] Overdose and the risks of a hepatitis C pandemic are often discussed but 
self-control strategies of drug use, proven to be successful, not.” (21 November 2000, French-
speaking newspaper Le Soir). Interviewees agreed that the differences in the political landscape 
as well as the characteristics of the news production (e.g. driven by publicity/sensationalism) 
played an important role here.  
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“The editors were interested in the cannabis issue, not in the other drug policy issues. They argued 
that the public was only interested in the cannabis discussion.” (Respondent 46, journalist). 
 
“The differences between the Flemish and Wallon media were large. Politically, a Flemish Minister 
did not appear in a French-speaking newspaper […] There were also two different public opinions 
with different topics at play […] Citizens only read one newspaper. The message they receive is 
fragmented.” (Respondent 45, journalist). 
 
5.3.1. Link media – parliamentary activity 
Media coverage triggered several interpellations and questions (i.e. MPs used media statements 
as an introduction to their question or interpellation) but the media was used to support bills or 
resolutions. The following examples of an MP introducing his question and of MPs supporting 
their bill, illustrate this point: 
 
“The Flemish newspaper De Morgen (20 July 1998) reported that police officers tolerated the use 
of soft drugs during the Gentse Feesten […] Can you confirm this? Who is responsible for this toler-
ance policy? Is this in accordance with the law? (Mr. Francis Van den Eynde, MP Vlaams Blok, 
Flemish extreme right party; Vr. en Antw. Kamer, 9 oktober 1998, nr. 49/B152). 
 
“[…] the average age at which youngsters start using illegal drugs has dropped from 15 to 12 
years, in the last two years. (De Standaard, March 17 1999). Accordingly, people even start talking 
about prevention in kindergarten!” (Mr. Filip De Man and Mr. Gerolf Annemans, MPs Vlaams Blok, 
Flemish extreme right party, Parl.St. Kamer 1999-2000, nr. 0389/001). 
 
Generally speaking, the media appeared to be a useful source of information for the opposition 
MPs: it informed them about what happened in the policy-making process. Newspapers were 
checked in order to set the parliamentary agenda. The accuracy of the media message was not 
taken into account (even if the sensationalists, emotive media discourse clearly fuelled miscon-
ceptions about the debate; see also §5.3.2.). 
 
“There was a lack of information. […] In the opposition, we mostly acted and reacted via the media. 
We had to create news or to react on newspaper articles. The media coverage was our only source 
of information.” (Respondent 42, policy-maker). 
 
The symbiosis between both worlds provided a powerful position for the media in 
(de)constructing success of policy-makers. The media interest in the activities of MPs guaran-
teed that (opposition as well as majority) MPs verbal or written reactions can pass the media 
gates and become news. An active search for media attention was a means of obtaining a higher 
public/political authority. Being aware that they speak for the public, MPs mostly formulated 
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their statements (one-liners) with the utmost caution (especially in sensitive matters like drug 
policy). 
 
“Media and politics? The media is very important. Without media attention, a MP does not exist. 
[…] How are MPs elected? […] MPs prefer an inaccurate coverage instead of no media coverage 
[…].” (Respondent 7, policy-maker). 
 
5.3.2. Coverage of scientific knowledge in the media 
Newspaper articles frequently included academic as well as non-academic sources: expert opin-
ions, police statistics, emergency cases, practice-based research and (inter)national prevalence 
studies. On the one hand, newspapers included scientific knowledge as a response to an event 
that had taken place or was brought to attention. For example, the Flemish newspaper De Mor-
gen reported: “… according to a study commissioned by the Ministerial Cabinet, which the newspa-
per could consult,…” (18 November 1998, Flemish newspaper De Morgen). On the other hand, sci-
entific knowledge was presented as factual information by the media itself. “An American study 
has shown that 10% of the people who have ever experimented with drugs get addicted” (14 May 
1998, Flemish newspaper Gazet van Antwerpen). 
 
The presentation of scientific knowledge in the media was often inaccurate or distorted. First of 
all, newspapers commonly omitted methodological and contextual information. Prominence was 
given to very general and vague labels of scientific knowledge.  
 
"This is supported by findings of the US National Institute of Mental Health." (8 July 1998, Flemish 
newspaper De Morgen). 
 
“A recent publication of a French report argues that cannabis may be less harmful than tobacco” 
(17 July 1998, French-speaking newspaper Le Vif). 
 
Equally, journalists often represented a rather simplistic and one-sided story by referring to 
someone (e.g. scientist, practitioner or former drug user) who confirmed their story. Journalists 
seemed to not pass up their story by displaying research results or experts which would contra-
dict it. For instance, even though the stepping-stone theory has proved to be unsustainable and 
lacking any real evidence base, this perspective still trickled down into the media discourse 
without comment.  
 
“Studies in the U.S. have shown that one in 10 of 18 year-old youngsters gets addicted. In other 
words, the progression from soft to hard drugs is much easier than a few years ago.” (27 February 
1999, Flemish newspaper Het Nieuwsblad). 
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Furthermore, in slow news periods, some newspapers took the opportunity to recycle scientific 
knowledge that had been published earlier. While it had been discussed before in Flemish news-
papers De Standaard (July 1997) and Gazet van Antwerpen (October 1997), another Flemish 
newspaper presented the particular registration study (regarding the number of prosecutions in 
Flanders) as ‘new’ in April 1998. ‘While presenting the new Ministerial Directive [...] Antwerp re-
searchers announced that the number of booked drug users has never been so high’ (28 April 1998, 
Flemish newspaper De Morgen). Although these results were old, newspapers presented them as 
new (by using active verbs) which may generate the impression among the public (and policy-
makers too) that a new study is confirms the conclusions that were made earlier (as they only 
get two separate snapshots). 
 
Journalists countered these problems by pointing to the personal approach of the journalist 
involved (which is never neutral) as well as to the characteristics of news production (e.g. 
limited space, driven by publicity/sensationalism and economic concerns): 
 
“A journalist is never neutral even when he tries to be objective […] Also the selection of experts 
was not totally neutral […] Media did not succeed in reporting in an objective, precise or complete 
way. This was mainly because of the lack of time and the difficulty of reporting information cor-
rectly. The topic of drugs as such is also very complex […] The phenomenon evolved quickly, scien-
tific knowledge evolved, society evolved. So, it was difficult to stay up-to-date.” (Respondent 53 
journalist).  
 
“I search for experts who are knowledgeable about the topic. I also read other journals to find out 
what they write about the topic. That is often the way it works in journalism […] One time, I re-
member, my editorial chief forbade me to speak to someone because he was too much in favour of 
depenalisation.” (Respondent 54, journalist). 
 
Given the strong link between the parliamentary process and the media, the media operated as 
linking mechanism or knowledge distributor between science and policy. Parliamentary activities 
(especially bills and resolutions) were regularly supported by scientific knowledge that was 
framed in newspapers (thus as an indirect reference). In particular, we found that scientific 
knowledge which was repeatedly or extensively included in the newspapers, had a significant 
chance of playing a role in the parliamentary activities. An MP introduced his question as fol-
lows: 
“On 18 December 1999 I have read in the Flemish newspaper ‘Het Belang van Limburg’ that Amer-
ican research has confirmed that cannabis contains more carcinogens than tobacco” (Mr. Francis 
Van Den Eynde, MP Vlaams Blok, Flemish extreme right party; Vr. en Antw. Kamer, 4 februari 
2000, nr. 50/22, 2415). 
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However, the inclusion of scientific knowledge as represented by the media was highly prone to 
political/symbolic utilisation. The lack of any contextual information in media coverage (e.g. 
‘some researchers explain’) as well as the selective inclusion of scientific knowledge, both re-
sulted in policy-makers picking and choosing (also called trawling; Stevens, 2007a) what was 
most supportive of their discourse. Even though scientists admitted that media coverage is a 
way to exert some pressure on policy-makers (e.g. entering the public debate may give the scien-
tist the label of credible expert; see also above), they remained rather hesitant about using me-
dia as an instrument to influence policy-makers. In other words, scientists who engaged in the 
public debate and shouted loudly with rather simple messages, were rarely conclusive. Their 
advice, however, became an instrument in the political game. Interviewees assumed that estab-
lishing a good relationship with some journalists was one way to solve this problem.  
 
“The relationship with the media is difficult. On the one hand, media coverage of scientific 
knowledge was often wrong, but on the other hand, you can take advantage of it […] If we ob-
tained some interesting results, we used the media to influence the policy-making process in a cer-
tain way […] I always tried to establish a good relationship with journalists. You have to be able to 
trust their writing.” (Respondent 24, scientist). 
 
6. Scientific knowledge: progress is initiated 
Scientific knowledge regarding the drug phenomenon in Belgium increased slowly during the 
intermezzo (De Ruyver, et al., 2004). The Verhofstadt I Government stimulated the development 
of scientific research and evaluation. In addition to the evaluation study of De Ruyver et al. 
(2000), several initiatives were taken (Devroe, 2010). First of all, the Belgian Federal Science 
Policy Office (previously known as the Federal Office for Scientific, Technical and Cultural Affairs 
(OSTC)) established research programmes in support of socio-economic (1995-2000) and judi-
cial policy themes (1997-1998). In later years, a ‘Social Cohesion’ research programme (2000-
2004) was also established. These research projects, commissioned by the Belgian Federal Sci-
ence Policy Office, included a study regarding drug use in prisons (1999-2000; social and eco-
nomic research programme), an inventory of drug-related research (1995-1996; social and eco-
nomic research programme) (De Ruyver, et al., 1997; Verslag namens de Parlementaire 
Werkgroep belast met het bestuderen van de drugproblematiek, Parl.St. Kamer, 1996-1997, 
1062/1-3; see also above), a study about the public expenditures of Belgian drug policy (2000-
2004, research programme ‘social cohesion’), and so on.  
 
Even though drug research in Belgium remained rather fragmented and incomplete, general 
trends observed in Belgium were very similar to those noticed in other European countries: an 
increasing drug use with cannabis being the most used drugs and young adults reporting higher 
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rates of cannabis and ecstasy use74, a stable but high level of hepatitis B and C among intrave-
nous drug users and an increase in cannabis treatment demands (EMCDDA, 1999; EMCDDA, 
2000). 
 
During this intermezzo, the three ‘Drugs Policy 2000’ conferences took place. Each of these 
conferences clearly included matters recently addressed by the Parliament and/or Government. 
For instance, in 1997, during the fifth conference, a lot of attention was given to the final report 
of the PWG which was submitted a few months before. Panel sessions concerned topics like the 
professional statute of prevention workers, the controlled substitution of heroin, and the lowest 
prosecution policy for cannabis possession. Similary, during the seventh conference (1999), the 
emphasis was on the development of an integrated and coordinated drug policy, the implemen-
tation of prevention projects on schools and drug treatment in prison, and the international en-
forcement of drug traffic. The programme of this conference clearly took into account the issues 
stipulated by the 1999 Federal Government Policy Statement. Due to the close link with the po-
litical agenda, these conferences provided an ideal forum to discuss particular issues among 
scientists, practitioners and (sometimes) policy-makers as well as to build up a (new) network 
(i.e. in the 1999, a six-party Coalition led by Flemish Liberal Leader Guy Verhofstadt was voted 
into power). At the same time, policy-makers were allowed to test their policy against the views 
and opinions of practitioners and scientists. According to some interviewees, these particular 
conferences influenced drug policy discourse and served as precursors of the coordination 
structures like the Drug Health Policy Cell and the General Drugs Policy Cell (see also Chapter 5). 
 
“Those conferences […] really exercised the minds and stimulated interaction. I think that the con-
sciousness of shared responsibility eventually has led to more cooperation which, in the next phase, 
has expanded to the Drug Health Policy Cell and the General Drugs Policy Cell […] It also stands for 
the foundation and development of a broader discourse: it is not only justice but also treatment 
and public health.” (Respondent 26, practitioner). 
 
7. Conclusion 
Between 1997 and 2000, the subject of drugs was largely overshadowed by the debates over the 
reorganisation of the entire police and justice system and the Dioxin Affair. However, some im-
portant political and/or scientific movements have had certain consequences for the develop-
ment of Belgian drug policy and the interaction between science and policy in particular. 
                                                          
74  The lifetime prevalence of cannabis use in the adult population increased from 1994 to 1999 from 12.8% to 
20.8%. At the age of 15-16 years, the proportion of life time users increased from 14.9% (1994) to 23.7% (1998). 
Cannabis treatment demands raised from 3.8% (1993) to 14% (1998). The rates of HBC and HCV infections were 
stable at respectively 24% (HBC) and 38-52% (HCV) of tested IVDUs (having injected at least once) (BIRN, 2000). 
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First of all, it became clear how scientific knowledge was used or regarded by members of the 
Government. Except for the launch of a new Ministerial Circular Letter in April 1998, many rec-
ommendations of the PWG were not implemented during the intermezzo. The Ministerial Circu-
lar Letter followed the conclusions of the PWG: possession of illegal drugs remained punishable, 
and the lowest prosecution priority was given to the possession of cannabis for personal use. For 
the first time, a distinction was made between the prosecution policy with regard to cannabis 
and to other illicit drugs. However, consistent with the political/symbolic utilisation of scientific 
knowledge (Weiss, 1979), the Ministerial Circular Letter ignored the fact that vague notions such 
as ‘public nuisance’, ‘problematic use’ and ‘limited possession for personal (single or occasional) 
use’ were heavily criticised by academics (and practitioners) (Kaminski, 1998). Consequently, 
the inclusion of these vague notions (as well as a wide range of possible interventions) contin-
ued to result in arbitrariness and a lack of uniformity in prosecutions by different Public Prose-
cutor’s offices (De Ruyver, et al., 2000). In a similar vein, on the threshold of the Federal elec-
tions in 1999, policy-makers used scientific knowledge rather strategically. In order to please 
their electorates and gain authority, some of them used a well-stocked portfolio of commis-
sioned research to demonstrate that they attach importance to scientific knowledge. Clearly, 
given this context, it is advisable to classify this type of use, termed status model in the literature 
(Cross, et al., 2000), into Weiss’s knowledge utilisation framework as a sub-type of politi-
cal/symbolic utilisation (Weiss, 1979). 
 
In 1999, Belgian voters rejected the longstanding Coalition Government of Christian Democrats 
and Socialists and voted into power a Coalition led by Flemish Liberal Leader Verhofstadt. This 
change turned out to be an important facilitator of the development of a public health drug poli-
cy. It also increased the credence given to scientific knowledge as an instrument of developing 
drug policy. On the one hand, it was the Minister of Public Health who was eventually given the 
responsibility of developing an integrated and integral drug policy. On the other hand, the Ver-
hofstadt I Government emphasised the importance of scientific knowledge as a resource in poli-
cy-making (evidence-based policy). Accordingly, the number of initiatives funded by research 
programmes of the Belgian Federal Science Policy Office slowly increased. One of the most im-
portant developments was the evaluation of the final conclusions of the PWG and the Ministerial 
Circular Letter of 8 May 1998 (De Ruyver, et al., 2000). This evaluation study was assigned to 
Prof. Dr. Brice De Ruyver (and Prof. Dr. Joris Casselman) as a reflection of his expertise and net-
works (due to the organisation of the national conferences ‘Drug Policy 2000’) as well as his 
important role in the PWG (as an observer-turned player; Loader and Sparks, 2011). Further-
more, Prof. Dr. Brice De Ruyver became the security advisor to Prime Minister Guy Verhofdstadt 
in April 2000. The prominent role of this scientist in the policy-making process (at the govern-
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mental level in particular) is quite exemplary and unique in the Belgian (drug policy) context, 
and will be discussed in Chapter Four. 
 
Secondly, this turbulent intermezzo also illustrated the different modalities through which sci-
entific knowledge contributed to the parliamentary process. Making use of their capacity to 
monitor and control the activities of the Government, opposition MPs engaged in the discursive 
struggle between social and public health issues and law enforcement concerns. MPs who sub-
mitted questions, interpellations, resolutions, bills or resolutions often used scientific knowledge 
(mainly including data from policy-funded studies or epidemiological research) to support their 
arguments. In particular, MPs selected scientific knowledge on the basis of their political ideolo-
gy and their personal preferences/networks/education (political/symbolic utilisation). In most 
cases, scientific knowledge was presented without naming the author or institutions. When 
footnotes and a bibliography were included, it became clear that these references were often 
incomplete or out-of-date. Instances where scientific knowledge was misused or misinterpreted 
(e.g. making facile interpretations, false generalisations and causalities) were also observed in 
the parliamentary debates. Given the prevalence of these examples, Weiss’s political/symbolic 
model (Weiss, 1979) seems to be too simplistic: it fails to distinguish between instances where 
research is truly being used as opposed to where research is being misused or misinterpreted. 
 
Institutional characteristics of the political setting and the individual experiences of policy-
makers impacted on the use of scientific knowledge in the parliamentary process (barriers). 
Parliamentary debates consisted of bargaining and negotiation using whatever arguments that 
could be mustered in support of their position. Over the months of the parliamentary debates, 
the use of political tactics occurred. MPs used rather extravagant vocabulary and metaphors to 
support their arguments, or relied on their personal opinions or experiences more often than on 
scientific knowledge. A similar strategy was inciting an emotional response in people in order to 
persuade them that a particular statement or argument was true or false. Another barrier to 
knowledge utilisation in the parliamentary process can be attributed to the international frame-
work. While using non-academic reports of international organisations (e.g. EMCDDA, WHO) or 
conclusions of international drug policy papers (e.g. the Inter-parliamentary Advisory Council of 
the Benelux countries (1998), Dutch policy paper ‘Pathways to the back door’ (2000), …), com-
pliance with the (developing) international framework was a frequent argument in the political 
debates in refuting scientific advice. 
 
Furthermore, policy-makers (Government and Parliament) commonly mentioned turning to 
scientists from their personal network for advice or background information (see also Ritter, 
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2009). Interaction with policy-makers was likely to improve the utilisation of scientific 
knowledge in the policy-making process. The conferences ‘Drugs Policy 2000’ provided a useful 
setting to discuss the issues central to parliamentary or governmental debates among scientists, 
practitioners and (sometimes) policy-makers as well as to maintain or build up a (new) network. 
In particular, given the new Coalition, these conferences worked as a facilitator of the science-
policy nexus: scientists got to know the new key policy players and were able to build relation-
ships with them (or their representatives). Exemplary too is the initiative of practitioners on the 
threshold of the 1999 elections. Dutch- and French-speaking practitioners united their concerns 
and interests related to budgets or staff in a Policy Memorandum (Memorandum group, 1999). 
This seemed to be a successful strategy. The distribution of the Policy Memorandum resulted in 
a hearing of these practitioners by the Minister involved. Similarly, the Policy Memorandum un-
derpinned some arguments of MPs in the parliamentary debates. 
 
While interest groups were not as vigorous during the intermezzo, a significant cooption of 
media issues in the parliamentary debate was observed. For instance, by means of triggering 
questions or interpellations in the Parliament, the media directed the parliamentary discourse 
towards the cannabis issue (priming; McCombs and Shaw, 1972). Media also influenced the val-
ue placed on scientific knowledge in the parliamentary debates. On the one hand, media state-
ments seemed to be an important resource in supporting assumptions (instead of scientific 
knowledge). On the other hand, the media frequently acted as a source of scientific knowledge. 
However, due to the characteristics of news production (e.g. limited space, driven by publici-
ty/sensationalism and economic concerns), media coverage did not provide a true reflection of 
the scientific results (e.g. incorrect or vague references, lack of accuracy of percentages) but ra-
ther generated political/symbolic utilisation by MPs. In spite of this, we observed that media op-
erated as a strong linking mechanism between science and policy. It became clear that scientific 
knowledge which was included in the press stood a good chance of playing a role in parliamen-
tary activities. Thus, the media may be an important facilitator of the science-policy nexus at the 
parliamentary level, since most research fails to go beyond academic publications. 
 
In 2000, the drug issue gradually re-entered the political agenda in Belgium. The Belgian Gov-
ernment proceeded to translate the final conclusions and recommendations of the PWG into an 
official policy document. We will discuss the development of the first national drug strategy 
(2001), the second milestone in Belgian drug policy between 1996-2003, in the following chap-
ter. 
 
Chapter 4  The Federal Drug Policy Note (2001) 
 
An Inter-Cabinet Working Group (ICWG) had been set up in order to develop the first national 
drug strategy (as was directed by the 1999 Federal Government Policy Statement  and the 2000 
Federal Safety and Detention Plan ). The Federal Drug Policy Note, the second milestone in the 
development of Belgian drug policy between 1996 and 2003, was eventually adopted by the 
Government on 19 January 2001 (Federal Government, 2001a). With the launch of the Federal 
Drug Policy Note, there was finally an official document putting forward the goal of a coherent 
and comprehensive Belgian drug policy. What followed was a chaotic and confusing political and 
media debate.  
 
1. First national drug strategy: the official elaboration of the recommenda-
tions of the PWG 
The Federal Drug Policy Note (2001) indicates that the drug phenomenon is considered to be a 
permanent social reality (i.e. normalisation policy). Accordingly, in the framework of an integral 
and integrated policy75, a discourse with a purely criminal focus was officially replaced by a dis-
course where the drug problem was primarily considered a problem of public health. The Federal 
Drug Policy Note covered both illicit and licit drugs and different Federal Ministers were consid-
ered responsible for the implementation of the national drug strategy76 (De Ruyver, et al., 2004; 
De Ruyver, et al., 2007). The main priorities of the Federal Government were to reduce the num-
ber of drug users, the physical and mental effects related to drug use, and the effects of the drug 
phenomenon on the society. Accordingly, three pillars were put forward: (1) prevention of drug 
consumption; (2) harm reduction, treatment and re-integration, and; (3) law enforcement as the 
last resort (Federal Government, 2001a; p.7). This approach, supported by the first Verhofstadt 
Government (1999-2003), was in line with the final conclusions and recommendations of the 
PWG and international trends (e.g. Inter-parliamentary Advisory Council of the Benelux coun-
tries (1998); European Action Plan to Combat Drugs 2000-200477). 
 
                                                          
75  ‘Integral’ refers to the idea that drug phenomenon is multidimensional and, therefore, all its aspects must conse-
quently be tackled. ‘Integrated’ means the involvement of and (vertical as well as horizontal) harmonisation be-
tween all relevant actors representing the different aspects (De Ruyver, et al., 2009). 
76  The Minister of Public Health, Food Chain Safety and the Environment, the Minister of Internal Affairs, Minister of 
Justice, Minister of Social Affairs, Minister for Social Integration, Minister of Mobility and Transport (traffic safety) 
and the Minister for Small Businesses, Self-Employed, Agriculture and Science policy. 
77  The European Action Plan to Combat Drugs 2000-2004 stressed the need for international cooperation, integra-
tion of drug control and priority to health, education, research and training activities and instruments to combat 
social exclusion. The European Action Plan to Combat Drugs 2000-2004 also clearly indicated the need to empha-
sise the imperatives of public health (De Ruyver, Vermeulen and Vander Beken, 2002). 
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The first national drug strategy consists of three distinguishable parts. The first part captured 
the recommendations of the PWG (p.8-14). The second part described the actual state of the drug 
problem and captured recommendations of the PWG that had already been implemented by the 
time the policy was created (p.14-31). The third part contained five action points (based on the 
three pillars of the Federal Drug Policy Note) and followed the same construction as the first two 
parts (p.31-68): (1) a global and integrated approach; (2) evaluation, epidemiology and re-
search; (3) prevention; (4) health care, harm reduction and reintegration, and; (5) repression. 
The execution of the action points received a substantial budget input: €12.4 million was made 
available for preventive or treatment projects, the creation of the General Cell Drugs, research, 
and so on. (De Ruyver, et al., 2004). In accordance with the recommendations of the PWG, the 
Federal Drug Policy Note dictated the use of this budget in favour of domains other than repres-
sion (e.g. prevention, treatment). Nevertheless, some initiatives were still considered too expen-
sive (e.g. the creation of residential time-out projects, the establishment of a controlled heroin 
maintenance project) (Internal communication Memorandum group, 26 October 2000). 
 
The first action point stressed the need for cooperation and coordination between different poli-
cy actors which was already emphasised by the Parliamentary Working Group on drugs (PWG). 
In pursuing a global and integrated approach, the establishment of a Health Policy Cell and a 
General Drugs Policy Cell was one of the most important action points (Federal Government, 
2001a; p.31). Within the framework of the Federal Drug Policy Note, the collaboration between 
justice and treatment (and thus the alternative measures towards drug users in the criminal jus-
tice system) was promoted as well. Furthermore, it was stated that Belgium had to be involved 
in international relationships and collaborations: EMCDDA, WHO (as national counterparts of 
European alcohol action plan / WHO-Europe), Pompidou working groups and European Union 
projects (Intereg-, Euregio-, Multicity- projects). Finally, in order to manage the diversity of ac-
tors and funding sources, the need for a detailed overview of the public expenditures was under-
lined. For instance, the importance of the study ‘Belgian Drug Policy in numbers’ (2000-2004, 
research programme ‘social cohesion’) was stressed (Federal Government, 2001a; p.15). 
 
In accordance with the recommendations of the PWG (and the priorities of the Federal Safety 
and Detention Plan), the Federal Drug Policy Note included references to the Governments’ (fu-
ture) investment in research and evaluation. It was argued that policy-makers needed reliable 
and accurate data about the nature and the extent of the drug phenomenon in order to formulate 
policy priorities, plan adequate interventions, and evaluate long-term policy (Federal Govern-
ment, 2001a). Even the concept evidence-based was adopted. The Federal Drug Policy Note 
aimed for the development of (1) uniform registrations of problematic drug users and (2) epide-
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miological research of drug use among general populations, school populations or at-risk popula-
tions. The evaluation study of medical-social treatment centres for drug users (MSOC’s) was 
referred to as one important illustration of this particular action point (Federal Government, 
2001a; p.40-41). Likewise, it was argued that questions on drug use had to be included in the 
national Health Interview Survey (HIS) of 2001.78 Furthermore, the Minister in charge of the 
Federal Science Policy received an annual budget to organise and manage a research programme 
supporting decision-making in the field of illegal drugs. The transformation of the national Focal 
Point (i.e. Scientific Institute of Public Health (WIV)) into a Belgian Monitoring Centre on Drugs 
and Drug addictions (BMCDDA) was also recommended. The BMCDDA had to fulfill the tasks 
requested by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) as well 
as further developing the Early Warning system. 
 
A third objective was to enhance prevention, a competence of the Federate governments. In 
accordance with the recommendations of the PWG, the Federal Drug Policy Note included a 
number of actions (e.g. conferences, prevention campaigns, etc.) regarding the use of psychoac-
tive medicines, the problem of driving under the influence of drugs and the alcohol/tobacco policy 
(Federal Government, 2001a; p.41-46). 
 
The Federal Drug Policy Note also aimed to develop a more integrated legal framework for 
treatment, harm reduction and reintegration through local care networks (care circuits) and 
case management. In these networks, some populations had to receive particular attention: e.g. 
youths or psychiatric patients with drug problems (double diagnosis). Similar ambitions related 
to the urgent need for an increase in the capacity of crisis care centres and better organisation of 
aftercare for former drug addicts. It was also determined that collaboration between justice and 
treatment had to be improved through cooperation protocols and agreements considering and 
respecting the different goals and principles of both sectors (e.g. professional confidentiality) 
(Federal Government, 2001a; p.33). Finally, the Federal Government advocated the need to re-
think the international conventions in order to produce a realistic response to cannabis use and 
to elaborate harm reduction initiatives. Regarding the harm reduction initiatives, the Federal 
Drug Policy Note (2001) also included the Federal Government’s aim to evaluate controlled her-
oin maintenance-projects (the establishment of a controlled heroin maintenance project was out 
of the question) (Federal Government, 2001a; p.54-55).  
 
                                                          
78  The questions on drugs were indeed included in the national Health Interview Survey (HIS) of 2001. The number 
of questions on drug use were however limited: two questions on cannabis prevalences and two questions on 
XTC-amphetamines (see also below, Chapter 5). 
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In the field of repression, the recommendations formulated by the PWG were included: the 
criminal response was primarily aimed at the illegal production and the trade of raw materials, 
against synthetic drugs and against the cocaine and heroin trade and to the public nuisance. At the 
same time, the approach towards drug users was supported by the so-called ultimum remedium. 
The focus was on a differentiation and individualisation of the criminal intervention, taking into 
account the specific situation (cannabis versus other illegal drugs; experimenting; problematic 
use; personal use; dealing with profit, and so on). In accordance with this point of view, the Fed-
eral Government planned to amend the Belgian Narcotic Drug Law of 1921 on two counts (Fed-
eral Government, 2001a; p.58). First, a distinction between cannabis and other illegal drugs was 
supported and secondly, the qualification ‘use of illicit drugs in a group’ had to be eliminated. 
The modalities concerning the distinction and the prosecution policy had to be outlined in a Min-
isterial Circular Letter. It was stated that the Ministerial Circular Letter had to be based on the 
recommendations of the PWG and had to meet the conditions stipulated by the evaluation study 
(De Ruyver, et al., 2000). Accordingly, the Federal Drug Policy Note put forward that the term 
‘public nuisance’ referred to ‘the use in the presence of minors or in situations of public nuisance as 
provided in art. 135, § 2, 7 of the New Community law’79; that problematic use included ‘a user’s 
pattern that can no longer be controlled, that is reflected in for example drug dependency80, drug-
related crime, ...’, and; that quantity for personal use referred to ‘a quantity of which one can say 
that it is not intended for supply’. Based on these considerations, it was recommended that, in the 
case of possession of an amount of cannabis for personal use by an adult, without the presence 
of public nuisance or problematic use, the police were obliged to enter a simple, anonymous 
registration of the facts. Problem users of cannabis or other illegal drugs needed to be diverted 
to a judicial case manager who directs the user to (drug) treatment. Treatment workers then 
give therapeutic advice on whether treatment is recommended and, depending on the advice, the 
Public Prosecutor may decide to proceed with prosecution or not, or to apply alternatives such 
as transaction81, mediation or praetorian probation. Thus, although the Minister of Public Health 
was assigned as the coordinator of the Inter-Cabinet Working Group (see below), the control 
remained firmly in the hands of police and the justice system.  
 
                                                          
79  This law concerns the local administrative sanctions. It gives the municipalities the possiblity of adding behav-
iours described as public nuisance to their police regulations and respond to those offences with administrative 
procedures (Wet van 13 mei 1999 betreffende de invoering van de gemeentelijke administratieve sancties, B.S. 10 
juni 1999). 
80  This included a reference to the DSM-IV which provides a common language and standard criteria for the classifi-
cation of mental disorders. 
81  A transaction is a unilateral offer by the Public Prosecutor to pay a certain amount of money within a limited time. 
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Furthermore, the Federal Drug Policy Note also emphasised the importance of a more scientific 
elaboration of the concepts of drug-related criminality and nuisance (in addition to the fragment-
ed statistics) (Federal Government, 2001a; p.25). Finally, in accordance with the final conclu-
sions and recommendations of the PWG, the development of a prison drug policy was recom-
mended. In pursuing this, attention had to be given to the prevention of drug use in prison, the 
organisation of substitution treatment, the creation of drug free units, and so on. 
 
2. An Inter-Cabinet Working Group (ICWG): the development of the Federal 
Drug Policy Note 
The Federal Government, under the coordination of Federal Minister of Public Health Magda 
Aelvoet82 (following the public health approach), started working on a national drug strategy in 
2000. An Inter-Cabinet Working Group (ICWG)83 including (representatives of) the Federal Min-
isters of Justice, Internal Affairs, Social Affairs, Economic Affairs and Public Health was estab-
lished on the request of the Council of Ministers. The representative of the Prime Minister, secu-
rity advisor Prof. Dr. Brice De Ruyver, participated in the ICWG (see also below, §2.1.1.). He act-
ed as a dynamic and proactive mediator between the representatives of the different Coalition 
partners in order to keep the discussion going. His research expertise, his (inter)national net-
work, and his key position as the security advisor to Prime Minister Guy Verhofstadt enabled 
him to play a prominent role. 
 
“Prof. Dr. Brice De Ruyver was in close contact with the Minister of Justice Marc Verwilghen and he 
listened to the different powerful actors of each Coalition partner. The Prime Minister Guy Verhof-
stadt, the Liberals and the Socialists also listened to him. He had a lot of influence.” (Respondent 
49, policy-maker).  
 
Ministers do not have the time to be intensively involved in every topic. Entrusting their techni-
cally and politically skilled representatives with this task, the Federal Drug Policy Note was for a 
large part developed without the direct participation of the Ministers.  
                                                          
82  Magda Aelvoet (AGALEV, Flemish Greens) was Vice-Minister and Minister of Consumption Affairs, Public Health 
and Environment during the Verhofstadt I Government (1999-2003). However, she resigned in 2002 as a result of 
a scandal related to the controversial supply of weapons to Nepal.  
83  As the preparation and writing of the Federal Drug Policy Note really took place in the Inter-cabinet Working 
Group (as a fundamental preparation of the final discussion in the Council of Ministers (in case of consensus) or 
the Inner Cabinet (in case no consensus is reached)), it can be perceived as a main actor in the decision-making 
process. The Inner Cabinet chaired by the Prime Minister constitutes a forum in which Coalition parties reach ma-
jor decisions on conflictual matters, which the Council of Ministers then formally ratifies (Brans, De Winter and 
Swenden, 2009). It is important to note that, as a result of the so-called Copernicus reforms of the Government 
(1999-2003), an Inter-Cabinet Working Group is now called a Policy Coordination Working Group. 
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Many action points of the Federal Drug Policy Note were decided easily. Three topics challenged 
the cohesion of the Coalition partners (Internal communication Ministerial Cabinet, 17 January 
2001). First, in the ‘drug plans’ (see Chapter 1, §2), the funds related to treatment were assigned 
to the Minister of Interior Affairs. It was proposed to assign these funds to the Minister of Public 
Health instead, to be more in accordance with the public health approach. As became clear in the 
Federal Drug Policy Note, this particular assignment of funds eventually became the responsibil-
ity of the Minister of Public Health in close cooperation with the Minister of Interior Affairs.  
 
Secondly, the division of budgets among the action priorities was also debated among the Coali-
tion partners in the Government. Consequently, as a (preliminary) solution, the Federal Drug 
Policy Note did not include any concrete budgets on most action points.  
 
Thirdly, the main point of discussion was the direction of the cannabis prosecution policy. A polit-
ical (discursive) struggle developed between the Coalition partners. Regardless of any individual 
disagreements among policy-makers, the French-speaking Socialists and the Flemish and 
French-speaking Green party were in favour of a more far-reaching liberalisation. The other Coa-
lition partners like the Flemish Socialists (SP), the French-speaking Liberals (PRL-FDF-MCC) and 
the Flemish Liberals (VLD), were opposed to what they called ‘a too liberal policy’.  
 
Below, we address the (f)actors that influenced the ICWG and, thus, the development of the Fed-
eral Drug Policy Note.  
 
2.1. Scientific knowledge and scientists 
Between meetings of the ICWG, representatives of the Federal Ministers often consulted (in-
ter)national scientists to get some background information, unravel a problem, determine clear 
definitions (e.g. of legalisation or depenalisation) or support or refute an argument in the discus-
sion. Scientific knowledge was perceived as a necessary resource in the policy-making process, 
useful in the development of a policy and in the evaluation of policy choices. 
 
“Scientific knowledge is necessary to understand a problem and how to tackle it. […] Essentially, it 
is a search for the truth and accuracy.” (Respondent 37, policy-maker).  
 
“Scientists and practitioners were not invited into the Inter-Cabinet Working Group, but we always 
tried to prepare ourselves and to check which issues were of any importance, which decisions were 
supported or not, which initiatives worked or not […] Concepts like legalisation, depenalisation, 
decriminalisation... it was the task of scientists to elucidate these concepts clearly.’’ (Respondent 
20, policy-maker). 
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If we perceive use as simply including references to scientists and scientific studies, several ex-
amples were found. Some publications and conference contributions of (inter)national scientists 
were included (Federal Government, 2001a; p.57). Equally, the Federal Drug Policy Note includ-
ed references to the 1994 Consensus Conference and the national conferences ‘Drug Policy 
2000’ (Federal Government, 2001a; p.53). However, as with the Parliament, some of the refer-
ences to scientific knowledge or experts were labelled in a general manner.  
 
“Ethnic minorities who abuse illicit drugs are apparently underrepresented in some treatment ser-
vices […] A lot of research on this topic exists.” (Federal Drug Policy Note; p.48).  
 
“Research, Belgian experiments and foreign experiences stressed the desirability of case manage-
ment in substance abuse treatment.” (Federal Drug Policy Note; p.49). 
 
2.1.1. Types of knowledge utilisation  
We found several types of knowledge utilisation (Weiss, 1979) in the activities of the ICWG. First 
of all, through the hearings of the PWG, scientific knowledge enlightened the development of 
Belgian drug policy. The final conclusions and recommendations of the PWG (also outlined in the 
first part of the Federal Drug Policy Note) provided the fundamental, but at the same time rather 
determining, framework for a debate within the ICWG. This can be considered as an indirect 
pathway through which scientific knowledge seeped into the policy discourse (cfr. conceptual 
utilisation). Likewise, the conceptual influence of highly attended national conferences ‘Drug 
policy 2000’ on the Federal Drug Policy Note was noted.  
 
“The report of the PWG and the evaluation study […] The Federal Drug Policy Note had to be in ac-
cordance with these documents […] We did not have to start ‘from scratch.’’ (Respondent 50, scien-
tist). 
 
“I am sure that the discourse of the Federal Drug Policy Note is inspired by the conferences ‘Drug 
Policy 2000’ and especially by some scientific conclusions. There certainly was an influence which 
was then included in the political debate.” (Respondent 36, policy-maker). 
 
Secondly, the evaluation study ‘Belgian drug policy in the year 2000: state of the art 3 years after 
the recommendations of the PWG’ (De Ruyver, et al., 2000) clearly inspired the ICWG (Federal 
Government, 2001a). The second part of the Federal Drug Policy Note (p.14-31) described the 
main conclusions of the evaluation study (De Ruyver, et al., 2000) detailing the actual state of the 
drug problem and capturing recommendations of the PWG that had already been implemented 
by the time the policy was created. Despite the multiple factors that may affect the ICWG (see 
below), the recommendations of the evaluation study were influential in determining the specif-
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ic policy actions by the Federal Government (third part Federal Drug Policy Note; see above, §1). 
The evaluation study fitted with the mood of the time and answered the questions which were at 
the top of the political agenda since the PWG (1996-1997). For instance, the evaluation report 
stressed that, in order to finally realise an integral and integrated drug policy with a vertical and 
a horizontal policy coordination, “the establishment of a General Drugs Policy Cell must be consid-
ered as necessary and crucial” (De Ruyver et al., 2000, p.8). Accordingly, the establishment of a 
General Drugs Policy Cell was one of the most important action points of the Federal Drug Policy 
Note in pursuing a global and integrated approach (Federal Government, 2001a, p.31). As an-
other example, inspired by the particular recommendations of the evaluation study regarding 
the problem of driving under the influence of illegal drugs and medication (De Ruyver et al., 2000, 
p.13-15, 23)84, the Federal Drug Policy Note included a number of actions (e.g. prevention cam-
paigns, implementation of drug tests, etc.) (Federal Government, 2001a, p.43). Also the persis-
tent concern about the lack of reliable numbers or registrations and the lack of (funding for) 
epidemiological studies on drug use was re-emphasised in the evaluation study (De Ruyver et al., 
2000, p.20-21). In the Federal Drug Policy Note, the Federal Government eventually demon-
strated commitment and responsiveness: e.g. by means of establishing a research programme 
supporting decision-making in the field of illegal drugs (Federal Government, 2001a, p.37-41).  
 
As this evaluation study gave direction to Belgian drug policy, and finally led to ac-
tion/implementation by the Federal Government, we may perceive this as an example of instru-
mental knowledge utilisation. Although this is the most typical interpretation of the science-
policy nexus, it is the least common example of knowledge utilisation (Edwards, Strang and Jaffe, 
1993; O’Dwyer, 2004; Brambila, et al., 2007). The fact that an evaluation study fulfills this par-
ticular role fits with the literature on evidence-based policies (Devroe, Deschamps and Hannes, 
2008). As stated by Devroe (2002), ‘evaluation studies lead to direct measurable and usable re-
sults for policy-makers’ (p.181). 
 
The use of this evaluation study had been promoted by the role of Prof. Dr. Brice De Ruyver. As 
the security advisor to Prime Minister Guy Verhofstadt, Prof. Dr. Brice De Ruyver acted as a so-
called observer-turned player (Loader and Sparks, 2011). He was able to function equally well in 
both the academic and political world and speak both languages fluently. Such a role required a 
substantial transition by the scientist, who moved from a position of absolute ‘outsider’ to a 
knowledgeable ‘outsider’. 
                                                          
84  “It is advisable to address the use of medications and illegal drugs in traffic” (p.13). “In addition to the repressive 
approach, there should be more attention to prevention” (p.23). References regarding the national conference ‘Drug 
Policy 2000' and the study into the consequences of drug use for road safety (ROSITA - 1999) were included 
(p.14). 
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“A scientist has to be aware that he is a technician, not a politician. A scientist presents his 
knowledge and expertise but he remains a technician. A scientist does not determine the direction 
of the policy […] Working at the governmental level is special: the aim is to unite the representa-
tives of the Ministers and to decide.” (Respondent 50, scientist). 
 
Having a privileged position, he gradually discovered how policy was made and who or what 
exerted the most influence. His role enabled him to promote the utilisation of his own scientific 
research and that of others in the political arena.  
 
“The importance of the evaluation study? This is certainly linked with the ‘Brice De Ruyver’ factor; 
he was standing alongside the Prime Minister.” (Respondent 15, journalist). 
 
“The evaluation study was very important. The content of the report and the permanent dialogue 
with the researchers were used to advance the debate.” (Respondent 34, policy-maker). 
 
However, we also found that some recommendations of the evaluation study were used in a 
more political/symbolic way. It was recommended that the Federal Drug Policy Note resolve the 
lack of uniformity in prosecutions of cannabis possession between different Public Prosecutor’s 
offices. The evaluation study attributed a large part of this problem to rather vague notions such 
as ‘public nuisance’, ‘problematic use’ and ‘limited possession for personal (single or occasional) 
use’ (De Ruyver, et al., 2000, p.41). However, we observed an important shortcoming in the ef-
forts to address this deficiency. Although the Federal Drug Policy Note introduced new defini-
tions85, they still remained too blurry and open to interpretation by police officers, prevention 
workers, social workers and the general public (Durieux, 2002; Guillain, 2003; Decorte, et al., 
2005). In other words, we found a rather political/symbolic utilisation: in the Federal Drug Poli-
cy Note reference was made to the Governments’ investment in the research, by way of demon-
strating commitment and responsiveness. Nevertheless, the vagueness of these notions was not 
resolved. It is clear that the impact of the observer-turned player on the facilitation of knowledge 
utilisation by policy-makers is also limited.  
 
In a similar vein, Prof. Dr. Brice De Ruyver promoted the utilisation of other (international) sci-
entific research. Taking into account that policy-makers are also responsible for the internation-
al aspects of their policy competences, several (inter)national drug policy studies (with special 
                                                          
85  As stated in §1, the Federal Drug Policy Note put forward that the concept ‘public nuisance’ referred to ‘the use in 
the presence of minors or in situations of public nuisance as provided in art. 135, § 2, 7 of the New Community law’; 
that ‘problematic use’ included ‘a user’s pattern that can no longer be controlled, that is reflected in for example 
drug dependency, drug-related crime, ...’, and; that ‘quantity for personal’ use referred to ‘a quantity of which one 
can say that it is not intended for supply’.  
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attention to the cannabis policy) were compared (Federal Government, 2001a, p.57-58).86 Fur-
thermore, the analysis of drug policies in other European countries (the Netherlands, France, 
Germany, Luxembourg, theUnited Kingdom), included in the attachment of the Federal Drug 
Policy Note, was very much a result of the promotion by this observer-turned player. 
 
“I remember that we took into account some international studies of drug policies in European 
countries and the prevalence rates provided by the EMCDDA. Brice De Ruyver joined the Inter-
Cabinet Working Group to stimulate the debate. He also urged more scientific support.” (Respond-
ent 20, policy-maker).  
 
In general, these analyses had an influence on the development of the Federal Drug Policy Note. 
For instance, the Federal Drug Policy Note adopted a positive appraisal of the Dutch decentral-
ised approach of drug nuisance and addiction treatment towards foreign people. The positive 
Dutch and German experiences with regard to the controlled supply of heroin were also taken 
into account, even though it was noted that there was no support for experiments with con-
trolled heroin maintenance in Belgium. Likewise, the modalities concerning cannabis policy 
were also discussed within this framework. Here, again, we noticed political/symbolic utilisation. 
Although the prevalence rates related to problematic drug use, drug deaths, infection diseases 
and police arrests were presented accurately, these data were accompanied with a rather politi-
cal interpretation of their level (low, high, moderate). For instance, numbers related to Dutch 
drug policy were presented as follows: 
 
“Estimates on national prevalence of problematic drug use in the age category of 15-54 years: 2.8-
3.2 per thousand (low); Trend in the number of deaths because of drugs: slightly rising; Prevalence 
of HIV infections among intravenous drug users: 2.0-2.6 % (numbers are vague); Arrests because 
of infringements on the drug legislation: increasing rapidly.” (Attachment Federal Drug Policy 
Note). 
                                                          
86  References in the Federal Drug Policy Note: De Ruyver, B., ‘Medisch en recreatief gebruik van cannabis, het juri-
disch kader in europees en V.N. perspectief.’, Vlaams Parlement, September 2000, Brussel, 15p.; Ministerie van 
Justitie Nederland, Notitie gedoogbeleid cannabis., 2000, p. 8.; DE NAUW, A., ‘Drugs’, A.P.R., 1998, p. 4.; Silvis, J., ‘De 
internationale juridische speelruimte voor Nederlands drugbeleid.’ in Blom, T.; De Doelder, H. en Hessing, D.J. 
(eds.), Naar een consistent drugbeleid. Een congresverslag. Deventer, 1996, p. 221-223; Arnao, G., ‘The Single Con-
vention and drug policy reform.’ The International Journal of Drug Policy, Vol. 10, No. 3, 1999, p. 173; Krajewski, 
K., ‘How flexible are the United Nations drug conventions ?’, The International Journal of Drug Policy, Vol. 10, No. 4, 
1999, p. 332; United Nations, Commentary on the United Nations Convention against illicit traffic in narcotic drugs 
and psychotropic substances 1988, United Nations, New York 1998, p. 85-89; DORN, N.en JAMISON, A., ‘Room for 
manoeuvre. Overview of comparative legal research into national drug laws of France, Germany, Italy, Spain, the 
Netherlands and Sweden and their relation to three international drugconventions, (based on research by an in-
ternational team Yann Bisiou (France), Tom Blom (The Netherlands), Lorenz Böllinger (Germany), Maria Luisa Ce-
soni (Italy), José Luis de la Cuesta and Isidoro Blanco (Spain), and Josef Zila (Sweden)), London, 2000, 24p;  DE 
RUYVER, B., Medisch en recreatief gebruik van cannabis, het juridisch kader in europees en V.N. perspectief, 
Vlaams Parlement, september 2000, Brussel; EMCDDA, jaarverslag over de stand van de drugsproblematiek in de 
Europese Unie, Lissabon 2000. 
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However, such direct comparisons between national policies cannot be made because these data 
are affected by differences in definition, methodology and statistical units (persons, offences, 
and arrests) and changing drug policies (e.g. introduction of harm reduction measures) or laws 
(Kraus, et al., 2003; Decorte, et al., 2009). This resulted in a political debate based on a rather 
meaningless representation of problematic drug use, drug deaths, infections, diseases and police 
arrests in each of these countries.  
 
Furthermore, instead of actually participating in the ICWG, some scientists acted as policy advi-
sors (Loader and Sparks, 2011). These scientists were on the sidelines of the ICWG. In order to 
inform the (public and political) debate, they brought in scientific knowledge through personal 
contacts with the Minister (or his/her representatives). This allowed for a flow of scientific in-
formation to the policy-making process (and stimulated conceptual utilisation). 
 
“That scientist was not an official advisor of the Cabinet but he kept close contacts with the policy-
makers. He had a very large political network, also in the French-speaking part of Belgium. It was 
useful to talk with him in order to get access to the French-speaking Ministers and to get a scien-
tific update.” (Respondent 34, policy-maker).  
 
Indeed, Ministers (or their representatives) reported turning to their own trustworthy network 
of scientists with recognised expertise and authorative claims in drug policy. In other words, 
they tended to pay careful attention to those policy advisors who (1) were known as appropriate-
ly discreet (e.g. taking into account media leaks; see below, §2.4.1.) and (2) who had the capacity 
to enlist supporters behind their claims, to legitimatise their arguments as authoritative, and to 
present themselves to the public and policy-makers as someone who could give voice to science. 
An important issue here is that scientists are assumed to engage with journalists (and the pub-
lic) as well.  
 
“Policy-makers do not primarily consult scientists because of their knowledge […] No way. They 
consult scientists because of their public presence. […] A scientist who is seen as an expert by the 
general public lends credibility to the arguments of policy-makers.” (Respondent 50, scientist).  
 
“Who is considered an expert? From the public point of view, it is someone who is more knowl-
edgeable than others. From the scientific point of view, it is someone who is more known than oth-
ers and has many publications. From a political point of view, an expert is someone who is publicly 
known and who is likely to meet their expectations.” (Respondent 48, scientist).  
 
It is important to note that an individual relationship with a scientist could result in either a de-
crease or an increase of knowledge utilisation. Some scientists may act as a lever in promoting 
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the use of research findings but others might not be fully supportive of their recommendations 
on research, rather acting out of personal motives (cfr. airport scientists; Uggen and Inderbitzin, 
2010). A focus on individual relationships also limits the policy-maker’s access to the broad 
spectrum of (sometimes conflicting) scientific insights (and promotes political/symbolic utilisa-
tion). The individual background, education or experiences of the Minister (and his/her repre-
sentatives) often (partly) determines who is and who is not included in their personal network. 
For instance, scientists were mostly sought within their own education and region: Flemish poli-
cy-makers were in favour of consulting Flemish experts.  
 
2.1.2. Characteristics of scientific knowledge 
Several characteristics of scientific knowledge were said to impede the interaction between sci-
entists and policy-makers and the use of scientific knowledge in the ICWG. The idea that policy-
makers and scientists operate in two different worlds and speak two different languages was 
often stressed (two communities thesis; Caplan, 1979). The issue that academic careers are 
geared towards and reward academic publications, rather than involvement in the policy-
making process (Nutley, Walter and Davies, 2007) was a recurring topic in the interviews. Fur-
thermore, interviewees stated that scientists apply a certain degree of nuance in their arguments 
while policy-makers often think in terms of practical solutions. 
 
“A scientist is different. The degree of truthfulness is important for scientists. In a political setting, 
it is not always about truthfulness. The goal of policy-makers is to decide, no matter what.” (Re-
spondent 5, policy-maker). 
 
Furthermore, whereas scientific studies can take years to be completed, policy issues often rise 
rapidly to the top of the political agenda (e.g. one legislature only lasts for four years) (Weiss and 
Bucuvalas, 1980; Ritter, 2009). The consequence of the fact that scientists and policy-makers 
operate under very different time-frames was clearly illustrated in the preparation of the final 
discussion in the Council of Ministers on 18 January 2001. A member of the Ministerial cabinet 
argued: 
 
“A study of three ULB professors argued that legalisation is consistent with the international UN-
conventions. They however acknowledged that their study only shows ‘preliminary’ results of a 
‘quick’ study. […] In other words, their study is worthless.” (Internal communication Ministerial 
Cabinet, 17 January 2001). 
 
The translation of scientific knowledge into policy principles was considered an even more com-
plex process. Policy-makers argued that reports should be brief, and contain useful information 
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in comprehensible language (see also Weiss, et al., 2008). Ministers (and their representatives) 
only have time to read a summary or even one page of a study. A lengthy report or publication is 
simply not read. In this context, policy-makers easily turn to their personal network for custom-
ised advice. Scientists also seem to be aware of the need to better translate the results of their 
research into policy implications. 
 
“There is no time, decisions must be made quickly. It is impossible to read the whole report […] I do 
not have time to read 200 pages. Good studies need to be apprehensible.” (Respondent 36, policy-
maker). 
 
“Scientists have to measure and to develop knowledge. However, policy-makers often do not un-
derstand the policy implications of a study. It is mostly descriptive, unfortunately.” (Respondent 52, 
scientist). 
 
2.2. Political context 
The discussions in the ICWG were affected by both institutional and individual characteristics of 
the policital context. For instance, the representatives of the Ministers in the ICWG had the com-
plex task of reconciling the opinion of their Minister and the viewpoint of their political party. In 
pursuing this, they had to bear in mind the differing opinions about cannabis policy among indi-
viduals from the own party as well (see also Public Debate in Chamber of Representatives below, 
§3.2.). Likewise, they also had to deal with the (representatives of the) Federate Ministers for a 
number of issues at stake. Individual characteristics/experiences of the Minister were definitely 
influential, especially in such heavily politicised discussions. 
 
“The situation was chaotic. Opinions differed within political parties, between Ministers, etc. […] In 
the Inter-Cabinet Working Group, members had several agendas and different Ministers were in-
volved. This state of affairs certainly complicated the discussions.” (Respondent 17, policy-maker). 
 
“The national drug strategy was developed in the Inter-Cabinet Working Group. Sometimes a par-
ticular Minister disagreed with decisions negotiated by his representatives […] Consequently, the 
topic reappeared on the agenda and representatives had to start all over again.” (Respondent 20, 
policy-maker). 
 
Furthermore, several institutional characteristics of the political setting also played a role. When 
it comes to policy-making, drug policy is just one priority. The Federal Drug Policy Note had to 
be considered as a kind of political compromise between the Coalition partners. Several exam-
ples illustrate this assumption. 
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First of all, policy-makers need to take into consideration the international aspects of their poli-
cy competences. Therefore, accordance with the international framework (e.g. 1990 Schengen 
Convention, the 1995 Dutch Drug Note and the official report ‘Pathways to the backdoor’) was 
one of the most compelling arguments. It is also within this framework that the input of the 
analysis of some drug policies in European countries was considered important (see also above, 
§2.1.1.). As another example, the United Nations contacted the representatives of the Minister of 
Public Health Magda Aelvoet to express their concern about the trend in some European coun-
tries, including Belgium, of laws becoming less rigorous. Afraid to be isolated internationally, a 
member of a Ministerial Cabinet argued, in the preparation of the final discussion in the Inner 
Cabinet on 18 January 2001: 
 
“Legalisation means resigning from the international conventions. Juridically, the reasoning is wa-
ter-tight (several international experts support this argument). The Ministerial Cabinets of the 
Minister of Labour Onkelinx, the Minister of Mobility Isabelle Durant and the Minister of Public 
Health Magda Aelvoet are in favour of a broad interpretation […] The Government has to decide if 
they should resign from the conventions. Then, the Government runs the risk of feeling the heat at 
the European level. Such a decision will have consequences on other policy debates too. No other 
country has taken this step.” (Internal communication Ministerial Cabinet, 17 January 2001).  
 
Eventually, the particular phrase in the Federal Drug Policy Note that ‘the Federal Government is 
an advocate of the need to rethink the international conventions in order to produce a realistic 
response to cannabis use as well as the establishment of harm reduction initiatives’ (p.46) reflects 
the political compromise.  
 
“The Flemish Greens claimed to include a phrase which supported the revision of the international 
conventions together with like-minded European partners. In this way, the Flemish Greens still 
hope to proceed towards a legalisation or regulation.” (Internal communication Ministerial Cabi-
net, 17 January 2001).  
 
Secondly, the determination of the maximum limit of the number of grams for personal use was 
also heavily debated. With the discussion of the final conclusions and recommendations of the 
PWG in 1997 in mind87, the Verhofstadt I Government also had difficulties in determining what 
amount had to be considered as for personal cannabis use. Some Coalition partners (Flemish 
Socialists (SP), Flemish Liberals (VLD) and French-speaking Liberals (PRL-FDF-MCC)) did not 
want to determine a number of grams. Others (Flemish Greens (AGALEV), French-speaking 
Greens (Ecolo) and French-speaking Socialists (PS)) initially introduced a maximum of 15 grams 
                                                          
87  Flemish and French-speaking Christian Democrats refused to determine a quantity for personal use (see above, 
Chapter 2, §5.1.). 
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of cannabis and a maximum of five female cannabis plants (Guillain, 2003). However, this was 
not approved. In order to reach an agreement, the Prime Minister suggested a ‘5 gram limit’. 
 
“The option of a ‘5 gram limit’ is developed by order of the Prime Minister to convince the French-
speaking Socialists (PS). The Minister of Labour Mrs. Laurette Onkelinx is in favour of legalisation 
and this suggestion is rather persuasive.” (Internal communication Ministerial Cabinet, 17 January 
2001). 
 
Eventually, a compromise was found to convince the French-speaking Socialists (PS). The Feder-
al Drug Policy Note recommended a legislative change and the development of a new Ministerial 
Circular Letter in order to guide judicial, administrative authorities and the police in tackling 
(local) drug issues, drug-related crime and nuisance.  
 
2.3. Practitioners 
Practitioners played an important role in the ICWG. Through the distribution of the Policy Mem-
orandum in 1999 (see also before, §2.1.1.), they tried to influence the development of the Feder-
al Drug Policy Note. Indeed, there was a rather large overlap between the Federal Drug Policy 
Note and the statements included in the 1999 Policy Memorandum (Memorandum group, 1999). 
For instance, several issues were (partly or entirely) addressed: the establishment of a forum for 
better cooperation and coordination between different policy actors (cfr. General Drugs Policy 
Cell); better cooperation between judicial actors and treatment workers; the development of 
initiatives like needle exchange and methadone substitution; the development of a uniform reg-
istration system among treatment centres, and; the clarification of the 1998 Ministerial Circular 
Letter. 
 
“There were a lot of issues integrated in the Federal Drug Policy Note. The 1999 Policy Memoran-
dum strongly influenced the development of the Federal Drug Policy Note in 2001. It became clear 
that policy-makers listened to the practitioners.” (Internal communication Memorandum group, 
26 October 2000). 
 
Additionally, some practitioners became members of the Ministerial Cabinet (e.g. magistrates, 
lawyers). Their presence promoted the translation of their particular day-to-day experiences 
and their needs related to budgets or staff into the policy-making process. 
 
“I wrote a large part of the Federal Drug Policy Note. Practitioners had a lot of influence […] They 
succeeded in determining some details and applying their vision […] I could not delete phrasings 
but I could influence the particular modalities […] This certainly influenced the development of the 
Federal Drug Policy Note […].” (Respondent 16, practitioner).  
Chapter 4  The Federal Drug Policy Note (2001) 
220 
2.4. Media coverage 
2.4.1. A succession of events: tumultuous… 
During the activities of the ICWG, media coverage (of the cannabis policy) gradually increased. A 
conference on recreational and medical use of cannabis organised by the Flemish Nationalists 
(VU-ID) in September 2000 gave an additional boost.  
 
“Recent research has shown that smoking one joint is comparable to smoking four to six cigarettes. 
The risk of developing lung cancer is similar.” (Prof. Dr. Arnold Vlietinck in Flemish newspaper 
Gazet van Antwerpen, 22 September 2000). 
 
“127 offenders of cannabis-related crimes. This is an increase of 20%.” (27 September 2000, Flem-
ish newspaper De Tijd).  
 
Media coverage further exploded in November 2000. A preliminary version of the Federal 
Drug Policy Note was leaked to the press on 10 November 2000. Leaking to the media is a 
common political strategy of a dissatisfied Coalition partner to hamper (and steer) the policy-
making process. Even though the Minister of Health Magda Aelvoet (AGALEV, Flemish Greens) 
repeatedly stated that the leaked note only contained preliminary thoughts, a heavily mediatised 
and political storm developed. It became clear that the controversy mainly occurred in Flanders 
where the two sides, the Minister of Justice Mark Verwilghen and the Minister of Public Health 
Magda Aelvoet, faced each other. 
 
“The Minister of Public Health Magda Aelvoet said that the international Schengen Agreement is 
not an obstacle […] Earlier, the Minister of Justice Marc Verwilghen said that Schengen does con-
stitute an obstacle.” (17 November 2000, Flemish newspaper Het Laatste Nieuws). 
 
The controversy intensified when MP Frans Lozie (AGALEV, Flemish Greens), as an individual 
political strategy, announced at an international conference that the Flemish Green party aimed 
to legalise all illegal drugs. The Green party AGALEV quickly blew the whistle on the MP: the 
Minister of Health Magda Aelvoet (AGALEV, Flemish Greens) called it a ‘wrong communication’ 
and a ‘big mistake’. A journalist explained: 
 
“I remember that I received a phone call from their spokesman refuting the statements of Frans 
Lozie. The spokesman clearly said that these statements were not in accordance with the ideas of 
the Flemish Green party. They were in favour of the legalisation of cannabis, not of all illegal 
drugs.” (Respondent 15, journalist). 
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Additionally, on 25 November 2000, Flemish newspaper De Morgen (again a Flemish whistle-
blower) published a letter by Minister of Health Magda Aelvoet (AGALEV, Flemish Greens). In 
this letter, addressed to the secretary of Ecolo (French-speaking Greens), she supported the de-
criminalisation of cannabis and the depenalisation of other illegal drugs. The controversy and the 
confusion only increased. The general problem with this media communication (especially in the 
Flemish media) was that it caused confusion between what was only an intention and what had 
already been decided. “The possession and the production of five grams of cannabis no longer 
prosecuted” (6 December 2000, Flemish newspaper De Tijd). At the same time, media coverage 
created confusion by juggling with the concepts ‘legalisation’, ‘depenalisation’ and ‘decriminali-
sation’. The media clearly were more interested in provoking controversy by emphasising stere-
otypes and publishing sensational headlines (instead of substantive discussions and reflections). 
 
Accordingly, this media discourse, issue coverage and media leaks influenced the public’s 
(mis)understanding of the debate. An opinion poll commissioned by French-speaking newspa-
per Le Soir and conducted by an university team (Prof. dr. Rene Patesson and Pascale Steinberg) 
between August and October 2000 (during the discussions in the ICWG) confirmed that 56,2% of 
the respondents did not know that cannabis use was prohibited. Flemish (and young) respond-
ents in particular thought that cannabis use was tolerated (Patesson and Steinberg, 2000).  
 
2.4.2. …but not decisive 
The media did not play a vital role in shaping policy, or in other words, there was no direct influ-
ence of the media coverage on the activities of the ICWG. However, policy-makers were interest-
ed about how the public (and their electorate) viewed and assessed policy decisions (e.g. the 
developments of the Federal Drug Policy Note). The fact that an embargo was put on the prelim-
inary drafts of the Federal Drug Policy Note (taking into account the local elections on 8 October 
2000) also exemplifies the political sensitivity of the debate. Another illustration is the demand 
of the French-speaking Liberals (PRL-FDF-MCC) at the Inner Cabinet in December 2000 to post-
pone the decision on the Federal Drug Policy Note. They preferred to consult with their elec-
torate first. Eventually, the decision was indeed postponed to mid-January 2001, which further 
stimulated the sensational public/media debate (see also below, §2.4.1.). 
 
“The French-speaking Liberals asked for a postponement of the final decision. This led to the poli-
cy-making process occurring in two phases. Meanwhile, there were some media leaks about the 
cannabis issue and indeed the debate did get off the rails.” (Respondent 37, policy-maker).  
 
Similarly, in December 2000 (in particular after the Inner Cabinet held on 6 December 2000), 
Minister of Public Health Magda Aelvoet tried to produce order out of chaos by hiring a spokes-
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man, Mr. Paul Geerts, for a couple of months. His first assignment was to deal with the ongoing, 
misleading media communication. Mr. Paul Geerts expressed: 
 
“The decision of the Council of Ministers in December 2000 to postpone the debate increased the 
controversy […] One of my first tasks was to call journalists and to explain the state of the art. In 
this way, they were well-informed about the developments […] Unfortunately, I never succeeded in 
rectifying the miscommunication.” (Mr. Paul Geerts, contracted spokesman of Minister of Public 
Health Magda Aelvoet).  
 
The media discourse influenced the informal discussions between Coalition partners or obliged 
Ministers to formulate some public statements and to answer a parliamentary ques-
tion/interpellation. 
 
“The political debates took place in the Inter-Cabinet Working Group. Media coverage was not a 
topic. Of course, indirectly, one is concerned with what their electorate thinks about the issue. But 
it has never been my experience that the media discourse guided or reversed a certain policy deci-
sion.” (Respondent 37, policy-maker). 
 
Finally, reflecting on the media as a distributor of scientific knowledge to Members of Parliament 
(see above, Chapter 3, §5.3.2.), our analysis showed that media coverage of scientific knowledge 
was not necessarily a precondition for playing a role in the ICWG. For instance, the evaluation 
study conducted by Prof. Dr. De Ruyver and Prof. Dr. Casselman (De Ruyver, et al., 2000), which 
gave direction to Belgian drug policy and could be perceived as an example of instrumental 
knowledge utilisation, was not repeatedly or extensively covered by the media.  
 
2.5. Interest groups 
In the anticipation of the decisions to come, a French-speaking interest group, Anti-Prohibition 
League [La Liaison anti-prohibitionniste], announced several debates and demonstrations re-
garding Belgian cannabis policy. An interest group of parents of drug users, named SOS Addicted 
[SOS Verslaafd] (the precursor of Parents against Drugs [Ouders tegen Drugs]; see below §4), also 
appeared in the media. By employing a rather emotional discourse, the latter interest group mis-
interpreted concepts like legalisation and decriminalisation and misrepresented scientific 
knowledge. For instance, they supported the stepping stone theory and exaggerated the preva-
lence rates of drug use.  
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“The legalisation of soft drugs will cause a snowball effect. Many youngsters will gradually use 
other, stronger, drugs too. It is a real danger. […] 18% of all youngsters in Tienen have experi-
mented with drugs. How are the questionnaires being filled in? We think that over 75% of all 
youngsters already have used drugs.” (19 December 2000, Flemish newspaper Het Laatste 
Nieuws).  
 
Similar to the impact of the media discourse on the Governmental debate, the influence of inter-
est groups on the actual policy-making process was rather limited. Some interest groups were 
consulted by a representative of the Minister of Public Health to articulate their points of view. 
However, generally, interest groups were not successful in influencing the ICWG (and thus the 
development of the Federal Drug Policy Note (2001)). This point was recognised by policy-
makers as well as the members of interest groups. 
 
“Using the media is a communication strategy of those interest groups. They did not influence poli-
cy-making; they did not make any impression.” (Respondent 37, policy-maker). 
 
“We criticised the detention of cannabis users. We underlined the problem, but we did not provide 
a good solution. Maybe that is why we did not have any substantial influence.” (Respondent 23, 
member of an interest group). 
 
2.6. Parliamentary activity: resolutions/bills 
High media activity, causing confusion and complications, influenced the parliamentary agenda. 
During the activities of the ICWG, MPs submitted some questions/interpellations and a resolu-
tion, particularly on cannabis policy88. None of these parliamentary activities had a direct influ-
ence on the ICWG. Ministers just had to answer questions/interpellations or to vote 
bills/resolutions.  
 
“Most Ministers considered the answering of questions as a waste of time […] Some of them took 
these questions or interpellations seriously, others did not. The real decision-making power is in 
the hands of the Government, the Cabinets, the Ministers. The Parliament is not powerful at all.” 
(Respondent 25, policy-maker). 
 
However, some opposition MPs had an indirect impact. It appeared that several practitioners, 
who were involved in the ICWG (see above, §2.3.), had close contacts with MPs from the Flemish 
and French-speaking Christian Democrats (CVP and PSC). 
                                                          
88  Hand. Kamer 1999-2000, 16 november 2000, 083, 7; Hand. Kamer 2000-2001, 7 december 2000, 086, 6-9; Hand. 
Kamer 2000-2001, 19 december 2000, COM 338, 12-13; Hand. Kamer 2000-2001, 11 januari 2001, 102, 19; Voor-
stel van resolutie over de herziening van de internationale drugsverdragen (ingediend door Mr. Vincent Van Quic-
kenborne and Mr. Patrik Vankrunkelsven), Parl.St. Senaat 2000-2001, nr. 2-584/1. 
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“The development of the Federal Drug Policy Note is also influenced by the Flemish Christian Dem-
ocrats. I had a lot of contact with MP Jo Vandeurzen and I was involved in the debates about the 
national drug strategy. I dare say that their points of view actually influenced the debate.” (Re-
spondent 9, practitioner).  
 
“On the Flemish side, the Flemish Christian Democrats were part of the opposition. […] They were 
in close contact with several practitioners.” (Respondent 4, policy-maker). 
 
3. Official publication of the Federal Drug Policy Note on 19 January 2001 
Eventually, on 19 January 2001, a press conference announced the official launch of the Federal 
Drug Policy Note. The press conference was characteristic of the difficulties of the Government 
in providing clear messages, especially regarding whether and when the possession of cannabis 
for personal use was allowed or not (Gelders and Vander Laenen, 2007). The Minister of Justice 
Marc Verwilghen (VLD, Flemish Liberals) stated that ‘it is wrong to claim that Belgium has im-
plemented a depenalisation’ and that ‘the possession and use of cannabis by minors will always be 
considered as problematic’. The Minister of Public Health Magda Aelvoet (AGALEV, Flemish 
Greens) softened this statement by saying that ‘a minor of 16 or 17 who smokes cannabis at home, 
without causing nuisance or without being in a problematic situation, will not be prosecuted’. 
Clearly, this latter statement was juridically wrong: the particular cannabis regulation in the 
Note only applied for adults. These confusing and conflicting statements caused huge misunder-
standings and it was a source of frustration for the Verhofstadt I Government that the public 
debate again focused on the cannabis issue (while ignoring the other elements of the Federal 
Drug Policy Note). Their fear was that the Federal Drug Policy Note would be interpreted as a 
tolerance policy. A similar position was taken by the Christian Democrats in the Dehaene II Gov-
ernment (1995-1999) when discussing and communicating about the final conclusions and rec-
ommendations of the PWG (see also above, Chapter 2, §5.1.). 
 
“The Flemish Christian Democrats were really afraid that the conclusions of the PWG would be in-
terpreted as a Belgian example of a tolerance policy. […] The same happened when the Liberals 
presented their Federal Drug Policy Note.” (Respondent 50, scientist).  
 
“The notion of a ‘tolerance policy’ was not supported. In Flanders, tolerance was perceived as ap-
proval, or as a message that everything was allowed.” (Respondent 37, policy-maker). 
 
The Federal Government, with the Minister of Public Health Magda Aelvoet (AGALEV, Flemish 
Greens) taking the lead, decided to launch an information campaign (Federal Government, 
2001b). The campaign aimed to shed some light on both policy and the status of the legislation, 
and to clarify the future penal policy with regard to cannabis (e.g. the implications for minors). 
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On 10 February 2001, the Federal Government launched the first part of their information cam-
paign through a media advertisement. Later, in May 2001, an information brochure (i.e. 600,000 
leaflets) was circulated through secondary schools, police offices, justice houses, courts, treat-
ment services, post offices, town halls, libraries and through the website of the Ministry of Public 
Health. The 24-page brochure presented the Federal Drug Policy Note along the format of Fre-
quently Asked Questions. 
 
The launch of the Federal Drug Policy Note and the information campaign led to a strong in-
crease in media and parliamentary attention to the drug topic (cannabis policy in particular). 
Concerned about how their electorate would perceive the Federal Drug Policy Note, the Minister 
of Public Health and the Minister of Justice were also actively involved in these debates. 
 
3.1. Media and interest groups: increasing polarisation and confusion 
The Federal Drug Policy Note and the information campaign determined the headlines of the 
Flemish and French-speaking media. Commotion first emerged from the confusing communica-
tion of both Ministers at the press conference. Politicians with a long political career such as 
Louis Tobback (SP, Flemish Socialists) involved themselves in the debate by criticising the stipu-
lations regarding cannabis policy (23 January 2001, Flemish newspaper Het Laatste Nieuws). 
Members of the opposition parties (CVP, Flemish Christian Democrats – Vlaams Blok, Flemish 
extreme right party – VU&ID, Flemish Nationalists) regularly appeared in the media. For in-
stance, members of the Flemish extreme right wing party Vlaams Blok announced their own 
brochure ‘Against the drug prophets’ criticising the policy choices of the Verhofstadt I Govern-
ment (De Man, 2001). The Minister of Secondary Education of the French Community, Mr. Pierre 
Hazette (PRL-FDF, French-speaking Liberals), announced a Ministerial Circular Letter on 1 Feb-
ruary 2001 reminding that cannabis use is strictly forbidden in schools.  
 
Dutch- and French-speaking drug treatment and prevention practitioners also actively partici-
pated in the media debate (Guillain, 2003). They pointed at the ambiguity of the Federal Drug 
Policy Note and the cannabis prosecution policy in particular.89 The media did not hesitate to 
polarise the discussion. 
                                                          
89  The Association for Alcohol and other Drug Problems (VAD), the Flemish umbrella organisation, published a doc-
ument detailing their point of view in order to contribute to the public debate and policy-making. The document 
stressed the need for a clear juridical framework taking into account the limited health risks of cannabis use, the 
different opinions of youngsters and adults and the polarised debate about cannabis. French-speaking associations 
also pointed to the ambiguity of the Federal Drug Policy Note (Guillain, 2003). For instance, the association In-
forDrogues argued that the Federal Drug Policy Note introduced a ‘liberalisation’ message but, at the same time, 
maintained a criminal approach with a lack of uniformity. Likewise, the Fédération wallonne des institutions pour 
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“The discussion was presented in black-and-white, drugs were bad or drugs were good. One had to 
prohibit, one had to depenalise. It was very binary. The reality is much more complex but yes, this 
is the media.” (Respondent 53, journalist).  
 
While the French-speaking newspapers announced a depenalisation, the Flemish newspapers 
created headlines that cannabis use was fully tolerated: 
 
“Depenalised possession and consumption of cannabis.” (19 January 2001, French-speaking news-
paper Echo). 
“The personal use of cannabis is tolerated. Cannabis depenalised by default.” (19 January 2001, 
French-speaking newspaper Le Soir). 
“The use of cannabis completely free.” (19 January 2001, Flemish newspaper Belang van Limburg). 
“Belgian policy of tolerance more tolerant than that of the Netherlands.” (19 January 2001, Flem-
ish newspaper De Morgen). 
 
The information campaign did not resolve the confusion (Gelders, 2006). For instance, the bro-
chure did not stress that a new bill had yet to be developed and adopted by the Parliament. Sev-
eral newspapers reported on the positive and negative elements of the new drug law while there 
was no new law at all. “The new drug law is better than the old one” (6 March 2001, Flemish news-
paper Het Nieuwsblad).  
 
At the same time, themes like the increasing THC content in cannabis, the increasing prevalence 
rates of use, and the health risks of cannabis use were increasingly captured in several quota-
tions. For instance: “Cannabis is twice as strong as 10 years ago” (2 March 2001, Flemish newspa-
per Het Laatste Nieuws). Likewise, the precautionary principle90 was mentioned for the first 
time: “Faced with such a number of health risks, we have to make an appeal to the ‘precautionary 
principle’” (28 March 2001, French-speaking newspaper Le Soir). 
 
Accordingly, amongst the public, emotions were running high. For instance, several readers’ 
opinions were dominated by an emotional discourse (with a mistaken appeal against the legali-
sation of cannabis and a focus on the stepping stone theory). Several schools also announced to 
set-up a campaign against the legalisation and decriminalisation of cannabis. The ‘Druglijn’, as 
part of the Association for Alcohol and other Drug Problems (VAD), confirmed this public con-
cern. They reported an increasing number of calls in 2001, especially related to the topic of can-
                                                                                                                                                                                     
toxicomanes (Fédito) criticised the vagueness and inconsistency of the notions ‘problematic use’ and ‘public nui-
sance’, which were already included in the 1998 MO of Van Parys. 
90  When a policy-maker is faced with a multiplicity of information and finds it difficult to identify the appropriate 
options for their particular situation, there is a tendency to invoke the precautionary principle (Singleton, et al., 
2014). 
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nabis (VAD, 2003). However, in terms of prevalence trends, the use of cannabis, ecstasy and am-
phetamines stabilised among adults as well as among youngsters (BIRN, 2002). 
 
It is in this context that the creation of the interest group Parents against Drugs [Ouders tegen 
Drugs] was noted. The president of the interest group was Mrs. Josefien Smits whose son died 
due to a drug overdose at the end of the nineties. Several like-minded parents of (ex-)drug users 
(together with some practitioners and scientists) joined the interest group and the members 
increasingly and proactively expressed their opinion in the media. Clearly, most interest groups 
were driven by the public and political attention. “Mother of a drug-addicted daughter angry 
about the statements of Senator Van Quickenborne of the Flemish Nationalist party” (31 January 
2001, Flemish newspaper Het Nieuwsblad). Consequently, through the media, this interest group 
succeeded in heating up and polarising the debate even more. 
 
3.2. Parliamentary debates 
The official launch of the Federal Drug Policy Note immediately provoked some parliamentary 
activity. Several members of the Chamber of Representatives submitted interpellations regard-
ing the content of the Federal Drug Policy Note (Hand. Kamer 2000-2001, 30 januari 2001, 106, 
1-56). Accordingly, it was decided to organise a public debate in the Chamber of Representatives 
on 30 January 2001. The public debate prompted some MPs to submit several motions91 (Hand. 
Kamer 2000-2001, 30 januari 2001, 0025/172, 1-3). Later on, the launch of the information 
campaign once again led to the submission of a high number of parliamentary questions and 
interpellations.92 
                                                          
91  A first reasoned motion was submitted by Mr. Jo Vandeurzen (CVP, Flemish Christian Democrats), Mr. Yves Le-
terme (CVP, Flemish Christian Democrats) and Mr. Jacques Lefevre (PSC, French-speaking Christian Democrats). 
These MPs criticised the compliance of the cannabis prosecution policy (as presented in the Note) with the inter-
national obligations and its lack of legal certainty. Mr. Filip De Man submitted a motion of no-confidence by arguing 
that the Ministers of Justice and Public Health had to be replaced. Some MPs from the majority (Mr. Daniel Bacque-
laine, MR (French-speaking liberals); Mr. Hugo Coveliers, VLD (Flemish Liberals); Mr. Dirk Van der Maelen, SP 
(Flemish Socialists); Mr. Thierry Giet, PS (French-speaking Socialists); Mr. Jef Tavernier, AGALEV (Flemish 
Greens); Mrs. Michel Dardenne, Ecolo (French-speaking Greens)) submitted a motion to go to the next item of the 
agenda in order to avoid taking a position in the political struggle with the opposition parties. 
92  Hand. Kamer 2000-2001, 31 januari 2001, COM 373, 1-4; Hand. Kamer 2000-2001, 6 februari 2001, COM 376, 9-
11; Hand. Kamer 2000-2001, 8 februari 2001, 108, 7-9; Hand. Kamer, 2000-2001, 13 februari 2001, COM 390, 4-6; 
Hand. Kamer 2000-2001, 20 februari 2001, COM 394, 17-21; Hand. Kamer 2000-2001, 7 maart 2001, COM 410, 
12-17; Hand. Kamer 2000-2001, 8 maart 2001, 112, 13-15; Hand. Kamer 2000-2001, 15 maart 2001, 114, 6-7; 
Hand. Kamer 2000-2001, 29 maart 2001, 119, 12-13; Hand. Kamer 2000-2001, 19 april 2001, 121, 5-7; Hand. Ka-
mer 2000-2001, 17 mei 2001, 125, 1-3; Hand. Kamer 2000-2001, 31 mei 2001, 130, 5-7; Hand. Kamer 2000-2001, 
7 juni 2001, 132, 9; Hand. Kamer 2000-2001, 3 juli 2001, 517, 11-12; Hand. Kamer 2000-2001, 19 juli 2001, 158, 
18-19; Hand. Kamer 2000-2001, 23 oktober 2001, 560, 32-35; Vr. en Antw. Kamer, 19 februari 2001, nr. 064 (Vr. 
nr. 309 A. Colen); Hand. Senaat 2000-2001, 1 februari 2001, 2-92, 21-23; Hand. Senaat 2000-2001, 8 februari 
2001, 2-94, 27-30; Hand. Senaat 2000-2001, 15 februari 2001, 2-96, 8-9; Hand. Senaat 2000-2001, 22 februari 
2001, 2-98, 9-12; Hand. Senaat 2000-2001, 8 maart 2001, 2-100, 25-27; Hand. Senaat 2000-2001, 29 maart 2001, 
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Generally, in these parliamentary debates, little attention was given to the creation of a General 
Drugs Policy Cell, the importance of prevention initiatives, the value of methadone treatment in 
prison, and the creation of the Belgian Monitoring Centre for Drugs and Drug Addictions 
(BMCDDA). The parliamentary debate was soon narrowed down to the cannabis prosecution 
policy and exacerbated the existing tensions between majority and opposition as well as among 
the Coalition partners in the Government.  
 
“The Parliament was not decisive. Some back-benchers used the controversial statements of the 
Minister of Public Health Magda Aelvoet […] But generally, the Federal Drug Policy Note was not 
rejected in the Parliament.” (Respondent 28, policy-maker). 
 
3.2.1. Scientific knowledge and scientists 
Similar to the parliamentary debates during the intermezzo (1997-2000), scientific knowledge 
was often attributed rather vaguely (e.g. ‘doctors said’, ‘lawyers mentioned’, ‘literature showed’, 
‘criminologists argued’, etc.).  
 
“The literature on harm reduction reveals that the implementation of harm reduction initiatives is 
possible without changing the international drug conventions.” (Mr. Jo Vandeurzen, MP CVP, Fle-
mish Christian Democrats; Hand. Kamer 2000-2001, 7 maart 2001, COM 410, 12-17). 
 
Members of the Government used scientific knowledge when answering questions and interpel-
lations. The consequence of the fact that scientists and policy-makers operate under very differ-
ent time-frames was clearly illustrated.  
 
“You referred to a research conducted by the Children's Hospital in Melbourne which shows that 
cannabis use leads to depression. This research will be soon published in an international journal? 
It would like to stress that it is difficult to access and consider a non-published research.” (Mrs. 
Magda Aelvoet, Federal Minister of Public Health, AGALEV, Flemish Greens; Hand. Senaat 2001-
2002, 19 maart 2002, 2-51, 2692). 
 
Furthermore, they mostly used scientific knowledge commissioned by the Federal authorities 
(policy-funded research; e.g. regarding the relationship between drug use and traffic accidents). 
A focus on policy-funded research is somehow logical: they can gain credibility by referring to 
studies that they (or their predecessor) commissioned. In the context of the status model elabo-
rated in the literature (Cross, et al., 2000), instances where scientific knowledge was referred to 
                                                                                                                                                                                     
2-104, 33-38; Hand. Senaat 2000-2001, 17 mei 2001, 2-114, 18-20; Hand. Senaat 2000-2001, 31 mei 2001, 2-119, 
11-12; Hand. Senaat 2001-2002, 6 december 2001, 2-162, 16-18; Vr. en Antw. Senaat, 12 juni 2001, nr. 2/36 (Vr. 
nr. 1265 C. Nyssen); Vr. en Antw. Senaat, 9 oktober 2001, nr. 2/42 (Vr. nr. 1509 M. De Schamphelaere); Vr. en 
Antw. Senaat, 6 november 2001, nr. 2/43 (Vr. nr. 1553 V. Van Quickenborne).  
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simply because of the government’s desire to be evidence-informed seem to require the introduc-
tion of a new category in Weiss’s political/symbolic utilisation model. 
 
Scientific knowledge (e.g. inter(national) epidemiological data or international drug policy stud-
ies) was also used by Members of Parliament. Sometimes, the media served as a channel through 
which scientific knowledge was introduced into parliamentary debates (indirect reference).  
 
“I would like to refer to the results of a recent survey of the Brussels University, published in the 
French-speaking newspaper Le Soir today.” (Mr. Patrick Moriau, MP PS, French-speaking social-
ists; Hand. Kamer 2000-2001, 30 januari 2001, 106). 
 
Several examples of political/symbolic utilisation of scientific knowledge were observed. MPs 
simply selected those studies or experts that advanced their political interests. For instance, MPs 
from the extreme right parties Vlaams Blok and Front National, who underlined a rather medical 
approach to the drug phenomenon, mainly referred to doctors or psychiatrists. Additionally, 
scientists or scientific studies which made conflicting opinions more apparent were excluded or 
criticised. For example, some MPs ignored scientific criticism on the stepping stone theory. 
 
“Doctor Beaucourt refers to a national disaster, he is extremely shocked. Therefore, he gives 
speeches all over Flanders against the Government plans. He also airs his worries to the electorate 
of the Flemish extreme right party Vlaams Blok […] Admit it, Minister: the stepping stone theory is 
correct. Chocolate cigarettes can lead to real ones. In a similar vein, the use of soft drugs can lead 
to hard drugs. I would like to hear your opinion (my emphasis).” (Mr. Filip De Man, MP Vlaams 
Blok, Flemish extreme right party; Hand. Kamer 2000-2001, 30 januari 2001, 106). 
 
Sometimes, the same study was interpreted differently. One example concerned a study that com-
pared the effect of alcohol and cannabis on driving behaviour. The results of this study assumed 
that the doses of cannabis sufficient to become ‘high’ is comparable with alcohol percentages of 
0,3 – 0,7 in the blood. A balanced statement was formulated by the Minister of Justice Marc Ver-
wilghen. Conversely, the statements made by Mr. Jos Ansoms and Mr. Jo Vandeurzen (both CVP, 
Flemish Christian Democrats; oppositional position) were less nuanced.  
 
“This study mentioned that the influence of test doses of cannabis to get high is comparable to a 
blood alcohol concentration of 0,3- 0,7 (my emphasis).” (Mr. Marc Verwilghen, Federal Minister of 
Justice, VLD, Flemish Liberals; Hand. Kamer 2000-2001, 20 februari 2001, COM 394, 17-21). 
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“The University of Maastricht published a scientific report regarding the influence of cannabis use 
on driving behaviour […] It is certain that smoking a joint is similar to a blood alcohol concentra-
tion of 0,7. (my emphasis).” (Mr. Jos Ansoms, MP CVP, Flemish Christian Democrats; Hand. Kamer 
2000-2001, 20 februari 2001, COM 394, 17-21). 
 
Finally, some MPs drew false conclusions by ignoring the different time frames of science and 
policy (Lindquist, 2001; Carden, 2004). A common statement was that the stipulations regarding 
cannabis policy in the Federal Drug Policy Note had led to an increase in the prevalence of can-
nabis use. Several MPs used scientific research to argue that cannabis use as well as the number 
of people driving under influence of cannabis had increased in the first half of 2001 (as a result 
of the Federal Drug Policy Note which was launched in January 2001).  
 
“There has been an increase in driving under the influence of cannabis since the launch of the Fed-
eral Drug Policy Note in January 2001” (Mrs. Clotilde Nyssens, MP CVP, Flemish Christian Demo-
crats; Vr. en Antw. Senaat, 12 juni 2001, nr. 2/36 (Vr. nr. 1265 C. Nyssen)). 
 
Whereas policy issues often rise rapidly to the top of the political agenda and require quick an-
swers, scientific research can take months or years to complete. As the parliamentary debates 
took place in the months following the launch of the Federal Drug Policy Note, it was not possi-
ble to draw conclusions like ‘cannabis use increased due to the Federal Drug Policy Note’ (Kinable, 
2002). 
 
3.2.2. Political context 
The Federal Drug Policy Note closely followed the final conclusions and recommendations of the 
PWG. However, a political struggle occurred between the opposition and the majority or, in 
other words, between the members of the Verhofstadt I Government and the members of the 
previous one (Dehaene II Government). 
 
“MPs were strongly opposed. Mr. Jo Vandeurzen was one of the most difficult opponents. He was an 
expert in public health matters. Based on his experiences in the PWG, he gave the majority a hard 
time in the Parliament. Those were sometimes difficult debates for the Government.” (Respondent 
34, policy-maker).  
 
Several MPs (from the majority as well as from the opposition) and members of the Government 
openly criticised the hypocrite, dual role of the CVP, Flemish Christian Democrats. For instance, 
some political opponents of the CVP (Flemish Christian Democrats) blamed the 1998 Ministerial 
Circular Letter of Tony Van Parys (CVP). The 1998 Ministerial Circular Letter was labelled the 
starting point of the normalisation of cannabis use (among youth).  
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“I want to stress the complete hypocrisy of the Flemish Christian Democrats. [...] They have been 
criticising the Federal Drug Policy Note. [...] Colleagues of the Flemish Christian Democrats, you 
started the discussion, for heaven’s sake. They opened Pandora’s box. The Verhofstadt I Govern-
ment just implemented your thoughts.” (Mr. Filip De Man, MP Vlaams Blok, Flemish extreme right 
party; Hand. Kamer 2000-2001, 30 januari 2001, 106). 
 
MPs from the Flemish Christian Democrats used two strategies to refute the accusation of being 
hypocrite. On the one hand, they (wrongly) argued that the principles of the ‘new’ cannabis poli-
cy in the Federal Drug Policy Note were much more tolerant than the conclusions of the PWG. On 
the other hand, they held on to the decisions that were made in the former period. For instance, 
they regularly stressed that the recommendations of the PWG were approved by a majority.  
 
The discussions exacerbated existing tensions among the Coalition partners in the Govern-
ment too. Several MPs from the majority expressed their doubts about the Federal Drug Policy 
Note (which emphasises the importance of the individual in the policy-making process). While 
supporting the progress made, French-speaking MPs from the majority pointed to several incon-
sistencies in the Federal Drug Policy Note. Criticism became even more virulent on the side of 
Flemish MPs from the majority (SP, VLD). The answers given by the Minister of Justice and the 
Minister of Public Health brought little clarification.  
 
“The 1998 Ministerial Circular Letter was criticised because of the vague notions ‘problematic use’ 
and ‘use with nuisance’, the last circular letter was vague. [...] The problems with these notions 
were not resolved.” (Mrs. Fientje Moerman, MP VLD, Flemish Liberals; Hand. Kamer 2000-2001, 30 
januari 2001, 106). 
 
Political tactics played an important role. Opposition parties were very active in formulating 
personal insults and using metaphors. These strategies were used in order to undermine the 
credibility of the Government and the political majority in the Parliament. Very often MPs pre-
sented themselves as ‘honest’ or aiming for ‘honesty’ while, at the same time, pointing to the 
unfairness of political opponents. Having a central position in the drug/cannabis debate, both 
the Minister of Justice Marc Verwilghen and the Minister of Public Health Magda Aelvoet were 
blamed. 
 
“Mrs Minister, I’m going to be honest with you. In the last year and a half, you have talked non-
sense more than once. You have a practically flawless feeling for blunders and inaccurate commu-
nication.” (Mr. Yves Leterme, MP CVP, Flemish Christian Democrats; Hand. Kamer 2000-2001, 30 
januari 2001, 106). 
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Moreover, MPs in an oppositional position consciously stimulated the confusion by using inaccu-
rate terminology. Many members of the Parliament did not make a distinction between the pos-
session and the use of cannabis and between the concepts ‘legalisation’, ‘depenalisation’ or ‘de-
criminalisation’.  
 
“It is astonishing that the Government has decided to no longer criminalise the use of cannabis.” 
(Mr. Jo Vandeurzen, MP CVP, Flemish Christian Democrats; Hand. Kamer 2000-2001, 30 januari 
2001, 106). 
 
The discourse of the opposition parties and some majority parties often included concepts like 
‘youth’, ‘children’, ‘minors’. Here, MPs pointed to the increase of cannabis consumption among 
youth, to the accuracy of the stepping-stone story, and the establishment of coffee-shops in Bel-
gium. Such emotional assumptions were not based on any scientific knowledge. Likewise, it was 
sometimes stated that the expertise as a parent was equally important as the expertise of a sci-
entist. 
 
“You don’t have to be a great psychologist or professor to know this. My children are 20 years old. 
In a discussion with youngsters about the use of drugs, the argument of ‘authority’ is taken down 
by the Government (my emphasis).” (Mr. Jos Ansoms, MP CVP, Flemish Christian Democrats; Hand. 
Kamer 2000-2001, 31 januari 2001, COM 373, 1-4). 
 
Finally, arguments related to the renegotiation of international conventions were very often 
observed in the public debate. A common strategy was to project the effects of depenalisation, 
decriminalisation or legalisation of cannabis on the basis of analogies to experiences of other 
countries (cf. policy platonism). The Dutch coffee-shop model was frequently mentioned to sup-
port the idea that liberalisation may lead to drug tourism and an increase in drug use. The ad-
vantages of prohibition were supported by the American example of the War on drugs. 
 
“Depenalisation of the possession of cannabis may increase the demand. That is obvious. This is 
confirmed by the current developments in the Netherlands.” (Mr. Jo Vandeurzen, MP CVP, Flemish 
Christian Democrats; Hand. Kamer 2000-2001, 30 januari 2001, 106). 
 
3.3.3. Media coverage 
There was a strong link between the parliamentary debate and media coverage. The news re-
ports on the cannabis issue frequently triggered opposition MPs. In other words, interpellations 
and questions were quite clearly and strongly led by media content. For instance, an MP from 
the extreme right party Vlaams Blok used the media to introduce his interpellation.  
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“You don’t have to believe me, but the newspaper headlines do not lie. I brought some with me. I 
quote ‘Cannabis free’, ‘Cannabis use no longer a criminal offence’, ‘The use of cannabis completely 
free’, ’Smoking joint in bars allowed’ and ‘Belgian policy of tolerance more tolerant than the Dutch 
one’. That is the message that is given.” (Mr. Filip De Man, MP Vlaams Blok, Flemish extreme right 
party; Hand. Kamer 2000-2001, 30 januari 2001, 106). 
 
Members of the Government and MPs from the majority used the media as well. For instance, 
MPs from the majority used media statements by political opponents to point to the hypocrisy of 
the Flemish Christian Democrats (as a result of switching from majority to an oppositional role). 
Even the Minister of Justice Marc Verwilghen and the Minister of Public Health Magda Aelvoet 
tried to refute the existing confusion by using media statements. This confirms once more that 
Ministers (and their representatives) were aware of the media coverage (see above, §2.4.2.). 
 
“Like I said in an interview in ‘Le Soir’ […]. Cannabis has a special status, but it is still an illegal 
drug.“ (Mrs. Magda Aelvoet, Federal Minister of Public Health, AGALEV, Flemish Greens; Hand. 
Kamer 2000-2001, 30 januari 2001, 106). 
 
4. Mobilisation of interest group ‘Parents against Drugs’ 
The existing tensions among the Coalition partners (heated by the media and parliamentary 
attention) as well as the ongoing debates about the reform of the police (‘Octopus reforms’) ini-
tially hampered any real progress of the realisation of the action points from the Federal Drug 
Policy Note.93  
 
“The unfortunate communication raised some tensions. That is the reason why it took so long be-
fore any legislative work was started […] I have to say we also had a lot of work with other topics. 
There were a lot of discussions about the reform of the police […] I also felt that the Government 
was totally fed up with the Federal Drug Policy Note.” (Respondent 50, scientist).  
 
Within this framework, statements of the Flemish interest group Parents against Drugs [Ouders 
tegen Drugs] regularly seeped into the discourse of some newspapers. For example, in Septem-
ber 2001, attention mostly focused on the first appearance of doctor Mireille Vergucht, a mem-
ber of the interest group Parents against Drugs [Ouders tegen Drugs], in the newspapers. Clearly, 
                                                          
93  The lack of progress was also felt by practitioners who tried to put some pressure on the Government. For exam-
ple, practitioners, united in a Memorandum Group, took the lead in inviting a representative of the Minister of 
Public Health Magda Aelvoet. The representative made clear that – amongst other topics - long-term or permanent 
contracts for prevention/treatment workers could not be guaranteed and still depended on the funding of the 
‘drug plans’ (Chapter 1, §2). Accordingly, stressing the importance of this particular action point in the Federal 
Drug Policy Note (Federal Drug Policy Note, p.34), they sent a letter to the Prime Minister Guy Verhofdstadt, the 
Minister of Justice Marc Verwilghen, the Minister of Public Health Magda Aelvoet and the Minister of Interior Af-
fairs Antoine Duquesne as well as to the presidents of the party factions in the Chamber of Representatives. 
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the media acted as an important communication tool for interest groups. However, by promot-
ing urine tests among youngsters (to check for drug use), doctor Mireille Vergucht was often 
openly criticised by practitioners in the media. At the same time, the interest group was criti-
cised by some (rather progressive) journalists. “Federal Drug Policy Note does not legalise canna-
bis. J. Smits, president of the interest group Parents against Drugs [Ouders tegen Drugs], is not al-
ways well-informed about the goals of the Government” (1 June 2001, Flemish newspaper Het 
Nieuwsblad).  
 
In addition to their use of the media, they employed several other methods to gain more public 
(and political) attention. First, members of Parents against Drugs [Ouders tegen Drugs] gave lec-
tures and distributed flyers in order to gain public support. Secondly, they actively tried to influ-
ence policy-making by making contact with (like-minded) members of the Parliament. Within 
this framework, they succeeded in convincing some MPs to submit questions or interpellations. 
In particular, the Flemish extreme right party Vlaams Blok was the only supporter of a radical 
interpretation of their message ‘say no to drugs’. Several interviewees stressed that the Flemish 
interest group Parents against Drugs [Ouders tegen Drugs] was financially and organisationally 
supported by this political party. 
 
“We had contacts with the interest group, we were their only political representative. But they 
knew that they risked negative attention by cooperating with the Vlaams Blok […] They were care-
ful, we were careful because we did not want to limit their work. They really cooperated with us. 
Organising meetings, a demonstration etc.” (Respondent 14, policy-maker). 
 
Thirdly, they collected signatures against legalisation and organised a large demonstration on 30 
September 2001. Some political parties were represented: CD&V94 (Flemish Christian Demo-
crats), Vlaams Blok (Flemish extreme right party), Front National (French-speaking extreme 
right party). Several newspapers reported on this demonstration. “More than 90% of the 3.000 
demonstrators were Flemish people responding to the appeal of the interest group” (1 October 
2001, French-speaking newspaper Le Soir). As a result of the petition and demonstration, mem-
bers of the interest groups were invited by the Prime Minister Guy Verhofstadt and the Minister 
of Public Health Magda Aelvoet. Even though they were heard and a dialogue was set up, all in-
terviewees (members of interest groups as well as policy-makers) agreed that their efforts did 
not result in effectively influencing the Ministers (and their representatives) of the Verhofstadt I 
Government.  
                                                          
94  The CVP became CD&V in September 2001. 
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“We organised a demonstration and, a couple of days later, we were invited by the Prime Minister 
Guy Verhofstadt […] We were allowed to discuss our worries, but in practice, nothing changed […] 
We were not decisive. We rang a bell but that’s it.” (Respondent 3, member of interest group). 
 
While scientific expertise was valued by its ‘objectivity’ and practitioners by their ‘day-to-day 
experience’, interest groups were viewed as hopelessly driven by emotions. Furthermore, it was 
frequently argued that their organisation and arguments were not structured enough and that 
they united only a small number of citizens who did not necessarily represent the larger public. 
The reality of policy-making dictates that most policy decisions need to be acceptable to a major-
ity of the voting population (Matthew-Simmons, 2011).  
 
“Their emotional discourse influenced some people but it was not structured enough […] Each sto-
ry was touching but, as a group, they did have less impact.” (Respondent 39, policy-maker). 
 
Additionally, their actions popped up too late (the Federal Drug Policy Note was already devel-
oped and politically approved in January 2001) and there is no easy flow of information between 
the Parliament and the Government (these are rather two different worlds). Attempts to influ-
ence policy-making therefore remained limited to setting the parliamentary agenda instead of 
influencing the Inter-Cabinet Working Group (ICWG). In other words, they affected policy-
makers on the level of the public feasibility of their policy choices instead of on the level of sub-
stantive argumentation in the ICWG. 
 
5. Conclusion 
The Federal Government translated the conclusions and recommendations of the Parliamentary 
Working Group on drugs (PWG) into the first national drug strategy in Belgium. The Federal 
Drug Policy Note, which I consider to be the second milestone in the development of Belgian 
drug policy between 1996-2003, stressed that the drug phenomenon is considered to be a per-
manent social reality (i.e. normalisation policy). Accordingly, in the framework of an integral and 
integrated policy, a discourse with a purely criminal focus was officially replaced by a discourse 
where the drug problem was primarily considered a problem of public health (Federal Govern-
ment, 2001a). 
 
The value of scientific knowledge was strongly acknowledged in the Federal Drug Policy Note. 
The concept evidence-based was adopted and it was decided that the Minister in charge of the 
Federal Science Policy received an annual budget to organise and manage a research pro-
gramme. A budget increase of this kind can be seen as an important indicator of the efforts that 
Chapter 4  The Federal Drug Policy Note (2001) 
236 
the policy-makers made in addressing the drug problem and in considering scientific knowledge 
as a priority. 
 
Likewise, the Federal Government seemed to be comfortable with scientific knowledge in or-
der to temper the ideas of opposition MPs in the Parliament and to shape the details of the policy 
they develop. Scientific knowledge contributed to the Inter-Cabinet Working Group (ICWG) 
through different modalities. First of all, the ICWG was strongly influenced by the concepts or 
perspectives provided by scientists in the PWG. This can be considered as an indirect pathway 
through which scientific knowledge seeped into the policy discourse (conceptual utilisation). 
Furthermore, as the evaluation study of Prof. Dr. Brice De Ruyver and Prof. Dr. Joris Casselman 
(2000) fitted with the mood of the time and answered the questions which were at the top of the 
political agenda since the PWG, the action points of the Federal Drug Policy Note followed the 
conclusions and recommendations of this evaluation study (De Ruyver, et al., 2000). In other 
words, this study led to action/implementation by the Federal Government (instrumental utilisa-
tion). The fact that an evaluation study fulfills this particular role fits with the literature on evi-
dence-based policies (Devroe, Deschamps and Hannes, 2008). Thirdly, examples of politi-
cal/symbolic utilisation were also noted. For instance, one of the objections of the evaluation 
study was that notions such as ‘public nuisance’ and ‘problematic use’ and ‘limited possession 
for personal (single or occasional) use’ included in the Ministerial Circular Letter of 8 May 1998 
were too vague and created a lack of uniformity in prosecutions for cannabis possession. Even 
though the Federal Drug Policy Note demonstrated commitment and responsiveness by includ-
ing a reference to the Governments’ investment in the evaluation study, the vagueness of the 
notions was not resolved at all (Durieux, 2002; Guillain, 2003). Additionally, members of the 
Government used scientific knowledge when answering questions and interpellations in the 
Parliament. They displayed commitment in the use of scientific knowledge in order to win politi-
cal authority (see also MacGregor, 2010). Even though most of these references to scientific 
knowledge or scientists were formulated in a generalistic way (e.g. ‘based on a conference, we 
know’, ‘foreign studies explored’), we identified a high utilisation of the studies that they (or 
their predecessor) had commissioned. Termed status model by Cross et al. (2000), these exam-
ples of the government’s desire to be evidence-informed support the extension of Weiss’s politi-
cal/symbolic utilisation model (Weiss, 1979).  
 
The parliamentary discussions following the launch of the Federal Drug Policy Note and the 
information campaign resulted in a struggle over the discourse on cannabis policy between the 
Verhofstadt I Government and the previous Dehaene II Government as well as between individ-
ual MPs from the majority. Scientific knowledge (e.g. inter(national) epidemiological data, inter-
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national drug policy studies) was one of the sources of information used by MPs. Similar to the 
contributions of the members of the Government, most of the references to scientific knowledge 
or experts were labelled generally (e.g. ‘studies showed’, ‘experts explained’). In this context, we 
found in particular examples of political/symbolic utilisation of scientific knowledge. MPs simply 
selected those studies or scientists that supported their political interests. Scientific knowledge 
was also (consciously) misinterpreted (e.g. ignoring the different time frames of science and 
policy) in order to enhance their position in these debates. Clearly, Weiss’s political/symbolic 
model has to include a distinction between instances where scientific knowledge is truly being 
used as opposed to when consciously misuse or misinterpretation. 
 
Many other factors in addition to scientific knowledge were also driving the Inter-Cabinet Work-
ing Group (ICWG) and the following parliamentary debates. In other words, several barriers of 
knowledge utilisation were noticed. A large influence can be attributed to the institutional and 
individual characteristics of the political setting. The ICWG had the task of taking into account the 
opinions of the individual Ministers and the viewpoints of their political party as well as the in-
ternational framework (i.e. Dutch drug policy, the international drug control conventions). The 
debate was clearly overshadowed by the disagreements between individual policy-makers with-
in the same party, even within majority parties. For instance, as a political strategy of a dissatis-
fied Coalition partner, some preliminary drafts of the Federal Drug Policy Note were leaked to 
the media to hamper (and influence) the policy-making process. The use of political tactics (e.g. 
incorrect terminology, personal insults, emotional assumptions, metaphors) in the parliamen-
tary discussions was also a tangible illustration of this point. The characteristics of scientific 
knowledge were reported to be important barriers of knowledge utilisation in the ICWG as well. 
The idea that policy-makers and scientists operate in two different worlds and speak two differ-
ent languages was stressed (two communities thesis; Caplan, 1979). For instance, interviewees 
pointed at the fact that scientific research often takes years to complete while policy issues often 
rise rapidly to the top of the political agenda. The translation of scientific knowledge into a short, 
comprehensible report was considered to be an even more complex process. Furthermore, it 
was acknowledged that scientists always apply a certain degree of nuance in their arguments 
while policy-makers think in terms of practical solutions. In pursuing this, it is no surprise that 
high value was placed on practitioner knowledge. Their interests are not only related to more 
practical day-to-day experiences and concerns but were also well-argued and proactively put 
forward through a Policy Memorandum (Memorandum group, 1999).  
 
Scientific knowledge was more likely to be used when it was introduced in the policy-making 
process (facilitator) (Loader and Sparks, 2011). In the Inter-Cabinet Working Group (ICWG), 
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Prof. Dr. Brice De Ruyver acted as an observer-turned player who was able to function equally 
well in the academic world and the policy-making process. His role as the security advisor to 
Prime Minister Guy Verhofdstadt enabled him to promote the utilisation of his own research and 
that of other researchers. In particular, he was of considerable value in enhancing the instrumen-
tal use of scientific knowledge (e.g. the evaluation study, international drug policy studies) in the 
ICWG. Furthermore, on the sidelines of the ICWG, several policy advisors facilitated the concep-
tual utilisation of scientific knowledge through personal relationships with the Ministers (or 
their representatives). Indeed, it often appeared that the Ministers (or their representatives) 
(selectively) consulted policy advisors from their personal network to get some background in-
formation, to unravel a problem or to support or refute some arguments in the discussion. In 
particular, they tended to turn to those scientists who were known to be appropriately discreet 
(especially in such a heavily mediatised domain) and had the capacity to convince public and 
political audiences. Clearly, when scientists want to act as policy advisors, they have to actively 
search for access to the personal networks of the Ministers (or their representatives). These 
scientists are assumed to engage with journalists (and the public) as well.  
 
The launch of the first national drug strategy as well as the information campaign were both 
heavily debated in the media. In particular, the media discourse (characterised by a focus on 
cannabis policy and the harmfulness of cannabis use) exaggerated the incomplete and contradic-
tory message of the Federal Government and, accordingly, further confused both the policy-
makers’ and the public’s understanding of the debate. Several opinion polls confirmed these 
public concerns and misunderstandings (Patesson and Steinberg, 2000). At the same time, me-
dia discourse triggered the submission of a large number of questions, interpellations, resolu-
tions or bills. Within this framework, the media operated as a kind of knowledge distributor be-
tween science and the parliamentary process (facilitator). Parliamentary activities were fre-
quently supported by scientific knowledge (e.g. inter(national) epidemiological data or interna-
tional drug policy studies) that was quoted in newspapers (thus as an indirect reference). The 
media did not play a vital role in shaping the Federal Drug Policy Note. However, Ministers and 
their representatives always take into account the media discourse, as they are driven by their 
concern about how the public (and their electorate) viewed and assessed their policy decisions.  
 
The main audiences for interest groups were the media (and the public opinion) and MPs. 
Flemish interest group Parents against Drugs [Ouders tegen Drugs] was mobilised after the 
launch of the Federal Drug Policy Note. This resulted in several (emotional) presentations in 
media, the establishment of contact with MPs, a petition and the organisation of a demonstra-
tion. This interest group succeeded in heating up and polarising the debate even more. However, 
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their attempts to influence policy-making remained limited to bringing issues onto the parlia-
mentary agenda. Their lack of influence on the Inter-Cabinet Working Group (ICWG) is the result 
of their deficient organisational and communication structure and reflects the fact that they only 
represented a small part of the public opinion. Furthermore, their mobilisation was initiated too 
late: the Federal Drug Policy Note was already developed and politically approved. 
 
As one of the action points, the Federal Government planned to put the drug policy priorities 
into action by means of a new legal framework. The adaptation of the drug law (and the Ministe-
rial Circular Letter), the third milestone in the development of Belgian drug policy between 1996 
and 2003, is discussed in the next chapter. 
 
 
Chapter 5  The reform of Belgian drug law (2002-2003) 
 
According to the Federal Drug Policy Note, a global and integrated policy requires prevention, 
early detection and intervention, treatment including risk-reduction and repression. Repression 
towards the users, however, had to remain a last resort (ultimum remedium) (Federal Govern-
ment, 2001a, p.7-8). In accordance with this point of view, the Federal Government planned to 
amend the Belgian Narcotic Drug Law of 1921 and, accordingly, to develop a new Ministerial 
Circular Letter. This action point was most heavily debated by MPs, members of the Govern-
ment, the media and interest groups. The Federal Drug Policy Note provided the substantive 
framework for the juridical-technical debates regarding the reform of Belgian drug law in an 
Inter-Cabinet Working Group (ICWG) and the Parliament (both Chamber of Representatives and 
Senate). I consider the implementation of the new law (2003) (and the new Ministerial Circular 
Letter) as the third milestone in the development of Belgian drug policy between 1996 and 
2003.  
 
1. The implementation of the Federal Drug Policy Note between 2001-2003 
Several recommendations of the Federal Drug Policy Note were implemented in the years fol-
lowing its launch. We first highlight two elements that are central to this study: the new drug 
law and the state of the art regarding scientific knowledge. In §1.3., the realisations related to 
coordination structures, prevention and harm reduction are discussed briefly.  
 
1.1. New drug law: modifications to the 1921 Narcotic Drug Act 
Criminal policy on drugs was anchored through an adaptation of the drug law (of 24 February 
1921; see Chapter 1) and the Ministerial Circular Letter of 8 May 1998 (De Ruyver, Vander Lae-
nen and Eelen, 2012). In particular, an important modification of the drug law was made by the 
Law of 4 April 2003 and the Law of 3 May 2003. These two laws were accompanied by the Royal 
Decree of 16 May 2003 and the Ministerial Circular Letter of 16 May 2003 which determined the 
prosecution policy (see below, §4). 95 As will become clear below, the modification fitted with the 
policy priorities put forward by the PWG (1996-1997) and the Federal Drug Policy Note (2001): 
the criminal justice response is primarily aimed at drug production and drug trade; problematic 
drug users who come in contact with the criminal justice system need to be promptly diverted to 
                                                          
95  Because of technical reasons (related to the Articles 77 and 78 of the Constitution), the legislative initiative was 
divided into two bills (nrs. 1888 and 1889). Both drug laws (of 4 April and 3 May 2003) should also be considered 
as linked with a Royal Decree (16 May 2003) detailing the categories of infringements and a Ministerial Circular 
Letter (16 May 2003) determining the prosecution policy of cannabis. Each of the initiatives is complementary to 
the realisation of the new public health policy. As we may treat both laws and the Royal Decree as one entity, we 
will regularly use the concept new drug law to refer to this package. 
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(drug) treatment, making use of the existing legal provisions on different levels of the criminal 
justice system (De Ruyver, Vander Laenen and Eelen, 2012). Thus, a criminal procedure should 
be an ultimum remedium, and within the criminal system, imprisonment should be used as a last 
resort (Federal Government, 2001a; p.7; Van Gaever, 2003; Mahieu, 2005; Dangreau and Serlip-
pens, 2007). 
 
In the new drug law96 (of 4 April 2003 and of 3 May 2003) and the Royal Decree (of 16 May 
2003) a criminal approach was suggested, with a focus on the differentiation and the individual-
isation of the criminal intervention (cannabis versus other illegal drugs; experimenting, prob-
lematic use, personal use, dealing with profit). One of the most important changes concerned the 
new statute of cannabis being defined as another category of drugs with its own distinct regula-
tions (i.e. the possession of an amount of cannabis, meant for personal use, by an adult (i.e. 18 
years or older), without the presence of nuisance or problematic use will only lead to a registra-
tion by the police). ‘Problematic use’ was defined as the use that is linked with a level of depend-
ence that disables users to control his/her use and that is expressed by psychological and physi-
cal symptoms. The definition of ‘public nuisance’ was provided by the broader definition of ‘pub-
lic nuisance’ in Art. 135, §2 of the New Community Law97. In particular, it was expressly stated 
that ‘public nuisance’, in accordance with the 1988 United Nations Convention against illegal 
traffic in narcotic drugs and psychotropic substances, referred to the ‘possession of cannabis in a 
prison, education institute, public institute or in their neighbourhood as well as in meeting plac-
es of minors like schools, sport centre, etc’. Other changes implemented by the new drug law 
were that ‘drug use in a group’ was no longer punishable and that substances that could be used 
to produce illicit substances (so-called precursors), under article 8 of a European Council Regu-
lation (n° 3677/90), were now incorporated as well.98  
                                                          
96  Wet van 4 april 2003 tot wijziging van de wet van 24 februari 1921 betreff ende het verhandelen van giftstoffen, 
slaapmiddelen en verdovende middelen, ontsmettingsstoffen en antiseptica (B.S. 2 juni 2003), en Wet van 3 mei 
2003 tot wijziging van de wet van 21 februari 1921 betreffende het verhandelen van giftstoffen, slaapmiddelen en 
verdovende middelen, psychotrope stoffen, ontsmettingsstoffen en antiseptica en van de stoffen die kunnen ge-
bruikt worden voor de illegale vervaardiging van verdovende middelen en psychotrope stoffen (B.S. 2 juni 2003). 
97  This law concerns the local administrative sanctions. It gives the municipalities the possibility of adding behav-
iours described as public nuisance to their police regulations and respond to those offences with administrative 
procedures (Wet van 13 mei 1999 betreffende de invoering van de gemeentelijke administratieve sancties, B.S. 10 
juni 1999). 
98  The new drug law changed the title including substances that could be used to produce illicit substances (so-called 
precursors) as well: ‘Wet van 3 mei 2003 tot wijziging van de wet van 21 februari 1921 betreffende het verhande-
len van giftstoffen, slaapmiddelen en verdovende middelen, psychotrope stoffen, ontsmettingsstoffen en antisepti-
ca en van de stoffen die kunnen gebruikt worden voor de illegale vervaardiging van verdovende middelen en psycho-
trope stoffen, B.S. 2 juni 2003’. Crimes concerning precursors are subject to the penalties specified in Art.2 quater 
of the drug law. 
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In this context, a distinction between infringements for personal use or infringements for profit 
(i.e. clear differentiation according to the intent) and between three categories of crimes was 
explicated. The first category involved the importation, production, transport, purchase, posses-
sion and cultivation of cannabis for personal use. The second category included the behaviour 
from category 1, but in cases of aggravating circumstances such as the presence of minors99, 
problematic use or public nuisance. The third category included all violations of the drug law 
that were not included in the first or second category. Both category 2 and 3 were linked with an 
imprisonment (between 3 months and 5 years) as well as a fine (between 5.000 and 500.000 €). 
Other penalties were placed in category 1: first infringement (fine of 15-25 €), repeated in-
fringement within one year (fine of 26-50 €), another repeated infringement within one year 
after the second infringement (imprisonment of eight days-one month and a fine of 50-100 €), in 
case of aggravating circumstances such as involvement of minors or criminal organisations (im-
prisonment of three months- one year and/or a fine of 1.000 – 100.000 €). Obviously, the com-
merce, production, export and importation of substances (for profit) remained forbidden, and 
retained their original punishments.  
 
Furthermore, the new drug law allowed a broader application of the Law of 29 June 1964 con-
cerning the conditional sentence, suspended sentence and probation (changed by the Law of 10 
February 1994).100 According to this law, a judge can decide to defer the pronouncement of a 
sentence or to postpone the execution of a sentence. Linking conditions to these decisions re-
sults in a ‘probationary conditional sentence’101 or a ‘probationary suspended sentence’102. 
While, according to art. 3 and 8, the person concerned should not have been earlier sentenced to 
a criminal sentence or a prison sentence of more than 12 months, art. 9 of the Law of 9 July 1975 
already added that, in particular cases, judicial antecedents were no impediments for probation 
(see also above, Chapter 1, §1). The new drug law (of 3 May 2003) replaced art. 9 of the Law of 9 
July 1975 by removing ‘drug use in a group’ (as this was no longer punishable). Simultaneously, 
the scope of art. 9 was extended. Art. 9 of the new drug law noted that, in case of offences for 
                                                          
99  Even though the concept of aggravating circumstances (e.g. drug use by minors) was implemented by the Law of 9 
July 1975, the Royal Decree (of 16 May 2003) underlined the importance of the protection of minors once more 
(B.S. 2 juni 2003, p.29935).  
100  Wet van 29 juni 1964 betreffende de opschorting, het uitstel en de probatie, B.S. 17 juli 1964. Wet van 10 februari 
1994 tot wijziging van de wet van 29 juni 1964 betreffende de opschorting, het uitstel en de probatie, B.S. 27 april 
1994. 
101  Probationary conditional sentence means a judicial decision according to which the imposition of the sentence is 
suspended with the condition that the person complies with probation measures.  
102  Probationary suspended sentence means that the judge pronounces a sentence but that the execution of the whole 
or a part of the sentence is suspended for a certain period, during which the person concerned must fulfil certain 
conditions.  
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personal use (i.e. the possession for personal use as well as the sale to finance one’s own use)103 
without aggravating circumstances, judicial antecedents were no impediments for probation 
(Mahieu, 2004; Geenens, et al., 2005). In aiming to reduce user’s physical and psychosocial prob-
lems that might accompany drug abuse and to protect society, this broader application allowed 
to guide problematic drug users more easily towards treatment (ultimum remedium philosophy).  
 
In a similar vein, as the importance of individualised and continuous care and of cooperation 
between the criminal justice and the treatment system has been stressed in the Federal Drug 
Policy Note (2001) (Vander Laenen and Dhondt, 2003; Geenens, et al., 2005), the Royal Decree of 
16 May 2003 formally introduced the terms risk reduction and therapeutic advice104. The new 
concept of ‘case-managers’ for judicial and health matters, to be appointed by the Federal Minis-
ters of Justice and Health respectively, was also introduced (see also Federal Government, 
2001a, p.34, 49). On the one hand, the chronic and complex problems of many drug abusers and 
the lack of coordination and continuity of care were the main reasons for introducing health case 
managers (Vanderplasschen, et al., 2004). A health case manager was said to be responsible for 
the personal observation of problematic drug users who are guided to treatment (in order to 
enhance treatment access, participation and retention and to improve treatment results con-
cerning drug use, employment, psychological problems or criminality) (Geenens, et al., 2005). 
Case-managers for health matters were implemented in 2002: a pilot project for the develop-
ment of crisis units for drug addicts and the implementation the role of case manager within 
these units was initiated (Geenens, et al., 2005; see also below, §1.3.2.).  
 
On the other hand, a judicial case manager had to bridge the gap between the criminal justice 
system and the (drug) treatment system, to inform magistrates about treatment possibilities for 
drug offenders, and to advise them about the desirability of coercion.105 In particular, it was de-
termined that, at every stage of the criminal justice system, magistrates had the opportunity 
(through a judicial case manager) to ask for therapeutic advice. The positive or negative advice 
of an independent therapeutic adviser (based on existing scientific, psycho-social and medical 
                                                          
103  This was to stress the distinction between personal use and profit (i.e. clear differentiation according to the intent) 
(Mahieu, 2004). 
104  The title of the Royal Decree of 31 December 1930 was changed and now included the terms ‘risk reduction’ and 
‘therapeutic advice’ (see also Todts, 2004). 
105  While the Royal Decree (16 May 2003) described the role of the judicial case manager as someone who assists in 
monitoring the drug problem and the people involved and supports the guidance of problematic drug users more 
easily towards treatment, the Ministerial Circular Letter (16 May 2003) adds that the judicial case manager should 
be in charge of the coordination of the treatment network in general (De Ruyver, et al., 2008a). Within this frame-
work, the importance of agreements considering and respecting the different goals and principles of both sectors 
(e.g. professional confidentiality) was stressed.  
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knowledge) was to help the magistrate to assess the extent of problematic use and the need for 
treatment, taking into account the interests of the user as well as of the society. The lack of struc-
tural clarity together with a limited financial support106 hampered its implementation for a long 
time (De Ruyver, et al., 2004). Nevertheless, worth mentioning are the pilot-projects like ‘Test 
Care’ (2005-2007), ‘Drug Treatment Court’ (2008), etc. which were established recently (De 
Ruyver, et al., 2008a; De Ruyver, Lemaître and Schoenaers, 2009; Luypaert, et al., 2007).107 
These pilot-projects aimed to divert drug offenders from different levels of the criminal justice 
system towards treatment: e.g. ‘Test Care’ at prosecution level and ‘Drug Treatment Court’ at 
sentencing level. The pilot-project ‘Test Care’ was initiated in the judicial district of Ghent in 
2005 and the pilot-project ‘Drug Treatment Court’ started in 2008 in the judicial district of Ghent 
as well. Evaluation research has indicated that these pilot projects can be labelled as ‘good prac-
tice’ (De Ruyver, et al., 2008; Colman, 2009; Colman, et al., 2011). However, the planned and de-
sired generalisation of these projects faces some capacity and financial obstacles (De Ruyver, 
Vander Laenen & Eelen, 2012).  
 
Finally, based on the two laws (of 4 April and 3 May 2003) and the Royal Decree (of 16 May 
2003), the Minister of Justice Marc Verwilghen, together with the College of Prosecutors-
General, had the task of developing a new Ministerial Circular Letter detailing the prosecution 
policy. This Ministerial Circular Letter of 16 May 2003 eventually replaced the Ministerial Circu-
lar Letter of 8 May 1998 (see §4). 
 
1.2. Scientific background: state of the art 
The elaboration of evaluation, epidemiology and research was already one of the action points in 
the 1995 Plan Toxicomania. Emphasised once again in the Parliamentary Working Group on 
drugs (1996-1997) and in the Federal Drug Policy Note (2001), scientific research in Belgium 
was in gradual expansion. 
 
First of all, we observed an increase of policy-funded drug research as a result of the implemen-
tation of the Federal Policy note in 2001. Budgets for drug research increased greatly from 
€445.975 in 1993 to €2.710.572 in 2002 (De Ruyver, et al., 2004). Since 2001, the Minister in 
charge of the Federal Science Policy received an annual budget to organise and manage a re-
                                                          
106  This is in contrast with the Federal Drug Policy Note which underlined that funding had to be reserved for the 
implementation of therapeutic advice and alternative sanctions (Federal Government, 2001a). 
107  Other examples are: project ‘Clean’ (Bruges), the ‘Pol’-project (Mechelen), project ‘Therapeutic consult’ (Limburg), 
... (Colman, et al., 2011).  
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search programme supporting decision-making in the field of illegal drugs.108 The contribution 
to the decision-making process (especially regarding topics that were supposed to be acute, tak-
ing into account the prevailing political points of view) was an essential aspect of the pro-
gramme. Likewise, the organisation of guidance committees to follow up the research project 
had to stimulate the interaction between scientists, policy-makers and practitioners. Even 
though this is an important step in order to develop Belgian drug research, this evolution also 
has a downside: it placed scientific researchers in a more dependent position (e.g. related to 
funding) and (personal) networks between scientists and policy-makers became even more val-
uable (see above, Chapter 2, §2.2.1.; those selected in formal advisory committees were partly 
similar to those conducting policy-funded research). 
 
Furthermore, epidemiological research increased (BIRN, 2003). For the first time, in 2001, a 
module on illicit drugs was introduced in the National Health Interview Survey (HIS).109 Moreo-
ver, Belgium (Flemish and French community) continued to take part in the Health Behaviour 
School-aged Children studies (HBSC) in 1993/94, 1997/98, 2001/02 too. Additionally, in 2002, 
evaluations of some syringe exchange projects were executed (De Maere, 2003; Hariga, Przyluki 
and Van Lierde, 2002). Results showed that the use of cannabis was still by far the preferred 
drug among youth and adults and, according to the trends observed in school surveys, lifetime 
and last month prevalences of cannabis, had increased slightly among youngsters while preva-
lence rates of amphetamines and ecstasy use had decreased. Prevalence of hepatitis among drug 
users seemed to have stabilised. Even though some (new) initiatives were taken, the general 
amount and comparability of the data provided to the EMCDDA remained extremely weak in 
comparison with other European countries (De Ruyver, et al., 2004). 
 
Equally, due to a recurrent lack of uniform and comparable registration systems, the newly cre-
ated Belgian Monitoring Centre for Drugs and Drug Addiction (BMCDDA) (i.e. the Scientific Insti-
tute of Public Health (WIV), the Belgian focal point) initiated a study aiming at analysing the Bel-
gian situation and making recommendations in order to improve and standardise the collection 
of the Treatment Data Indicator data. Eventually, a protocol agreement regarding treatment de-
                                                          
108  The first call (2002) resulted in an evaluation of substitution treatment, an evaluation of the adequacy between 
diagnosis and therapeutics (matching), a feasibility study for the evaluation of the treatment for dual diagnosis pa-
tients, a study of the effect of the long term use of cannabis, and a study regarding local drugs nuisance. In 2003, 
the focus was on themes like case management in substance abuse treatment and the criminal justice system, the 
concept of problematic drug use, heroin and substitution treatment, medicinal cannabis use, etc. 
109  This module included four questions regarding cannabis and amphetamines use. These questions were related to 
lifetime and last month prevalence (recent use) of cannabis and XTC/amphetamines use. The questionnaire was 
self-administrated and addressed to people over 15 years (Wetenschappelijk Instituut voor Volksgezondheid, 
2002). 
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mand indicators was signed in 2005. The Federal Drug Policy Note also demanded that the Bel-
gian Monitoring Centre for Drugs and Drug Addiction (BMCDDA) was responsible for the Euro-
pean Monitoring Centre for Drugs and Drug Addiction’s (EMCDDA) request to further develop an 
Early Warning System. An early warning system on drugs (first for ATS (amphetamine-type 
stimulants) and later on for new synthetic drugs and psychotropic substances) had been devel-
oped in order to facilitate the collection and exchange of information between existing networks 
within Belgium and within other European countries.110 A Royal Decree (29 June 2003, B.S., 14 
July 2003) and a law (7 February 2014, B.S., 10 March 2014) introduced the obligation for labor-
atories to report every discovery of dangerous substances. 
 
Furthermore, in order to get a good understanding of the scientific state of the art regarding 
cannabis, its policy and the effects of cannabis use on health and behaviour, several Health Min-
isters (Mrs. Els Borst, the Netherlands; Mrs. Andrea Fischer, succeeded by Mrs. Ulla Schmidt, 
Germany; Mrs. Ruth Dreifuss, Switserland; Mr. Bernard Kouchner, France; Mrs. Magda Aelvoet, 
Belgium) took the initiative to organise an international scientific conference on the subject of 
cannabis. The conference took place in Brussels, on 25 February 2002, and was hosted by Mrs. 
Magda Aelvoet within the framework of Belgian’s EU presidency. The topics of discussion were 
the biochemical characteristics of cannabis (e.g. THC), the health consequences of use as well as 
the evolution towards more tolerant cannabis policies in various European countries (e.g. Swit-
zerland, Spain, the UK). The focus of the conference clearly fitted within the public health ap-
proach of the Federal Drug Policy Note (2001) and the sustained concern about the international 
framework, the developing media discourse on THC concentration, harmlessness of cannabis 
(see above, Chapter 4, §3.3.3.) and the increasing importance of scientific knowledge. For in-
stance, one of the conclusions of the conference clearly stated: “We sincerely believe that science 
can help to ensure that cannabis policy gradually develops into an evidence-based policy” (p.125).  
 
Another conference, ‘Drug policy 2000’, was held in February 2003 during the parliamentary 
debates about the new drug law. The goal of the conference was to evaluate the state of the art 
regarding Belgian drug policy two years after the establishment of the Federal Drug Policy Note 
(De Biasio, De Ruyver and Schleiper, 2003). Despite the clear goal of this conference to keep the 
issue on the agenda and to test or evaluate policy measures, the drug law was already approved 
                                                          
110  In August 2001, two drug-related deaths (PMA, a synthetic drug related to ecstasy) raised some controversy in the 
media and the political arena. This incident resulted in the establishment of an Inter-Cabinet Working Group un-
der the coordination of the Minister of Public Health. Accordingly, the creation of a Coordination Cell of synthetic 
drugs and the development of the Early Warning system (which was one of the action points of the Federal Drug 
Policy Note) were decided (Internal communication Ministerial Cabinet, 30 August 2001). It is clear that so-called 
incident-driven decisions by the Minister of Public Health Magda Aelvoet have led to the creation or elaboration of 
(new) systems in the short-term. 
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by the Chamber of Representatives at the time of the conference (the debates in the Senate were 
still ongoing).  
 
1.3. Realisations related to the Federal Drug Policy Note (2001): coordination structures, 
prevention, harm reduction and repression 
1.3.1. Integral and integrated drug policy 
Belgium has clearly chosen an integral and integrated drug policy with both vertical policy co-
ordination between different policy levels (federal, regional, provincial and local) in the domains 
of prevention, treatment and social policy, and horizontal coordination between the various pol-
icy domains and at the various levels (De Ruyver, Vander Laenen and Eelen, 2012).  
 
Several structures to develop and monitor an integral and integrated drug policy were estab-
lished (De Ruyver, et al., 2004). As a first step, a cooperation agreement between the Federal 
Government and the federate entities was signed in September 2002.111 Accordingly, a General 
Drugs Policy Cell and the Inter-Ministerial Conference on Drugs became the fora for coordi-
nation and consultation in putting the global and integrated drug policy into practice (Inter-
Ministeriële Conferentie, 2010). The Inter-Ministerial Conference on Drugs unites all Ministers at 
several policy levels with competence or part competence for aspects of the drug phenomenon 
in order to develop common policy objectives and harmonisation. As the starting point of the 
Federal Drug Policy Note was that drug use is a matter of public health, the Minister of Public 
Health is in charge of the integrated and integral drug policy and chairs the Inter-Ministerial 
Conference on Drugs (De Ruyver, Vander Laenen and Eelen, 2012). 
 
The General Drugs Policy Cell became operational in 2010 and is comprised of a coordinator 
(Prof. Dr. Brice De Ruyver), a deputy coordinator (Dr. Claire Remy) and representatives of the 
authorised Ministers. This body prepares the decisions of the Inter-Ministerial Conference and 
guards the integrated character of the policy measures (De Ruyver, et al., 2004; De Ruyver, et al., 
2007). The General Drugs Policy Cell consists of three supporting working cells: Drug Health Pol-
icy Cell, Control Cell and International Cooperation Cell (Inter-Ministeriële Conferentie, 2010, 
p.72). For instance, whereas the General Drugs Policy Cell focuses on all aspects of the drug phe-
nomenon, the Drug Health Policy Cell is focused specifically on health aspects of the problem. 
Already on 30 May 2001, the various Ministers involved in Belgian drug policy signed a protocol 
agreement regarding the establishment of an integrated health policy on drugs (Inter-
                                                          
111  Wet van 11 mei 2003 houdende instemming met het Samenwerkingsakkoord tussen de Staat, de Gemeenschap-
pen, de Gemeenschappelijke Gemeenschapscommissie, de Franse Gemeenschapscommissie en de Gewesten voor 
een globaal en geïntegreerd drugsbeleid, B.S. 2 juni 2003. 
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Ministeriële Conferentie, 2010). Accordingly, in order to stimulate and to gear policy initiatives 
regarding prevention and treatment towards drug users/addicts, the Drug Health Policy Cell was 
set up and became operational in June 2001. Policy advisor Prof. Dr. Isidore Pelc was appointed 
president of the Unit, which was comprised of the representatives of the (Federal and Regional) 
Ministerial Cabinets involved in this matter (and some practitioners were appointed as substi-
tutes) (Cel Gezondheidsbeleid Drugs, 2002).  
 
The fact that scientists who had long played a proactive role in the drug policy-making process 
(e.g. PWG, policy-funded research,…) were appointed as the presidents of the Drug Health Policy 
Cell and the General Drugs Policy Cell underlines the value of a public role as observer- turned 
player or policy advisor (Loader and Sparks, 2011). They obtained a privileged position to engage 
the interaction between science and policy and to generate an evidence-informed policy-making 
(see also below, §2). Given that the General Drugs Policy Cell became operational in 2010 and 
that the development of a coherent, integrated drug policy is an ongoing process112, it would be 
interesting to investigate its role regarding the science-policy nexus in further research. 
 
As another example of the development of a coherent, integrated drug policy, the criminal jus-
tice system aimed, when possible, to divert problem drug users to (drug) treatment (based on 
the ultimum remedium philosophy). In this context, the cooperation between the criminal 
justice system and treatment services gradually increased, not least because of the success of 
the ‘Test care’ and ‘Drug treatment court’ pilot projects, both in the judicial district of Ghent (see 
also §1.1.; De Ruyver, Vander Laenen and Eelen, 2012). 
 
Finally, Belgian drug policy took into account international treaties and European policy plans 
and aimed to ensure consistency with international and European policy. In this context, sev-
eral Intereg-, Euregio-, Multicity- projects had been established (Inter-Ministeriële Conferentie, 
2010, p.30-32).  
 
1.3.2. Treatment – harm reduction 
The Federal Drug Policy Note aimed for the development of a more integrated legal framework 
for treatment, harm reduction and reintegration. Some of the action points were already realised 
in 2003. For instance, stimulated by the former methadone conference (1994) and the Federal 
Action Plan Toxicomania-Drugs (1995), a legal basis for substitution treatment in Belgium was 
finally established by the Law of 22 August 2002 (B.S. 1 October 2002). Accordingly, a medical 
                                                          
112  On 25 January 2010, the Inter-Ministerial Conference on Drugs approved a joint declaration, which carries on the 
principles adopted in the Federal Drug Policy Note of 2001 (Inter-Ministeriële Conferentie, 2010). 
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practitioner could no longer be punished for using controlled substances for treatment. Howev-
er, the application modalities defining the preconditions and registrations were still lacking 
(even though the Federal Drug Policy Note required a good registration system in order to pre-
vent methadone shopping and to develop a coherent policy). A Royal Decree was eventually vot-
ed in the Parliament in 2004 (19 March 2004, B.S. 30 April 2004).  
 
A harm reduction perspective was provided for the first time by the 1995 Federal Action Plan 
Toxicomania-Drugs. Since 2001, needle exchange programmes have been implemented 
throughout the country (Todts, 2005).  
 
Furthermore, within this framework, the ‘Rijksinstituut voor ziekte- en invaliditeitsverzekering 
(RIZIV – social security administration)’ made a financing agreement with twenty-nine special-
ised rehabilitation services for drug addicts (e.g. medical-social treatment centres for drug us-
ers). Two target populations of the agreement were addicted parents and minor addicts (Inter-
Ministeriële Conferentie Drugs, 2010, p.20).  
 
Moreover, making use of the additional funding for drug treatment (De Ruyver, et al., 2004), 
three pilot projects were initiated at the end of 2002: (1) a pilot project for the intensive treat-
ment of patients with dual diagnosis; (2) a pilot project for the development of crisis units for 
drug addicts and the implementation the role of case manager within these units; and (3) a pilot 
project for the implementation of the function of a care coordinator within the Consultation Plat-
form Mental Health. Scientific evaluations of these pilot projects took place in 2004, contributing 
to the development of an evidence-based policy: e.g. through the evaluation, the capacity of crisis 
centers and for double diagnoses patients increased (Inter-Ministeriële Conferentie, 2010, p.11-
14). 
First of all, the goal of the pilot project on the intensive treatment of patients with dual 
disorders was to measure the feasibility of such an intensive treatment of the specific target 
group. These programs were evaluated within the framework of the research programme in 
support of the Federal Drug Policy Note. In accordance with a preliminary study including an 
overall evaluation study on treatment services for patients with dual disorders in 2002, the ef-
fectiveness of inpatient treatment programs for dually diagnosed patients was evaluated in 2004 
(Van Ham and Sabbe, 2006). The evaluation study confirmed the effectiveness of the programs: 
positive results were found regarding psychological functioning, global functioning, drug use 
and the quality of life of the patients involved. The evaluation also demonstrated the usefulness 
of the role of a case manager in this context. 
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The Federal Minister of Public Health also supported the implementation of a pilot pro-
ject on crisis units and case management in 2002. The pilot project aimed to integrate crisis 
units in existing care organisations in order to map the expectations and needs of the patients 
rapidly, to refine the diagnosis and to organise long-term care more efficiently. Later on (2008-
2010), researchers evaluated this pilot project positively (Evaluation of Crisis and Case Man-
agement - ECCAM) (Bruffaerts, et al., 2011).  
The development of a more integrated legal framework by means of care circuits and 
case management was studied through the establishment of another pilot project in 2002. Each 
Consultation Platform Mental Health made an appeal to all provinces to participate in the pilot 
project. The goal was to implement the function of a care coordinator within the Consultation 
Platform Mental Health in order to improve the consultation between the responsible provincial 
actors involved. Several Platforms decided to participate but, in 2012, the pilot project was halt-
ed. 
 
Finally, the Federal Drug Policy Note (2001), in accordance with earlier developments (i.e. 
Methadone conference in 1994 and the PWG in 1996-1997), directed the Federal Government to 
evaluate controlled heroin maintenance-projects. Initially, the task of making an inventory of 
controlled heroin maintenance-projects was given to the Drug Health Policy Cell (Cel Gezond-
heidsbeleid Drugs, 2002) but, in a subsequent phase, the Federal Science Policy Office included 
this inventory and evaluation in the call for proposals of the research programme. As a result, 
the policy-funded study ‘Heroin Delivery under Control: feasibility and follow-up study (DHCo)’ 
started at the end of 2003 (Ansseau, et al., 2002). In 2007, the Minister of Justice Laurette On-
kelinx and the Minister of Public Health Rudy Demotte (both PS, French-speaking Socialists) 
affirmed their commitment to a pilot project on ‘Treatment Assisted by Diacetylmorphine’ in the 
city of Liège between 2011 and 2013 (Inter-Ministeriële Conferentie Drugs, 2010; Demaret, et 
al., 2013). 
 
1.3.3. Prevention 
Prevention campaigns regarding the abuse of sedatives were launched in November 2002 and 
February 2003. The goal was to provide health care providers with information, interactive 
training and tools to assist patients and to provide answers for questions about the use of psy-
choactive medicines (Inter-Ministeriële Conferentie Drugs, 2010, p.14). 
 
In the 1990s, the Belgian Institute for Road Safety organised prevention campaigns on the con-
sequences of drug use (especially alcohol) in road traffic (e.g. BOB – Wodca). These initiatives 
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continued after the launch of the Federal Drug Policy Note in 2001 (Inter-Ministeriële Conferen-
tie Drugs, 2010, p.37). 
 
In 2002, the Flemish Government subsidised some new regional prevention workers (the num-
ber raised from 10 to 20) (Inter-Ministeriële Conferentie, 2010, p.43). However, within this 
framework (and despite the efforts of the Policy Memorandum Group), any long-term or perma-
nent contracts were still not guaranteed. They still depended on the short-term funding of the 
‘drug plans’. 
 
Generally, it became clear that, based on the detailed overview of the public expenditures of 
2002, prevention received only 4% of the total budget while 54% went to repression, 38% to 
treatment and harm reduction, and; 3% to policy management. Research and epidemiology was 
the least financed area with only 1% of the total budget (De Ruyver, et al., 2004). This budget 
allocation was in contrast with Belgian drug policy priorities which suggested that prevention 
has the highest priority, followed by treatment and only then repression (ultimum remedium).  
 
1.3.4. Repression 
In the field of repression, several initiatives were taken next to the adaption of the Belgian Nar-
cotic Drug Law of 1921. For instance, as the Federal Drug Policy Note (2001) stressed the need 
for a more scientific elaboration of drug-related criminality and nuisance, the Federal Sci-
ence Policy launched several research projects within the framework of the research pro-
gramme (Ponsaers, et al., 2005; De Ruyver, et al., 2008b).  
 
Furthermore, in 2002, in accordance with the demand of the PWG (1996-1997) and the Federal 
Drug Policy Note (2001), the development of a prison drug policy gradually started in 2006. A 
Central Steering Group Drug Policy as well as Local Steering Groups Drugs in each prison were 
created. For the actual implementation and coordination, two Regional Coordinators of Drug 
Policy in Prisons were assigned. Furthermore, drug free units were gradually established in sev-
eral prisons (e.g. Verviers (2007), Bruges (2009)) (De Ruyver, et al., 2004; De Ruyver, et al., 
2007).  
 
2. Towards a drug law reform: an Inter-Cabinet Working Group (ICWG) 
The new drug law was developed by an Inter-Cabinet Working Group (created after the launch 
of the Federal Drug Policy Note). In accordance with the Federal Drug Policy Note (2001), the 
Minister of Justice Marc Verwilghen (VLD, Flemish Liberals), in close cooperation with the Minis-
ter of Public Health Magda Aelvoet, supervised the ICWG. The ICWG was guided by the same 
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principles that were stated above (see Chapter 4, §2). It was comprised of the technically and 
politically skilled representatives of the Ministers. Prof. Dr. Brice De Ruyver, as the security advi-
sor to the Prime Minister, also participated in the ICWG mediating between the opposing points 
of view. While the substantive framework was determined by the Federal Drug Policy Note 
(2001), the ICWG mainly included a juridical-technical discussion about the new drug law. 
 
2.1. Scientific knowledge and scientists 
With the exception of the observer-turned player Prof. Dr. Brice De Ruyver (as security advisor to 
Prime Minister Guy Verhofstadt), scientists were less directly involved in the ICWG due to the 
juridical-technical nature of the discussion.  
 
“Scientists were less involved. Clearly, the discussion was much more about the criminal law and its 
application in practice […] It wasn’t really a rational, scientific debate.” (Respondent 21, policy-
maker). 
 
The typical characteristics of scientific knowledge also provide a partial explanation. While some 
of the studies commissioned by the Federal Science Policy were certainly relevant to the drug 
law reform (e.g. ‘Case management in the substance abuse treatment and criminal justice sys-
tem’, ‘study of the effect of the long term use of cannabis’, ‘Problematic drug use: a study of the 
operationalisation of the concept in a legal context’ and ‘Drugs and nuisance: a study of the phe-
nomenon, control and effects of drug-related nuisances from various standpoint’), the results of 
these policy-funded research projects came too late to contribute to the development of a legal 
framework in 2002-2003. For instance, the research projects clarifying the concepts of ‘prob-
lematic drug use’ and ‘drug nuisance’ and gaining insight in the constitutive elements of these 
concepts, could have supported the determination of the notions ‘problematic drug use’ and 
‘public nuisance’ in the new drug law (Decorte, et al., 2005; see also below, §2.2.). Likewise, the 
results of the study ‘Case management in the substance abuse treatment and criminal justice 
system’ could have been helpful in determining the position of case managers for judicial and 
health matters (Geenens, et al., 2005). Thus, one of the most common barriers between science 
and policy was observed: the long time period of conducting research versus the short policy-
making time-frames. 
 
“Scientific research is sometimes too late. Commissioned studies often provide answers to ques-
tions or problems that appeared before.” (Respondent 26, practitioner).  
 
“Problematic drug use was a very difficult concept. We encountered the limitations of scientific 
knowledge. A definition of problematic use was not provided by scientific research in time.” (Re-
spondent 34, policy-maker). 
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Although the evaluation study of De Ruyver et al. (2000) already pointed to the problems with 
the blurry definitions implemented in the 1998 Ministerial Circular Letter, the Government still 
did not succeed in clearly determining the notions ‘public nuisance’, ‘user quantity’ and ‘prob-
lematic use’. 
 
The newly coordinated Drug Health Policy Cell, under the presidency of policy advisor Prof. Dr. 
Isidore Pelc, discussed some preliminary policy documents (bill, Royal Decree, Cooperation 
agreement, etc.) and eventually formulated some advice in 2002 (Cel Gezondheidsbeleid Drugs, 
2002, p.17). In this way, advice from the Drug Health Policy Cell may be inspired by scientific 
knowledge indirectly. 
 
2.2. Political context 
Policy-makers needed to deal with the values and the opinions of the political parties, the affect-
ed stakeholders and the general public. They have responsibilities, especially to their electorates 
and parties, and have to find compromises (Lenton, 2004; Ritter, et al., 2007). The ICWG includ-
ed a negotiation of policy compromises that were acceptable to the Coalition partners. 
 
“It is clear that everyone has tried to push forward his or her vision or ideas. The new drug law was 
a compromise.” (Respondent 10, policy-maker). 
 
Regarding cannabis possession for personal use, there were disagreements about the value of 
correctional sentences (and thus the assignment to the Correctional Court). The French-
speaking Socialists (PS) and Greens (Ecolo), in favour of a liberal, progressive approach, were 
most obstructive (as they were in favour of the assignment to the Police Court and a fine of 15-
25€ for the first category).  
 
Furthermore, the fear of implementing a tolerance policy resulted in a debate about the aggra-
vating circumstances related to the importation, production, transport, purchase, possession 
and cultivation of cannabis for personal use such as ‘problematic use’ or ‘public nuisance’ (Inter-
nal communication Ministerial Cabinet, 16 January 2002). These debates uncovered the recur-
rent political contradictions between the Coalition partners. From their rather liberal, progres-
sive perspective, the French-speaking Socialists (PS) and Greens (Ecolo) and the Dutch-speaking 
Greens (AGALEV) did not want criminal prosecution of cannabis possession at all. On the contra-
ry, the French and Dutch-speaking Liberals (MR and VLD) as well as the Dutch-speaking Social-
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ists (SP.A)113 advocated the inclusion of the concepts of ‘problematic use’ and ‘public nuisance’ 
(which was most in accordance with the Federal Drug Policy Note (2001)). The definitions of 
‘problematic use’ and ‘public nuisance’, two key notions guiding any decision about the criminal 
prosecution of cannabis possession, were debated once again. An attempt was made to better 
define these notions in order to make it clear how to use these in practice (e.g. by police offic-
ers). 
 
“It was a difficult debate. A policy note with intentions is totally different from translating these in-
tentions into a clear text […] It was a politically and juridical-technically difficult debate. The dis-
cussion consisted of issues like the distinction between categories of crimes, the concepts like ‘nui-
sance’ and other ‘aggravating circumstances.’” (Respondent 36, policy-maker). 
 
“This is inconsistent with the Federal Drug Policy Note. We avoided a tolerance policy. Accordingly, 
we underlined the importance of notions like ‘problematic use’ and ‘nuisance’. The lack of a differ-
entiation is ridiculous and the Flemish Christian Democrats (CVP) are right when criticising this.” 
(Internal communication Ministerial Cabinet, 30 April 2002). 
 
The international framework was also cited as an important political consideration. During the 
activities of the ICWG, some international pressure was felt. For instance, the International Nar-
cotics Control Board (INCB) published a report in 2001 arguing that ‘adding another drug to the 
same category as alcohol and tobacco would be a historical mistake’ (INCB, 2001, p.37). An inter-
viewee explained 
 
“At the time of the Inter-Cabinet Working Group, a meeting was arranged with the head office of 
the INCB. We had to counter the misinterpretation and to explain the position of Belgium regard-
ing international and European policy.” (Respondent 55, policy-maker). 
 
Eventually, both the bill and the Royal Decree were sent to the Council of State for some external 
advice.114 Key comments of the Council of State were related to the sloppy language and the fun-
damental (and recurrent) problems about the definitions used. For instance, they commented on 
the vague notions of ‘problematic drug use’, ‘public nuisance’, ‘case manager for judicial and 
health purposes’ and ‘therapeutic advice’. The Government took the advice onboard. For in-
stance, while the descriptions of ‘case manager for judicial and health purposes’ and ‘therapeutic 
advice’ were further detailed, the Government also decided to specify the notion ‘problematic 
                                                          
113  The SP became SP.A on 13 October 2001 (while also creating a cartel together with SPIRIT (Flemish Social-Liberal 
party) in November 2002). 
114  The bill approved by the Council of Ministers was sent to the Council of State on 18 January 2002 (Internal com-
munication Ministerial Cabinet, 30 April 2002). Likewise, the Council of Ministers decided on 28 March 2003 to 
send the Royal Decree to the Council of State. 
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use’ with the additional phrase ‘in the case the individual by means of his/her behaviour is a threat 
towards society and him/herself’.115 Despite these efforts, the remarks of the evaluation study of 
De Ruyver et al. (2000) about the vagueness of these notions were still valid.116 
 
2.3. Practitioners 
The ICWG involved work from a host of people originating from outside the policy-making pro-
cess. The inclusion of technical expertise (e.g. in law or criminal procedure) was seen as appro-
priate in a juridical-technical discussion with numerous issues in the field of practicability and 
feasibility (e.g. registration police officer, cooperation justice-treatment, etc.). Therefore, a signif-
icant role was played by practitioners. Similar to the development of the Federal Drug Policy 
Note, some practitioners (e.g. lawyers) became advisors to the Ministerial Cabinet. Some inter-
viewees noted: 
 
“I became the advisor to the Ministerial Cabinet. I was engaged to change the law. I already had 
some expertise related to the international conventions, I published some articles, etc. The Minister 
asked me to bring into practice the Federal Drug Policy Note and to develop a new drug law.” (Re-
spondent 55, policy-maker). 
 
“Some lawyers were very helpful and supportive in the juridical translation of the policy options. 
They had a lot of knowledge about the national and international laws. They helped to decide 
what was possible, what was not, and how to implement this in practice.” (Respondent 34, policy-
maker). 
 
Some practitioners indirectly influenced the ICWG. For instance, some prevention and treatment 
workers were heard by some members of the ICWG about the issue of ‘therapeutic advice’ 
(Roose, 2002). As another example, mentioned by several interviewees, the Council of Prosecu-
tors General put a lot of pressure on the Minister of Justice about the clarity and workability of 
the cannabis prosecution policy.  
                                                          
115  Koninklijk besluit tot wijziging van het Koninklijk Besluit van 31 december 1930 omtrent de handel in slaap- en 
verdovende middelen alsmede van het Koninklijk Besluit van 22 januari 1998 tot reglementering van sommige 
psychotrope stoffen, B.S. 2 juni 2003. 
116  Accordingly, on 28 November 2003, five non-profit organisations demanded the Court of Arbitration strike article 
16 of the Law of 3 May 2003 (i.e. Article 16 “The possession of an amount of cannabis for personal use by an adult, 
without the presence of public nuisance or problematic use, would only lead to a registration by the police”) because 
the terms “public nuisance” and “problematic drug use” were too vague and in violation of the principle of legality. 
The Constitutional Court agreed and article 16 of the 2003 drug law (i.e. the article that caused most political 
commotion) was invalidated (Arbitragehof 20 oktober 2004, nr. 158/2004, rolnrs. 2727 en 2850, B.S. 28 oktober 
2004; Gelders and Vander Laenen, 2007).  
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“The development of the law occured in consultation with the Council of Prosecutors General. It 
took longer than expected. There was some resistance […] It was difficult to put the policy into 
practice. For example, the definitions of ‘problematic use’ and ‘nuisance’ were not clear.” (Re-
spondent 37, policy-maker).  
 
2.4. Media and interest groups 
While the Government was deciding on the stipulations of the bill in the ICWG, the media con-
tinued to create confusion and polarisation on cannabis policy. Representative of this state of 
affairs was the manipulation of prevalence rates (indirect references). For example, some Flem-
ish newspapers (De Morgen, Het Laatste Nieuws and Gazet van Antwerpen) reported a lifetime 
prevalence rate of 38% or 40% among the Belgian population (sample of 1.200 respondents) 
while the report mentioned lifetime prevalence of 21% among a representative sample of 3.311 
respondents. As another example, the bill was often incorrectly called Federal Drug Note and it 
was implied that the tolerance policy was already approved.  
 
“Federal Drug Policy Note finally decided.” (10 January 2002, Flemish newspaper De Morgen). 
 
“The Government only tolerates smoking a joint at home […] The Government developed a Note 
and three Royal Decrees to legally formalise the drug policy.” (10 January 2002, Flemish newspa-
per De Tijd).  
 
The actual influence of media coverage on the ICWG remained limited to a high level of atten-
tiveness of policy-makers towards the public opinion and their electorate. A clear media com-
munication strategy was considered of particular importance due to the ambiguous communica-
tion about the Federal Drug Policy Note and the information campaign (January – May 2001) on 
the one hand and the looming elections (May 2003) on the other hand. Accordingly, Prof. Dr. 
Brice De Ruyver was appointed to report about the drug policy issues in the media. 
 
“Prime Minister Verhofstadt learned from the previous communication about this topic. Together 
with the Minister of Justice and the Minister of Public Health, he entrusted this task to Prof. Dr. 
Brice De Ruyver. The message had to be clear. It was important to know the pitfalls and to know 
how the media operated.” (Respondent 50, scientist). 
 
Interest groups also indirectly affected the policy-making process because of their strong link 
with the public opinion (and electorates of policy-makers). For instance, Flemish interest group 
Parents against Drugs [Ouders tegen Drugs] frequently made use of the media coverage. They 
stressed their concerns about the increase of cannabis use among youth and the addictive char-
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acteristics of cannabis. Apart from that, there were hardly any initiatives or actions by interest 
groups during the activities of the ICWG. 
 
“A joint is equal to an alcohol dosage of 0.8. Cannabis is addictive, some people use more and more. 
Accordingly their problems increase.” (27 February 2002, Flemish newspaper De Morgen).  
 
An important exception was the active involvement of a member of the interest group Anti-
Prohibition League [La Liaison anti-prohibitionniste] in the ICWG. This particular practitioner 
became an advisor of the Minister of Public Health Magda Aelvoet and was able to give voice to 
this interest group. This particular engagement may be the only effective way for interest groups 
to play a certain role in the policy-making process at the governmental level. However, in this 
case, having a small voice should be interpreted as having the opportunity to communi-
cate/advise and engage in the debate and not as having the means to directly influence the out-
come of the ICWG. 
 
“Working in the Inter-Cabinet Working Group, I supported the rather radical perspective as a 
member of the interest group Anti-Prohibition League [La Liaison anti-prohibitionniste]. In the In-
ter-Cabinet Working Group, I tried to put forward their perspective while discussing the drug law 
[…] It was a juridical-technical discussion. In my opinion, the debate was influenced by the dis-
course of the interest group […] I tried to get the most out of it (my emphasis).” (Respondent 55, 
policy-maker). 
 
“[…] The practitioner supported the most radical points of view but he was well aware that some 
directions were not supported politically. […] The broader application of the Probation Law was 
not a radical decision but it was an important step forward. He was actively involved in this debate 
in the Inter-Cabinet Working Group.” (Respondent 50, scientist). 
 
2.5. Parliament 
During the debates in the ICWG, MPs from the opposition parties put pressure on the Govern-
ment by regularly asking questions about the state of the art regarding the new drug law (Hand. 
Kamer 2001-2002, 10 januari 2002, 197, 15-16; Hand. Kamer 2001-2002, 21 februari 2002, 208, 
32-33; Hand. Kamer 2001-2002, 28 februari 2002, 210, 11-13; Hand. Senaat 2001-2002, 16 mei 
2002, 2-204, 22-23; Vr. en Antw. Senaat, 5 maart 2002, nr. 2/50 (Vr. nr. 1544 V. Van Quickenbor-
ne); Vr. en Antw. Senaat, 19 maart 2002, nr. 2/51 (Vr. nr. 1886 Y. Buysse)). In particular, opposi-
tion party CD&V (Flemish Christian Democrats) sought to give the Government a hard time 
based on their experiences in the PWG: e.g. they were fully aware of the existing pitfalls and the 
political divergences. The strategy to put some pressure on the Government can be seen as a 
tactic to stimulate controversy among the Coalition partners but also as a way to keep the item 
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on the political and public agenda (as they believed they could benefit from these disagreements 
in the following elections). Indeed, an interviewee as well as the arguments of the ICWG showed 
the indirect influence of the opposition parties on the ICWG. 
 
“The Inter-Cabinet Working Group took a while because of the contradictions between the Coali-
tion partners and between several individuals within the same party. The opposition took ad-
vantage of these disagreements by regularly asking when the new drug law would be approved.” 
(Respondent 17, policy-maker). 
 
“Police and judicial actors look like fools. Why do they have to invest in crimes that are punished 
with a fine of 25 euros? Frankly, this is ridiculous. CD&V (Flemish Christian Democrats) rightly 
criticised this decision.” (Internal communication Ministerial Cabinet, 30 April 2002). 
 
3. Parliamentary process: time is almost up 
Eventually, on 21 June 2002, a bill was submitted by the Government to the Parliament’s Cham-
ber of Representatives.117 Both bills and the Royal Decree were treated as a whole in the Cham-
ber of Representatives and the Senate.118 The power of the Parliament in this particular phase 
should be put into perspective. On the one hand, the bill had already been heavily discussed and 
approved in the Inter-Cabinet Working Group (ICWG) and the Council of Ministers. On the other 
hand, the pressure of the end of the legislature was increasingly felt. Even though the opposition 
parties took their role seriously and put pressure on the Government, their discourse was soon 
buried by the voting mechanism (see below). As a result, the debates in the Chamber of Repre-
sentatives and the Senate were rather soft. 
 
“Generally, the parliamentary discussions were less important. There was an agreement in the In-
ter-Cabinet Working Group. At the same time, the end of the legislature was near. By all means, the 
new drug law had to be approved.” (Repondent 36, policy-maker).  
 
“The decisions about what is allowed and what is not, were made in the Inter-Cabinet Working 
Group. The Parliament had nothing more to add.” (Respondent 13, scientist). 
 
                                                          
117  Wetsontwerp tot wijziging van de wet van 24 februari 1921 betreffende het verhandelen van de giftstoffen, 
slaapmiddelen en verdovende middelen, ontsmettingsstoffen en antiseptica en Wetsontwerp tot wijziging van de 
wet van 24 februari 1921 betreffende het verhandelen van de giftstoffen, slaapmiddelen en verdovende middelen, 
ontsmettingsstoffen en antiseptica, en van artikel 137 van het Wetboek van Strafvordering, Parl.St. Kamer 2001-
2002, nr. 1888/001 en nr. 1889/01. 
118  As we may treat both bills, the Royal Decree and Ministerial Circular Letter as one entity, we will regularly use the 
concept ‘bill’ to refer to this package of initiatives.  
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3.1. Debate in the Chamber of Representatives and Senate 
The submitted bill included a request for urgent debate (because of the elections in May 2003). 
In the plenary meeting of the Chamber of Representatives on 20 July 2002, there was a discus-
sion about the assignment of the debate to the Commission of Public Health or the Commission 
of Justice (still reflecting the discursive struggle) (Hand. Kamer 2001-2002, 20 juli 2002, 260, 36-
39). Eventually, the Conference of Presidents decided that the bill had to be discussed in the 
Commission of Justice as well as in the Commission of Public Health with the primary role given 
to the Commission of Public Health (in accordance with the perception of the drug phenomenon 
as a matter of public health).119 
 
3.1.1. Commission of Justice 
Several meetings of the Commission of Justice took place between October and November 
2002.120 The vagueness of the definitions ‘public nuisance’, ‘user quantity’ and ‘problematic use’, 
the compliance with the international conventions, and the ambivalent role of the Flemish Chris-
tian Democrats (CD&V) were discussed. Responding to the (juridical) comments and questions, 
the Minister of Public Health Mr. Jef Tavernier (AGALEV, Flemish Greens)121, in cooperation with 
the representatives of both the Prime Minister and the Minister of Justice, disseminated two 
additional notes. The note clearly was interpreted differently by both Ministers. The internal 
divergences among the Verhofstadt I Government became clear once more.  
 
“The Inter-Cabinet Working Group reached a political compromise. However, there were still dif-
ferent opinions among Coalition partners. Even during the presentation of the bill in the Commis-
sion of Justice, both Ministers approached the topic differently. Their approach was not supported 
by the same analysis. There was a difference between the medical-psychological and social analy-
sis on the one hand and the juridical focus on the other hand.” (Respondent 10, policy-maker). 
 
At the end of the debate, MPs from the political majority122 submitted positive feedback. At the 
same time, negative feedback was submitted by some opposition MPs (i.e. CD&V, Flemish Chris-
                                                          
119  Verslag namens de Commissie voor de Volksgezondheid, het Leefmilieu en de Maatschappelijke Hernieuwing 
uitgebracht door de Heren Jacques Germeaux en Luc Paque, Parl.St. Kamer 2001-2002, nr. 1888/004. 
120  Verslag namens de Commissie voor de Volksgezondheid, het Leefmilieu en de Maatschappelijke Hernieuwing 
uitgebracht door de Heren Jacques Germeaux en Luc Paque, Parl.St. Kamer 2001-2002, nr. 1888/004, 245-292. 
121  Magda Aelvoet (AGALEV) was Vice-Minister and Minister of Consumption Affairs, Public Health and Environment 
during the Verhofstadt I government (1999-2003). However, she resigned in 2002 as a result of a scandal related 
to the controversial supply of weapons to Nepal. Mr. Jef Tavernier replaced her. 
122  Mrs. Fauzaya Talhaoui (AGALEV, Flemish Greens), Mrs. Fientje Moerman (VLD, Flemish Liberals), Mrs. Dalila 
Douifi (SP.A, Flemish Socialists), Mrs. Michel Dardenne (Ecolo, French-speaking Greens), Mrs. Karine Lalieux (PS, 
French-speaking Socialists), Mrs. Anne Barzin (MR), Mr. Jacques Germeaux (VLD, Flemish Liberals) and Mr. Thier-
ry Giet (PS, French-speaking Socialists). 
Chapter 5  The reform of Belgian drug law (2002-2003) 
261 
tian Democrats). They pointed to the importance of prevention and argued against a more toler-
ant cannabis policy. They stressed the harmfulness of cannabis, the confusing signals of the Gov-
ernment, the risk of increasing drug use and drug tourism and the lack of compliance with inter-
national conventions. A final voting resulted in the acceptance of the positive advice which was 
sent to the Commission of Public Health. 
 
3.1.2. Commission of Public Health 
The meetings of the Commission of Public Health123 were held in December 2002 and January-
February 2003 and included hearings with scientists (5), practitioners (16) and members of the 
interest group Parents against Drugs [Ouders tegen Drugs]124 (3). A Commission may, within the 
framework of its legislative competences, seek the advice of individuals or institutions which do 
not belong to the Parliament and ask for some documentation (Van der Hulst, 2010). While the 
PWG aimed to get a status questionis of all aspects of the drug problem, the focus in the Commis-
sion of Public Health was solely on public health issues (in accordance with the approach sup-
ported by the Federal Drug Policy Note).125 
 
24 experts126 were heard on 14-15 January 2003. These experts were selected according to the 
same principles as the selection of experts by the PWG (1996-1997) (Chapter 2, §2.2.1.). In se-
                                                          
123  In the Commission of Public Health, every political party was represented by one or more members: Mrs. Yolande 
Avontroodt (VLD, Flemish Liberals), Mr. Igor Philtjens (VLD, Flemish Liberals), Mr. Jacques Germeaux (VLD, Flem-
ish Liberals), Mr. Hubert Brouns (CD&V, Flemish Christian Democrats), Mr. Luc Goutry (CD&V, Flemish Christian 
Democrats), Mr. Roel Deseyn (CD&V, Flemish Christian Democrats), Mrs. Anne-mie Descheemaeker (AGALEV, 
Flemish Greens), Mrs. Georges Gilkinet (Ecolo, French-speaking Greens), Mrs. Colette Burgeon (PS, French-
speaking Socialists), Mr. Yvan Mayeur (PS, French-speaking Socialists), Mr. Robert Hondermarcq (MR, French-
speaking Liberals), Mr. Philippe Seghin (MR, French-speaking Liberals), Mr. Koen Bultinck (Vlaams Blok, Flemish 
extreme right party), Mr. Guy D’Haeseleer (Vlaams Blok, Flemish extreme right party), Mrs. Magda De Meyer 
(SP.A), Mr. Luc Paque (CDH, French-speaking Christian Democrats) and Mrs. Els Van Weert (Spirit, Flemish Social-
Liberal party). 
124  Parents of (former) drug users created the interest group Parents against Drugs [Ouders tegen Drugs]. Mrs. Jose-
fien Smits, Mrs. Marjan Van Den Eynde, Mrs. Mireille Vergucht presented theirselves as the representatives of 
thousands of parents and family members in a painful and difficult situation.  
125  Verslag namens de Commissie voor de Volksgezondheid, het Leefmilieu en de Maatschappelijke Hernieuwing 
uitgebracht door de Heren Jacques Germeaux en Luc Paque, Parl.St. Kamer 2001-2002, nr. 1888/004, 5-244. 
126  Experts were: Prof. Dr. G. Van Hal (Department Epidemiology and Social Medicine, Antwerp University), Prof. Dr. I. 
Pelc (Psychiatrist, Head of Department Psychiatry and Medical Psychology ULB and Director of the Laboratory 
Medical Psychology, Alcohology and Drug Addiction), Prof. Dr. A. Noirfalise (Faculty of Medicine, University of Li-
ège), Mrs. M. Geirnaert (Director Association for Alcohol and other Drug Problems, VAD), Mr. Marcel Van Hex (Di-
rector CAD Limburg), Mr. M. Tack (Coordinator Centre for Study, Prevention and Treatment of Alcohol disease and 
other toxomanias), Mr. P. Bastin (Director Infor-Drogues), Mr. D. Ballotta (EMCDDA), Mr. C. De Winter (Head of 
Federal Police – Central Department Drugs), Mr. F. Clarysse (Deputy Attorney Bruges), Mr. C. Visart de Bocarmé 
(Deputy Attorney Namur), Mrs. F. Biot (Head Department Local Police Charleroi), Mrs. J. Smits (Parents against 
Drugs [Ouders tegen Drugs]), Mrs. M. Van Den Eynde (Parents against Drugs [Ouders tegen Drugs]), Mrs. M. 
Vergucht (Doctor, Parents against Drugs [Ouders tegen Drugs]), Prof. Dr. J. Hulselmans (Doctor – Head Psychiatry 
ACZA-Stuyvenberg), Mr. J. Van Bouchaute (Doctor- Director MSOC Ghent), Mr. S. Zombek (Doctor- Director MASS 
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lecting these experts, the media and personal contacts/networks played an important role. For 
instance, the selection of members of the interest group Parents against Drugs [Ouders tegen 
Drugs] was clearly supported by MPs from the Flemish extreme right party Vlaams Blok (see 
also Chapter 4, §4). They intensively used the media to represent their actions (e.g. demonstra-
tion), to strengthen their position and to become more widely known amongst the public and 
policy-makers. “Some members of the interest group Parents against Drugs reacted emotional. 
According to them, the government introduces a tolerance policy but doesn’t mind the drug use 
among minors” (28 November, Flemish newspaper De Tijd). Equally, the selected scientists and 
practitioners had regularly appeared in the media since the launch of the Federal Drug Policy 
Note (2001). As an example, “The governmental communication on Belgian drug policy is confus-
ing […] That is said by Prof. Dr. Guido Van Hal” (13 November 2002, Flemish newspaper Gazet van 
Antwerpen) and “A joint replaces a cigarette more often, says Prof. Dr. Guido Van Hal.” (29 Novem-
ber 2002, Flemish newspaper Het Volk). An interviewee explained: 
 
“In the Commission of Public Health, each MP made a list in accordance with the political party […] 
The main issue is: ‘unknown, unloved’. Personal contacts played a role. This is also the case with 
the media. The same experts are selected over and over again. […] Accordingly, the public and MPs 
often adopt the idea that there are only a limited number of experts in this matter.” (Respondent 
35, policy-maker).  
 
If we compare the selection of experts with those selected by the PWG, we observed some obvi-
ous overlap. However, clearly, medical practitioners and psychiatrists were now increasingly 
considered as experts in this matter. For instance, the selection of Prof. Dr. Jef Hulselmans (Doc-
tor – Head Psychiatry Stuyvenberg Hospital) who elaborated upon the issues related to the link 
between cannabis and psychoses or schizophrenia, has to be understood in the light of the evo-
lution of the Belgian drug policy debate. While none of these issues were discussed or elaborated 
upon in the PWG, this particular focus of the Commission of Public Health can be framed within 
the increasing scientific knowledge (e.g. about the harmfulness of cannabis)127 and the sustained 
media coverage on the dangers of cannabis use, the increasing THC concentration and the in-
                                                                                                                                                                                     
Brussels), Mr. J. Theuwen (Kompas), Mr. J. Maertens (Director De Sleutel), Mr. D. Vandevelde (Director De Kiem), 
Mr. Paul Van Deun (Director De Spiegel), Mr. G. Van Der Straeten (Director Trempoline), Mr. A. Wouters (La 
Teignouse). 
127  During the 1970s and mid1980s, many clinical and experimental studies were established in order to measure the 
effect of cannabis on different vital organs and functions. Academics studied the somatic effects of cannabis intoxi-
cation and chronic cannabis use, the effects of cannabis on human and animal offspring and the effects on psy-
chomotor and cognitive functions and mental health. As a result, the first studies on the association between in-
tensive cannabis use and psychotic disorders date back from the beginning of the 1970s. Studies on the effect of 
cannabis use on schizophrenia were established in the late 1980s. The results of all these clinical and experimental 
studies were hotly debated among researchers at that time. However, these issues were not picked up in the PWG 
(instead cannabis was considered as a relatively harmless substance; see above). Since the beginning of the 21th 
century, there has been of profusion of writings on this topic (Vuillaume, 2008). 
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creasing prevalence rates since 2000-2001 (see also above, Chapter 3, §5.3. and Chapter 4, 
§3.3.3.). In empowering the enlightenment function of scientific knowledge, media coverage 
seemed to have increased the likelihood of policy-makers being more sympathetic towards the 
harmfulness of cannabis (linked with schizophrenia, the higher % of THC, etc.). In other words, 
the media encouraged the refutation of the arguments of the advocates of a liberal policy that 
cannabis use is harmless (evolutionary model; Stevens, 2007a). The correlation between early 
and regular cannabis use and the risk of developing schizophrenia, depression or other psychot-
ic disorders featured increasingly in many parliamentary discussions from 2002-2003 onwards 
(Hand. Kamer 2001-2002, 21 februari 2002, 208, 32-33; Hand. Senaat 2001-2002, 19 maart 
2002, 2-51, 2692). 
 
Reflecting on the typology of Loader and Sparks (2011), most of the selected scientists acted as 
scientific experts. They used their knowledge and methodological skills to answer questions of 
policy-makers, without engaging in the policy-making process outside the Commission of Public 
Health.  
 
“I did not take a position as a proponent or an opponent. I did not do that. I just presented some 
findings and that is it […] They asked me as an expert, I did not take the initiative myself to get in-
volved. That was not my goal.” (Respondent 13, scientist). 
 
“My contribution was illustrative. I gave some additional information. That’s it […] I was not 
searching for participation, I did not make any effort.” (Respondent 24, scientist). 
 
Similar to the Inter-Cabinet Working Group, the hearings focused on political issues like the def-
initions of ‘problematic use’ or ‘public nuisance’ and the compliance with the international con-
ventions. The internal disagreements between the Minister of Justice Marc Verwilghen and the 
Minister of Public Health Jef Tavernier were outlined once more. For instance, they argued dif-
ferently about the determination of ‘quantity for personal use’. While the Minister of Justice 
mentioned in the Commission of Justice that a ‘quantity for personal use’ contains maximal five 
grams, his representative reported a maximum of 2,5 grams in the Commission of Public 
Health.128 Minister of Public Health Jef Tavernier declared himself to be against any determina-
tion of a number of grams. Exceptionally, the hearings and the debate in the Commission of Pub-
lic Health focused on other topics like the establishment of the Drug Health Policy Cell and some 
pilot projects (e.g. dual diagnosis treatment offer, crisis intervention and case-management, 
                                                          
128  Verslag namens de Commissie voor de Volksgezondheid, het Leefmilieu en de Maatschappelijke Hernieuwing 
uitgebracht door de Heren Jacques Germeaux en Luc Paque, Parl.St. Kamer 2001-2002, nr. 1888/004, 236 and 
280. 
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networks for integrated drug treatment programs), the cooperation agreement between the 
Federal Government and the federate entities, drug use in prison, therapeutic advice, the evalua-
tion of methadone treatment, the lack of staff resources, the role of prevention (e.g. in educa-
tion), etc. The latter topics were mostly highlighted by practitioners. MPs themselves were less 
concerned with these less ‘political’, though important, issues.  
 
Both bills (with small revisions based on the amendments) were adopted on 11 February 
2003.129 Afterwards, the bills proceeded to the plenary session of the Chamber of Representa-
tives where they were eventually approved on 13 February 2003.130  
 
3.1.3. Senate: Commission of Social Affairs and plenary meeting 
The debates in the Commission of Social Affairs of the Senate commenced on 26 February 2003 
and addressed the same topics as the Chamber of Representatives (Hand. Senaat 2002-2003, 26 
maart 2003, 2-278, 9-40). During the debates, several amendments were submitted by MPs of 
CD&V (Flemish Christian Democrats). Eventually, each of the amendments was rejected. Only a 
small linguistic adaptation was made. Then, the bill was sent to the plenary meeting of the Sen-
ate where it was discussed on 26 March 2003 and approved on 27 March 2003.131 
 
3.2. Scientific knowledge and scientists 
In the Commission of Public Health, scientists gave an updated overview of the current state of 
the art by means of general descriptions (e.g. ‘research shows’, ‘research confirms’, ‘some au-
thors mention’, ‘the literature shows’, etc) or prepositional arguments. Sometimes, footnotes and 
bibliographies were added. International drug policy studies were often used as a source of in-
                                                          
129  After the hearings and lengthy discussions in the Commission of Public Health, some MPs submitted amendments 
regarding bill 1888. Mr. Jo Vandeurzen, Mr. Roel Deseyn and Mr. Luc Goutry (CD&V, Flemish Christian Democrats) 
submitted five amendments relating to confiscation of cannabis, drug prevention organised by police officers, the 
mode of registration (continuation of registration by police report) and the definition of problematic use. MP Filip 
De Man submitted an amendment focusing on the registration by means of a police report in case of the posses-
sion of other illegal drugs than cannabis and the opportunity of dismissal of prosecution in case of treatment by a 
specialised addiction care centre. Each of these amendments of the MPs was rejected. Eventually, bill 1888 was ac-
cepted with 10 yes votes against six no votes. Bill 1889 was accepted with 11 yes votes against six no votes. 
130  The bill was debated in a plenary meeting on 12 February 2003 and finally put to a vote and approved on 13 Feb-
ruary 2003. After discussions in the plenary meeting of the Chamber of Representative, the submitted amend-
ments of Mr. Jo Vandeurzen (CD&V, Flemish Christian Democrats) and of Mr. Filip De Man (Vlaams Blok, Flemish 
extreme right party) were rejected. A voting about the bills in general was also held on 13 February. After voting 
declarations, the first bill (1888) was adopted by means of 75 yes votes, 40 no votes, four abstentions (total 119 
votes). The second bill (1889) was also adopted (yes: 75; no: 45; Abstention: five; total 120). 
131  The bill was voted on 27 March 2003: bill 1889 by 30 yes votes against 19 no and seven abstentions; After the 
rejection of the submitted amendments (10 yes votes against 43 no votes and 4 abstensions), bill 1888 was adopt-
ed by means of 40 yes votes, 18 no votes and no abstentions. As the Chamber of Representatives has the last word, 
on 27 March 2003 it was again sent to this organ for ratification by the King. 
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formation because similar discussions sparked off in various European countries at that time 
(e.g. Portugal, Spain, Italy) or previously (e.g. Schengen Convention, Inter-parliamentary Adviso-
ry Council of the Benelux countries).132  
 
“It is justifiable to treat cannabis differently because the substance is less dangerous compared to 
other drugs (see the report of professor Roques).” (Prof. Dr. Isidore Pelc, scientist, Report of the 
Commission Public Health, p14.). 
 
“… two articles that were respectively published in 1986 and 2002 in the Revue médicale de Liège. 
Some experimental research showed that there is a risk of genetic mutations, cancer, deformations 
or a low sperm count.” (Prof. Dr. Alfred Noirfalise, scientist, Report of the Commission Public 
Health, p.26). 
 
Although the intervention of these scientists was only advisory, they have enlightened the par-
liamentary debates with some new scientific knowledge. In other words, they sensitised MPs to 
(new) issues like the harmfulness of cannabis and the connection between cannabis use and 
psychiatric disorders (e.g. depression, schizophrenia,…) (conceptual utilisation). As it was argued 
that cannabis was more harmful and dangerous than initially thought (e.g. the increasing level of 
THC was frequently mentioned), these elements offered strong support to arguments against the 
bills. 
 
“In the past, colleagues minimised the problems related to the regular use of cannabis. Today, 
more and more youngsters are into trouble because of their cannabis use. We all know that the 
level of THC increased drastically (my emphasis).” (Mr. Filip De Man, MP Vlaams Blok, Flemish ex-
treme right party; Hand. Kamer 2002-2003, 12 februari 2003, 325, 36). 
 
However, most of the time, scientific knowledge was used for political/symbolic reasons (Weiss, 
1979). In the long and controversial discussion in the Parliament, each ‘side’ highlighted differ-
ent sets of harms. When making an argument, MPs often cherry-picked information that made 
their case look stronger (also called trawling; Stevens, 2007a). The evidence that cannabis use 
can adversely affect the mental health (e.g. depression, schizophrenia,…) of some adolescents 
and young adults had been undermining the simplest argument that cannabis caused no harm. 
                                                          
132  A number of independent Commissions have investigated the cannabis issue during the 20th century: LaGuardia 
Commission (1944), British Wooton Commission (1969), Canadian LeDain Commission (1970), Dutch Baan Com-
mission (1972), American Shafer Commission (1972), Commission of the Australian Government (1977), Commis-
sion by the Dutch government (1995), Roques Commission (1997), etc. (Zimmer and Morgan, 1997). These Com-
missions were appointed to evaluate the scientific evidence on the dangers of cannabis to individuals and society. 
Each of these Commissions came to the conclusion that the public had been needlessly frightened about the dan-
gers. For instance, in France, the ‘Roques report’ was commissioned in 1997 by the Minister of Public Health Ber-
nard Kouchner, and conducted by Professor Bernard Roques, an internationally renowned neuropharmacologist. 
These assumptions and others were extensively used by scientists in the hearings. 
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Contradictory information tended to be ignored or criticised. For instance, they ignored the so-
cial costs of prohibition and the survey results that had failed to find a larger increase in rates of 
cannabis use in countries that had decriminalised cannabis. 
 
Some MPs from the opposition parties misused or (consciously) misinterpreted scientific 
knowledge. For instance, MP Roel Deseyn (CD&V, Flemish Christian Democrats) exaggerated the 
number of cannabis addicts. While Prof. Dr. Isidore Pelc stated that 2% of the regular cannabis 
users became cannabis addicts, this MP argued that  
 
“It is now clear that 10% of the cannabis users become addicted.” (Mr. Roel Deseyn, MP CD&V, 
Flemish Christian Democrats; Hand. Kamer 2002-2003, 12 februari 2003, 327, 10). 
 
Additionally, when issues become more widely researched, there is an increasing likelihood that 
the process of utilisation becomes more political/symbolic. For instance, in the hearings, scien-
tists emphasised the scientific controversy about the consequences of cannabis use.  
 
“The regular use of cannabis by very young teenagers could induce schizophrenia, school fatigue 
and, obviously, demotivation (my emphasis).” (Prof. Dr. Alfred Noirfalise, scientist, Report of the 
Commission Public Health, p.21). 
 
“Cannabis was seen as a harmless drug. However, this widely held belief has recently been under 
discussion in the psychiatric and scientific literature. The study quoted most frequently to support 
the hypothesis that cannabis causes schizophrenia, is a Swedish study that examined the incidence 
of schizophrenia among 50.000 army recruits between 1969 and 1970. The conclusions of Zammit 
raised some skepticism among several authors (my emphasis).” (Prof. Dr. Jef Hulselmans, scientist, 
Report of the Commission Public Health, p.112). 
 
Although absolute certainty in science is never guaranteed, we may assume that scientific uncer-
tainties are hightened in this complex policy domain, for example: the introduction of the pre-
cautionary principle in the parliamentary debates. The precautionary principle133 entails that no 
full scientific knowledge is needed to make policy decisions; scientific indications (in the absence 
of scientific consensus) are considered sufficient. When a policy-maker is faced with a multiplici-
ty of information and finds it difficult to identify the appropriate options for their particular sit-
uation, there is a tendency to invoke the precautionary principle (Singleton, et al., 2014). Adop-
ting precautionary measures can be considered to be contrary to the principles of evidence-based 
policy (Monaghan, Pawson and Wicker, 2012). The uncertainty of some scientific results (e.g. 
                                                          
133  Although this principle is commonly used in climate debates, the precautionary principle was also invoked in 
relation to the drug issue. 
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causal link between cannabis use and schizophrenia) and the precautionary principle clearly 
supported some MPs in their arguments.  
 
“It is less relevant whether or not all these factors have been scientifically proven. The fact that 
there is a correlation is interesting and can encourage us to take a closer look.” (Mr. Roel Deseyn, 
MP CD&V, Flemish Christian Democrats; Hand. Kamer 2002-2003, 12 februari 2003, 327, 10). 
 
“The famous precautionary principle is helpful. Where scientific knowledge does not give a clear 
answer, this principle can be used in making decisions.” (Mr. Jo Vandeurzen, MP CD&V, Flemish 
Christian Democrats; Hand. Kamer 2002-2003, 12 februari 2003, 325, 21). 
 
3.3. Political context 
The parliamentary debates were mainly governed by political considerations. For instance, the 
discourse of MPs included a large number of prepositional arguments (e.g. ‘cannabis is a step-
ping-stone to hard drugs’, ‘cannabis is addictive’, ‘the level of THC is multiplied by ten’, ‘cannabis is 
very dangerous and harmful’, …). International examples were frequently included in the dis-
course of the oppositional parties (policy platonism).134 MPs wrongly used terminology like tol-
erance policy, depenalisation, decriminalisation and Belgian coffee-shops while focusing on poten-
tial negative consequences of a liberal policy and the lack of compliance with the international 
conventions. Clearly, the link with the (rejected) Dutch drug policy model was never far away.  
 
“The drug law favours a tolerance policy. This policy choice does not take into account the interna-
tional conventions.” (Mr. Filip De Man, MP Vlaams Blok, Flemish extreme right party, Report of the 
Commission Public Health, p.270). 
 
“We learned from other countries. This law will lead to a boost in criminal activities because it tol-
erates a certain demand in the illegal market” (Mr. Jo Vandeurzen, MP CD&V, Flemish Christian 
Democrats; Hand. Kamer 2002-2003, 12 februari 2003, 325, 22). 
 
“Concepts like decriminalisation, depenalisation, legalisation were used in a political way. Policy 
interests were decisive.” (Respondent 55, policy-maker). 
 
Additionally, opposition parties were very active in formulating personal insults. Undoubtedly, 
these actions often originated from self-interest in gaining power and favouring certain elec-
torates. Several interviewees illustrated this point: 
                                                          
134  For instance, although not any reference to the Commission LeDain was made, the final conclusions and recom-
mendations of the report ‘Commission Le Dain’ were included in the appendix of the final report of the parliamen-
tary discussion of the bill. The Le Dain Commission, set up in 1969, was a Canadian Commission of Inquiry into the 
Non-Medical Use of Drugs named after its chair Gerald Le Dain. The report recommended the decriminalisation of 
possession and cultivation of cannabis for personal use. 
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“The parliamentary debate is a show in front of the media and the public […] A game is played in 
order to win votes. That’s it. It is just kicking up a fuss.“ (Respondent 14, policy-maker). 
 
“In politics, personal insults are often made. MPs always have to seize the opportunity to weaken 
the opponents.” (Respondent 44, policy-maker). 
 
In similar vein, some MPs applied a rather emotive tone. An appeal to emotions was linked with 
the strategy of the members of the Parliament to speak from their role as parent or doctor (dual 
role).  
 
“I refer to the note of the Ministers Verwilghen and Tavernier of 13 November, 2002. That note 
clearly stated: “Regular use is not necessarily problematic”… Thus, the injection of heroin is not a 
problem according to the Minister.” (Mr. Filip De Man, MP Vlaams Blok, Flemish extreme right par-
ty; Hand. Kamer 2002-2003, 12 februari 2003, 325, 44). 
 
“As a mother of three young children I am absolutely concerned about the addictive character of 
cannabis use and the influence of use on the health of youngsters and people in general.” (Mrs. Els 
Van Weert, MP Spirit, Flemish Social-Liberal party; Hand. Kamer 2002-2003, 12 februari 2003, 
326, 5). 
 
Finally, the upcoming Federal elections on 18 May 2003 put a lot of pressure on the activities 
surrounding the new drug law. The development of a coherent (public health) drug policy had 
been mentioned as one of the pillars in the 1999 Federal Government Policy Statement: ‘Related 
to the drug issue, the Government will provide an evaluation study within 6 months [...] Based on 
the results of this study, the Government will, in close cooperation with the parliament, develop a 
coherent drug policy’ (p.36, Federal Government Policy Statement, 1999). As the Federal Govern-
ment Policy Statement was a powerful tool in assessing the policy realisations in a legislature, 
the majority pressed the matter strongly.  
 
“The Government applauded the launch of the Federal Drug Policy Note. It eventually changed the 
policy direction. The new drug law was part of this movement. The Government was concerned 
about the realisation of their Federal Government Policy Statement […] This concern played a role. 
The new drug law had to be approved. The Federal elections were looming.” (Respondent 36, poli-
cy-maker).  
 
MPs and members of the Government became more and more concerned about how their deci-
sions and actions were viewed by potential voters at the next Federal elections (May 2003). The 
majority (Liberals, Socialists and Green parties) stated that the new drug legislation was clear 
and more stringent (and in case of the Green parties too stringent) than the previous version. 
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Conversely, the oppositional Flemish Christian-Democratic party CD&V and the Flemish radical 
right-wing populist party Vlaams Blok argued that the new drug law introduced a tolerance poli-
cy and encouraged people to use drugs (Gelders and Van Mierlo, 2004). All feared a political de-
feat. It is no surprise that this element became very influential as the bill was adopted only two 
months before the Federal elections on 18 May 2003.  
 
“It was a very sensitive matter because it was always presented as a tolerance policy […] The pub-
lic debate was difficult. A confrontation with mothers or fathers in pre-election debates always re-
sulted in the loss of votes. It was very sensitive and difficult […] There were only two positions: ‘I 
am pro’ or ‘I am against’.” (Respondent 6, policy-maker). 
 
“A policy-maker always takes his/her electorate into account. They determine the result of the next 
elections. A policy-maker who does not take his/her electorate seriously, commits a political sui-
cide.” (Respondent 36, policy-maker). 
 
Several opinion polls (e.g. survey on “Belgians and drugs” (Patesson and Steinberg, 2000), …) 
provided some interesting indications for policy-makers. It was clear that ‘drug problems among 
youngsters’ was ranked as one of the most important problems in society and that the poor 
communication about whether and when the possession of cannabis for personal use was prose-
cuted, caused a lot of confusion among the public (Administratie Planning en Statistiek, 2006). 
Furthermore, an increasing number of calls were made to the ‘Druglijn’ in 2002 about the new 
drug law (VAD, 2003). In 2003, the ‘Druglijn’ was increasingly consulted during the first year 
half (with a peak in April-May 2003) (VAD, 2004).  
 
3.4. Practitioners 
Many of the issues elaborated upon in the parliamentary debates between 2002 and 2003 were 
influenced by the 2003 Policy Memorandum. Similar to previous elections (Chapter 3, §3), prac-
titioners united their needs and demands in a Policy Memorandum and distributed the docu-
ment to the political parties. The 2003 Policy Memorandum (Memorandum group, 2003) was 
clearly inspired by the previous Policy Memorandum, the (lack of) realisations of the Federal 
Drug Policy Note (2001) and the new drug law. Some demands for further policy engagement 
related to the new evolutions. Practitioners noted the importance of structural funding and the 
extension of the pilot projects (e.g. concerning dual diagnosis treatment, crisis intervention and 
case-management, and care coordination) as well as the need for clarification about the new 
drug law (e.g. about the position of minors and detainees; about the issue of professional confi-
dentiality related to the collaboration between justice and treatment). Finally, the development 
of a coherent alcohol policy (in accordance with the drug policy) was also underlined.  
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3.5. Media coverage 
From the start of the parliamentary debates, Flemish and French-speaking newspapers reflected 
on the debates on the bill in detail. For instance, media attention increased when the Commis-
sion of Justice made revisions. “CD&V rejects policy of tolerance” (22 October 2002, Flemish news-
paper Gazet van Antwerpen). In the following stage, some parts of the expert hearings in the 
Commission of Public Health were published in the newspapers. “Police, treatment workers and 
Public Prosecutors are very critical of the new drug law […] Everyone criticised the unclear notions 
in the law” (15 January 2003, Flemish newspaper Gazet van Antwerpen). In accordance with the 
sustained media coverage on the harmfulness of cannabis use, the discourse of medical expert 
Prof. Dr. Jef Hulselmans was particularly integrated in the newspapers. For example, French-
speaking newspaper La Libre Belgique described several medical studies (without detailed or 
contextual information) regarding the link between cannabis and schizophrenia, the increasing 
level of THC, etc. “Cannabis should no longer be considered as a harmless product“ (26 February 
2003, French-speaking newspaper La Libre Belgique). 
 
However, messages from the media were often ambiguous and polarised. For example, some 
statements of medical expert Prof. Dr. Jef Hulselmans were manipulated in the Flemish newspa-
per Gazet van Antwerpen (16 January 2003). 
 
“Because of the new cultivating techniques, the THC content can be 30 times higher than it used to 
be.” (Gazet van Antwerpen) 
“A regular joint contains about 10 mg, now the content is much higher: 150 mg.” (Prof. Dr. Jef 
Hulselmans) 
 
“1% of all Belgians become schizophrenic.” (Gazet van Antwerpen) 
“Up to 1% life-time prevalence, not only Belgians.” (Prof. Dr. Jef Hulselmans) 
 
“Research shows that 10% of the users become addicted.” (Gazet van Antwerpen) 
“9% in one research; 7,7% and 4,8% in other researches.” (Prof. Dr. Jef Hulselmans) 
 
The media also regularly suggested that the new drug law was already voted and implemented 
while the bill still had to be discussed in the Senate (Gelders, 2006). “The Verhofstadt Govern-
ment finally accepted the new drug law […] The Parliament approved the new drug law yesterday 
evening. This closed the discussion that has lasted for two years (29 January 2003, Flemish news-
paper De Morgen). 
 
Nevertheless, in the parliamentary debates, media statements were used to support certain ar-
guments. Similarly, MPs clearly acquired information about scientific knowledge as contextual-
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ised in newspaper articles. For instance, the submitted amendments in the Senate were exten-
sively supported by these so-called ‘indirect references’ to scientific knowledge.  
 
“These numbers are confirmed by the national report on drugs that was published in the press re-
cently. This report was drawn up by the university of Ghent based on a survey of 10.000 pupils.“ 
(Mr. Jacques D’Hooghe and Mrs. Mia Van Schamphelaere, CD&V, Flemish Christian Democrats, 
Parl.St. Senaat 2000-2001, nr. 2 - 1475/2, 17). 
 
Even though MPs were aware that journalists do not evaluate scientific knowledge critically (as 
they are driven by publicity/sensationalism, time constraints and economic and/or political 
concerns), they did not investigate the accuracy of the media representation.  
 
“Media is often the only source of information. We know that the information is not always pre-
sented correctly […] However, we never checked the trustworthiness of the information provided.” 
(Respondent 42, policy-maker). 
 
3.6. Interest group ‘Parents against Drugs’ 
The media was an important instrument for the interest group Parents against Drugs [Ouders 
tegen Drugs] in their efforts to proclaim their concerns and to stimulate the political awareness 
of the issue. For example, they put forward their opinion on the parliamentary debates and the 
voting of the bill.  
 
“If the drug law is approved, we willl organise a demonstration before the elections. […] We are 
proud to represent the parents and the families. We continue our activities even of policy choices 
are made.” (14 January 2003, Flemish newspaper Het Nieuwsblad).  
 
Their public actions (e.g. media presence, demonstration) were successful in obtaining political 
attention and setting the parliamentary agenda. Three members of the interest group Parents 
against Drugs [Ouders tegen Drugs] were selected as experts in the Commission of Public Health. 
They took the opportunity to express their feelings about Belgian drug policy and the new drug 
law. In the Commission of Public Health, they also proactively contacted some scientists in order 
to strengthen their arguments.  
 
“They were familiar with my story and asked me to send some additional information and studies 
to enforce their case.” (Respondent 13, scientist). 
 
By promoting their position, they further increased the likelihood of MPs being more sympathet-
ic towards the harmfulness of cannabis. However, their (rather emotional) hearing in the Com-
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mission was overshadowed by criticism of several MPs about their connections with the Flemish 
extreme right party Vlaams Blok. 
 
“The link with the Flemish extreme right party Vlaams Blok had a negative influence on their hear-
ing. They were stigmatised.” (Respondent 19, policy-maker). 
 
“During our hearing, an MP criticised the link between one of our members and the Flemish ex-
treme right party Vlaams Blok. It was over.” (Respondent 3, member of interest group). 
 
Due to internal conflicts caused by these political squabbles, the interest group Parents against 
Drugs [Ouders tegen Drugs] ceased to exist a few months later.  
 
4. Ministerial Circular Letter of 16 May 2003135 
While the new drug law was voted at the end of March 2003, the Minister of Justice Marc Ver-
wilghen, together with the College of Prosecutors-General, still had to develop a Ministerial Cir-
cular Letter. The new Ministerial Circular Letter had to take into consideration the principles of 
the drug law (of 4 April and 3 May 2003), the Royal Decree (of 16 May 2003) and the main ob-
jections about the 1998 Ministerial Circular Letter such as the lack of uniformity or legal certain-
ty (De Ruyver, et al., 2000; see also above, Chapter 4, §4.1.). Within the context of the Federal 
elections and the polarised media coverage, the work took a rather long time. 
 
The drug law reform was one of the major themes of the 2003 election campaign (Gelders, 
2006). While the drug law was used by the Flemish Greens as a kind of showpiece, the other 
Coalition partners gradually kept their hands off this sensitive issue. They gratefully pointed to 
the Green party AGALEV. In other words, being the ideal scapegoat, the Minister of Public Health 
Magda Aelvoet (later on replaced by Mr. Jef Tavernier) became the personification of the debate 
(even though the bill was a result of a political compromise). The dismissal of the Minister of 
Mobility Isabelle Durant (Ecolo, French-speaking Green party) on 5 May 2003 (after a dispute 
about the nocturnal flights at Brussels national airport)136 increased the political tensions among 
the Verhofstadt I Government even more.  
                                                          
135  Ministeriële omzendbrief van 16 mei 2003, betreffende vervolgingsbeleid inzake het bezit van en de detailhandel 
in illegale verdovende middelen, B.S. 2 juni 2003.  
136  The French-speaking Green party Ecolo disagreed with the other Coalition parties about the norms on the amount 
of noise of nocturnal flights from Brussels national airport over the city of Brussels. 
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“It was a strategy of the Socialists and the Liberals to point to the Green party, especially for the 
sensitive issues […] Despite the dismissal of the French-speaking Green party Ecolo, there was still 
a majority. […] Eventually, I think they were glad that the Flemish Green party AGALEV was still 
part of the government because it was easy to point the finger at the Greens.” (Respondent 21, pol-
icy-maker). 
 
Eventually, the Ministerial Circular Letter of 16 May 2003 on ‘the prosecution policy with regard 
to the possession of and the retail trade in illegal narcotic substances’ (B.S., 2 June 2003) includ-
ed the guidelines for the Public Prosecutors’ office as to how should be reacted towards the pos-
session of cannabis for personal use. The new Ministerial Circular Letter determined the amount 
of cannabis for personal use on three grams or one female plant while adding the confusing mes-
sage that the quantity for personal use was for a single time or for use within a maximum of 24 
hours. Conversely, in another paragraph of the Ministerial Circular Letter, it was stated that the 
Government was not in favour of determining a maximum amount of grams (because the THC 
level of cannabis products may vary a lot) (Vander Laenen and Dhont, 2003). The determination 
of a quantity for personal use was innovative taking into account the previous debates in the 
PWG (see Chapter 2, §5.1.) and in the Inter-Cabinet Working Group deciding on the Federal Drug 
Policy Note (see Chapter 4, §1). Despite the contradictions, the Ministerial Circular Letter deter-
mined that, provided there were no aggravating circumstances (such as use in the presence of 
minors, public nuisance or problematic drug use), the police had to make a simple, anonymous 
registration of the facts (instead of a regular process-verbal).137 The Ministerial Circular Letter 
also contained a set of specific guidelines for police officers in this context (Mahieu, 2005). 
 
Furthermore, related to other situations than the possession of cannabis for personal use out-
lined above, the 2003 Ministerial Circular Letter emphasised the importance of alternative 
measures and guidance towards treatment (Dangreau, et al., 2012). For instance, in cases of lim-
ited possession of other illegal drugs for single or occasional use, the Public Prosecutor has to 
decide whether or not to prosecute or to apply alternatives (e.g. praetorian probation, transac-
tion,…). The 2003 Ministerial Circular further asked the Public Prosecutors to be severe in the 
case of retail sale for profit but to take into consideration alternative measures (e.g. transaction, 
praetorian probation,…) in the cases in which the only purpose of the sale was to finance one’s 
own use. Related to drug-related criminality, the 2003 Ministerial Circular Letter emphasised 
that addiction can never be a justification for criminal behavior. It is explicitly stated that the 
Public Prosecutors in deciding whether or not to prosecute or to apply alternatives always 
                                                          
137  Art. 16 of the drug law (of 3 May 2003) only stated that ‘a registration’ by the police forces was required.  
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should consider the seriousness of the crime and the individual situation of the offender (i.e. 
principle of expediency).  
 
Driven by the fear that the Federal Drug Policy Note as well as the drug law (of 4 April and 3 May 
2003) and the Royal Decree (16 May 2003) would be interpreted as a tolerance policy, the new 
Ministerial Circular Letter (replacing the 1998 Ministerial Circular Letter of S. De Clerck and T. 
Van Parys; Chapter 3, §2) detailing the prosecution policy was implemented on 16 May 2003, 
only two days before the Federal elections. Although the cannabis controversy was deemed ‘re-
solved’ by the Government, sensitive matters such as the cultivation/supply of cannabis were 
still not clearly addressed. 
 
“The issue of the supply of cannabis was not resolved. […] However, the minimum number of grams 
was determined just before the elections. The Minister of Justice Marc Verwilghen was forced by 
the Prime Minister Guy Verhofstadt to keep the amount low. The Prime Minister wanted to avoid 
that the Verhofstadt I Government was seen as the government that created a tolerance policy. 
That was an unpopular topic. […] A clear instruction was given.” (Respondent 17, policy-maker). 
 
Both the election of a new government (without the Green parties) and the fact that the cannabis 
controversy was assessed as ‘resolved’, closed the policy window (Kingdon, 2002). In the Federal 
elections of 2003, the Greens suffered significant losses (partly due to their role in the cannabis 
discussion) and the Liberal Prime Minister Guy Verhofstadt reconstituted the Coalition as a four-
party government with only the Flemish and French-speaking Liberals and the Flemish and 
French-speaking Socialists in power (Verhofstadt II Government). The Green parties moved 
from a majority position towards the opposition again. 
 
5. Conclusion 
Criminal policy on drugs was anchored through an adaptation of the drug law (of 24 February 
1921) and the Ministerial Circular Letter of 8 May 1998 (De Ruyver, Vander Laenen and Eelen, 
2012). The juridical-technical discussion of the drug law, which was a rather long one (June 
2002 – May 2003), made its way through the Government and the Parliament. The complexity of 
the law-making procedure as well as the existing political (and individual) disagreements among 
the Government are the main causes. Eventually, a new drug law and a new Ministerial Circular 
Letter were endorsed just before the 2003 elections. These decisions together with the election 
of a new government (Verhofstadt II Government; a four-party government without the Green 
parties) marked the closing of the policy window (Kingdon, 2002). 
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Despite research and epidemiology was the least financed area with only 1% of the total budget 
(De Ruyver, et al., 2004), the commitment to an evidence-based policy in the Federal Drug Policy 
Note (2001) led to a greater investment in policy research and evaluation (facilitator). For ex-
ample, the “Research programme in support of the Federal Drug Policy Note” certainly stimulat-
ed Belgian drug research (especially about the topics that were supposed to be acute). The in-
ternational conference on cannabis policy which was hosted by the Belgian Minister of Public 
Health Magda Aelvoet within the framework of Belgian’s EU presidency, also illustrated the Bel-
gian political interest in research and evaluation. The focus of the conference clearly fitted with 
the public health approach of the Federal Drug Policy Note (2001), the sustained concern about 
the international framework and the increasing importance of evidence-based policy-making. 
 
Reflecting on Weiss’ knowledge utilisation categories (Weiss, 1979), several types of 
knowledge utilisation were distinguished. The Commission of Public Health, within the 
framework of the legislative competences of the Parliament, sought the advice of several scien-
tists. They gave an updated overview of the current state of the art by means of general descrip-
tions (e.g. ‘research shows’, ‘research confirms’, ‘some authors mention’, ‘the literature shows’, 
etc) or prepositional arguments. Although the debate largely focused on juridical-technical is-
sues, these scientists sensitised MPs to ‘new’ scientific knowledge focusing on the harmfulness of 
cannabis (e.g. the increasing level of THC, the connection between cannabis use and psychiatric 
disorders) (conceptual/enlightenment utilisation). There were also some clear examples where 
the utilisation of scientific knowledge could be categorised according to Weiss’ political/symbolic 
model. For instance, it appeared that, even though the evaluation study (De Ruyver, et al., 2000) 
had already pointed to the problems with the 1998 Ministerial Circular Letter, the Government 
still did not succeed in unambiguously determining the notions of ‘public nuisance’, ‘user quanti-
ty’ and ‘problematic use’ in the new drug law and the new Ministerial Circular Letter. Further-
more, the evolving and uncertain nature of scientific knowledge (e.g. about the harmfulness of 
cannabis) provided some examples of political/symbolic utilisation. References to scientific con-
troversy and the precautionary principle were selectively used by MPs as a justification for their 
actions or points of view. In a similar vein, we found that some MPs misinterpreted scientific 
knowledge to support their personal policy narrative (e.g. public health vs. legalistic/repressive 
framework). Clearly, the political/symbolic utilisation of Weiss’s three categories needs to be 
extended in order to address these different issues.  
 
A number of barriers impacted on the likelihood that scientific knowledge would be used. First 
of all, the characteristics of scientific knowledge acted as a barrier to knowledge utilisation. The 
first flow of research projects within the “Research programme in support of the Federal drugs 
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policy document” started in 2002. While some of these studies may have been particularly rele-
vant (e.g. research projects ‘Case management in the substance abuse treatment and criminal 
justice system’ and ‘Problematic drug use: a study of the operationalisation of the concept in a 
legal context’), the results of these policy-funded research projects came too late to contribute to 
the activities in the Inter-Cabinet Working Group (ICWG) or to the development of the new Min-
isterial Circular Letter. This reflects the challenge of the different time-frames of researchers and 
policy-makers. Secondly, the debates were clearly grounded on political considerations. The up-
coming Federal elections on 18 May 2003 put a lot of pressure on the activities surrounding the 
new drug law. While the new drug law was voted in at the end of March 2003, the new Ministe-
rial Circular (replacing the 1998 Ministerial Circular Letter) was implemented on 16 May 2003, 
only two days before the Federal elections. Unsurprisingly, the theme of drugs was broadly cov-
ered in the election campaigns in which each of the Coalition partners feared electoral loss. Re-
gardless of the position they took, the regular use of prepositional arguments and political tac-
tics (e.g. incorrect terminology, personal insults, emotional assumptions) illustrated their con-
cerns regarding a potential electoral backlash. Furthermore, a number of references to interna-
tional examples (e.g. international commissions like ‘Le Dain’, the 2002 international cannabis 
conference) were found (policy platonism). The persuasive burden in this debate was according-
ly higher for advocates of a drug law reform: the Government had to persuade the community 
that it is possible to change the law without increasing cannabis use and harm. Thirdly, the jurid-
ical-technical nature of the negotiations in the ICWG, appointed to develop a bill and a Royal 
Decree, particularly encouraged the involvement of practitioners with juridical knowledge and 
skills (e.g. lawyers, magistrates,…). 
 
Reflecting on the typology of Loader and Sparks (2011), several scientific experts enlightened the 
Commission of Public Health without engaging in the policy-making process outside the formal 
advisory structure. In selecting scientists to be involved in the Commission of Public Health, it 
appeared that their personal contacts/networks and/or regular appearances in the media were 
advantageous. A long-term engagement, and in particular as an observer-turned player or policy 
advisor (Loader and Sparks, 2011), was observed as an important facilitating mechanism as 
well. While scientists were less involved in the ICWG, the observer-turned player Prof. Dr. Brice 
De Ruyver (as security advisor to Prime Minister Guy Verhofstadt) still had a privileged position 
to engage in the interaction between science and policy. At the same time, due to his proactive 
and long-term involvement in the drug policy-making process (e.g. PWG, policy-funded re-
search,…), policy advisor Prof. Dr. Isidore Pelc was appointed the president of the Drug Health 
Policy Cell, a supporting working cell of the General Drugs Policy Cell. As the General Drugs Policy 
Cell prepares the decisions of the Inter-Ministerial Conference and guards the integrated charac-
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ter of the policy measures, this policy advisor also has a facilitating role to play in the science-
policy nexus. 
 
Media communication was often ambiguous and polarising, particularly in the manipulations of 
prevalence rates or expert opinions (indirect references). However, as a major source of scientific 
knowledge, media coverage facilitated the enlightenment role of scientific knowledge in the poli-
cy-making process by broadening and even determining frames of reference. In other words, the 
media encouraged refutation of the argument that cannabis use is harmless (evolutionary model; 
Stevens, 2007a). An example of MPs taking notice and getting sensitised to these issues is the 
large selection of doctors and psychiatrists in the Commission of Public Health. The correlation 
between early and regular cannabis use and the risk of developing schizophrenia, depression or 
other psychotic disorders also featured increasingly in many parliamentary discussions from 
2002-2003 onwards. The actual influence of media coverage on the ICWG was restricted to the 
high levels of attention policy-makers gave to the public opinion and their electorate (especially 
because Federal elections were looming). For instance, as a result of the ambiguous communica-
tion about the Federal Drug Policy Note, security advisor Prof. Dr. Brice De Ruyver was entrust-
ed to report about the drug policy issues in the media univocally. 
 
Finally, the engagement of interest groups seemed to be most effective at the parliamentary 
level. Interest group Parents against Drugs [Ouders tegen Drugs] intensively used the media to 
publicise their actions (e.g. demonstration), to strengthen their position and become more wide-
ly known among the public and policy-makers. As a result, three members were heard in the 
Commission of Public Health. By sharing their discourse, they increased the likelihood of MPs 
being more sympathetic towards their arguments on the harmfulness of cannabis. However, this 
interest group did not play a role in the ICWG, with one exception. In his capacity as an advisor 
of the Minister of Public Health Magda Aelvoet, a member of interest group Anti-Prohibition 
League [La Liaison anti-prohibitionniste] participated in the ICWG. This may the only effective 
way for interest groups to have a small voice in the debate at the governmental level. 
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Introduction 
 
Evidence-based policy-making assumes that policy-makers should be informed by scientists, so 
that policy will reflect accurate factual knowledge rather than political biases (Rich, 1997). How-
ever, this assumption is not based on a realistic view of how policy processes operate, especially 
in a heavily politicised domain (Monaghan, 2011). Together with the strong interest in the na-
ture of policy processes (Lindblom, 1959; Roe, 1991; Sabatier, 1998; Kingdon, 2002), a consid-
erable amount of literature also exists detailing whether and how (scientific) knowledge informs 
policy. In her typology, Weiss (1979) distinguished three prominent ways in which scientific 
knowledge is used: conceptually, instrumentally and politically/symbolically. Some authors have 
recently advocated newer models (evolutionary model and processual model) in order to concep-
tualise the relationship between science and policy in heavily politicised policy areas (Mona-
ghan, 2009; Stevens, 2011). In general, it has become clear that many players (e.g. interest 
groups and the media) are involved in the policy-making process (Kingdon, 2002; Sabatier, 
1998) and that scientific knowledge is just one of the factors contributing to the policy-making 
process, alongside personal interests and institutional rules (Weiss, et al., 2008; Hoppe, 2005; 
Stevens, 2007b; Monaghan, 2011). Although the interaction between science and policy now 
resonates in the recent debate about the public engagement of scientists (public criminology; 
Loader and Sparks, 2011) and the interest in studying the science-policy nexus in the drug field 
emerged in the last decade (especially in the United Kingdom, Australia and Canada) (Lenton, 
2004; Hall, 2008; Ritter, 2009; Monaghan, 2011; Hughes and Stevens, 2012), very little is known 
about whether and how the main political institutions (i.e. Parliament and Government) in Bel-
gium utilise scientific knowledge (for one exception, see Smet, 2013).  
 
In this final part, I offer some concluding observations and answer the central research ques-
tions of this study. Having examined how Belgian drug policy has been developed between 1996 
and 2003, I explored how scientific knowledge contributed to the development of Belgian drug 
policy between 1996 and 2003. In particular, the following questions are answered: through 
which modalities did scientific knowledge contribute to the drug policy-making process? What 
has counted as scientific knowledge in this particular drug policy-making process? Is there a 
difference in the role played by scientific knowledge within the main political institutions (i.e. 
Parliament and Government)? Which other types of information competed with scientific 
knowledge in this particular drug policy-making process? Given the relevance of interest groups 
and the media standing alongside the science-policy nexus, the following question is also ad-
dressed: what is the particular influence of the media and interest groups on the contribution of 
scientific knowledge to the development of Belgian drug policy between 1996 and 2003?
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A case-study design was used to explore and understand the contribution of scientific 
knowledge in the development of Belgian drug policy (1996-2003). I have selected a qualitative 
methodological approach, including a (critical) discourse analysis of policy and media docu-
ments (Fairclough, 2003) and 55 interviews with key informants (Tieberghien, 2014b). 
 
1. Three milestones in the development of Belgian drug policy between 
1996 and 2003 
Through the analysis of policy and media documents and interviews, I established that the de-
velopment of Belgian drug policy between 1996 and 2003 can be divided into three stages. 
While the drug issue entered the legislative framework with the Belgian law criminalising drugs 
and drugs possession (1921), the foundations of Belgian drug policy were laid down rather late. 
In the first half of the 1990s, a number of major cities were confronted with a steep increase in 
crime that seriously affected the quality of life in a number of neighbourhoods (Guillain, 2003). 
The assumption (though not backed up by data) was that problematic drug users were respon-
sible for the rise in crime and nuisance. Eventually, a policy window (Kingdon, 2002) was opened 
by an MP of the French-speaking socialist party (PS) who publicly emphasised in the newspaper 
Le Soir (17 November 1995) that he would submit a proposal to legalise cannabis possession. 
Although it was only a threat (he did not submit his proposition), this event ignited the Parlia-
mentary Working Group on Drugs (1996-1997). The Federal Parliament established a Parlia-
mentary Working Group (1996-1997) in order to develop a clear and timely perspective on all 
aspects of the Belgian drug phenomenon (first milestone). The Parliamentary Working Group 
(PWG) asked national and international experts (e.g. scientists, practitioners), working in all 
domains of drug policy, to convey their analysis and to give clear recommendations to the Fed-
eral Government (bottom-up approach). Apart from topics such as drug epidemiology, prescrip-
tion and substitution of methadone and/or heroin, international drug production and metha-
done and/or heroin substitution, a large part of the discursive struggle between a social and pub-
lic health framework and a legalistic/repressive framework focused on the question of the crimi-
nalisation of drugs. Eventually, across the different domains (welfare, social integration, educa-
tion, security, justice and economy) most of the members of the PWG agreed about the need for a 
multidisciplinary and coherent approach to the multi-dimensional drug phenomenon (Parl.St. 
Kamer, 1996-1997, 1062/1-3).  
 
During a turbulent intermezzo between 1997 and 2000, the entire drug debate was overshad-
owed by a large paedophilia scandal (i.e. the Dutroux case) as well as the resulting focus on re-
form of the judicial authorities and the police (Octopus reforms). Meanwhile, in 1999, Belgian 
voters rejected the longstanding Coalition Government of Christian Democrats and Socialists and 
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voted a six-party Coalition into power consisting of the Flemish and Francophone Liberals, So-
cialists and Greens led by Flemish Liberal Guy Verhofstadt (1999-2003). This change turned out 
to be an important facilitator of the development of a coherent (public health) drug policy. It also 
increased the credibility given to scientific knowledge as tool of developing drug policy. 
 
Gradually, the drug issue re-emerged on the political agenda. The new Belgian Government fur-
ther elaborated the principles and recommendations of the Parliamentary Working Group 
(1996-1997) and established the first ‘national drug strategy’ in 2001 (second milestone). The 
Federal Drug Policy Note (2001) indicates that the drug phenomenon is considered to be a per-
manent social reality (i.e. normalisation policy). Accordingly, in the framework of an integral and 
integrated policy, a discourse with a purely criminal focus was officially replaced by a discourse 
where the drug problem was primarily considered a problem of public health (Federal Govern-
ment, 2001a). From this starting point, the Federal Drug Policy Note put forward three pillars: 
(1) prevention of drug consumption; (2) harm reduction, treatment and re-integration, and; (3) 
law enforcement as the last resort (Federal Government, 2001a; p.7). The Federal Drug Policy 
Note (2001) also expressed the commitment to an evidence-based policy and the budget for drug 
research increased greatly. For instance, since 2001, the Minister in charge of the Federal Sci-
ence Policy has received an annual budget to organise and manage a Research Programme sup-
porting decision-making in the field of illegal drugs. It was an important indicator of the efforts 
that the policy-makers made in addressing the drug problem and in considering scientific 
knowledge as a priority (facilitator).  
 
The Federal Drug Policy Note determined the policy priorities and thus the legislative and pros-
ecution framework. As one of the action points of the Federal Drug Policy Note (2001), the Fed-
eral Government planned to amend the Belgian Narcotic Drug Law of 1921 and, accordingly, to 
develop a new Ministerial Circular Letter. The new drug law and the new Ministerial Circular 
Letter were endorsed just before the 2003 elections (third milestone). These decisions, togeth-
er with the election of a new Government (Verhofstadt II Government: a four-party Government 
with only the Flemish and French-speaking liberals and the Flemish and French-speaking social-
ists in power), marked the closing of the policy window (Kingdon, 2002). 
 
2. Weiss’ three-folded typology of knowledge utilisation 
Given that the debate in the drug policy field is often contested, part of a heated controversy or 
subject to rapid change, the drug policy-making process has been frequently considered an un-
evidenced-based mess (Monaghan, 2008b). Against such a background, some interviewees indeed 
labelled the development of Belgian drug policy between 1996 and 2003 as ‘fact-free politics’ – 
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what they saw as non-rational policy-making -, ignoring the rather subtle or hard-to-trace roles 
of scientific knowledge in the policy-making process. These accounts over-simplify the science-
policy nexus and, following Monaghan (2011), this mistaken perception can in itself be seen as 
an important barrier towards the utilisation of scientific knowledge in the policy-making pro-
cess.  
 
However, evidence-informed policy or evidence-aware policy concepts that have been developed 
to demonstrate scepticism towards such zero-sum statements (evidence-based or evidence-free), 
tend to capture the reality of the science-policy nexus more accurately (Young, et al., 2002; Do-
brow, Goel and Upshur, 2004). Applying Weiss’ three-folded typology (1979), interviews and the 
analysis of the submissions, hearings and parliamentary/governmental reports demonstrated 
that scientific knowledge contributed to the policy-making process through different modalities. 
While previous Anglo-Saxon studies (originating from countries with a two-party system) have 
shown that the nature of knowledge utilisation in the drug policy-making process is strongly 
politicised (Hall, 2008; Monaghan, 2011; Hughes and Stevens, 2012; Ritter and Lancaster, 2013; 
MacGregor, 2012), I found several illustrations of conceptual and instrumental utilisation as 
well.  
 
Although instrumental utilisation is the most common interpretation of the science-policy 
nexus (and is linked with the evidence-based thinking), it is the least common example of 
knowledge utilisation (Edwards, Strang and Jaffe, 1993; O’Dwyer, 2004; Brambila, et al., 2007). 
In this study, however, a policy-funded evaluation study aiming at examining the progress of the 
Belgian drug policy as well as the experiences of other countries (De Ruyver, et al., 2000) did in 
fact lead to action/implementation (instrumental utilisation). In particular, the recommenda-
tions of the evaluation study of Prof. Dr. Brice De Ruyver and Prof. Dr. Joris Casselman (2000) 
was highly relevant in determining the specific policy actions by the Federal Government: the 
report fitted with the mood of the time and answered questions at the top of the political agenda 
since the PWG. Additionally, the fact that an evaluation study, considered to have led to direct 
measurable and usable results for policy-makers (Devroe, 2002), fulfils this particular role fits 
with the literature on evidence-based policies (Devroe, Deschamps and Hannes, 2008). 
 
It was more likely than instrumental utilisation that scientific knowledge contributed to an 
overall enlightenment by identifying possible policy options, clarifying issues and changing the 
understanding of the drug problem (conceptual utilisation). In the Parliamentary Working 
Group on drugs (1996-1997), scientific knowledge contributed to the percolation of (new) ideas 
and concepts and the development of a substantial body of knowledge. The new frameworks for 
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understanding the drug problem provided by scientists clearly altered the discourse in the Bel-
gian drug policy-making process. For instance, the study of De Ruyver et al. (1992; Poverty, drug 
use and criminality) and the study of Vercaigne and Walgrave (1995; Youth between 
(sub)cultures and business: a study focusing on discotheques, house music and nuisance) both 
served respectively as an endorsement of the argument that (problematic) drug users in the 
criminal justice system ought to be oriented more towards treatment, and the argument that 
prevention initiatives have to pay special attention to youth, smart drugs and the consequences 
of drug use for road safety. Eventually, in pursuing a global and integrated policy, the final con-
clusions and recommendations of the PWG expressed that prevention was to be the first goal 
and a criminal approach towards drug users was supported by the so-called ultimum remedium 
philosophy. These final conclusions and recommendations by the PWG provided the fundamen-
tal framework for the development of the Federal Drug Policy Note (2001) in the ICWG. 
 
In a similar vein, the accumulation of scientific knowledge over time has been used to shape the 
parliamentary debates on Belgian drug law (2002-2003). For example, through participation in 
the Commission of Public Health (2002-2003), scientists have enlightened MPs to (new) issues 
like the dangers of cannabis and the connection between cannabis use and psychiatric disorders 
(e.g. depression, schizophrenia,…). As it was argued that cannabis was more harmful and dan-
gerous than initially thought (e.g. the increasing level of THC was frequently noted), these ele-
ments offered strong support to arguments against the bills. 
 
In line with the conclusions of other researchers in the field of drugs, there were also a number 
of examples where the utilisation could be categorised according to Weiss’s political/symbolic 
utilisation. Parliamentary debates consisted of bargaining and negotiation using whatever ar-
guments could be mustered in support of their position. Scientific knowledge can be seen as one 
tool to help win their case (as an instrument to enact power). MPs who submitted questions, 
interpellations, resolutions, bills or resolutions often selected scientific knowledge on the basis 
of their political (i.e. majority versus opposition, party policy) and cultural/linguistic (e.g. Flem-
ish MPs preferred the selection of Flemish experts) motives and their functional specialisation 
(e.g. MPs with a medical background tended to select doctors or professors in toxicology or 
pharmacology). Scientists or scientific studies which made conflicting opinions more apparent 
were excluded or criticised (cherry-picking or trawling; Stevens, 2007a). Similarly, I observed 
examples of political/symbolic use of scientific knowledge in governmental discussions. For ex-
ample, when answering questions and interpellations in the Parliament or when addressing the 
topic in a speech, Ministers readily distorted scientific arguments which were detrimental to the 
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chosen policy direction, by criticising them as irrational or incorrect (a tactic of creating 'flak'; 
Stevens, 2007a).  
 
Serving as another example, the evaluation study of De Ruyver et al. (2000) recommended that 
the lack of uniformity in the prosecution of cannabis possession between different Public Prose-
cutor’s offices should be resolved. A large part of this problem was attributed to the rather vague 
notions such as ‘public nuisance’, ‘problematic use’ and ‘limited possession for personal (single 
or occasional) use’. However, although the Federal Drug Policy Note (2001) introduced new def-
initions, they still remained too vague and open to interpretation. In other words, politi-
cal/symbolic utilisation was noted: in the Federal Drug Policy Note reference was made to the 
governments’ investment in the research by way of demonstrating commitment and respon-
siveness, although the vagueness of these notions was left unresolved. This example also pro-
vides support for the argument made by Greenberg and Mandell (1991) and Nutley, Walter and 
Davies (2007) that Weiss’s typology is not exclusive: several forms of utilisation occurred simul-
taneously (i.e. the evaluation study of De Ruyver et al. (2000) was used both in an instrumental 
and a political/symbolic way).  
 
In this context, I have experienced some difficulties in capturing how some examples could be 
classified according to Weiss’s three-folded typology. In accordance with Stevens (2007a) and 
Monaghan (2011), this typology tends to offer only limited descriptions of some modalities 
through which scientific knowledge was used. In particular, Weiss’s political/symbolic model 
(Weiss, 1979) seems too simplistic and requires the introduction of new categories. First of all, 
this model fails to distinguish between instances where research is being used appropriately as 
opposed to research being misused or misinterpreted (see also Stevens, 2007a). Instances 
where scientific knowledge was misused or misinterpreted (e.g. making blunt interpretations, 
false generalisations and causalities) were frequently observed in the parliamentary debates. 
According to Weiss (1986), this may lead to confusion or so-called endarkenment (instead of 
enlightenment). Second, Weiss’ political/symbolic model does not cover the occasions where 
scientific knowledge is cited simply to justify the government’s commitment to knowledge utili-
sation. For example, in accordance with what Cross et al. (2000) termed the status model in the 
literature, policy-makers aim to gain credibility (and status) by referring to studies that they (or 
their predecessor) commissioned. These references can be categorised as a subtype of politi-
cal/symbolic utilisation as they were used to support personal policy narratives. 
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3. Knowledge utilisation: Parliament versus Government? 
Having examined the examples of knowledge utilisation, it seems incorrect to argue that scien-
tific knowledge is more influential in the Parliament than in the governmental policy-making 
(Johnson, et al., 2004; Smet, 2013). In accordance with the findings of MacGregor (2012), there is 
rather a difference in the types of utilisation depending on different institutional cultures. The 
media plays a powerful role in this regard as well (see below, §7). 
 
Political/symbolic utilisation (in contrast to instrumental or conceptual utilisation) was likely to 
be more evident in parliamentary discussions. Making use of their capacity to monitor and con-
trol the activities of the Government, opposition MPs often engaged in a discursive struggle be-
tween social and public health concerns and law enforcement priorities. In order to set and keep 
this particular issue high on the political agenda, they simply selected or even misinterpreted 
those studies or scientists that supported their political narrative or interests. This finding is of 
course indicative of the institutional culture of the Parliament: it is mainly a forum for political 
games between majority and opposition (Johnson, et al., 2004; Thomson, Wilson and Howden-
Chapman, 2007). 
 
The Government, more than the Parliament, must strike a balance between important public and 
political values that are in conflict. Members of the Government have to persuade other people, 
within and outside the policy-making process, that their ideas are worth acting on. In spite of 
some instances of political/symbolic utilisation, the utilisation of scientific knowledge in an in-
strumental or conceptual manner tended to be more associated with the activities of the Gov-
ernment. As stated above, the Federal Drug Policy Note was strongly influenced by the concepts 
and perspectives provided by scientists in the PWG. This can be considered as an indirect path-
way through which scientific knowledge seeped into the policy discourse (conceptual utilisa-
tion). At the same time, the evaluation study of Prof. Dr. Brice De Ruyver and Prof. Dr. Joris Cas-
selman (De Ruyver, et al., 2000) was directly used in developing the Federal Drug Policy Note 
(instrumental utilisation). 
 
However, in retrospect, the case of the development of Belgian drug policy (between 1996 and 
2003) can be termed rather atypical. It was the Federal Parliament (and not the Federal Gov-
ernment) who took the initiative to inform itself about the complexity and multidisciplinary na-
ture of the drug phenomenon. At the same time, the PWG relied on national and international 
experts (e.g. scientists, practitioners), working in all domains of drug policy, to get an idea of 
good practices as well as of scientific findings regarding the drug phenomenon. This bottom-up 
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approach has been one of the strong characteristics of the development of Belgian drug policy 
and the first national drug strategy by the Federal Government in particular. 
 
4. Scientists’ discourses: ‘speaking truth to power’? 
Reflecting the evidence-based policy account which is premised on the notion of an independent, 
truth-seeking scientist (Hartnoll, 2004; Nutley, Walter and Davies, 2007), policy-makers as-
sessed scientific knowledge as the way to get at truth and to understand a phenomenon satisfac-
torily. MPs and members of the Government sought ‘certainties’ or ‘facts’ to support their case or 
improve their credibility and scientific knowledge was clearly assumed to reflect ‘objectivity’ 
and ‘authoritative, truth-producing’ data. Scientific knowledge commissioned by the Federal 
authorities (policy-funded research) and scientific knowledge giving a quantified input on dis-
cussions about the drug phenomenon appeared to be particularly attractive to policy-makers. In 
addition, a particular factual claim of a scientist was often believed to be true because it had 
been put forward by those who are considered competent to speak ‘truth’. In line with Jasanoff 
(1990) and Boland (2008), it was assumed that the use of authoritative claims such as ‘scientists 
show’ or ‘scientific research confirms’ made a particular discourse ‘true’. Footnote references 
and bibliographies were rarely included and often incomplete (wrong order, no author, no place 
of publication, no page numbers, etc.) or out-of-date. 
 
The view that scientific knowledge is objective, context-free or interest-neutral stems from the 
positivist tradition (Rubin and Rubin, 2005). According to Zampini (2014), such a value-free 
ideal may allow scientists to see themselves as separate from the social and political world. In-
deed, scientists’ discourses in formal advisory structures such as the PWG (1996-1997) or the 
Commission of Public Health (2002-2003) were largely fed by prepositional assumptions (i.e. 
assumptions about what is or can be or will be the case; ‘truth’) declared without citations. For 
instance, ‘cannabis use leads to...’, ‘it is determined that 90% of the drug addicts…’, ‘poly drug 
use increased’, ‘the war against drugs caused a lot of suffering’, ‘50% of our youngsters has ex-
perimented with drugs’.  
 
However, a nuanced account of scientists’ discourses is necessary (i.e. processual model; Mon-
aghan, 2011). In their claims to capture ‘truth’, scientists were observed misusing science in sev-
eral ways during the hearings in the formal advisory structures (e.g. Parliamentary Working 
group on drugs (1996-1997), Commission of Public Health (2002-2003)). Some neglected the 
main principles of scientific knowledge by using ambiguous terminologies (e.g. a comparison 
was made between the number of hashish users and the number of cannabis users) or by pre-
senting data regardless of the methodological purity with which it had been developed (e.g. ne-
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glecting statistical significance, comparing different methodologies, ignoring methodological 
pitfalls). In addition, scientific results were sometimes distorted in several – often subtle – ways, 
including making simplistic interpretations, false generalisations and causal inferences. As par-
ticipating in a formal advisory structure allow scientists to control which message is provided 
and how it is absorbed in the political setting, it is important that scientists offering their exper-
tise in the policy-making process accept their responsibility to provide correct information in-
stead of losing sight of their scientific research base (cfr. so-called airport scientists; Uggen and 
Inderbitzin, 2010). If scientists misrepresent their findings, there is even less hope for well-
informed coverage in the policy-making process.  
 
5. Other types of information and factors competing with scientific 
knowledge 
Ideally, developing policy is a deliberative process in which all information and opinions rele-
vant to the issue are treated equally. In reality, however, policy-making often falls short of this 
ideal. Consistent with the theoretical models of policy-making and knowledge utilisation, this 
dissertation has shown that this process is interactive and shaped by other types of information 
(structured interaction; also termed as ‘governance’) as opposed to what is accepted in the tradi-
tional, rational view on the policy-making process (authoritative choice) on which the notion of 
evidence-based policy is founded. The illustrations below further underpin criticism of evidence-
based policy thinking.  
 
Policy-makers were particularly influenced by practitioner’s knowledge and experience as 
opposed to scientific knowledge. Practitioners not only provided practical and clear information 
based on their day-to-day experiences: their remarks in relation to budgets or staff made clear 
that they were more directly involved in the policy-making process. For example, both Dutch- 
and French-speaking practitioners of drug treatment and prevention adopted the common 
strategy of developing a Policy Memorandum. This document described the concerns and inter-
ests of each organisation. The intensive interactions between practitioners and policy-makers 
worked well. For instance, when comparing the Federal Drug Policy Note (2001) with the state-
ments included in the 1999 Policy Memorandum, there is a significant overlap. In the context of 
the hierarchy of evidence, a concept emerging from evidence-based policy thinking, this is an in-
teresting point. The evidence hierarchy assumes that policy-makers are generally best served by 
studies that use experimental and quasi-experimental research designs with good measures 
(Randomised Control Trials – RCT) (Wildavsky, 1979), and portrays knowledge derived from 
practitioners’ experiences as unsystematic and not rigorous. In this case, however, these experi-
ences had a crucial role in shaping policy-makers’ perspectives. 
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Furthermore, I have shown that the utilisation of scientific knowledge in the policy-making pro-
cess depends on various factors, such as the characteristics of the policy-making apparatus and 
the characteristics of scientific knowledge. Echoing other studies (Sorian and Baugh, 2002; Mit-
ton, et al., 2007; Ritter, et al., 2007; Huston, 2008), this study frequently reflects Caplan’s obser-
vations (two communities thesis) that the gaps between scientists and policy-makers are funda-
mental barriers to the use of scientific knowledge. Several institutional and individual charac-
teristics of policy-making shaped how scientific knowledge was used, or whether it was used 
at all at particular points in the policy process. This is natural as policy-makers still have a re-
sponsibility that other ‘external’ actors do not have. The international context has been an im-
portant factor as policy-makers are also responsible for the international aspects of their policy 
competences. Right from the start, several international drug control treaties, strongly support-
ed by the international community, determined particular policy choices (e.g. regarding canna-
bis policy). The (developing) international framework (e.g. the 1997 Amsterdam Treaty; the 
Inter-parliamentary Advisory Council of the Benelux countries (1998); the Dutch policy paper 
‘Pathways to the back door’ (2000), and; the 1990 Schengen Convention) was frequently refer-
enced in political arguments refuting scientific advice. For instance, the strategy of projecting the 
effects of criminalisation or legalisation based on comparisons with the experiences of other 
countries (e.g. the Dutch coffee-shop model policy versus the American War on Drugs), so-called 
policy platonism (MacCoun and Reuter, 1997), was regularly adopted. 
 
Knowledge utilisation also depends on the electoral cycle and the battle between political par-
ties (Flitcroft, et al., 2011; MacGregor, 2012). As it can be damaging to be too closely involved in 
such a politicised and mediatised debate, policy-makers were always concerned with how their 
electorate (and the public opinion in general) would perceive and respond to policy decisions. 
For instance, the theme of drugs was broadly covered in the 2003 election campaign, during 
which all of the coalition partners feared electoral losses. Regardless of the position they took, 
the consistent use of prepositional arguments and political tactics (e.g. using incorrect terminol-
ogy, employing personal insults, inciting emotional responses) illustrated their concerns of a 
potential electoral backlash. Individual characteristics (their interest, education, research recep-
tivity, …) played a very influential role in the policy-making process as well (Weiss, 1999; Land-
ry, Lamari and Amara, 2003). For instance, the personal background, education or experiences 
of the Minister (and his/her representatives) often (partly) determined which scientist is or is 
not included in their personal network. At the same time, in order to advance particular posi-
tions, to satisfy their electorates or to gain higher authority, policy-makers have sometimes ig-
nored scientific knowledge, preferring to rely on their personal opinions or experiences (so-
called tacit knowledge; Smet, 2013; Richardson, 2013).  
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The characteristics of scientific knowledge were also reported to be important barriers of 
knowledge utilisation. In line with the findings of several empirical studies (Mitton, et al., 2007; 
Ritter, et al., 2007; Huston, 2008), the issue that academic careers are geared towards and re-
ward academic publication, rather than involvement in the policy-making process, was a recur-
ring topic in the interviews. Furthermore, interviewees indicated that scientific research often 
takes years to complete while policy issues often rise rapidly to the top of the political agenda. 
For instance, while the first flow of research projects within the ‘Research Programme in sup-
port of the Federal Drug Policy Note’ in 2002 could have been particularly relevant (e.g. ‘Case 
management in the substance abuse treatment and criminal justice system’, ‘Problematic drug 
use: a study of the operationalisation of the concept in a legal context’), the results of these poli-
cy-funded research projects came too late to contribute to the development of Belgian drug law 
(2002-2003). Additionally, the translation of scientific knowledge into a short, comprehensible 
report was considered to be an even more complex process. The poor fit between the way in 
which academic information is reported by researchers (e.g. lengthy scientific reports) and the 
practical need for brevity by policy-makers was noted. Finally, whereas scientists may be famil-
iar with the conditions of scientific uncertainty (e.g. about the causal link between cannabis use 
and schizophrenia), policy-makers seek clear explanations. As a consequence, the utilisation of 
scientific knowledge was sometimes completed with data (numbers and statistics) derived from 
non-academic research or supplied by an (inter)national organisation (e.g. EMCDDA, WHO, 
WIV). When a policy-maker was faced with difficulties in identifying the appropriate options, 
there was also a tendency to invoke the precautionary principle. This principle is premised on 
the idea that a strong research base with rigorous research findings is not required to make pol-
icy decisions; scientific indications (in the absence of scientific consensus) are considered suffi-
cient (Head, 2010). Against such a background, the precautionary argument can be considered 
to be a kind of barrier to knowledge utilisation and evidence-based policy-making in particular 
(Monaghan, Pawson and Wicker, 2012; Singleton, et al., 2014; Hughes, Ritter and Cowdery, 
2014). 
 
6. Public engagement of scientists and pathways of knowledge utilisation 
The aim of understanding the modalities through which scientific knowledge contributed to the 
development of Belgian drug policy between 1996 and 2003, also encompasses exchange or 
linkage issues between science and policy. While a considerable amount of literature focuses on 
facilitators of knowledge utilisation (Lampinen, 1992; Nutley, Walter and Davies, 2007; Head, 
2010), little attention has been given to the ways that public engagement of scientists influences 
knowledge utilisation (Haynes, et al., 2011b). 
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6.1. Personal networks 
The present study identified a number of opportunities to improve the likelihood that scientific 
knowledge will feed into the drug policy process (see also above: e.g. budget increase, change in 
Coalition partners in Government). In empirically exploring the interplay between science and 
policy, a notable finding was the central importance of relationships and interactions (strong 
facilitator). Long-standing relationships with key players inside the Parliament and the Govern-
ment created pathways of influence (Ritter, 2009; Lenton and Allsop 2010; Haynes, et al., 
2011a). Clearly, knowledge utilisation is not solely about the research, but also very much about 
the researcher (Hird, 2009; Ritter, 2009; Haynes, et al., 2012). It often appeared that the Minis-
ters (or their representatives) and MPs consulted scientists from their own trustworthy net-
work to gather background information, unravel a problem or support or refute arguments in 
the discussion. In particular, policy-makers consulted scientists as an alternative to published 
research because this tailored advice and dialogue made it easier to adapt policy arguments to 
achieve the closest fit. However, an individual relationship with a scientist may result in either a 
decrease or an increase of knowledge utilisation. A focus on individual relationships clearly lim-
its the policy-maker’s access to the broad spectrum of (sometimes conflicting) scientific insights 
(and promotes political/symbolic utilisation). At the same time, while some scientists may act as 
a lever in promoting the use of research findings, others might not be fully supportive of their 
recommendations on research, rather acting out of personal motives (cfr. airport scientists; Ug-
gen and Inderbitzin, 2010). 
 
Similar to the findings of Haynes et al. (2012), this study established that policy-makers tended 
to turn to those scientists with recognised expertise and authoritative presence in drug policy, 
who were known to be appropriately discreet (especially in such a heavily mediatised domain) 
and had the capacity to enlist public and political supporters behind their claims. As an example, 
in selecting scientists to be involved in formal advisory structures (e.g. the PWG (1996-1997), 
the Parliamentary Commission of Public Health (2002-2003)), it appeared that personal con-
tacts/networks and/or regular appearances in the media were advantageous. An important issue 
here is that scientists are assumed to engage with journalists (and the public) as well to estab-
lish networks with policy-makers. 
 
It is important for scientists – who have the intention of bringing scientific knowledge into the 
public and political debate – to make themselves available for informal consultation by policy-
makers. For instance, the participation of some scientists in study groups from political par-
ties can be seen as a successful route to bringing scientific knowledge to the policy-making pro-
cess and to establish an interaction between science (and practice) and policy. Likewise, the 
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highly attended national conferences ‘Drug Policy 2000’ deeply engaged with the debate be-
tween scientists, practitioners and policy-makers. Through the mobilising forces of criticism and 
enthusiasm for knowledge about the drug phenomenon and policy solutions, the conferences 
can be seen as one of the initiatives driving the (conceptual) utilisation of scientific knowledge in 
the policy-making process. In particular, the conferences provided a useful setting for discussing 
the issues central to the parliamentary or governmental debates among scientists, practitioners 
and (sometimes) policy-makers as well as to maintaining or building up (new) networks. 
 
6.2. The public roles of scientists  
Reflecting on the debate regarding public criminology (Loader and Sparks, 2011), it became clear 
how scientists managed the relationship between their academic activities and policy-making. 
While the two communities thesis minimises the heterogeneity within scientists and policy-
makers (Ginsburg and Gorostiaga, 2001; Monaghan, 2011), this study has shown that some sci-
entists maintained simultaneous memberships in both worlds (Loader and Sparks, 2011). While 
the categories used are less straightforward than they have been portrayed, scientists may cool 
down the debate via a public role as ‘observer-turned player’ and to a lesser extent via positions 
as ‘policy advisors’ and ‘scientific experts’ or heat the political climate in providing critical dis-
courses (of e.g. social movement theorists/activists; Loader and Sparks, 2011). In accordance 
with the findings of Lampinen (1992), this study established that their public engagement had 
an influence on the ways in which their own findings and those of others were used. 
 
Some researchers took a public stance in presenting their findings in formal advisory structures 
(e.g. PWG, Commission of Public Health) and answering the questions of policy-makers (scien-
tific experts). Even though this type of engagement did not go beyond this rare participation, 
these scientific experts enlightened the policy-making process (conceptual use). For instance, 
although the parliamentary debate about Belgian drug law (2002-2003) largely focused on ju-
ridical-technical issues, scientific experts sensitised MPs to ‘new’ scientific knowledge focusing 
on the dangers of cannabis (e.g. the increasing level of THC, the connection between cannabis 
use and psychiatric disorders). Likewise, in the PWG (1996-1997), scientific experts stimulated 
discussion and reflection among policy-makers (e.g. related to the prevention projects towards 
youth or related to the orientation of (problematic) drug users in the criminal justice system 
towards treatment). 
 
Social movement theorists/activists took up a similar role as scientific experts. However, 
these scientists, putting forward a more critical, alternative discourse towards the drug phe-
nomenon and drug policy, only succeeded in heating up the political climate. These alternative 
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approaches, focusing on the largely unproblematic characteristic of drug use or the usefulness of 
self-control strategies, generated a public response (e.g. several interest groups were estab-
lished) and narrowed down the complexity of the discussion to the legitimacy of the criminalisa-
tion of drugs (cannabis in particular). These insights were often used as ammunition in political 
struggles among MPs but tended to be left unused by Members of the Government. In other 
words, even though their knowledge was embedded in the policy process, scientists who were 
deemed too critical were likely to be excluded. Indeed, like in the evolutionary model advocated 
by Stevens (2007a), it is clear that some scientific knowledge may fit the interests of the power-
ful groups, while others may not. The choice of what counts as ‘usable’ scientific knowledge and 
who is considered authoritative or trustworthy involves acts of power (Becker, 1967; Foucault, 
1976; Van Swaaningen, 2001; Young, 2011). In this context, Walters (2003) called scientific 
knowledge which was deemed marginalised or disregarded by policy-makers as deviant 
knowledge. 
 
Other scientists have occupied core roles in the policy-making process (Loader and Sparks, 
2011). Policy advisors have successfully exploited research opportunities (policy-funded re-
search) and engaged in the policy process through personal relationships with policy-makers 
(MPs or Ministers) or through active participation in parliamentary debates or study groups 
from political parties. Often they established good contacts with professionals (e.g. police, out-
reach workers, and so on) as well. On the side lines of the policy-making process, several policy 
advisors allowed for a flow of scientific information to the policy-making process (and stimulat-
ed conceptual utilisation). For instance, due to his proactive and long-term involvement in the 
drug policy-making process (e.g. PWG or policy-funded research), policy advisor Prof. Dr. Isidore 
Pelc was appointed President of the Drug Health Policy Cell, a supporting working cell of the 
General Drugs Policy Cell. It is the General Drugs Policy Cell who prepares the decisions of the 
Inter-Ministerial Conference and guards the integrated character of the policy measures. 
 
Examples have shown that one scientist adopted a role as observer-turned player in the drug 
policy-making process (Loader and Sparks, 2011). Performing as observer-turned player, this 
scientist adopted different types of engagement in the PWG and the Government. For instance, 
based on his expertise (e.g. coordination of (policy-funded) research projects) and networks 
(e.g. through the organisation of the annual conferences ‘Drug Policy 2000’), Prof. Dr. Brice De 
Ruyver was appointed by the PWG as ‘external expert’ to integrate the findings from the hear-
ings into a report and, secondly, to write a draft of the final conclusions and recommendations. 
This draft served as a starting point in the political discussion about Belgian drug policy among 
the members of the PWG. The summarising report and its bibliography provided a clear and 
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careful integration of most of the good practices and recommendations of the scientists, practi-
tioners and members of the Government. Altering the tone of the political discussion (conceptual 
utilisation), the report produced a clear expression of the social and health discourse with the 
emergence of the harm reduction movement and the ultimum remedium philosophy instead of a 
strict repressive discourse. However, within this framework, some questions raised about the 
thin line between the role of a neutral/external expert and a policy-advocating expert. Even 
though the summarising report of the hearings in the PWG made clear that scientific knowledge 
(and practitioner’s knowledge) was integrated, it already offered and tailored advice in accord-
ance with the preferences of the policy-makers. In particular, the summarising report with the 
findings from the hearings displayed less sensitivity to the views of more critical contributors (of 
e.g. social movement theorists/activists) (see also above, evolutionary model; Stevens, 2011). 
Clearly, as the members of the PWG aimed to have a sufficient base for policy debate, the ‘exter-
nal expert’ (observer-turned player) could not retain his autonomy/neutrality completely in writ-
ing the summarising report.  
 
Furthermore, the evidence-based policy discourse and movement, despite its criticisms, has giv-
en scientists a more overt and direct role in Belgian drug policy-making at the governmental 
level as well. In 1999, the Verhofstadt I Government underlined that scientific knowledge was an 
important resource in policy-making (evidence-based policy). As a result, uniquely in the Belgian 
(drug policy) context, Prof. Dr. Brice De Ruyver, acting as an observer-turned player, was the se-
curity advisor to Prime Minister Guy Verhofstadt. Working within the Government was an excel-
lent way to establish oneself and understand how policy is made and who or what exerted the 
most influence (Bammer, et al., 2010). In particular, his role enabled him to promote the instru-
mental utilisation of his own scientific research and that of others in the political arena (e.g. the 
evaluation study, international drug policy studies). Such a public role is by far the most effective 
means to advance an evidence-informed drug policy. However, it is important to set realistic ex-
pectations about the contributions of scientists in the policy-making process (Petersilia, 2008). 
An observer-turned player is able to inform policy-making, not to make it. A judgment about 
whether or not a policy direction should be pursued is never solely a scientific judgment (Rock, 
2010). For instance, some findings of the evaluation study and international drug policy studies 
were also used in a more political/symbolic way by policy-makers. 
 
7. Media as a strong facilitator of the science-policy nexus 
Previous studies have assumed that the media is an important factor in drug policy debates, and 
in the science-policy nexus in particular (Duke, 2001; Hughes, 2009; Macleod and Hickman, 
2010; Monaghan, 2011; MacGregor, 2012). However, details about its particular influence have 
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been largely missing in knowledge utilisation studies in the drug policy area. The development 
of Belgian drug policy between 1996 and 2003 provided a clear case in which the media acted as 
a strong facilitator of knowledge utilisation in the drug policy-making process.  
 
Even though the effect of the media is not always so obvious given the multiple factors that may 
affect drug policy, I found evidence of the power of the media in defining political interest (agen-
da-setting) and in contextualising issues through selection and prominence (framing) (McCombs 
and Shaw, 1972; Entman, 1989; Lancaster, et al., 2011). The media has the necessary platform to 
quickly put issues on the public agenda and has access to policy-makers, and vice versa. First of 
all, it became clear that, since drug policy is a highly politically sensitive issue, the media nar-
rowed down the focus to one single element (cannabis policy) and stimulated further confusion 
and conflicting interests (framing). Coverage by the media was found to have fuelled public fear 
(‘moral panic’) and speculation by using terms such as ‘legalisation’ and ‘tolerance policy’ (Co-
hen, 1972). As a consequence, MPs (and the public) believed that there were two positions: ei-
ther cannabis use is harmless (or at least less harmful than alcohol), and hence it should be de-
criminalised (if not legalised); or cannabis is harmful to health, and therefore its use should con-
tinue to be prohibited. Secondly, the media seemed to be a powerful player in setting the policy 
agenda. Through media-generated panic, drug policy had shot to prominence on the political 
agenda, demanding action from the Parliament in 1995 (resulting in the PWG in 1996). Later on, 
a substantial adoption of media issues in the parliamentary debate was also observed. By means 
of triggering questions or interpellations in the Parliament, media coverage strongly directed the 
parliamentary discourse towards the cannabis issue. 
 
A major way in which policy-makers heard about scientific knowledge was through the media 
(Weiss and Singer, 1988). However, media coverage has some particular drawbacks: space is 
limited, and it interlinks sensationalism, disclosure and economic concerns in a manner that 
pushes accuracy down the list of priorities (Coomber, Morris and Dunn, 2000). The starting 
point for journalists was what made a story fit in with their particular framework and narrative. 
In a heavily politicised and mediatised debate such as drugs, media was fact-checking far less 
often than scientists would prefer. Media reports have tended to exaggerate scientific knowledge 
by drawing on research or expert opinions in a selective manner and by describing them one-
sided or in more dramatic terms. In this context, MPs did not and often could seek further infor-
mation regarding scientific knowledge picked up through the media. 
 
Once scientific knowledge was picked up by the media, it was indeed harder to ignore it in the 
policy-making process (Lenton, 2004; Lancaster, et al., 2011). However, the actual influence of 
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media coverage in shaping Belgian drug policy was restricted to the high levels of attention Min-
isters and their representatives gave to the public opinion and their electorate. In this context, 
media coverage influenced informal discussions between Coalition partners or obliged Ministers 
to formulate public statements or answer parliamentary questions/interpellations. Indirectly, 
the media also determined the authorised agents of knowledge to be adopted in a personal net-
work of a Minister (see above).  
 
In accordance with the findings of Chan (1995), Kingdon (2002), and Walgrave and Van Aelst 
(2006), media discourse (and scientific knowledge as contextualised in newspaper articles) was 
clearly more influential in the parliamentary activities. The media can be considered to be an 
important facilitator of the science-policy nexus at the parliamentary level. It became clear that 
scientific knowledge which was repeatedly or extensively included in newspaper accounts stood 
a good chance of playing a role in parliamentary activities. MPs clearly acquired information 
about scientific knowledge as contextualised in newspaper articles. However, the inclusion of 
scientific knowledge as represented by the media is highly prone to political utilisation. The 
lack of any contextual information in media coverage, as well as the selective inclusion of scien-
tific knowledge or expert opinion, resulted in policy-makers picking and choosing what was 
most supportive of their discourse. 
 
Nevertheless, media coverage of scientific knowledge was not necessarily a precondition for 
playing a role in the policy-making process. For instance, the evaluation study conducted by De 
Ruyver et al. (2000), which gave direction to Belgian drug policy and could be perceived as an 
example of instrumental knowledge utilisation, was not repeatedly or extensively covered by 
the media.  
 
The media also played a significant role in empowering the enlightenment function of scientific 
knowledge in our particular case. For instance, it was media coverage, and not scientific 
knowledge, which initially shaped political action in Belgium. The debate on Belgian drug policy 
was mainly initiated by an MP of the French-speaking socialist party (PS) who, in the French-
speaking newspaper Le Soir (17 November 1995), publicly emphasised that he would submit a 
proposal to decriminalise cannabis possession. By means of generating public reaction through a 
series of newspaper articles, the media succeeded in placing an item on the political agenda, 
which in turn increased the likelihood of action on the part of the Federal Parliament and the 
Government. In particular, the Federal Parliament took the initiative to establish a PWG in 1996.  
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In addition, the sustained media focus on scientific studies on the increasing THC concentration, 
increasing prevalence rates, health risks of cannabis use and the ‘precautionary principle’ in-
creased the likelihood of policy-makers being more sympathetic to the view that cannabis is 
harmful. In other words, the media encouraged arguments against a more liberal policy (evolu-
tionary model; Stevens, 2007a). Even though none of these findings (Vuillaume, 2008) (which 
were limited, of poor quality and generated equivocal and conflicting ideas) informed political 
debates in Belgium before 2002, the correlation between early and regular cannabis use and the 
risk of developing schizophrenia, depression or other psychotic disorders featured increasingly 
in numerous parliamentary discussions from 2002-2003 onwards. An example of MPs taking 
notice and becoming sensitised to these issues is the large selection of doctors and psychiatrists 
in the Commission of Public Health (2002-2003). 
 
8. Interest groups 
This dissertation attempted to highlight the relatively unexplored role of interest groups advo-
cating for drug users’ rights as well as groups representing parents or ex-drug users against 
drug use in the science-policy nexus. Several interest groups (Belgian Cannabis Consumers’ Or-
ganisation [Belgische Cannabis Consumenten Bond]; A citizen just like any other [Citoyens comme 
les autres]; Anti-Prohibition League [La Liaison anti-prohibitionniste]; Parents against Drugs 
[Ouders tegen Drugs]) succeeded in heating up and polarising the debate and in putting and 
keeping the drug issue on the parliamentary agenda (agenda setting). In particular, through ex-
tensive media coverage, organising demonstrations and making contacts with MPs, members of 
these interest groups were invited as experts to the hearings in the PWG (1996-1997) and the 
Commission of Public Health (2002-2003). In this context, they have, together with the media, 
played a role in the enlightenment function of scientific knowledge and influenced the arguments 
taken up in the political struggle (especially by progressive political voices). Nevertheless, gen-
erally, their discourse was mostly supported by personal experiences instead of scientific 
knowledge. At the same time, by employing a rather emotional discourse, interest groups some-
times misinterpreted scientific knowledge. Therefore, the associations advocating for drug us-
ers’ rights as well as groups representing parents or ex-drug users against drug use can be con-
sidered rather weak facilitators of knowledge utilisation in the drug policy field (as opposed to 
what is assumed in the literature; Bergin, 2013).  
 
The influence on policy-making remained limited to bringing issues on the parliamentary agen-
da. It appeared to be particularly hard for these groups to contribute to governmental debates. 
The lack of influence is the result of their deficient organisational and communication structure 
and reflects the fact that they only represented a small part of the public opinion. Confronted 
Final Conclusions 
299 
with internal conflicts caused by political and financial squabbles, most interest groups ceased to 
exist when the topic disappeared from the political agenda (e.g. during the intermezzo or after 
the 2003 elections). An important exception was the active involvement of a member of the in-
terest group Anti-Prohibition League [La Liaison anti-prohibitionniste] in the Inter-Cabinet Work-
ing Group developing Belgian drug law (2002-2003). Being an advisor of the Minister of Public 
Health Magda Aelvoet, this may the only effective way for interest groups to have a small voice in 
the debate at the governmental level. 
 
9. Reflections on methodology 
Assessments of knowledge utilisation are rather difficult to make due to the multiplicity of ac-
tors and the dynamics of the policy processes (Ritter and Lancaster, 2013). The methodology 
adopted in this study proved viable in tracking how scientific knowledge was being represented 
and used (various types of knowlegde utilisation), who was using this source, as well as as-
sessing the relationship of scientific knowledge to other forms of available information. The 
combination of two data collection methods (a (critical) discourse analysis of Norman Fair-
clough and elite interviews) seemed necessary to reach a holistic understanding of the phenom-
enon. In line with Ritter and Lancaster (2013), documents were useful in revealing instances of 
instrumental, conceptual and political/symbolic utilisation as well as assessing the particular 
role of the political context and the media. In other words, a (critical) discourse analysis allowed 
us to unpick the unexpected and more subtle, indirect mechanisms by which scientific 
knowledge comes to play a role in policy development. In a similar vein, interviewing elites sup-
plied in-depth information that could rarely be gleaned from examining documents alone 
(Bogner, Littig and Menz, 2009; Tieberghien, 2014b). Scientific knowledge is often not cited 
within public policy documents or is used informally in off-the-record discussions. Interviews 
assisted me detailing the role played practitioners, journalists, members of interest groups and 
scientists as well as exploring the (un)suitability of scientific knowledge. Nevertheless, due to 
selective memory and many other (self-serving) concerns and background assumptions, key 
informants cannot always make sharp distinctions in explaining how they use knowledge (Aber-
bach and Rockman, 2002). The only way to sense the extent of these biases in the data was to 
compare the interviews with the documents.  
 
A case-study design was particularly useful in understanding and describing how scientific 
knowledge contributed to the development of Belgian drug policy between 1996 and 2003. This 
methodological choice was influenced by our (critical) constructionist view and by the existing 
research on the science-policy nexus. As our findings are based on a single case study, caution is 
needed in drawing conclusions or making comparisons. Generalising from one case-study on 
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drug policy to other areas of Belgian policy or to drug policy in other countries is rather prob-
lematic. However, even though it is possible that the extent and the modalities of uptake as doc-
umented here has only occurred in this policy window (Kingdon, 2002) (see also recommenda-
tions for further research), reflections on theoretical frameworks can be useful in analysing simi-
lar cases (analytical generalisation) (Swanborn, 2003; Bloor and Wood, 2006; Gerring, 2007). 
According to Mills, Durepos and Wiebe (2010), “generalizability of the findings from a single case 
study increases immeasurably if similar results have been found with other case studies - whether 
such studies already existed in the literature or were completed after the first case study” (p.22). 
 
10. Recommendations for further research 
Given the fact that this study was the first of its kind in Belgium to involve an analysis of whether 
and how the main political institutions (i.e. Parliament and Government) use scientific 
knowledge in the drug policy-making process and which (f)actors are at play, the findings 
emerging from this study should be considered as a starting point for future research. In particu-
lar, it would also be interesting to investigate how scientific knowledge is used or regarded by 
local policy-makers and how knowledge utilisation may differ across local drug policies in Bel-
gium (e.g. cities like Antwerp, Brussels, Ghent, Liège). For instance, Black (2001) argued that 
scientific knowledge is more influential in national policy than in local drug policy, where policy-
making is marked by a higher extent of negotiation and uncertainty. In a similar vein, it would be 
interesting to examine if scientific knowledge is used differently in other policy areas (e.g. migra-
tion policy) in Belgium. 
 
Second, there is some sense in this study as to the productive nature of (print) journalism and 
the relationships between journalists and many players who are trying to present a particular 
message or narrative in the media. However, further research into the role of media as a linking 
mechanism between science and policy is needed. For instance, the role played by broadcast 
media, the internet and the proliferation of new forms of media in modern society need to be 
addressed. For instance, consistent with the rise of the internet (e.g. Google) and social media 
(e.g. Twitter), policy-makers may have easier access to a wider range of information/expertise 
(Lawrence, et al., 2014). A study by Ritter (2009) has already found that the internet was used in 
about half the cases even though the most frequent sources remained the advice from an expert 
or the consultation of technical reports. 
 
Third, little research has been conducted on the role of interest groups in the science-policy 
nexus. Those advocating for drug users’ rights as well as groups representing parents or ex-drug 
users against drug use are of course not the only interest groups who can affect drug policy-
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making (Bergin, 2013). Even though some scholars recently gave attention to the role of advoca-
cy organisations (Duke and Thom, 2014; O’Gorman, et al., 2014), the question remains how civil 
society associations, NGOs or third sector organisations, alliances, coalitions and networks of 
existing organisations or professional associations of lawyers or law enforcement officers may 
actually influence the science-policy nexus.  
 
Fourth, 55 individuals were interviewed, including Members of Parliament, employees of Mem-
bers of Parliament, members of the Federal (and Regional) Government, employees of members 
of the Federal (and Regional) Government, scientists, journalists, members of interest groups, 
and professionals working with drug users. Interviewees were selected according to their direct 
involvement in the case. By examining relevant documents and snowballing a number of rele-
vant key informants who played a significant role in the debate were identified. While the docu-
ments only revealed the most visible (and most powerful) respondents - for example, Ministers - 
the snowball technique (Farquharson, 2005) identified respondents who worked on a lower 
level (e.g. Ministerial Cabinets/ employees of MPs). While theoretical saturation occurred after 
about 50 interviews, it gradually became clear that the most important actors involved in my 
case had been interviewed. Request for names and contact details of others whom they thought 
were important for me to interview directed me more and more to individuals already included 
in the study. Nevertheless, taking the selection of interviewees into account, a clear limitation 
of this sample (and a recommendation for further research) is the underrepresentation of civil 
servants of the Federal Administration (Federal Public Services (FPS)). As civil servants of the 
FPS do not come and go with the Minister but have a permanent tenure (regardless of the politi-
cal colour of the Minister), their perceptions could also have been very interesting (Stevens, 
2011).  
 
Fifth, this study drew upon several knowledge utilisation models, including some newer theoret-
ical models that were developed for the study of knowledge utilisation in heavily politicised pol-
icy areas (evolutionary model and processual model), to answer the research questions and to 
develop a theoretical base. These newer models, building on Weiss’ three-folded typology, of-
fered significant potential for exploring and explaining the science-policy nexus in the specific 
case of Belgian drug policy-making between 1996 and 2003. The processual model (Monaghan, 
2011) captures the knowledge utilisation processes most fully. Its strength lies in the analysis of 
the selection/power issues in the policy-making processes (adopted from the evolutionary mod-
el) on the one hand, and the recognition that the nature of scientific knowledge may be contest-
ed and that a multiplicity of (f)actors (e.g. politics, media) may play a role in dynamics of the 
policy-making process on the other hand. However, the model is not capable of explaining in 
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enough detail the facilitating role of the media. For instance, armed with my findings about 
whether and how the media may, or may not, have an impact on the contribution of scientific 
knowledge in the drug policy-making process, I advocate an extension of the processual model. 
In this context, I also recommend that the (extended) processual model be put to empirical test 
in other countries and other (heavily politicised) policy areas as well. 
 
Sixth, as a final recommendation for further research, the period between 1996 and 2003 was 
chosen because drugs appeared on the political and media agenda in 1996 (window of oppor-
tunity opened) and increasingly attracted the attention of policy-makers, scientists and media 
until 2003. In the literature, it was argued that the opening of a policy window is often the pri-
mary means for achieving meaningful, evidence-based policy development or change (Kingdon, 
2002; Lenton, 2004; Hyshka, 2009). This means that this case fulfilled the requirement that poli-
cy was linked to scientific knowledge. I am aware that choosing a time period that had the great-
est amount of discussion might bias the results in favour of showing the strongest links between 
science, policy (and media). An interesting question that needs to be addressed in future studies 
is how science and policy interact when there is no policy window. In particular, it would be 
interesting to examine if and how the science-policy nexus unfolded in Belgian drug policy from 
2003 onwards. Policy-makers tended to agree on the need to keep the drug issue marginal. Nev-
ertheless, some interesting evolutions followed.  
First, there was a large increase of policy-funded studies managed by the Research Pro-
gramme. For example, from 2002 until now (2015), seventy drug research projects were com-
missioned and financed by the Federal Science Policy Office through the Research Programme in 
support of the Federal Drug Policy Note. The question is if the Research Programme which was 
set out to support the uptake of scientific knowledge in the policy-making process, achieved its 
purpose. Commissioned research seems to be more likely to influence policy than that which is 
external to policy-making (Nutley, Walter and Davies, 2007).  
Second, the General Drugs Policy Cell, operational since 2010, prepares the decisions of 
the Inter-Ministerial Conference and guards the integrated character of the policy measures (De 
Ruyver, et al., 2004; De Ruyver, et al., 2007; Inter-Ministeriële Conferentie, 2010). It would be 
interesting to investigate the role of the General Drugs Policy Cell and whether scientific 
knowledge is influential in this context.  
Third, the activity related to the Belgian drug law is worth examining. On 28 November 
2003, five non-profit organisations demanded the Court of Arbitration to strike article 16 of the 
Law of 3 May 2003 (i.e. Article 16 “The possession of an amount of cannabis for personal use by an 
adult, without the presence of public nuisance or problematic use, will only lead to a registration by 
the police”) because the terms “public nuisance” and “problematic drug use” were too vague and 
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in violation of the principle of legality. The Constitutional Court agreed and article 16138 of the 
2003 drug law (i.e. the article that caused most political commotion) was struck out (Arbitrage-
hof 20 oktober 2004, nr. 158/2004, rolnrs. 2727 en 2850, B.S. 28 oktober 2004). This move had 
implications for the Ministerial Circular Letter of 16 May 2003 which accompanied the new drug 
law. In particular, there was a need for a new directive to fill in the gap opened by the deleted 
article139. Eventually, a new (transitional) directive was issued by the new Minister of Justice 
Laurette Onkelinx and the College of Prosecutors-General in February 2005.140 Although both 
the Minister of Justice Laurette Onkelinx and the Minister of Public Health Rudy Demotte admit-
ted in 2004 that a new law had to be made in order to redefine in a clear way the suppressed 
notions of article 16, this adaptation is not yet realised in 2015141. Except for a restricted number 
of media articles and some parliamentary questions, it would be interesting to examine why 
these decisions did not provoke the opening of a policy window.  
Fourth, given the importance of the international framework in the science-policy nexus, 
a similar and intriguing question is whether the current (inter)national debates regarding the 
reforms in national and global drug control policies (Global Commission on Drug Policy, 2011; 
Decorte, De Grauwe and Tytgat, 2014; Edwards and Galla, 2014; Fijnaut and De Ruyver, 2014) 
will move drug issues onto the Belgian political agenda again (and create a policy window). 
 
11. Concluding comment 
I wish to end this dissertation with a short reflexive note. Ongoing debate about evidence-based 
policies and the public roles of scientists in policy-making (public criminology) signifies the im-
portance of advancing theory and of improving the capacity to act efficiently in the science-
                                                          
138  In discussing the striking out of article 16, some authors speak of the annulment of article 11. Both are right. This 
conceptual confusion is caused by the fact that article 16 of the Law of 3 May 2003 states that an article 11 must 
be added to the original Drug Act of 1921. So, both articles refer to the same legislative principles. 
139  Legally, the striking out of this article implied that the old law had become active again (i.e. a formal report has to 
be written for every offence instead of an anonymous police registration). 
140  The new Ministerial Circular Letter called for prosecution of an adult in possession of cannabis for personal use (3 
grams or 1 plant) only in cases involving disturbance of ‘public order’ (defined as possession of cannabis in or 
near educational or similar institutions, possession of cannabis in a prison or institution of child protection, pos-
session of cannabis in a public place or building) or other aggravating circumstances such as the involvement of 
minors, being a member or leader of an association or causing severe illness or death. The 2005 Ministerial Circu-
lar Letter deleted the concept ‘problematic use’ and replaced ‘public nuisance’ with ‘public order’ to provide more 
clarity. On the condition that there are no aggravating circumstances (like use in the presence of minors, disturb-
ance of public order), the police had to make a simplified process-verbal (as was included in the 1998 Ministerial 
Circular Letter) and an overview was sent to the Public Prosecutors’ Office every month. Nevertheless, the new di-
rective still did not give any clear definition of some of the concepts. 
141  As an exception, in 2006, a new Law (20 July 2006) further modified the basic Belgian law (of 24 February 1921). 
It included two amendments to the Narcotic Drug Act (art. 9 bis and art. 9 ter). This law formally regulated the au-
thority of the mayor in closing drug joints as well as the authority of the police to arrest a person for six hours be-
ing under the influence of substances and exposing him/herself and others to dangers.  
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policy nexus. Since most research fails to go beyond academic publications, many challenges as 
well as opportunities lie ahead for scientists who want to influence the policy-making process. 
Likewise, the rich and detailed discussion of this case may provide policy-makers with a frame-
work for reasoned reflection on the evidence-based movement, on the ways they identify scien-
tists whom they introduce to their trustworthy networks and on the (ambiguous) role of the 
media in parliamentary and governmental debates. But will this reasoned reflection actually 
occur? Will this study really increase the awareness of policy-makers of how the science-policy 
nexus works, and improve the uptake of scientific knowledge in the policy-making process? Un-
less I became a 'trusted voice' and achieved a public role as observer-turned player or policy advi-
sor through a careful and long-term investment, it is unlikely that policy-makers are going to 
adopt my findings. Another lengthy scientific report of 300 pages is very far away from the short 
and concise documents policy-makers want. Thus, what’s next for me? Sending a summary to a 
few policy-makers? Writing an opinion letter to the newspaper? 
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APPENDIX I  SCHEDULE DISCOURSE ANALYSIS 
 
 
Source 
Title 
Type of publication 
Publication date (refers to context) 
Author(s) (refers to actors in the policy-making process) 
Authority author(s) (Who wrote or said it? Who has the power to make decisions and 
how are they using their power?) 
 
Context 
 
Characteristics document: social practices - genre 
The text is part of which social event(s) or social practice(s)? 
Is the text part of a chain of texts or genres? 
 
nature of the document 
time (in policy process) 
goal(s) 
target population 
commissioner 
motivation for drawing the document 
publication form 
central theme/emphasis 
 
Text 
 
Drugs: discourse – difference – assumptions 
Which (different) discourses are present in text? 
What are the characteristics of the discourses pronounced in text? (e.g. the terminology and 
definition(s) of drug use or drug policy options used and the use of assumptions) 
 
(textual) elements that characterize the discourse 
terminology and definition of drug use/cannabis (differences) 
 decriminalisation – depenalisation – legislation - …. 
 ‘soft’ vs. ‘hard’ drugs 
assumptions 
existential assumptions (i.e. assumptions about what exists, characterised 
by using classificatory categories) 
prepositional assumptions (i.e. assumptions about what is or may be) 
value assumptions (i.e. assumptions about what is good and/or bad) 
ideological assumptions 
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Knowledge utilisation: intertextuality – evaluation – modality  
How are the actors referring to or discussing scientific knowledge and what are their motivations? 
Which types of knowledge utilisation are found? 
What is the relationship of scientific knowledge to other forms of information available? 
How do texts assess scientific knowledge in terms of good/bad or (un)desirable, affective attributes? 
How do texts assess scientific knowledge in terms of truth and necessity?actors commit themselves to 
statements about good/bad or (un)desirable, affective attributes of scientific knowledge? (e.g. is 
more power and authority attributed to scientists than to other actors? which scientific knowledge is 
included and which are excluded) 
 
Utilisation of scientific knowledge 
Utilisation: whether scientific research is cited explicitly by mentioning 
specific studies or implicitly where studies are not identified (e.g. when 
the terms "research," "studies" or "evidence" are used without identifying 
the source) 
    Reference without content 
    Reference with content 
Motivation for reference/utilisation: whether the research is cited in 
support of a statement, or where no clear position is taken 
Modes of utilisation 
 Instrumental 
 Conceptual 
 Political/symbolic 
  Powerful selection mechanisms 
  Misuse 
  Precautionary principle 
Other types of knowledge (not scientific research/scientist) 
Form of knowledge 
Utilisation: whether other forms of knowledge are cited explicitly or 
implicitly  
    Reference without content 
    Reference with content 
Motivation for reference/utilisation: whether the knowledge is cited in 
support of a statement, or where no clear position is taken (discourse?) 
 
Representation of scientific knowledge 
   Characteristics scientific knowledge 
    Qualitative – quantitative data 
    Theme/topic 
Paradigm/Perception about drugs (terminology) 
    Quality judgments (timing – usefulness) 
 
 Actors:  style 
Which actors are represented?  
How are actors represented in the text and from which perspective or viewpoint? (e.g. do they 
perceive themselves as experts or as having authority? are they part of a network? which (public) 
position do they take?) 
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Central actors 
 Policy-makers – scientists – media – interest groups 
whether scientists are cited (explicitly by name or implicitly with no 
names mentioned, e.g. "researchers believe") 
whether policy-makers are cited (explicitly by name or implicitly with no 
names) 
whether media or interest groups are cited (explicitly by name or 
implicitly with no names) 
   Ideology – values – interests 
whether the actors are cited in support of or against a 
statement/discourse, or where no clear position is taken 
Scientist: public roles 
   Scientific experts 
Policy advisors 
Observer-turned players 
Lonely prophets 
Social movement theorists/activists 
  Networks 
Reference to other actors 
Representation of networks 
 
 Context: representation of social events 
Which contextual elements play a role? 
 
Context 
Political context (window of opportunity) 
Economic context - budget 
   Social/cultural context (normalisation, harmful characteristics cannabis) 
International drug policy context (references to and evaluations of policy 
options in other countries) 
 
 
APPENDIX II  TOPIC LIST ‘ELITE’ INTERVIEWS1 
 
 
INTERVIEW SCHEDULE SCIENTISTS – PRACTITIONERS 
 
Introduction: actor’s involvement in the case 
- How were you involved in the development of the Belgian drug policy between 1996 and 
2003? 
 - What was your role/title/job description? 
- In which phase(s) were you involved? (PWG-Intermezzo-FDN-Drug law reform) 
- How did you come to be involved, in effect how did you become to be involved in giving 
(scientific) knowledge to the policy-making process? 
- Why were you (not) reselected in the following discussion? 
- What level of involvement do you think you have had in the formation of the Belgian 
drug policy between 1996 and 2003? 
- Do you see yourself as a central actor/figure in the process or more on the edge of the 
process? 
- Based on your experience who was the most powerful in shaping Belgian drug policy 
between 1996-2003? 
- Can you explain in further detail your (personal/professional) relationship with who 
you see as the key players in the case? 
 
Content of the debate 
- What were the topics most discussed in the Parliament/Government? Were there evolutions 
regarding these topics? 
- What were the arguments most commonly used in the Parliament/Government? Were there 
evolutions regarding these topics? 
- Do you perceive there to be a visible policy network or community that has arisen over the 
issue of Belgian drug policy? 
- How decisive do you perceive the argument of the international conventions?  
- Based on your experiences and knowledge, did you perceive a difference between Flanders and 
the French-speaking part of Belgium? 
 
Factors playing a role 
1/ Scientific knowledge 
Based on you experience and knowledge, what has been the role of scientific knowledge in this 
particular case? Can you give an example? 
 - In which phase(s) has scientific knowledge played a role? 
- Which type of scientific knowledge was involved? Is there a hierarchy? 
- Was some kind of scientific knowledge excluded consciously? If so why 
- How was scientific knowledge used in the debate? By who (not)? 
- Has scientific knowledge been misused in the debate? By who (not)? 
 
                                                          
1  Our topic list was inspired by the topic list used in the study of Monaghan (2008) and Duke (2002) completed with 
the topics raised during the analysis of the policy and media documents. 
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- You brought some expertise (of your own or of others) into the debate through your 
participation in the formal advisory structures (PWG – drug law reform). 
- Which (scientific) knowledge did you bring into the debate? 
- Do you see your work and the way it was handled as having any influence? If so why, if 
not why not? 
 
- We found some references to scientific knowledge in the debates outside formal advisory 
structures. 
 - Have you brought some scientific knowledge in these particular debates? 
- Which (scientific) knowledge did you bring into these particular debates? 
- Do you see this work and the way it was handled as having any influence? If so why, if 
not why not? 
 
Specific question: 
- Based on your experience or knowledge, what do you know about the incident with 
expert Claude Stoclet in the Parliamentary Working Group on drugs? 
 
2/ Ideological, political motives 
- Based on you experience and knowledge, what has been the role of ideological, political 
motives in this particular case? Can you give an example? 
 - Was there a tension between science and ideology in the case? 
- Did the elections of 1999 or 2003 play a role? 
 - Did the change in governmental coalition in 1999 play a role? 
 
- Has your role or contribution been inspired or influenced by ideological, political motives? 
Why(not)? Can you give an example? 
 
3/ Media 
- Based on you experience and knowledge, what has been the role of the media in this particular 
case? Can you give an example? 
- In which phase(s) has the media played a decisive role? 
- How was the media used in this debate? By who? 
- What do you know about the media leaks that were organised during the debate? 
 
- Has your role or contribution been inspired or influenced by the media? Why(not)? Can you 
give an example? 
- Has the media covered your (scientific) knowledge? If so how? If not, why not? 
- Are you aware that scientific knowledge is sometimes misrepresented in the media? Do you 
anticipate on this? 
 
Specific question: 
- Why was the media attention for the evaluation study of De Ruyver and Casselman 
(2000) rather limited even though the study seems to have played an important role 
in the case?  
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4/ Other factors 
- Based on you experience and knowledge, what has been the role of interest groups in this 
particular case? Can you give an example? 
 - Which interest groups played a role? 
 - In which phase(s) and how do they have played a role?  
- Interest groups were selected to participate in formal advisory structures (PWG – drug 
law reform). Was this participation influential in the formation of the Belgian drug policy 
between 1996 and 2003? 
- Has your role or contribution been inspired or influenced by the interest groups? Why(not)? 
Can you give an example? 
 
- Based on you experience and knowledge, what has been the role of the public opinion in this 
particular case? Can you give an example? 
- Has your role or contribution been inspired or influenced by the public opinion? Why(not)? 
Can you give an example? 
 
- Are there other (f)actors that have been playing an important role in these debates? 
- Has your role or contribution been inspired or influenced by these other (f)actors? Why(not)? 
Can you give an example? 
 
 
Closing questions 
- Based on your own experience how do you see the relationship between scientific knowledge 
and policy where regard to the particular case? Is the development of the Belgian drug policy 
between 1996 and 2003 ‘evidence-based’? 
- Who else is worth interviewing regarding this issue? 
- Have you any suggestions about additional relevant documentation? 
 
Appendix II 
350 
INTERVIEW SCHEDULE POLICY-MAKERS (GOVERNMENT – PARLIAMENT) 
 
Introduction: actor’s involvement in the case 
- How were you involved in the development of the Belgian drug policy between 1996 and 
2003? 
 - What was your role/title/job description? 
- In which phase(s) were you involved? (PWG-Intermezzo-FDN-Drug law reform) 
- What level of involvement do you think you have had in the formation of the Belgian 
drug policy between 1996 and 2003? 
- Do you see yourself as a central actor/figure in the process or more on the edge of the 
process? 
- Based on your experience who was the most powerful in shaping Belgian drug policy 
between 1996-2003? 
- Can you explain in further detail your (personal/professional) relationship with who 
you see as the key players in the case? 
 
Content of the debate 
- What were the topics most discussed in the Parliament/Government? Were there evolutions 
regarding these topics? 
- What were the arguments most commonly used in the Parliament/Government? Were there 
evolutions regarding these topics? 
- Do you perceive there to be a visible policy network or community that has arisen over the 
issue of Belgian drug policy? 
- How decisive do you perceive the argument of the international conventions?  
- Based on your experiences and knowledge, did you perceive a difference between Flanders and 
the French-speaking part of Belgium? 
 
Specific questions about ‘hidden processes’: 
- What do you know about the debates within PWG or the Inter-cabinet working groups (FDN-
Drug law reform)? 
- Which actors played a decisive role in these ‘hidden processes’? 
- Which arguments were most commonly used? 
- Which (f)actors have been playing an important role in these debates? 
- What do you know about the inclusion of a reference to the Commission Le Dain in the 
attachment of the new drug law? 
- What do you know about the petition for a plea for a decriminalization of the possession and 
use of drugs as well as for a legalization of the controlled distribution of drugs that was 
submitted by Mr. M. Hancisse (coordination radical anti-prohibitionist) in the PWG? 
 
Factors playing a role 
1/ Scientific knowledge 
Based on you experience and knowledge, what has been the role of scientific knowledge in this 
particular case? Can you give an example? 
 - In which phase(s) has scientific knowledge played a role? 
- Which type of scientific knowledge was involved? Is there a hierarchy? 
- Was some kind of scientific knowledge excluded consciously? If so why 
- How was scientific knowledge used in the debate? By who (not)? 
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- Has scientific knowledge been misused in the debate? By who (not)? 
 
- We found some references to scientific knowledge in policy documents. 
- Have you brought some scientific knowledge in these particular debates? 
- Which (scientific) knowledge did you bring into these particular debates? 
- Do you see this input and the way it was handled as having any influence? If so why, if 
not why not? 
- How are policy-makers informed about scientific knowledge? How do they have access 
to this information? 
 
Specific question: 
- Based on your experience or knowledge, what do you know about the incident with 
expert Claude Stoclet in the Parliamentary Working Group on drugs? 
 
2/ Ideological, political motives 
- Based on you experience and knowledge, what has been the role of ideological, political 
motives in this particular case? Can you give an example? 
 - Was there a tension between science and ideology in the case? 
- Did the elections of 1999 or 2003 play a role? 
 - Did the change in governmental coalition in 1999 play a role? 
 
- Has your role or contribution been inspired or influenced by ideological, political motives? 
Why(not)? Can you give an example? 
 
3/ Media 
- Based on you experience and knowledge, what has been the role of the media in this particular 
case? Can you give an example? 
- In which phase(s) has the media played a decisive role? 
- How was the media used in this debate? By who? 
- What do you know about the media leaks that were organised during the debate? 
 
- Has your role or contribution been inspired or influenced by the media? Why(not)? Can you 
give an example? 
- Has the media covered your political interventions? If so how? If not, why not? 
- Are you aware that scientific knowledge is sometimes misrepresented in the media? Do you 
anticipate on this? 
 
Specific question: 
- Why was the media attention for the evaluation study of De Ruyver and Casselman 
(2000) rather limited even though the study seems to have played an important role 
in the case?  
 
4/ Other factors 
- Based on you experience and knowledge, what has been the role of interest groups in this 
particular case? Can you give an example? 
 - Which interest groups played a role? 
 - In which phase(s) and how do they have played a role?  
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- Interest groups were selected to participate in formal advisory structures (PWG – drug 
law reform). Was this participation influential in the formation of the Belgian drug policy 
between 1996 and 2003? 
- Has your role or contribution been inspired or influenced by the interest groups? Why(not)? 
Can you give an example? 
 
- Based on you experience and knowledge, what has been the role of the public opinion in this 
particular case? Can you give an example? 
- Has your role or contribution been inspired or influenced by the public opinion? Why(not)? 
Can you give an example? 
 
- Are there other (f)actors that have been playing an important role in these debates? 
- Has your role or contribution been inspired or influenced by these other (f)actors? Why(not)? 
Can you give an example? 
 
Closing questions 
- Based on your own experience how do you see the relationship between scientific knowledge 
and policy where regard to the particular case? Is the development of the Belgian drug policy 
between 1996 and 2003 ‘evidence-based’? 
- Who else is worth interviewing regarding this issue? 
- Have you any suggestions about additional relevant documentation? 
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INTERVIEW SCHEDULE MEDIA 
 
Introduction: actor’s involvement in the case 
- How were you involved in the development of the Belgian drug policy between 1996 and 
2003? 
 - What was your role/title/job description? 
- In which phase(s) were you involved? (PWG-Intermezzo-FDN-Drug law reform) 
- What level of involvement do you think you have had in the formation of the Belgian 
drug policy between 1996 and 2003? 
- Do you see yourself as a central actor/figure in the process or more on the edge of the 
process? 
- Based on your experience who was the most powerful in shaping Belgian drug policy 
between 1996-2003? 
- Can you explain in further detail your (personal/professional) relationship with who 
you see as the key players in the case? 
 
Content of the debate 
- What were the topics most discussed in the Parliament/Government? Were there evolutions 
regarding these topics? 
- What were the arguments most commonly used in the Parliament/Government? Were there 
evolutions regarding these topics? 
- Do you perceive there to be a visible policy network or community that has arisen over the 
issue of Belgian drug policy? 
- How decisive do you perceive the argument of the international conventions?  
- Based on your experiences and knowledge, did you perceive a difference between Flanders and 
the French-speaking part of Belgium? 
 
Factors playing a role 
1/ Scientific knowledge 
Based on you experience and knowledge, what has been the role of scientific knowledge in this 
particular case? Can you give an example? 
 - In which phase(s) has scientific knowledge played a role? 
- Which type of scientific knowledge was involved? Is there a hierarchy? 
- Was some kind of scientific knowledge excluded consciously? If so why 
- How was scientific knowledge used in the debate? By who (not)? 
- Has scientific knowledge been misused in the debate? By who (not)? 
 
- We found some references to scientific knowledge in policy documents. 
- Have you brought some scientific knowledge in these particular debates through media 
coverage? 
- Which (scientific) knowledge did you bring into these particular debates? 
- Do you see this input and the way it was handled as having any influence? If so why, if 
not why not? 
- How are policy-makers informed about scientific knowledge? How do they have access 
to this information? 
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Specific question: 
- Based on your experience or knowledge, what do you know about the incident with 
expert Claude Stoclet in the Parliamentary Working Group on drugs? 
 
2/ Ideological, political motives 
- Based on you experience and knowledge, what has been the role of ideological, political 
motives in this particular case? Can you give an example? 
 - Was there a tension between science and ideology in the case? 
- Did the elections of 1999 or 2003 play a role? 
 - Did the change in governmental coalition in 1999 play a role? 
 
- Has your role or contribution been inspired or influenced by ideological, political motives? 
Why(not)? Can you give an example? 
 
3/ Media 
- Based on you experience and knowledge, what has been the role of the media in this particular 
case? Can you give an example? 
- In which phase(s) has the media played a decisive role? 
- How was the media used in this debate? By who? 
- What do you know about the media leaks that were organised during the debate? 
- Were there formal/informal connections between journalists in both parts of the 
country? 
 
- We found some references to scientific knowledge in media documents. 
- Have you brought some scientific knowledge into media coverage? 
- Which (scientific) knowledge did you cover? 
- Are you aware that scientific knowledge is sometimes misrepresented in the media?  
- Do you see this input and the way it was handled as having any influence on the policy-
making process? If so why, if not why not? 
- How are policy-makers informed about scientific knowledge? How do they have access 
to this information? 
 
Specific question: 
- Why was the media attention for the evaluation study of De Ruyver and Casselman 
(2000) rather limited even though the study seems to have played an important role 
in the case?  
 
4/ Other factors 
- Based on you experience and knowledge, what has been the role of interest groups in this 
particular case? Can you give an example? 
 - Which interest groups played a role? 
 - In which phase(s) and how do they have played a role?  
 - Do interest groups play a role in the policy-making process through the media? 
- Interest groups were selected to participate in formal advisory structures (PWG – drug 
law reform). Was this participation influential in the formation of the Belgian drug policy 
between 1996 and 2003? 
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- Has your role or contribution been inspired or influenced by the interest groups? Why(not)? 
Can you give an example? 
 
- Based on you experience and knowledge, what has been the role of the public opinion in this 
particular case? Can you give an example? 
- Has your role or contribution been inspired or influenced by the public opinion? Why(not)? 
Can you give an example? 
 
- Are there other (f)actors that have been playing an important role in these debates? 
- Has your role or contribution been inspired or influenced by these other (f)actors? Why(not)? 
Can you give an example? 
 
Closing questions 
- Based on your own experience how do you see the relationship between scientific knowledge 
and policy where regard to the particular case? Is the development of the Belgian drug policy 
between 1996 and 2003 ‘evidence-based’? 
- Who else is worth interviewing regarding this issue? 
- Have you any suggestions about additional relevant documentation? 
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INTERVIEW SCHEDULE INTEREST GROUPS 
 
Introduction: actor’s involvement in the case 
- How were you involved in the development of the Belgian drug policy between 1996 and 
2003? 
 - What was your role/title/job description? 
- In which phase(s) were you involved? (PWG-Intermezzo-FDN-Drug law reform) 
- What level of involvement do you think you have had in the formation of the Belgian 
drug policy between 1996 and 2003? 
- Do you see yourself as a central actor/figure in the process or more on the edge of the 
process? 
- Based on your experience who was the most powerful in shaping Belgian drug policy 
between 1996-2003? 
- Can you explain in further detail your (personal/professional) relationship with who 
you see as the key players in the case? 
 
Content of the debate 
- What were the topics most discussed in the Parliament/Government? Were there evolutions 
regarding these topics? 
- What were the arguments most commonly used in the Parliament/Government? Were there 
evolutions regarding these topics? 
- Do you perceive there to be a visible policy network or community that has arisen over the 
issue of Belgian drug policy? 
- How decisive do you perceive the argument of the international conventions?  
- Based on your experiences and knowledge, did you perceive a difference between Flanders and 
the French-speaking part of Belgium? 
 
Factors playing a role 
1/ Scientific knowledge 
Based on you experience and knowledge, what has been the role of scientific knowledge in this 
particular case? Can you give an example? 
 - In which phase(s) has scientific knowledge played a role? 
- Which type of scientific knowledge was involved? Is there a hierarchy? 
- Was some kind of scientific knowledge excluded consciously? If so why 
- How was scientific knowledge used in the debate? By who (not)? 
- Has scientific knowledge been misused in the debate? By who (not)? 
 
- You brought some expertise (of your own or of others) into the debate through your 
participation in the formal advisory structures (PWG – drug law reform). 
- Which (scientific) knowledge did you bring into the debate? 
- Do you see your work and the way it was handled as having any influence? If so why, if 
not why not? 
 
- We found some references to scientific knowledge in the debates outside formal advisory 
structures. 
 - Have you brought some scientific knowledge in these particular debates? 
- Which (scientific) knowledge did you bring into these particular debates? 
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- Do you see this work and the way it was handled as having any influence? If so why, if 
not why not? 
 
Specific question: 
- Based on your experience or knowledge, what do you know about the incident with 
expert Claude Stoclet in the Parliamentary Working Group on drugs? 
 
2/ Ideological, political motives 
- Based on you experience and knowledge, what has been the role of ideological, political 
motives in this particular case? Can you give an example? 
 - Was there a tension between science and ideology in the case? 
- Did the elections of 1999 or 2003 play a role? 
 - Did the change in governmental coalition in 1999 play a role? 
 
- Has your role or contribution been inspired or influenced by ideological, political motives? 
Why(not)? Can you give an example? 
 
3/ Media 
- Based on you experience and knowledge, what has been the role of the media in this particular 
case? Can you give an example? 
- In which phase(s) has the media played a decisive role? 
- How was the media used in this debate? By who? 
- What do you know about the media leaks that were organised during the debate? 
 
- Has your role or contribution been inspired or influenced by the media? Why(not)? Can you 
give an example? 
- Has the media covered your interventions? If so how? If not, why not? 
 
4/ Interest groups 
- Based on you experience and knowledge, what has been the role of interest groups in this 
particular case? Can you give an example? 
 - Which interest groups were involved in which phase(s) of the debate? 
- Were there formal/informal connections between interest groups in both parts of the 
country? 
- Do interest groups play a role through the media? 
- Interest groups were selected to participate in formal advisory structures (PWG – drug 
law reform). Was this participation influential in the formation of the Belgian drug policy 
between 1996 and 2003? 
- Do you see the activities of interest groups outside the formal advisory structures and 
the way it was handled as having any influence? If so why, if not why not? 
- Did you have any formal/informal contacts with policy-makers, scientists, practitioners or 
journalists? 
 
5/ Other factors 
- Based on you experience and knowledge, what has been the role of the public opinion in this 
particular case? Can you give an example? 
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- Has your role or contribution been inspired or influenced by the public opinion? Why(not)? 
Can you give an example? 
 
- Are there other (f)actors that have been playing an important role in these debates? 
- Has your role or contribution been inspired or influenced by these other (f)actors? Why(not)? 
Can you give an example? 
 
Closing questions 
- Based on your own experience how do you see the relationship between scientific knowledge 
and policy where regard to the particular case? Is the development of the Belgian drug policy 
between 1996 and 2003 ‘evidence-based’? 
- Who else is worth interviewing regarding this issue? 
- Have you any suggestions about additional relevant documentation? 
 
 
